<?xml version="1.0" encoding="UTF-8"?>
<experiments api-revision="091015" api-version="2" revision="091015" total="49" total-assays="29322" total-samples="29414" version="1.2">
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism part
   </category>
   <value>
    placental tissue
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    sample type
   </category>
   <value>
    pooled-sample reference
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    subject status
   </category>
   <value>
    controls who delivered at term (&gt;36 weeks)
   </value>
   <value>
    controls who delivered preterm (&lt;34 weeks)
   </value>
   <value>
    patients with early-onset (&lt;34 weeks) preeclampsia (EOPE)
   </value>
   <value>
    patients with late-onset (&gt;36 weeks) preeclampsia (LOPE)
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    subject status
   </name>
   <value>
    controls who delivered at term (&gt;36 weeks)
   </value>
   <value>
    controls who delivered preterm (&lt;34 weeks)
   </value>
   <value>
    patients with early-onset (&lt;34 weeks) preeclampsia (EOPE)
   </value>
   <value>
    patients with late-onset (&gt;36 weeks) preeclampsia (LOPE)
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    1
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    5
   </overallscore>
  </miamescores>
  <id>
   531095
  </id>
  <accession>
   E-GEOD-74341
  </accession>
  <secondaryaccession>
   GSE74341
  </secondaryaccession>
  <name>
   Gene expression profiling reveal different molecular pattern in G-protein coupled receptor protein signaling pathway between early- and late-onset preeclampsia
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2015-10-27
  </releasedate>
  <lastupdatedate>
   2015-11-24
  </lastupdatedate>
  <samples>
   50
  </samples>
  <assays>
   25
  </assays>
  <arraydesign>
   <id>
    24553
   </id>
   <accession>
    A-GEOD-16699
   </accession>
   <name>
    Agilent-039494 SurePrint G3 Human GE v2 8x60K Microarray 039381
   </name>
   <count>
    25
   </count>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    25
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    25
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    25
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    25
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    25
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    25
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Weiping Zhou
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Longding Chen
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Yuheng Zhou
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Liang Zhang
   </contact>
   <role>
    submitter
   </role>
   <email>
    geo@ncbi.nlm.nih.gov
   </email>
  </provider>
  <provider>
   <contact>
    Jian Ma
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Hua Deng
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Huikun Xu
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Jianmin Niu
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Dongmei Duan
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Mengmeng Liang
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    Background: Early-onset preeclampsia (EOPE) and late-onset preeclampsia (LOPE) has been regarded as two different phenotypes with heterogeneous manifestation. The underlying mechanisms remain elusive. Aim to gain insight into the pathogenesis of the two traits, we analyzed the placental gene expression profiles in preeclampsia placentas.  Methods: Whole genome-wide microarray was used to describe the gene expression profiles in the placenta tissues from patients with early-(n=7; &lt;34 weeks), late-onset(n=8; &gt;36 weeks) PE and their controls who delivered preterm (n=5;&lt;34 weeks) or at term(n=5; &gt;36 weeks) Genes were selected as differentially expressed upon a fold-change≥2 and q-value&lt;0.05. qRT-PCR was undertaken to verify the results. Western blot was further performed to verify secreted genes at the protein level.  Results: A total of 627 genes were differentially expressed in early-compared with late-onset PE. Of these, 177 genes were up-regulated and 450 genes down-regulated in early-onset PE. Go analysis showed significant alteration in several biological processes, in addition to the processes which have been found before, such as immune and inflammatory response, cell adhension, female pregnancy and blood vessel development. We also found alteration in G-protein coupled receptor protein signaling pathway, G protein-coupled receptor 124 (GPR124) (P=0.0064) and MAS-related GPR, member F (MRGPRF)(P=0.0155 ) were both down-regulated obviously in early-onset PE.  Conclusion: The different gene expression profiles suggested early- and late-onset PE are separate disease entities. Moreover, G-protein coupled receptor protein signaling pathway may contribute to the mechanism underlying early- and late-onset preeclampsia. Whole genome-wide microarray was used to describe the gene expression profiles in the placenta tissues from patients with early-(n=7; &lt;34 weeks), late-onset (n=8; &gt;36 weeks) PE and their controls who delivered preterm(n=5;&lt;34 weeks) or at term(n=5; &gt;36 weeks). Pooled controls who delivered at term were labled with cy5.
   </text>
  </description>
  <protocol>
   <id>
    1169153
   </id>
   <accession>
    P-GSE74341-4
   </accession>
  </protocol>
  <protocol>
   <id>
    1169151
   </id>
   <accession>
    P-GSE74341-6
   </accession>
  </protocol>
  <protocol>
   <id>
    1169152
   </id>
   <accession>
    P-GSE74341-5
   </accession>
  </protocol>
  <protocol>
   <id>
    1169154
   </id>
   <accession>
    P-GSE74341-3
   </accession>
  </protocol>
  <protocol>
   <id>
    1169155
   </id>
   <accession>
    P-GSE74341-2
   </accession>
  </protocol>
  <protocol>
   <id>
    1169150
   </id>
   <accession>
    P-GSE74341-1
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-GEOD-74341.raw.1.zip">
   </raw>
   <fgem available="true" name="E-GEOD-74341.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-74341.idf.txt">
   </idf>
   <sdrf name="E-GEOD-74341.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    diagnosis
   </category>
   <value>
    normotensive
   </value>
   <value>
    preeclamptic
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    gestational age
   </category>
   <value>
    22
   </value>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    30
   </value>
   <value>
    32
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    35
   </value>
   <value>
    36
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
   <value>
    39
   </value>
   <value>
    40
   </value>
   <value>
    41
   </value>
   <value>
    African American
   </value>
   <value>
    Asian
   </value>
   <value>
    Caucasian
   </value>
   <value>
    Hispanic
   </value>
   <value>
    Other
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    maternal age
   </category>
   <value>
    19
   </value>
   <value>
    20
   </value>
   <value>
    22
   </value>
   <value>
    24
   </value>
   <value>
    25
   </value>
   <value>
    26
   </value>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    30
   </value>
   <value>
    31
   </value>
   <value>
    32
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    35
   </value>
   <value>
    36
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism part
   </category>
   <value>
    placenta
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    race
   </category>
   <value>
    22
   </value>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    30
   </value>
   <value>
    32
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    35
   </value>
   <value>
    36
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
   <value>
    39
   </value>
   <value>
    40
   </value>
   <value>
    41
   </value>
   <value>
    African American
   </value>
   <value>
    Asian
   </value>
   <value>
    Caucasian
   </value>
   <value>
    Hispanic
   </value>
   <value>
    Other
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    diagnosis
   </name>
   <value>
    normotensive
   </value>
   <value>
    preeclamptic
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    gestational age
   </name>
   <value>
    22
   </value>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    30
   </value>
   <value>
    32
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    35
   </value>
   <value>
    36
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
   <value>
    39
   </value>
   <value>
    40
   </value>
   <value>
    41
   </value>
   <value>
    African American
   </value>
   <value>
    Asian
   </value>
   <value>
    Caucasian
   </value>
   <value>
    Hispanic
   </value>
   <value>
    Other
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    maternal age
   </name>
   <value>
    19
   </value>
   <value>
    20
   </value>
   <value>
    22
   </value>
   <value>
    24
   </value>
   <value>
    25
   </value>
   <value>
    26
   </value>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    30
   </value>
   <value>
    31
   </value>
   <value>
    32
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    35
   </value>
   <value>
    36
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    race
   </name>
   <value>
    22
   </value>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    30
   </value>
   <value>
    32
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    35
   </value>
   <value>
    36
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
   <value>
    39
   </value>
   <value>
    40
   </value>
   <value>
    41
   </value>
   <value>
    African American
   </value>
   <value>
    Asian
   </value>
   <value>
    Caucasian
   </value>
   <value>
    Hispanic
   </value>
   <value>
    Other
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    0
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    3
   </overallscore>
  </miamescores>
  <id>
   529822
  </id>
  <accession>
   E-GEOD-73377
  </accession>
  <secondaryaccession>
   GSE73377
  </secondaryaccession>
  <name>
   Epigenetics and Preeclampsia: Defining Functional Epimutations in the Preeclamptic Placenta Related to the TGF-β Pathway
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <experimenttype>
   methylation profiling by array
  </experimenttype>
  <releasedate>
   2015-09-24
  </releasedate>
  <lastupdatedate>
   2015-09-25
  </lastupdatedate>
  <samples>
   72
  </samples>
  <assays>
   72
  </assays>
  <arraydesign>
   <id>
    19396
   </id>
   <accession>
    A-GEOD-13534
   </accession>
   <name>
    Illumina HumanMethylation450 BeadChip (HumanMethylation450_15017482_v.1.1)
   </name>
   <count>
    36
   </count>
  </arraydesign>
  <arraydesign>
   <id>
    24568
   </id>
   <accession>
    A-GEOD-16686
   </accession>
   <name>
    [HuGene-2_0-st] Affymetrix Human Gene 2.0 ST Array [transcript (gene) version]
   </name>
   <count>
    36
   </count>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    36
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    36
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    72
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    72
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    72
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    72
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Rebecca Catherine Fry
   </contact>
   <role>
    submitter
   </role>
   <email>
    rfry@unc.edu
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
   </text>
  </description>
  <protocol>
   <id>
    1163630
   </id>
   <accession>
    P-GSE73377-40
   </accession>
  </protocol>
  <protocol>
   <id>
    1163643
   </id>
   <accession>
    P-GSE73377-26
   </accession>
  </protocol>
  <protocol>
   <id>
    1163666
   </id>
   <accession>
    P-GSE73377-3
   </accession>
  </protocol>
  <protocol>
   <id>
    1163632
   </id>
   <accession>
    P-GSE73377-44
   </accession>
  </protocol>
  <protocol>
   <id>
    1163665
   </id>
   <accession>
    P-GSE73377-4
   </accession>
  </protocol>
  <protocol>
   <id>
    1163644
   </id>
   <accession>
    P-GSE73377-25
   </accession>
  </protocol>
  <protocol>
   <id>
    1163669
   </id>
   <accession>
    P-GSE73377-43
   </accession>
  </protocol>
  <protocol>
   <id>
    1163645
   </id>
   <accession>
    P-GSE73377-24
   </accession>
  </protocol>
  <protocol>
   <id>
    1163628
   </id>
   <accession>
    P-GSE73377-1
   </accession>
  </protocol>
  <protocol>
   <id>
    1163670
   </id>
   <accession>
    P-GSE73377-42
   </accession>
  </protocol>
  <protocol>
   <id>
    1163667
   </id>
   <accession>
    P-GSE73377-2
   </accession>
  </protocol>
  <protocol>
   <id>
    1163629
   </id>
   <accession>
    P-GSE73377-41
   </accession>
  </protocol>
  <protocol>
   <id>
    1163646
   </id>
   <accession>
    P-GSE73377-23
   </accession>
  </protocol>
  <protocol>
   <id>
    1163647
   </id>
   <accession>
    P-GSE73377-22
   </accession>
  </protocol>
  <protocol>
   <id>
    1163662
   </id>
   <accession>
    P-GSE73377-7
   </accession>
  </protocol>
  <protocol>
   <id>
    1163648
   </id>
   <accession>
    P-GSE73377-21
   </accession>
  </protocol>
  <protocol>
   <id>
    1163661
   </id>
   <accession>
    P-GSE73377-8
   </accession>
  </protocol>
  <protocol>
   <id>
    1163649
   </id>
   <accession>
    P-GSE73377-20
   </accession>
  </protocol>
  <protocol>
   <id>
    1163664
   </id>
   <accession>
    P-GSE73377-5
   </accession>
  </protocol>
  <protocol>
   <id>
    1163663
   </id>
   <accession>
    P-GSE73377-6
   </accession>
  </protocol>
  <protocol>
   <id>
    1163660
   </id>
   <accession>
    P-GSE73377-9
   </accession>
  </protocol>
  <protocol>
   <id>
    1163640
   </id>
   <accession>
    P-GSE73377-29
   </accession>
  </protocol>
  <protocol>
   <id>
    1163641
   </id>
   <accession>
    P-GSE73377-28
   </accession>
  </protocol>
  <protocol>
   <id>
    1163642
   </id>
   <accession>
    P-GSE73377-27
   </accession>
  </protocol>
  <protocol>
   <id>
    1163656
   </id>
   <accession>
    P-GSE73377-13
   </accession>
  </protocol>
  <protocol>
   <id>
    1163638
   </id>
   <accession>
    P-GSE73377-31
   </accession>
  </protocol>
  <protocol>
   <id>
    1163657
   </id>
   <accession>
    P-GSE73377-12
   </accession>
  </protocol>
  <protocol>
   <id>
    1163639
   </id>
   <accession>
    P-GSE73377-30
   </accession>
  </protocol>
  <protocol>
   <id>
    1163636
   </id>
   <accession>
    P-GSE73377-33
   </accession>
  </protocol>
  <protocol>
   <id>
    1163654
   </id>
   <accession>
    P-GSE73377-15
   </accession>
  </protocol>
  <protocol>
   <id>
    1163637
   </id>
   <accession>
    P-GSE73377-32
   </accession>
  </protocol>
  <protocol>
   <id>
    1163655
   </id>
   <accession>
    P-GSE73377-14
   </accession>
  </protocol>
  <protocol>
   <id>
    1163634
   </id>
   <accession>
    P-GSE73377-35
   </accession>
  </protocol>
  <protocol>
   <id>
    1163635
   </id>
   <accession>
    P-GSE73377-34
   </accession>
  </protocol>
  <protocol>
   <id>
    1163668
   </id>
   <accession>
    P-GSE73377-37
   </accession>
  </protocol>
  <protocol>
   <id>
    1163658
   </id>
   <accession>
    P-GSE73377-11
   </accession>
  </protocol>
  <protocol>
   <id>
    1163659
   </id>
   <accession>
    P-GSE73377-10
   </accession>
  </protocol>
  <protocol>
   <id>
    1163633
   </id>
   <accession>
    P-GSE73377-36
   </accession>
  </protocol>
  <protocol>
   <id>
    1163631
   </id>
   <accession>
    P-GSE73377-39
   </accession>
  </protocol>
  <protocol>
   <id>
    1163671
   </id>
   <accession>
    P-GSE73377-38
   </accession>
  </protocol>
  <protocol>
   <id>
    1163652
   </id>
   <accession>
    P-GSE73377-17
   </accession>
  </protocol>
  <protocol>
   <id>
    1163653
   </id>
   <accession>
    P-GSE73377-16
   </accession>
  </protocol>
  <protocol>
   <id>
    1163650
   </id>
   <accession>
    P-GSE73377-19
   </accession>
  </protocol>
  <protocol>
   <id>
    1163651
   </id>
   <accession>
    P-GSE73377-18
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-GEOD-73377.raw.1.zip E-GEOD-73377.raw.2.zip">
   </raw>
   <fgem available="true" name="E-GEOD-73377.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-73377.idf.txt">
   </idf>
   <sdrf name="E-GEOD-73377.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="false">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    diagnosis
   </category>
   <value>
    normotensive
   </value>
   <value>
    preeclamptic
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    gestational age
   </category>
   <value>
    African American
   </value>
   <value>
    Asian
   </value>
   <value>
    Caucasian
   </value>
   <value>
    Hispanic
   </value>
   <value>
    Other
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    maternal age
   </category>
   <value>
    19
   </value>
   <value>
    20
   </value>
   <value>
    22
   </value>
   <value>
    24
   </value>
   <value>
    25
   </value>
   <value>
    26
   </value>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    30
   </value>
   <value>
    31
   </value>
   <value>
    32
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    35
   </value>
   <value>
    36
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism part
   </category>
   <value>
    placenta
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    race
   </category>
   <value>
    22
   </value>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    30
   </value>
   <value>
    32
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    35
   </value>
   <value>
    36
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
   <value>
    39
   </value>
   <value>
    40
   </value>
   <value>
    41
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    diagnosis
   </name>
   <value>
    normotensive
   </value>
   <value>
    preeclamptic
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    gestational age
   </name>
   <value>
    African American
   </value>
   <value>
    Asian
   </value>
   <value>
    Caucasian
   </value>
   <value>
    Hispanic
   </value>
   <value>
    Other
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    maternal age
   </name>
   <value>
    19
   </value>
   <value>
    20
   </value>
   <value>
    22
   </value>
   <value>
    24
   </value>
   <value>
    25
   </value>
   <value>
    26
   </value>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    30
   </value>
   <value>
    31
   </value>
   <value>
    32
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    35
   </value>
   <value>
    36
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    race
   </name>
   <value>
    22
   </value>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    30
   </value>
   <value>
    32
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    35
   </value>
   <value>
    36
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
   <value>
    39
   </value>
   <value>
    40
   </value>
   <value>
    41
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    0
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    3
   </overallscore>
  </miamescores>
  <id>
   529820
  </id>
  <accession>
   E-GEOD-73375
  </accession>
  <secondaryaccession>
   GSE73375
  </secondaryaccession>
  <name>
   Epigenetics and Preeclampsia: Defining Functional Epimutations in the Preeclamptic Placenta Related to the TGF-β Pathway [methylation]
  </name>
  <experimenttype>
   methylation profiling by array
  </experimenttype>
  <releasedate>
   2015-09-24
  </releasedate>
  <lastupdatedate>
   2015-09-25
  </lastupdatedate>
  <samples>
   36
  </samples>
  <assays>
   36
  </assays>
  <arraydesign>
   <id>
    19396
   </id>
   <accession>
    A-GEOD-13534
   </accession>
   <name>
    Illumina HumanMethylation450 BeadChip (HumanMethylation450_15017482_v.1.1)
   </name>
   <count>
    36
   </count>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    36
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    36
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    36
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    36
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Rebecca C Fry
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Lisa Smeester
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Paul D Ray
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Rebecca Catherine Fry
   </contact>
   <role>
    submitter
   </role>
   <email>
    rfry@unc.edu
   </email>
  </provider>
  <provider>
   <contact>
    Kim Boggess
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Elizabeth Martin
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Matthew R Grace
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    Placental Tissue Samples from 36 women (17 normotensive women, denoted with a P, and 19 preeclamptic women, denoted with a Q) were analyzed for differenital methylation Preeclamptic womene were compared direclty to normotensive women controlling for gestational age, race, maternal age, and baby sex 36 samples were analyzed, 18 in each group
   </text>
  </description>
  <protocol>
   <id>
    1163599
   </id>
   <accession>
    P-GSE73375-20
   </accession>
  </protocol>
  <protocol>
   <id>
    1163596
   </id>
   <accession>
    P-GSE73375-23
   </accession>
  </protocol>
  <protocol>
   <id>
    1163595
   </id>
   <accession>
    P-GSE73375-24
   </accession>
  </protocol>
  <protocol>
   <id>
    1163598
   </id>
   <accession>
    P-GSE73375-21
   </accession>
  </protocol>
  <protocol>
   <id>
    1163597
   </id>
   <accession>
    P-GSE73375-22
   </accession>
  </protocol>
  <protocol>
   <id>
    1163592
   </id>
   <accession>
    P-GSE73375-27
   </accession>
  </protocol>
  <protocol>
   <id>
    1163591
   </id>
   <accession>
    P-GSE73375-28
   </accession>
  </protocol>
  <protocol>
   <id>
    1163594
   </id>
   <accession>
    P-GSE73375-25
   </accession>
  </protocol>
  <protocol>
   <id>
    1163593
   </id>
   <accession>
    P-GSE73375-26
   </accession>
  </protocol>
  <protocol>
   <id>
    1163590
   </id>
   <accession>
    P-GSE73375-29
   </accession>
  </protocol>
  <protocol>
   <id>
    1163618
   </id>
   <accession>
    P-GSE73375-1
   </accession>
  </protocol>
  <protocol>
   <id>
    1163617
   </id>
   <accession>
    P-GSE73375-2
   </accession>
  </protocol>
  <protocol>
   <id>
    1163583
   </id>
   <accession>
    P-GSE73375-40
   </accession>
  </protocol>
  <protocol>
   <id>
    1163609
   </id>
   <accession>
    P-GSE73375-10
   </accession>
  </protocol>
  <protocol>
   <id>
    1163608
   </id>
   <accession>
    P-GSE73375-11
   </accession>
  </protocol>
  <protocol>
   <id>
    1163607
   </id>
   <accession>
    P-GSE73375-12
   </accession>
  </protocol>
  <protocol>
   <id>
    1163606
   </id>
   <accession>
    P-GSE73375-13
   </accession>
  </protocol>
  <protocol>
   <id>
    1163605
   </id>
   <accession>
    P-GSE73375-14
   </accession>
  </protocol>
  <protocol>
   <id>
    1163604
   </id>
   <accession>
    P-GSE73375-15
   </accession>
  </protocol>
  <protocol>
   <id>
    1163603
   </id>
   <accession>
    P-GSE73375-16
   </accession>
  </protocol>
  <protocol>
   <id>
    1163602
   </id>
   <accession>
    P-GSE73375-17
   </accession>
  </protocol>
  <protocol>
   <id>
    1163601
   </id>
   <accession>
    P-GSE73375-18
   </accession>
  </protocol>
  <protocol>
   <id>
    1163600
   </id>
   <accession>
    P-GSE73375-19
   </accession>
  </protocol>
  <protocol>
   <id>
    1163620
   </id>
   <accession>
    P-GSE73375-39
   </accession>
  </protocol>
  <protocol>
   <id>
    1163621
   </id>
   <accession>
    P-GSE73375-38
   </accession>
  </protocol>
  <protocol>
   <id>
    1163622
   </id>
   <accession>
    P-GSE73375-37
   </accession>
  </protocol>
  <protocol>
   <id>
    1163619
   </id>
   <accession>
    P-GSE73375-36
   </accession>
  </protocol>
  <protocol>
   <id>
    1163616
   </id>
   <accession>
    P-GSE73375-3
   </accession>
  </protocol>
  <protocol>
   <id>
    1163584
   </id>
   <accession>
    P-GSE73375-35
   </accession>
  </protocol>
  <protocol>
   <id>
    1163585
   </id>
   <accession>
    P-GSE73375-34
   </accession>
  </protocol>
  <protocol>
   <id>
    1163615
   </id>
   <accession>
    P-GSE73375-4
   </accession>
  </protocol>
  <protocol>
   <id>
    1163586
   </id>
   <accession>
    P-GSE73375-33
   </accession>
  </protocol>
  <protocol>
   <id>
    1163614
   </id>
   <accession>
    P-GSE73375-5
   </accession>
  </protocol>
  <protocol>
   <id>
    1163613
   </id>
   <accession>
    P-GSE73375-6
   </accession>
  </protocol>
  <protocol>
   <id>
    1163587
   </id>
   <accession>
    P-GSE73375-32
   </accession>
  </protocol>
  <protocol>
   <id>
    1163588
   </id>
   <accession>
    P-GSE73375-31
   </accession>
  </protocol>
  <protocol>
   <id>
    1163612
   </id>
   <accession>
    P-GSE73375-7
   </accession>
  </protocol>
  <protocol>
   <id>
    1163611
   </id>
   <accession>
    P-GSE73375-8
   </accession>
  </protocol>
  <protocol>
   <id>
    1163589
   </id>
   <accession>
    P-GSE73375-30
   </accession>
  </protocol>
  <protocol>
   <id>
    1163610
   </id>
   <accession>
    P-GSE73375-9
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <fgem available="true" name="E-GEOD-73375.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-73375.idf.txt">
   </idf>
   <sdrf name="E-GEOD-73375.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    diagnosis
   </category>
   <value>
    normotensive
   </value>
   <value>
    preeclamptic
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    gestational age
   </category>
   <value>
    22
   </value>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    30
   </value>
   <value>
    32
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    35
   </value>
   <value>
    36
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
   <value>
    39
   </value>
   <value>
    40
   </value>
   <value>
    41
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    maternal age
   </category>
   <value>
    19
   </value>
   <value>
    20
   </value>
   <value>
    22
   </value>
   <value>
    24
   </value>
   <value>
    25
   </value>
   <value>
    26
   </value>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    30
   </value>
   <value>
    31
   </value>
   <value>
    32
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    35
   </value>
   <value>
    36
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism part
   </category>
   <value>
    placenta
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    race
   </category>
   <value>
    African American
   </value>
   <value>
    Asian
   </value>
   <value>
    Caucasian
   </value>
   <value>
    Hispanic
   </value>
   <value>
    Other
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    diagnosis
   </name>
   <value>
    normotensive
   </value>
   <value>
    preeclamptic
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    gestational age
   </name>
   <value>
    22
   </value>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    30
   </value>
   <value>
    32
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    35
   </value>
   <value>
    36
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
   <value>
    39
   </value>
   <value>
    40
   </value>
   <value>
    41
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    maternal age
   </name>
   <value>
    19
   </value>
   <value>
    20
   </value>
   <value>
    22
   </value>
   <value>
    24
   </value>
   <value>
    25
   </value>
   <value>
    26
   </value>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    30
   </value>
   <value>
    31
   </value>
   <value>
    32
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    35
   </value>
   <value>
    36
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    race
   </name>
   <value>
    African American
   </value>
   <value>
    Asian
   </value>
   <value>
    Caucasian
   </value>
   <value>
    Hispanic
   </value>
   <value>
    Other
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    0
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    3
   </overallscore>
  </miamescores>
  <id>
   529821
  </id>
  <accession>
   E-GEOD-73374
  </accession>
  <secondaryaccession>
   GSE73374
  </secondaryaccession>
  <name>
   Epigenetics and Preeclampsia: Defining Functional Epimutations in the Preeclamptic Placenta Related to the TGF-β Pathway [gene expression]
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2015-09-24
  </releasedate>
  <lastupdatedate>
   2015-09-25
  </lastupdatedate>
  <samples>
   36
  </samples>
  <assays>
   36
  </assays>
  <arraydesign>
   <id>
    24568
   </id>
   <accession>
    A-GEOD-16686
   </accession>
   <name>
    [HuGene-2_0-st] Affymetrix Human Gene 2.0 ST Array [transcript (gene) version]
   </name>
   <count>
    36
   </count>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    36
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    36
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    36
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    36
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    36
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    36
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Paul D Ray
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Kim Boggess
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Lisa Smeester
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Rebecca C Fry
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Matthew R Grace
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Elizabeth Martin
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Rebecca Catherine Fry
   </contact>
   <role>
    submitter
   </role>
   <email>
    rfry@unc.edu
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    Placental Tissue Samples from 36 women (17 normotensive women, denoted with a P, and 19 preeclamptic women, denoted with a Q) were analyzed for differenital methylation Preeclamptic womene were compared direclty to normotensive women controlling for gestational age, race, maternal age, and baby sex 36 samples were analyzed: 17 normotensive, 19 preeclamptic
   </text>
  </description>
  <protocol>
   <id>
    1163625
   </id>
   <accession>
    P-GSE73374-4
   </accession>
  </protocol>
  <protocol>
   <id>
    1163624
   </id>
   <accession>
    P-GSE73374-5
   </accession>
  </protocol>
  <protocol>
   <id>
    1163626
   </id>
   <accession>
    P-GSE73374-3
   </accession>
  </protocol>
  <protocol>
   <id>
    1163627
   </id>
   <accession>
    P-GSE73374-2
   </accession>
  </protocol>
  <protocol>
   <id>
    1163623
   </id>
   <accession>
    P-GSE73374-1
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-GEOD-73374.raw.1.zip E-GEOD-73374.raw.2.zip">
   </raw>
   <fgem available="true" name="E-GEOD-73374.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-73374.idf.txt">
   </idf>
   <sdrf name="E-GEOD-73374.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="false">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    gestational age wks
   </category>
   <value>
    25
   </value>
   <value>
    26
   </value>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    30
   </value>
   <value>
    31
   </value>
   <value>
    32
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    35
   </value>
   <value>
    36
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
   <value>
    39
   </value>
   <value>
    40
   </value>
   <value>
    41
   </value>
   <value>
    42
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    gravidity
   </category>
   <value>
    1
   </value>
   <value>
    2
   </value>
   <value>
    3
   </value>
   <value>
    4
   </value>
   <value>
    5
   </value>
   <value>
    6
   </value>
   <value>
    8
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    infant sex
   </category>
   <value>
    F+F
   </value>
   <value>
    female
   </value>
   <value>
    male
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    infant weight g
   </category>
   <value>
    1000
   </value>
   <value>
    1081
   </value>
   <value>
    1100
   </value>
   <value>
    1120
   </value>
   <value>
    1122
   </value>
   <value>
    1125
   </value>
   <value>
    1190
   </value>
   <value>
    1250
   </value>
   <value>
    1292
   </value>
   <value>
    1340
   </value>
   <value>
    1360
   </value>
   <value>
    1365
   </value>
   <value>
    1420
   </value>
   <value>
    1470
   </value>
   <value>
    1510
   </value>
   <value>
    1525
   </value>
   <value>
    1556
   </value>
   <value>
    1590
   </value>
   <value>
    1640
   </value>
   <value>
    1648
   </value>
   <value>
    1720
   </value>
   <value>
    1735
   </value>
   <value>
    1740
   </value>
   <value>
    1780+1630
   </value>
   <value>
    1845
   </value>
   <value>
    1850
   </value>
   <value>
    1955
   </value>
   <value>
    1970
   </value>
   <value>
    2110
   </value>
   <value>
    2190
   </value>
   <value>
    2195
   </value>
   <value>
    2535
   </value>
   <value>
    2635
   </value>
   <value>
    2700
   </value>
   <value>
    2706
   </value>
   <value>
    2712
   </value>
   <value>
    2740
   </value>
   <value>
    2825
   </value>
   <value>
    2838
   </value>
   <value>
    2870
   </value>
   <value>
    2880
   </value>
   <value>
    2920
   </value>
   <value>
    2935
   </value>
   <value>
    2938
   </value>
   <value>
    2990
   </value>
   <value>
    3034
   </value>
   <value>
    3050
   </value>
   <value>
    3060
   </value>
   <value>
    3095
   </value>
   <value>
    3105
   </value>
   <value>
    3108
   </value>
   <value>
    3110
   </value>
   <value>
    3125
   </value>
   <value>
    3126
   </value>
   <value>
    3130
   </value>
   <value>
    3145
   </value>
   <value>
    3155
   </value>
   <value>
    3240
   </value>
   <value>
    3245
   </value>
   <value>
    3258
   </value>
   <value>
    3306
   </value>
   <value>
    3315
   </value>
   <value>
    3325
   </value>
   <value>
    3332
   </value>
   <value>
    3336
   </value>
   <value>
    3365
   </value>
   <value>
    3385
   </value>
   <value>
    3395
   </value>
   <value>
    3400
   </value>
   <value>
    3415
   </value>
   <value>
    3420
   </value>
   <value>
    3445
   </value>
   <value>
    3450
   </value>
   <value>
    3461
   </value>
   <value>
    3465
   </value>
   <value>
    3468
   </value>
   <value>
    3480
   </value>
   <value>
    3490
   </value>
   <value>
    3554
   </value>
   <value>
    3566
   </value>
   <value>
    3576
   </value>
   <value>
    3580
   </value>
   <value>
    3585
   </value>
   <value>
    3618
   </value>
   <value>
    3620
   </value>
   <value>
    3635
   </value>
   <value>
    3645
   </value>
   <value>
    3670
   </value>
   <value>
    3690
   </value>
   <value>
    3692
   </value>
   <value>
    3760
   </value>
   <value>
    3785
   </value>
   <value>
    3786
   </value>
   <value>
    3808
   </value>
   <value>
    3822
   </value>
   <value>
    3830
   </value>
   <value>
    3875
   </value>
   <value>
    3935
   </value>
   <value>
    3978
   </value>
   <value>
    4212
   </value>
   <value>
    425
   </value>
   <value>
    4310
   </value>
   <value>
    4365
   </value>
   <value>
    4415
   </value>
   <value>
    4598
   </value>
   <value>
    516
   </value>
   <value>
    635
   </value>
   <value>
    650
   </value>
   <value>
    659
   </value>
   <value>
    665
   </value>
   <value>
    720
   </value>
   <value>
    730
   </value>
   <value>
    732
   </value>
   <value>
    831
   </value>
   <value>
    835
   </value>
   <value>
    850
   </value>
   <value>
    886
   </value>
   <value>
    940
   </value>
   <value>
    990
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    maternal age yrs
   </category>
   <value>
    18
   </value>
   <value>
    19
   </value>
   <value>
    20
   </value>
   <value>
    21
   </value>
   <value>
    22
   </value>
   <value>
    23
   </value>
   <value>
    24
   </value>
   <value>
    25
   </value>
   <value>
    26
   </value>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    30
   </value>
   <value>
    31
   </value>
   <value>
    32
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    35
   </value>
   <value>
    36
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
   <value>
    39
   </value>
   <value>
    40
   </value>
   <value>
    41
   </value>
   <value>
    42
   </value>
   <value>
    46
   </value>
   <value>
    47
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism part
   </category>
   <value>
    decidua basalis
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    parity
   </category>
   <value>
    1
   </value>
   <value>
    2
   </value>
   <value>
    3
   </value>
   <value>
    4
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    subject status
   </category>
   <value>
    normotensive control patient
   </value>
   <value>
    pre-eclamptic patient
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    gestational age wks
   </name>
   <value>
    25
   </value>
   <value>
    26
   </value>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    30
   </value>
   <value>
    31
   </value>
   <value>
    32
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    35
   </value>
   <value>
    36
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
   <value>
    39
   </value>
   <value>
    40
   </value>
   <value>
    41
   </value>
   <value>
    42
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    gravidity
   </name>
   <value>
    1
   </value>
   <value>
    2
   </value>
   <value>
    3
   </value>
   <value>
    4
   </value>
   <value>
    5
   </value>
   <value>
    6
   </value>
   <value>
    8
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    infant sex
   </name>
   <value>
    F+F
   </value>
   <value>
    female
   </value>
   <value>
    male
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    infant weight g
   </name>
   <value>
    1000
   </value>
   <value>
    1081
   </value>
   <value>
    1100
   </value>
   <value>
    1120
   </value>
   <value>
    1122
   </value>
   <value>
    1125
   </value>
   <value>
    1190
   </value>
   <value>
    1250
   </value>
   <value>
    1292
   </value>
   <value>
    1340
   </value>
   <value>
    1360
   </value>
   <value>
    1365
   </value>
   <value>
    1420
   </value>
   <value>
    1470
   </value>
   <value>
    1510
   </value>
   <value>
    1525
   </value>
   <value>
    1556
   </value>
   <value>
    1590
   </value>
   <value>
    1640
   </value>
   <value>
    1648
   </value>
   <value>
    1720
   </value>
   <value>
    1735
   </value>
   <value>
    1740
   </value>
   <value>
    1780+1630
   </value>
   <value>
    1845
   </value>
   <value>
    1850
   </value>
   <value>
    1955
   </value>
   <value>
    1970
   </value>
   <value>
    2110
   </value>
   <value>
    2190
   </value>
   <value>
    2195
   </value>
   <value>
    2535
   </value>
   <value>
    2635
   </value>
   <value>
    2700
   </value>
   <value>
    2706
   </value>
   <value>
    2712
   </value>
   <value>
    2740
   </value>
   <value>
    2825
   </value>
   <value>
    2838
   </value>
   <value>
    2870
   </value>
   <value>
    2880
   </value>
   <value>
    2920
   </value>
   <value>
    2935
   </value>
   <value>
    2938
   </value>
   <value>
    2990
   </value>
   <value>
    3034
   </value>
   <value>
    3050
   </value>
   <value>
    3060
   </value>
   <value>
    3095
   </value>
   <value>
    3105
   </value>
   <value>
    3108
   </value>
   <value>
    3110
   </value>
   <value>
    3125
   </value>
   <value>
    3126
   </value>
   <value>
    3130
   </value>
   <value>
    3145
   </value>
   <value>
    3155
   </value>
   <value>
    3240
   </value>
   <value>
    3245
   </value>
   <value>
    3258
   </value>
   <value>
    3306
   </value>
   <value>
    3315
   </value>
   <value>
    3325
   </value>
   <value>
    3332
   </value>
   <value>
    3336
   </value>
   <value>
    3365
   </value>
   <value>
    3385
   </value>
   <value>
    3395
   </value>
   <value>
    3400
   </value>
   <value>
    3415
   </value>
   <value>
    3420
   </value>
   <value>
    3445
   </value>
   <value>
    3450
   </value>
   <value>
    3461
   </value>
   <value>
    3465
   </value>
   <value>
    3468
   </value>
   <value>
    3480
   </value>
   <value>
    3490
   </value>
   <value>
    3554
   </value>
   <value>
    3566
   </value>
   <value>
    3576
   </value>
   <value>
    3580
   </value>
   <value>
    3585
   </value>
   <value>
    3618
   </value>
   <value>
    3620
   </value>
   <value>
    3635
   </value>
   <value>
    3645
   </value>
   <value>
    3670
   </value>
   <value>
    3690
   </value>
   <value>
    3692
   </value>
   <value>
    3760
   </value>
   <value>
    3785
   </value>
   <value>
    3786
   </value>
   <value>
    3808
   </value>
   <value>
    3822
   </value>
   <value>
    3830
   </value>
   <value>
    3875
   </value>
   <value>
    3935
   </value>
   <value>
    3978
   </value>
   <value>
    4212
   </value>
   <value>
    425
   </value>
   <value>
    4310
   </value>
   <value>
    4365
   </value>
   <value>
    4415
   </value>
   <value>
    4598
   </value>
   <value>
    516
   </value>
   <value>
    635
   </value>
   <value>
    650
   </value>
   <value>
    659
   </value>
   <value>
    665
   </value>
   <value>
    720
   </value>
   <value>
    730
   </value>
   <value>
    732
   </value>
   <value>
    831
   </value>
   <value>
    835
   </value>
   <value>
    850
   </value>
   <value>
    886
   </value>
   <value>
    940
   </value>
   <value>
    990
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    maternal age yrs
   </name>
   <value>
    18
   </value>
   <value>
    19
   </value>
   <value>
    20
   </value>
   <value>
    21
   </value>
   <value>
    22
   </value>
   <value>
    23
   </value>
   <value>
    24
   </value>
   <value>
    25
   </value>
   <value>
    26
   </value>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    30
   </value>
   <value>
    31
   </value>
   <value>
    32
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    35
   </value>
   <value>
    36
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
   <value>
    39
   </value>
   <value>
    40
   </value>
   <value>
    41
   </value>
   <value>
    42
   </value>
   <value>
    46
   </value>
   <value>
    47
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    parity
   </name>
   <value>
    1
   </value>
   <value>
    2
   </value>
   <value>
    3
   </value>
   <value>
    4
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    subject status
   </name>
   <value>
    normotensive control patient
   </value>
   <value>
    pre-eclamptic patient
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    1
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    5
   </overallscore>
  </miamescores>
  <id>
   526569
  </id>
  <accession>
   E-GEOD-60438
  </accession>
  <secondaryaccession>
   GSE60438
  </secondaryaccession>
  <name>
   Transcriptome profiling of deciduas from pre-eclamptic and normotensive pregnancies
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2015-08-05
  </releasedate>
  <lastupdatedate>
   2015-08-19
  </lastupdatedate>
  <samples>
   125
  </samples>
  <assays>
   125
  </assays>
  <arraydesign>
   <id>
    7604
   </id>
   <accession>
    A-GEOD-10558
   </accession>
   <name>
    Illumina HumanHT-12 V4.0 expression beadchip
   </name>
   <count>
    77
   </count>
   <legacy_id>
    2501282336
   </legacy_id>
  </arraydesign>
  <arraydesign>
   <id>
    12299
   </id>
   <accession>
    A-MEXP-1173
   </accession>
   <name>
    Illumina HumanWG-6 v3.0 Expression BeadChip
   </name>
   <count>
    48
   </count>
   <legacy_id>
    1633118223
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    125
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    125
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    125
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    125
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bibliography>
   <accession>
    26010865
   </accession>
   <authors>
    Yong HE, Melton PE, Johnson MP, Freed KA, Kalionis B, Murthi P, Brennecke SP, Keogh RJ, Moses EK
   </authors>
   <title>
    Genome-wide transcriptome directed pathway analysis of maternal pre-eclampsia susceptibility genes.
   </title>
  </bibliography>
  <provider>
   <contact>
    B Kalionis
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    R J Keogh
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    P E Melton
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Eric K Moses
   </contact>
   <role>
    submitter
   </role>
   <email>
    geo@ncbi.nlm.nih.gov
   </email>
  </provider>
  <provider>
   <contact>
    K A Freed
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Hannah E Yong
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    P Murthi
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    M P Johnson
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    S P Brennecke
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    Genome-wide analysis of decidual transcriptome in pre-eclampsia compared with normotensive controls to find differentially expressed genes/pathways. Preeclampsia (PE) is a common and serious pregnancy hypertensive disorder with a strong genetic component. The study aims were to use genome-wide analysis of decidual transcriptome in pre-eclampsia compared with normotensive controls to identify differentially expressed biological pathways, and to determine common pathways between the transcriptome and previously identified maternal susceptibility genes. Total RNA from decidua basalis obtained from pre-eclamptic and normotensive control patients at Caesarean section
   </text>
  </description>
  <protocol>
   <id>
    1148833
   </id>
   <accession>
    P-GSE60438-5
   </accession>
  </protocol>
  <protocol>
   <id>
    1148832
   </id>
   <accession>
    P-GSE60438-6
   </accession>
  </protocol>
  <protocol>
   <id>
    1148835
   </id>
   <accession>
    P-GSE60438-3
   </accession>
  </protocol>
  <protocol>
   <id>
    1148834
   </id>
   <accession>
    P-GSE60438-4
   </accession>
  </protocol>
  <protocol>
   <id>
    1148831
   </id>
   <accession>
    P-GSE60438-1
   </accession>
  </protocol>
  <protocol>
   <id>
    1148836
   </id>
   <accession>
    P-GSE60438-2
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <fgem available="true" name="E-GEOD-60438.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-60438.idf.txt">
   </idf>
   <sdrf name="E-GEOD-60438.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="false">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    cell line
   </category>
   <value>
    (pool of 16 cancer cell lines)
   </value>
   <value>
    04-147
   </value>
   <value>
    10
   </value>
   <value>
    1089 luminal
   </value>
   <value>
    10A
   </value>
   <value>
    11
   </value>
   <value>
    11A
   </value>
   <value>
    1205-Lu
   </value>
   <value>
    184B5 MeM
   </value>
   <value>
    1Cc8
   </value>
   <value>
    22Rv1
   </value>
   <value>
    36M2
   </value>
   <value>
    5-8F
   </value>
   <value>
    527MEL
   </value>
   <value>
    6-10B
   </value>
   <value>
    624MEL
   </value>
   <value>
    697
   </value>
   <value>
    6a
   </value>
   <value>
    76N
   </value>
   <value>
    76N RhoA
   </value>
   <value>
    786-O
   </value>
   <value>
    786-VHL
   </value>
   <value>
    8226/S
   </value>
   <value>
    888MEL
   </value>
   <value>
    8d
   </value>
   <value>
    90-8
   </value>
   <value>
    92,1
   </value>
   <value>
    928MEL
   </value>
   <value>
    9A
   </value>
   <value>
    A02
   </value>
   <value>
    A04
   </value>
   <value>
    A06
   </value>
   <value>
    A1
   </value>
   <value>
    A11
   </value>
   <value>
    A13
   </value>
   <value>
    A15
   </value>
   <value>
    A172
   </value>
   <value>
    A2058
   </value>
   <value>
    A2780
   </value>
   <value>
    A3-Kawakami
   </value>
   <value>
    A375
   </value>
   <value>
    A375M2
   </value>
   <value>
    A375P
   </value>
   <value>
    A375SM
   </value>
   <value>
    A427
   </value>
   <value>
    A431
   </value>
   <value>
    A4_Fukada
   </value>
   <value>
    A549
   </value>
   <value>
    A6
   </value>
   <value>
    ABC1
   </value>
   <value>
    abl
   </value>
   <value>
    AF6
   </value>
   <value>
    AG04147
   </value>
   <value>
    AG05416
   </value>
   <value>
    AG06237
   </value>
   <value>
    AG07139
   </value>
   <value>
    AG07307
   </value>
   <value>
    AG08046
   </value>
   <value>
    AG08048
   </value>
   <value>
    AG09699
   </value>
   <value>
    AG09877
   </value>
   <value>
    AG10049
   </value>
   <value>
    AG10941
   </value>
   <value>
    AG11364
   </value>
   <value>
    AG11696
   </value>
   <value>
    AG11726
   </value>
   <value>
    AG13066
   </value>
   <value>
    AG13145
   </value>
   <value>
    AG13150
   </value>
   <value>
    AG14446
   </value>
   <value>
    AGS
   </value>
   <value>
    AGS and MKN-45
   </value>
   <value>
    AMO-1
   </value>
   <value>
    ANBL-6
   </value>
   <value>
    ARPE-19
   </value>
   <value>
    AsPC-1
   </value>
   <value>
    AU565
   </value>
   <value>
    Awells
   </value>
   <value>
    AZ521
   </value>
   <value>
    B41
   </value>
   <value>
    BattP12
   </value>
   <value>
    BC-3
   </value>
   <value>
    BCN
   </value>
   <value>
    BCWM1
   </value>
   <value>
    BE(2)-C
   </value>
   <value>
    BEAS-2B
   </value>
   <value>
    BJ
   </value>
   <value>
    BJ1
   </value>
   <value>
    BJAB
   </value>
   <value>
    BL
   </value>
   <value>
    BPLER
   </value>
   <value>
    BT-474
   </value>
   <value>
    BT-474-EI
   </value>
   <value>
    BT-483
   </value>
   <value>
    BT-549
   </value>
   <value>
    BT-5491
   </value>
   <value>
    BT/HerR0.2D clone (Her2-positive BT474)
   </value>
   <value>
    BT/HerR0.2J clone (Her2-positive BT474)
   </value>
   <value>
    BT/HerR1.0C clone (Her2-positive BT474)
   </value>
   <value>
    BT/HerR1.0E clone (Her2-positive BT474)
   </value>
   <value>
    BxPC-3
   </value>
   <value>
    C-32
   </value>
   <value>
    C1
   </value>
   <value>
    C32
   </value>
   <value>
    C33-A
   </value>
   <value>
    C4-2
   </value>
   <value>
    C7H2
   </value>
   <value>
    C7H2-R10E7
   </value>
   <value>
    C7H2-R19E5
   </value>
   <value>
    C7H2-R19E7
   </value>
   <value>
    C7H2-R19F2
   </value>
   <value>
    C7H2-R3B5
   </value>
   <value>
    C7H2-R9C10
   </value>
   <value>
    C7H2-S10
   </value>
   <value>
    C7H2-S11
   </value>
   <value>
    C7H2-S12
   </value>
   <value>
    C7H2-S15
   </value>
   <value>
    C7H2-S2
   </value>
   <value>
    C7H2-S27
   </value>
   <value>
    C7H2-S27(ZR)
   </value>
   <value>
    CA1
   </value>
   <value>
    CA2
   </value>
   <value>
    Caco-2
   </value>
   <value>
    Caki-1
   </value>
   <value>
    CAL-120
   </value>
   <value>
    CAL-1201
   </value>
   <value>
    CAL-148
   </value>
   <value>
    CAL-51
   </value>
   <value>
    CAL-851
   </value>
   <value>
    Calu-1
   </value>
   <value>
    Calu-3
   </value>
   <value>
    Calu-3 subclone 2B4
   </value>
   <value>
    Calu-6
   </value>
   <value>
    CAMA-1
   </value>
   <value>
    Caov-3
   </value>
   <value>
    Capan-1
   </value>
   <value>
    Capan-2
   </value>
   <value>
    CCD-1079Sk
   </value>
   <value>
    CCD-1108SK
   </value>
   <value>
    CCD-13Lu
   </value>
   <value>
    CCD-16Lu
   </value>
   <value>
    CCD-18Co
   </value>
   <value>
    CCD-19Lu
   </value>
   <value>
    CCD-25Lu
   </value>
   <value>
    CCD-29Lu
   </value>
   <value>
    CCD-8Lu
   </value>
   <value>
    CCRF-CEM
   </value>
   <value>
    CCRF-CEM-c1
   </value>
   <value>
    CCRF-CEM-C7R1
   </value>
   <value>
    CEM
   </value>
   <value>
    CFPAC
   </value>
   <value>
    CFT-2
   </value>
   <value>
    CI-1
   </value>
   <value>
    CJM
   </value>
   <value>
    CL-11
   </value>
   <value>
    CL-40
   </value>
   <value>
    CL1-5
   </value>
   <value>
    CLS145
   </value>
   <value>
    CMK
   </value>
   <value>
    CNE2
   </value>
   <value>
    CNMel
   </value>
   <value>
    COLO-201
   </value>
   <value>
    COLO-205
   </value>
   <value>
    Colo-206
   </value>
   <value>
    Colo-320 DM
   </value>
   <value>
    Colo-320 HSR
   </value>
   <value>
    Colo-357
   </value>
   <value>
    Colo-678
   </value>
   <value>
    COLO-704
   </value>
   <value>
    Colo-741
   </value>
   <value>
    Colo-829
   </value>
   <value>
    Con1
   </value>
   <value>
    CP-A hTERT
   </value>
   <value>
    CRL-2054
   </value>
   <value>
    CRMel
   </value>
   <value>
    CS-1
   </value>
   <value>
    CS-1/ER
   </value>
   <value>
    CS-1/PR
   </value>
   <value>
    CWR22Rv1
   </value>
   <value>
    CX-1
   </value>
   <value>
    D01
   </value>
   <value>
    D04
   </value>
   <value>
    D05
   </value>
   <value>
    D08
   </value>
   <value>
    D10
   </value>
   <value>
    D11
   </value>
   <value>
    D14
   </value>
   <value>
    D17
   </value>
   <value>
    D20
   </value>
   <value>
    D22
   </value>
   <value>
    D24
   </value>
   <value>
    D25
   </value>
   <value>
    D28
   </value>
   <value>
    D29
   </value>
   <value>
    D32
   </value>
   <value>
    D35
   </value>
   <value>
    D36
   </value>
   <value>
    D38
   </value>
   <value>
    D40
   </value>
   <value>
    D41
   </value>
   <value>
    DAOY
   </value>
   <value>
    DB
   </value>
   <value>
    DBTRG-05MG
   </value>
   <value>
    Detroit 551
   </value>
   <value>
    Detroit 562
   </value>
   <value>
    dH1F
   </value>
   <value>
    DLD-1
   </value>
   <value>
    DM175
   </value>
   <value>
    DM366
   </value>
   <value>
    DM368
   </value>
   <value>
    DM382
   </value>
   <value>
    DM391
   </value>
   <value>
    DM401p
   </value>
   <value>
    DM414
   </value>
   <value>
    DM422
   </value>
   <value>
    DM424
   </value>
   <value>
    DM425
   </value>
   <value>
    DM440
   </value>
   <value>
    DM443
   </value>
   <value>
    DM451
   </value>
   <value>
    DM459
   </value>
   <value>
    DM467
   </value>
   <value>
    DM497
   </value>
   <value>
    DM555
   </value>
   <value>
    DM578
   </value>
   <value>
    DM589
   </value>
   <value>
    DM59
   </value>
   <value>
    DM598
   </value>
   <value>
    DM6
   </value>
   <value>
    DM602
   </value>
   <value>
    DM608
   </value>
   <value>
    DM636
   </value>
   <value>
    DM643
   </value>
   <value>
    DM646
   </value>
   <value>
    DM711
   </value>
   <value>
    DM733
   </value>
   <value>
    DM738
   </value>
   <value>
    DM745
   </value>
   <value>
    DM751
   </value>
   <value>
    DM779
   </value>
   <value>
    DM787
   </value>
   <value>
    DM792
   </value>
   <value>
    DM798
   </value>
   <value>
    DM806
   </value>
   <value>
    DM833
   </value>
   <value>
    DM868
   </value>
   <value>
    DoHH2
   </value>
   <value>
    DU145
   </value>
   <value>
    DU4475
   </value>
   <value>
    EBC1
   </value>
   <value>
    EBV-LCL 721
   </value>
   <value>
    EC109
   </value>
   <value>
    EES-1
   </value>
   <value>
    EFM19
   </value>
   <value>
    EFM192A
   </value>
   <value>
    EFO21
   </value>
   <value>
    EKVX
   </value>
   <value>
    Eol1
   </value>
   <value>
    EREB2-5
   </value>
   <value>
    ES-2
   </value>
   <value>
    EVSA
   </value>
   <value>
    FaDu
   </value>
   <value>
    Farage
   </value>
   <value>
    FarageX1
   </value>
   <value>
    FG
   </value>
   <value>
    fibroblast derived cell line
   </value>
   <value>
    FL
   </value>
   <value>
    FU-OV-1
   </value>
   <value>
    Fu97
   </value>
   <value>
    G111
   </value>
   <value>
    G112
   </value>
   <value>
    G118
   </value>
   <value>
    G120
   </value>
   <value>
    G121
   </value>
   <value>
    G122
   </value>
   <value>
    G124
   </value>
   <value>
    G130
   </value>
   <value>
    G140
   </value>
   <value>
    G141
   </value>
   <value>
    G142
   </value>
   <value>
    G144-NS
   </value>
   <value>
    G166-NS
   </value>
   <value>
    G174-NS
   </value>
   <value>
    G179-NS
   </value>
   <value>
    G22
   </value>
   <value>
    G28T
   </value>
   <value>
    G361
   </value>
   <value>
    G44
   </value>
   <value>
    G59
   </value>
   <value>
    G61
   </value>
   <value>
    G63
   </value>
   <value>
    G84
   </value>
   <value>
    G96
   </value>
   <value>
    GBS6
   </value>
   <value>
    GI-LI-N
   </value>
   <value>
    GI-ME-N
   </value>
   <value>
    GliNS1
   </value>
   <value>
    GliNS2
   </value>
   <value>
    GM
   </value>
   <value>
    GM00144
   </value>
   <value>
    GM01652C
   </value>
   <value>
    GM02036A
   </value>
   <value>
    GM02767
   </value>
   <value>
    GM03348E
   </value>
   <value>
    GM03349C
   </value>
   <value>
    GM03377
   </value>
   <value>
    GM04981
   </value>
   <value>
    GM06944
   </value>
   <value>
    GM06985
   </value>
   <value>
    GM06993
   </value>
   <value>
    GM06994
   </value>
   <value>
    GM07000
   </value>
   <value>
    GM07022
   </value>
   <value>
    GM07034
   </value>
   <value>
    GM07055
   </value>
   <value>
    GM07056
   </value>
   <value>
    GM07345
   </value>
   <value>
    GM07357
   </value>
   <value>
    GM08398A
   </value>
   <value>
    GM11829
   </value>
   <value>
    GM11830
   </value>
   <value>
    GM11831
   </value>
   <value>
    GM11832
   </value>
   <value>
    GM11839
   </value>
   <value>
    GM11840
   </value>
   <value>
    GM11881
   </value>
   <value>
    GM11882
   </value>
   <value>
    GM11992
   </value>
   <value>
    GM11993
   </value>
   <value>
    GM11994
   </value>
   <value>
    GM11995
   </value>
   <value>
    GM12003
   </value>
   <value>
    GM12004
   </value>
   <value>
    GM12005
   </value>
   <value>
    GM12006
   </value>
   <value>
    GM12043
   </value>
   <value>
    GM12044
   </value>
   <value>
    GM12056
   </value>
   <value>
    GM12057
   </value>
   <value>
    GM12144
   </value>
   <value>
    GM12145
   </value>
   <value>
    GM12146
   </value>
   <value>
    GM12154
   </value>
   <value>
    GM12155
   </value>
   <value>
    GM12156
   </value>
   <value>
    GM12234
   </value>
   <value>
    GM12236
   </value>
   <value>
    GM12239
   </value>
   <value>
    GM12248
   </value>
   <value>
    GM12249
   </value>
   <value>
    GM12264
   </value>
   <value>
    GM12716
   </value>
   <value>
    GM12717
   </value>
   <value>
    GM12750
   </value>
   <value>
    GM12751
   </value>
   <value>
    GM12760
   </value>
   <value>
    GM12761
   </value>
   <value>
    GM12762
   </value>
   <value>
    GM12763
   </value>
   <value>
    GM12812
   </value>
   <value>
    GM12813
   </value>
   <value>
    GM12814
   </value>
   <value>
    GM12815
   </value>
   <value>
    GM12872
   </value>
   <value>
    GM12873
   </value>
   <value>
    GM12874
   </value>
   <value>
    GM12875
   </value>
   <value>
    GM12891
   </value>
   <value>
    GM12892
   </value>
   <value>
    GM14381
   </value>
   <value>
    GM14382
   </value>
   <value>
    GM14405
   </value>
   <value>
    GM14406
   </value>
   <value>
    GM14408
   </value>
   <value>
    GM14409
   </value>
   <value>
    GM14414
   </value>
   <value>
    GM14417
   </value>
   <value>
    GM14432
   </value>
   <value>
    GM14433
   </value>
   <value>
    GM14439
   </value>
   <value>
    GM14440
   </value>
   <value>
    GM14447
   </value>
   <value>
    GM14448
   </value>
   <value>
    GM14452
   </value>
   <value>
    GM14453
   </value>
   <value>
    GM14454
   </value>
   <value>
    GM14455
   </value>
   <value>
    GM14464
   </value>
   <value>
    GM14465
   </value>
   <value>
    GM14467
   </value>
   <value>
    GM14468
   </value>
   <value>
    GM14474
   </value>
   <value>
    GM14475
   </value>
   <value>
    GM14476
   </value>
   <value>
    GM14477
   </value>
   <value>
    GM14478
   </value>
   <value>
    GM14479
   </value>
   <value>
    GM14480
   </value>
   <value>
    GM14481
   </value>
   <value>
    GM14501
   </value>
   <value>
    GM14502
   </value>
   <value>
    GM14503
   </value>
   <value>
    GM14504
   </value>
   <value>
    GM14506
   </value>
   <value>
    GM14507
   </value>
   <value>
    GM14508
   </value>
   <value>
    GM14509
   </value>
   <value>
    GM14520
   </value>
   <value>
    GM14521
   </value>
   <value>
    GM14532
   </value>
   <value>
    GM14533
   </value>
   <value>
    GM14535
   </value>
   <value>
    GM14536
   </value>
   <value>
    GM14568
   </value>
   <value>
    GM14569
   </value>
   <value>
    GM14581
   </value>
   <value>
    GM14582
   </value>
   <value>
    GM14583
   </value>
   <value>
    GM14584
   </value>
   <value>
    GM15029
   </value>
   <value>
    GM15036
   </value>
   <value>
    GM15038
   </value>
   <value>
    GM15056
   </value>
   <value>
    GM15061
   </value>
   <value>
    GM15072
   </value>
   <value>
    GM15144
   </value>
   <value>
    GM15213
   </value>
   <value>
    GM15215
   </value>
   <value>
    GM15216
   </value>
   <value>
    GM15221
   </value>
   <value>
    GM15223
   </value>
   <value>
    GM15224
   </value>
   <value>
    GM15226
   </value>
   <value>
    GM15227
   </value>
   <value>
    GM15236
   </value>
   <value>
    GM15242
   </value>
   <value>
    GM15245
   </value>
   <value>
    GM15268
   </value>
   <value>
    GM15324
   </value>
   <value>
    GM15385
   </value>
   <value>
    GM15386
   </value>
   <value>
    GM15510
   </value>
   <value>
    GM15590
   </value>
   <value>
    GM15850
   </value>
   <value>
    GM15851
   </value>
   <value>
    GM17102
   </value>
   <value>
    GM17103
   </value>
   <value>
    GM17104
   </value>
   <value>
    GM17105
   </value>
   <value>
    GM17106
   </value>
   <value>
    GM17107
   </value>
   <value>
    GM17108
   </value>
   <value>
    GM17109
   </value>
   <value>
    GM17110
   </value>
   <value>
    GM17111
   </value>
   <value>
    GM17112
   </value>
   <value>
    GM17113
   </value>
   <value>
    GM17114
   </value>
   <value>
    GM17115
   </value>
   <value>
    GM17116
   </value>
   <value>
    GM17117
   </value>
   <value>
    GM17118
   </value>
   <value>
    GM17119
   </value>
   <value>
    GM17121
   </value>
   <value>
    GM17122
   </value>
   <value>
    GM17124
   </value>
   <value>
    GM17125
   </value>
   <value>
    GM17126
   </value>
   <value>
    GM17127
   </value>
   <value>
    GM17129
   </value>
   <value>
    GM17130
   </value>
   <value>
    GM17131
   </value>
   <value>
    GM17132
   </value>
   <value>
    GM17133
   </value>
   <value>
    GM17134
   </value>
   <value>
    GM17135
   </value>
   <value>
    GM17136
   </value>
   <value>
    GM17137
   </value>
   <value>
    GM17138
   </value>
   <value>
    GM17139
   </value>
   <value>
    GM17140
   </value>
   <value>
    GM17141
   </value>
   <value>
    GM17142
   </value>
   <value>
    GM17143
   </value>
   <value>
    GM17144
   </value>
   <value>
    GM17145
   </value>
   <value>
    GM17146
   </value>
   <value>
    GM17147
   </value>
   <value>
    GM17148
   </value>
   <value>
    GM17149
   </value>
   <value>
    GM17150
   </value>
   <value>
    GM17154
   </value>
   <value>
    GM17155
   </value>
   <value>
    GM17156
   </value>
   <value>
    GM17157
   </value>
   <value>
    GM17158
   </value>
   <value>
    GM17159
   </value>
   <value>
    GM17160
   </value>
   <value>
    GM17161
   </value>
   <value>
    GM17162
   </value>
   <value>
    GM17163
   </value>
   <value>
    GM17164
   </value>
   <value>
    GM17165
   </value>
   <value>
    GM17166
   </value>
   <value>
    GM17167
   </value>
   <value>
    GM17168
   </value>
   <value>
    GM17170
   </value>
   <value>
    GM17171
   </value>
   <value>
    GM17172
   </value>
   <value>
    GM17176
   </value>
   <value>
    GM17177
   </value>
   <value>
    GM17179
   </value>
   <value>
    GM17180
   </value>
   <value>
    GM17181
   </value>
   <value>
    GM17182
   </value>
   <value>
    GM17183
   </value>
   <value>
    GM17184
   </value>
   <value>
    GM17185
   </value>
   <value>
    GM17186
   </value>
   <value>
    GM17187
   </value>
   <value>
    GM17188
   </value>
   <value>
    GM17189
   </value>
   <value>
    GM17190
   </value>
   <value>
    GM17192
   </value>
   <value>
    GM17196
   </value>
   <value>
    GM17197
   </value>
   <value>
    GM17198
   </value>
   <value>
    GM17199
   </value>
   <value>
    GM17201
   </value>
   <value>
    GM17202
   </value>
   <value>
    GM17203
   </value>
   <value>
    GM17204
   </value>
   <value>
    GM17205
   </value>
   <value>
    GM17206
   </value>
   <value>
    GM17207
   </value>
   <value>
    GM17208
   </value>
   <value>
    GM17209
   </value>
   <value>
    GM17210
   </value>
   <value>
    GM17211
   </value>
   <value>
    GM17212
   </value>
   <value>
    GM17213
   </value>
   <value>
    GM17214
   </value>
   <value>
    GM17215
   </value>
   <value>
    GM17216
   </value>
   <value>
    GM17217
   </value>
   <value>
    GM17218
   </value>
   <value>
    GM17220
   </value>
   <value>
    GM17221
   </value>
   <value>
    GM17222
   </value>
   <value>
    GM17223
   </value>
   <value>
    GM17224
   </value>
   <value>
    GM17225
   </value>
   <value>
    GM17226
   </value>
   <value>
    GM17227
   </value>
   <value>
    GM17228
   </value>
   <value>
    GM17229
   </value>
   <value>
    GM17230
   </value>
   <value>
    GM17231
   </value>
   <value>
    GM17232
   </value>
   <value>
    GM17233
   </value>
   <value>
    GM17234
   </value>
   <value>
    GM17235
   </value>
   <value>
    GM17236
   </value>
   <value>
    GM17237
   </value>
   <value>
    GM17238
   </value>
   <value>
    GM17239
   </value>
   <value>
    GM17240
   </value>
   <value>
    GM17241
   </value>
   <value>
    GM17242
   </value>
   <value>
    GM17243
   </value>
   <value>
    GM17244
   </value>
   <value>
    GM17245
   </value>
   <value>
    GM17246
   </value>
   <value>
    GM17247
   </value>
   <value>
    GM17248
   </value>
   <value>
    GM17249
   </value>
   <value>
    GM17250
   </value>
   <value>
    GM17251
   </value>
   <value>
    GM17252
   </value>
   <value>
    GM17253
   </value>
   <value>
    GM17254
   </value>
   <value>
    GM17255
   </value>
   <value>
    GM17256
   </value>
   <value>
    GM17257
   </value>
   <value>
    GM17258
   </value>
   <value>
    GM17259
   </value>
   <value>
    GM17260
   </value>
   <value>
    GM17261
   </value>
   <value>
    GM17263
   </value>
   <value>
    GM17264
   </value>
   <value>
    GM17265
   </value>
   <value>
    GM17266
   </value>
   <value>
    GM17267
   </value>
   <value>
    GM17268
   </value>
   <value>
    GM17269
   </value>
   <value>
    GM17270
   </value>
   <value>
    GM17272
   </value>
   <value>
    GM17274
   </value>
   <value>
    GM17275
   </value>
   <value>
    GM17276
   </value>
   <value>
    GM17278
   </value>
   <value>
    GM17281
   </value>
   <value>
    GM17282
   </value>
   <value>
    GM17283
   </value>
   <value>
    GM17284
   </value>
   <value>
    GM17285
   </value>
   <value>
    GM17286
   </value>
   <value>
    GM17288
   </value>
   <value>
    GM17290
   </value>
   <value>
    GM17733
   </value>
   <value>
    GM17734
   </value>
   <value>
    GM17735
   </value>
   <value>
    GM17736
   </value>
   <value>
    GM17737
   </value>
   <value>
    GM17738
   </value>
   <value>
    GM17739
   </value>
   <value>
    GM17741
   </value>
   <value>
    GM17742
   </value>
   <value>
    GM17743
   </value>
   <value>
    GM17744
   </value>
   <value>
    GM17745
   </value>
   <value>
    GM17746
   </value>
   <value>
    GM17747
   </value>
   <value>
    GM17749
   </value>
   <value>
    GM17752
   </value>
   <value>
    GM17753
   </value>
   <value>
    GM17754
   </value>
   <value>
    GM17755
   </value>
   <value>
    GM17757
   </value>
   <value>
    GM17759
   </value>
   <value>
    GM17761
   </value>
   <value>
    GM17762
   </value>
   <value>
    GM17764
   </value>
   <value>
    GM17765
   </value>
   <value>
    GM17766
   </value>
   <value>
    GM17767
   </value>
   <value>
    GM17768
   </value>
   <value>
    GM17769
   </value>
   <value>
    GM17770
   </value>
   <value>
    GM17771
   </value>
   <value>
    GM17773
   </value>
   <value>
    GM17774
   </value>
   <value>
    GM17775
   </value>
   <value>
    GM17776
   </value>
   <value>
    GM17779
   </value>
   <value>
    GM17780
   </value>
   <value>
    GM17782
   </value>
   <value>
    GM17783
   </value>
   <value>
    GM17785
   </value>
   <value>
    GM17787
   </value>
   <value>
    GM17789
   </value>
   <value>
    GM17790
   </value>
   <value>
    GM17791
   </value>
   <value>
    GM17792
   </value>
   <value>
    GM17793
   </value>
   <value>
    GM17794
   </value>
   <value>
    GM17795
   </value>
   <value>
    GM17796
   </value>
   <value>
    GM17797
   </value>
   <value>
    GM17798
   </value>
   <value>
    GM17799
   </value>
   <value>
    GM17800
   </value>
   <value>
    GM17801
   </value>
   <value>
    GM17802
   </value>
   <value>
    GM17803
   </value>
   <value>
    GM17804
   </value>
   <value>
    GM17805
   </value>
   <value>
    GM17806
   </value>
   <value>
    GM17807
   </value>
   <value>
    GM17808
   </value>
   <value>
    GM17809
   </value>
   <value>
    GM17810
   </value>
   <value>
    GM17811
   </value>
   <value>
    GM17812
   </value>
   <value>
    GM17814
   </value>
   <value>
    GM17815
   </value>
   <value>
    GM17816
   </value>
   <value>
    GM17817
   </value>
   <value>
    GM17818
   </value>
   <value>
    GM17823
   </value>
   <value>
    GM17825
   </value>
   <value>
    GM17826
   </value>
   <value>
    GM17828
   </value>
   <value>
    GM17833
   </value>
   <value>
    GM17835
   </value>
   <value>
    GM17838
   </value>
   <value>
    GM2036A
   </value>
   <value>
    GM5659
   </value>
   <value>
    GOTO
   </value>
   <value>
    Granta-519
   </value>
   <value>
    GS-1
   </value>
   <value>
    GS-10
   </value>
   <value>
    GS-11
   </value>
   <value>
    GS-12
   </value>
   <value>
    GS-2
   </value>
   <value>
    GS-3
   </value>
   <value>
    GS-3 clone
   </value>
   <value>
    GS-4
   </value>
   <value>
    GS-5
   </value>
   <value>
    GS-6
   </value>
   <value>
    GS-7
   </value>
   <value>
    GS-7 clone
   </value>
   <value>
    GS-8
   </value>
   <value>
    GS-9
   </value>
   <value>
    H1
   </value>
   <value>
    H1112
   </value>
   <value>
    H1155
   </value>
   <value>
    H125
   </value>
   <value>
    H13B
   </value>
   <value>
    H1435
   </value>
   <value>
    H1437
   </value>
   <value>
    H14A
   </value>
   <value>
    H1568
   </value>
   <value>
    H157
   </value>
   <value>
    H1618
   </value>
   <value>
    H1650
   </value>
   <value>
    H1651
   </value>
   <value>
    H1666
   </value>
   <value>
    H1703
   </value>
   <value>
    H1781
   </value>
   <value>
    H1793
   </value>
   <value>
    H1819
   </value>
   <value>
    H1838
   </value>
   <value>
    H187
   </value>
   <value>
    H1993
   </value>
   <value>
    H1L
   </value>
   <value>
    H2009
   </value>
   <value>
    H2030
   </value>
   <value>
    H209
   </value>
   <value>
    H2122
   </value>
   <value>
    H2126
   </value>
   <value>
    H226
   </value>
   <value>
    H23
   </value>
   <value>
    H2347
   </value>
   <value>
    H2405
   </value>
   <value>
    H292
   </value>
   <value>
    H295R
   </value>
   <value>
    H322c
   </value>
   <value>
    H322T
   </value>
   <value>
    H358
   </value>
   <value>
    H4
   </value>
   <value>
    H441
   </value>
   <value>
    H446
   </value>
   <value>
    H460
   </value>
   <value>
    H520
   </value>
   <value>
    H522
   </value>
   <value>
    H526
   </value>
   <value>
    H596
   </value>
   <value>
    H647
   </value>
   <value>
    H650
   </value>
   <value>
    H661
   </value>
   <value>
    H69
   </value>
   <value>
    H720
   </value>
   <value>
    H82
   </value>
   <value>
    H838
   </value>
   <value>
    H9
   </value>
   <value>
    H9-derived
   </value>
   <value>
    H929
   </value>
   <value>
    HaCaT
   </value>
   <value>
    HANK
   </value>
   <value>
    hBEC
   </value>
   <value>
    HBEC2
   </value>
   <value>
    HBEC2-E
   </value>
   <value>
    HBEC2-KT
   </value>
   <value>
    HBEC3
   </value>
   <value>
    HBEC3-ET
   </value>
   <value>
    HBEC3-KT
   </value>
   <value>
    HBEC4
   </value>
   <value>
    HBEC4-KT
   </value>
   <value>
    HBEC5-KT
   </value>
   <value>
    HBL-2
   </value>
   <value>
    HCC-1008
   </value>
   <value>
    HCC-1143
   </value>
   <value>
    HCC-1395
   </value>
   <value>
    HCC-1396
   </value>
   <value>
    HCC-1402
   </value>
   <value>
    HCC-1419
   </value>
   <value>
    HCC-1428
   </value>
   <value>
    HCC-1500
   </value>
   <value>
    HCC-1569
   </value>
   <value>
    HCC-1599
   </value>
   <value>
    HCC-1806
   </value>
   <value>
    HCC-1937
   </value>
   <value>
    HCC-1954
   </value>
   <value>
    HCC-202
   </value>
   <value>
    HCC-2218
   </value>
   <value>
    HCC-38
   </value>
   <value>
    HCC-70
   </value>
   <value>
    HCT-116
   </value>
   <value>
    HCT-15
   </value>
   <value>
    HCT-29
   </value>
   <value>
    HCT-8
   </value>
   <value>
    HCT-8Sa
   </value>
   <value>
    HD90/FE07-142-L1
   </value>
   <value>
    HDLM-2
   </value>
   <value>
    HDQP1
   </value>
   <value>
    Hec50
   </value>
   <value>
    Hec50co
   </value>
   <value>
    HEK-293
   </value>
   <value>
    HEK-293 clone
   </value>
   <value>
    HEK-293-2C6
   </value>
   <value>
    HEK-293H
   </value>
   <value>
    HEK-293T
   </value>
   <value>
    HEK-TLR2
   </value>
   <value>
    HeLa
   </value>
   <value>
    HeLa clone
   </value>
   <value>
    HeLa-S3
   </value>
   <value>
    Hep-3B
   </value>
   <value>
    HepaRG
   </value>
   <value>
    HepG2
   </value>
   <value>
    HepG2/C3A
   </value>
   <value>
    hES-T3
   </value>
   <value>
    hESC BG01
   </value>
   <value>
    hESC BG03
   </value>
   <value>
    HET-1A
   </value>
   <value>
    HeyA8
   </value>
   <value>
    hf240-NS
   </value>
   <value>
    hf286-NS
   </value>
   <value>
    hf289-NS
   </value>
   <value>
    HFF1
   </value>
   <value>
    hFOB
   </value>
   <value>
    HG23
   </value>
   <value>
    HGADFN003
   </value>
   <value>
    HGADFN127
   </value>
   <value>
    HGADFN155
   </value>
   <value>
    HGADFN167
   </value>
   <value>
    HGADFN188
   </value>
   <value>
    HGC-27
   </value>
   <value>
    HIGK
   </value>
   <value>
    hiPS
   </value>
   <value>
    hiPS 17914 line E
   </value>
   <value>
    hiPS 17914 line G
   </value>
   <value>
    hiPS 3975
   </value>
   <value>
    hiPS line 1
   </value>
   <value>
    hiPS line 18
   </value>
   <value>
    hiPS line 2
   </value>
   <value>
    HK-2
   </value>
   <value>
    HK-Hep1
   </value>
   <value>
    HL60
   </value>
   <value>
    HLF-A
   </value>
   <value>
    HME
   </value>
   <value>
    HMEC
   </value>
   <value>
    HMF3A
   </value>
   <value>
    HMLER
   </value>
   <value>
    HOP18
   </value>
   <value>
    HOP62
   </value>
   <value>
    HOP92
   </value>
   <value>
    Hotz
   </value>
   <value>
    HP75
   </value>
   <value>
    HPAC
   </value>
   <value>
    HPAF-II
   </value>
   <value>
    HS181
   </value>
   <value>
    HS27a
   </value>
   <value>
    Hs294T
   </value>
   <value>
    HS5
   </value>
   <value>
    HS578T
   </value>
   <value>
    HS683
   </value>
   <value>
    Hs683
   </value>
   <value>
    Hs695T
   </value>
   <value>
    Hs746T
   </value>
   <value>
    HS766t
   </value>
   <value>
    HSB2
   </value>
   <value>
    HSC-3
   </value>
   <value>
    HSF1
   </value>
   <value>
    HT
   </value>
   <value>
    HT-29
   </value>
   <value>
    HT1080
   </value>
   <value>
    HT144
   </value>
   <value>
    HT29 CL.16E
   </value>
   <value>
    HT55
   </value>
   <value>
    HTB-58
   </value>
   <value>
    hTERT-immortalized BPEC
   </value>
   <value>
    HTETOP
   </value>
   <value>
    HTR8
   </value>
   <value>
    Hues9
   </value>
   <value>
    Huh7
   </value>
   <value>
    Huh7.5
   </value>
   <value>
    HuPT3
   </value>
   <value>
    HuT-102
   </value>
   <value>
    HuT-78
   </value>
   <value>
    huvec
   </value>
   <value>
    I83E95
   </value>
   <value>
    IGROV
   </value>
   <value>
    IGROV-1
   </value>
   <value>
    IM-9
   </value>
   <value>
    IM-95
   </value>
   <value>
    IMC-1
   </value>
   <value>
    IMR-32
   </value>
   <value>
    IMR-32-DKK1
   </value>
   <value>
    IMR90
   </value>
   <value>
    IOSE
   </value>
   <value>
    iPSC 15
   </value>
   <value>
    iPSC 1i
   </value>
   <value>
    iPSC 1M
   </value>
   <value>
    iPSC 4
   </value>
   <value>
    iPSC 9
   </value>
   <value>
    iPSC clone 3975.4
   </value>
   <value>
    iPSC clone IMR9.4
   </value>
   <value>
    iPSC T4
   </value>
   <value>
    Ishikawa
   </value>
   <value>
    Ishikawa H
   </value>
   <value>
    Ist1
   </value>
   <value>
    JEG-3
   </value>
   <value>
    JeKo-1
   </value>
   <value>
    Jeko-1
   </value>
   <value>
    JIM3
   </value>
   <value>
    Jurkat
   </value>
   <value>
    Jurkat/IM-9/Raji/THP-1
   </value>
   <value>
    K562
   </value>
   <value>
    KAI3
   </value>
   <value>
    Karpas-1106P
   </value>
   <value>
    Karpas-422
   </value>
   <value>
    KG1
   </value>
   <value>
    KHYG1
   </value>
   <value>
    Kit225
   </value>
   <value>
    KM12
   </value>
   <value>
    KMH2
   </value>
   <value>
    KMS11
   </value>
   <value>
    KMS12
   </value>
   <value>
    KNS62
   </value>
   <value>
    KPL-1
   </value>
   <value>
    KPL-4
   </value>
   <value>
    KTCL 140
   </value>
   <value>
    KTCL 26
   </value>
   <value>
    KYSE-140
   </value>
   <value>
    L-1236
   </value>
   <value>
    L-428
   </value>
   <value>
    L-540
   </value>
   <value>
    L3.6pl
   </value>
   <value>
    LAN-1
   </value>
   <value>
    LB84-1
   </value>
   <value>
    LI90
   </value>
   <value>
    line 18
   </value>
   <value>
    line1
   </value>
   <value>
    line2
   </value>
   <value>
    LL24
   </value>
   <value>
    LL47
   </value>
   <value>
    LL86
   </value>
   <value>
    LM1
   </value>
   <value>
    LM2
   </value>
   <value>
    LN18
   </value>
   <value>
    LN215
   </value>
   <value>
    LN229
   </value>
   <value>
    LN235
   </value>
   <value>
    LN319
   </value>
   <value>
    LN340
   </value>
   <value>
    LN382
   </value>
   <value>
    LN443
   </value>
   <value>
    LN444
   </value>
   <value>
    LN464
   </value>
   <value>
    LNCaP
   </value>
   <value>
    LNCaP late passage (LP50)
   </value>
   <value>
    LNZ308
   </value>
   <value>
    LOVO
   </value>
   <value>
    LOX-IMVI
   </value>
   <value>
    LP1
   </value>
   <value>
    LS1034
   </value>
   <value>
    LS174T
   </value>
   <value>
    LS180
   </value>
   <value>
    LS2 derived
   </value>
   <value>
    LXFL529
   </value>
   <value>
    M059J
   </value>
   <value>
    M059K
   </value>
   <value>
    M12
   </value>
   <value>
    M202
   </value>
   <value>
    M202R1
   </value>
   <value>
    M29
   </value>
   <value>
    Malme-3M
   </value>
   <value>
    MC116
   </value>
   <value>
    MCF-10A
   </value>
   <value>
    MCF-10A MycER
   </value>
   <value>
    MCF-10F
   </value>
   <value>
    MCF-7
   </value>
   <value>
    MCF-7-14
   </value>
   <value>
    MCF-7-DN-CLIM-TetOff
   </value>
   <value>
    MCF-7-FR
   </value>
   <value>
    MCF-7-G11TamR
   </value>
   <value>
    MCF-7:2A
   </value>
   <value>
    MCF-7:5C
   </value>
   <value>
    MCF-7R4
   </value>
   <value>
    MCH58
   </value>
   <value>
    MDA-MB-134VI
   </value>
   <value>
    MDA-MB-157
   </value>
   <value>
    MDA-MB-175
   </value>
   <value>
    MDA-MB-231
   </value>
   <value>
    MDA-MB-361
   </value>
   <value>
    MDA-MB-415
   </value>
   <value>
    MDA-MB-435
   </value>
   <value>
    MDA-MB-436
   </value>
   <value>
    MDA-MB-453
   </value>
   <value>
    MDA-MB-468
   </value>
   <value>
    MDA-MB-468GFP-LN
   </value>
   <value>
    MDST8
   </value>
   <value>
    ME180
   </value>
   <value>
    ME181
   </value>
   <value>
    ME182
   </value>
   <value>
    ME183
   </value>
   <value>
    ME184
   </value>
   <value>
    ME185
   </value>
   <value>
    MEG-01
   </value>
   <value>
    Met5A
   </value>
   <value>
    MeWo
   </value>
   <value>
    MFM-223
   </value>
   <value>
    MHH-PREB-1
   </value>
   <value>
    MIA PaCa2
   </value>
   <value>
    Mino
   </value>
   <value>
    MKN-1
   </value>
   <value>
    MKN-28
   </value>
   <value>
    MKN-45
   </value>
   <value>
    MKN-7
   </value>
   <value>
    MKN-74
   </value>
   <value>
    MkTBr
   </value>
   <value>
    ML-4
   </value>
   <value>
    ML-5
   </value>
   <value>
    ML-8
   </value>
   <value>
    ML-9
   </value>
   <value>
    MM.1R
   </value>
   <value>
    MM.1S
   </value>
   <value>
    MM.1s
   </value>
   <value>
    MM127
   </value>
   <value>
    MM170
   </value>
   <value>
    MM200
   </value>
   <value>
    MM229
   </value>
   <value>
    MM253
   </value>
   <value>
    MM329
   </value>
   <value>
    MM370
   </value>
   <value>
    MM383
   </value>
   <value>
    MM386
   </value>
   <value>
    MM415
   </value>
   <value>
    MM426
   </value>
   <value>
    MM455
   </value>
   <value>
    MM466
   </value>
   <value>
    MM473
   </value>
   <value>
    MM485
   </value>
   <value>
    MM537
   </value>
   <value>
    MM540
   </value>
   <value>
    MM548
   </value>
   <value>
    MM576
   </value>
   <value>
    MM595
   </value>
   <value>
    MM603
   </value>
   <value>
    MM608
   </value>
   <value>
    MM622
   </value>
   <value>
    MM648
   </value>
   <value>
    MM649
   </value>
   <value>
    MM96L
   </value>
   <value>
    MOLT-3
   </value>
   <value>
    MOLT4
   </value>
   <value>
    MonoMac 6
   </value>
   <value>
    Mpanc-96
   </value>
   <value>
    MRC-5
   </value>
   <value>
    MSK-Leuk1
   </value>
   <value>
    MT-1
   </value>
   <value>
    MT-2
   </value>
   <value>
    MT-3
   </value>
   <value>
    MT-4
   </value>
   <value>
    N1
   </value>
   <value>
    N2
   </value>
   <value>
    N3
   </value>
   <value>
    N4
   </value>
   <value>
    N5
   </value>
   <value>
    Namalwa
   </value>
   <value>
    NAN
   </value>
   <value>
    NB4
   </value>
   <value>
    NB69
   </value>
   <value>
    NB9
   </value>
   <value>
    NCI-H1299
   </value>
   <value>
    NCI-N87
   </value>
   <value>
    NCR-EW2
   </value>
   <value>
    NCR-EW3
   </value>
   <value>
    NGP
   </value>
   <value>
    NHDF 17914
   </value>
   <value>
    NHDF1
   </value>
   <value>
    NK-YS
   </value>
   <value>
    NK92
   </value>
   <value>
    NOMO-1
   </value>
   <value>
    Nor-P1
   </value>
   <value>
    NPC 5-8F
   </value>
   <value>
    NPrEC
   </value>
   <value>
    NRS-1
   </value>
   <value>
    NT-1
   </value>
   <value>
    NT2/D1
   </value>
   <value>
    NU-DHL-1
   </value>
   <value>
    NU-DUL-1
   </value>
   <value>
    NUGC3
   </value>
   <value>
    NUGC4
   </value>
   <value>
    NZM12
   </value>
   <value>
    NZM15
   </value>
   <value>
    OCI AML2
   </value>
   <value>
    Oci-Ly-19
   </value>
   <value>
    OCM-1
   </value>
   <value>
    OCUB-M
   </value>
   <value>
    OCUM1
   </value>
   <value>
    OPM1
   </value>
   <value>
    OPM2
   </value>
   <value>
    OV90
   </value>
   <value>
    OVCA429
   </value>
   <value>
    OVCAR-8
   </value>
   <value>
    OVCAR3
   </value>
   <value>
    P493-6
   </value>
   <value>
    Panc 1
   </value>
   <value>
    Panc 10.05
   </value>
   <value>
    Panc 2.03
   </value>
   <value>
    Panc 2.13
   </value>
   <value>
    Panc 3.03
   </value>
   <value>
    Panc 3.27
   </value>
   <value>
    Panc 4.03
   </value>
   <value>
    Panc 5.04
   </value>
   <value>
    Panc 8.13
   </value>
   <value>
    PaTu8902
   </value>
   <value>
    PaTu8988s
   </value>
   <value>
    PaTu8988t
   </value>
   <value>
    PC-3
   </value>
   <value>
    PC-3MM2
   </value>
   <value>
    PCSC-1
   </value>
   <value>
    PCSC-2
   </value>
   <value>
    PCSC-3
   </value>
   <value>
    PDB
   </value>
   <value>
    PDB1lox_17
   </value>
   <value>
    PDB1lox_21
   </value>
   <value>
    PDB1lox_22
   </value>
   <value>
    PDB1lox_5
   </value>
   <value>
    PEER
   </value>
   <value>
    Pfeiffer
   </value>
   <value>
    PGF
   </value>
   <value>
    PL45
   </value>
   <value>
    PLC-PRL
   </value>
   <value>
    PLC/PRF/5
   </value>
   <value>
    PLC8024
   </value>
   <value>
    pMIP3 line 3
   </value>
   <value>
    PreB 697 R4G4
   </value>
   <value>
    PRMel
   </value>
   <value>
    PSN1
   </value>
   <value>
    Ptci
   </value>
   <value>
    R11
   </value>
   <value>
    R18
   </value>
   <value>
    R28
   </value>
   <value>
    R43
   </value>
   <value>
    R46
   </value>
   <value>
    R8
   </value>
   <value>
    Raji
   </value>
   <value>
    Ramos
   </value>
   <value>
    RC-K8
   </value>
   <value>
    RCC4
   </value>
   <value>
    RD-ES
   </value>
   <value>
    REC-1
   </value>
   <value>
    Reh
   </value>
   <value>
    ReNCell
   </value>
   <value>
    RERF-LC-AD1
   </value>
   <value>
    RERF-LC-KJ
   </value>
   <value>
    RERF-LC-MS
   </value>
   <value>
    RERF-LC-OK
   </value>
   <value>
    RerfGC1B
   </value>
   <value>
    RI-1
   </value>
   <value>
    RKO
   </value>
   <value>
    RKOAS451
   </value>
   <value>
    RL
   </value>
   <value>
    round5 A2780
   </value>
   <value>
    RPMI-7951
   </value>
   <value>
    RPMI-8226
   </value>
   <value>
    RWPE1
   </value>
   <value>
    S462
   </value>
   <value>
    SA01
   </value>
   <value>
    SACHI
   </value>
   <value>
    SAOS
   </value>
   <value>
    Saos-2
   </value>
   <value>
    SC-1
   </value>
   <value>
    SCC-3
   </value>
   <value>
    SCC1
   </value>
   <value>
    SCC4
   </value>
   <value>
    SCC47
   </value>
   <value>
    SCC74A
   </value>
   <value>
    SCCH-196
   </value>
   <value>
    SCH
   </value>
   <value>
    Sez-4
   </value>
   <value>
    SF268
   </value>
   <value>
    SF539
   </value>
   <value>
    SF763
   </value>
   <value>
    SH-EP2
   </value>
   <value>
    SH-SY5Y
   </value>
   <value>
    SH-SY5Y-A
   </value>
   <value>
    SH-SY5Y-E
   </value>
   <value>
    SH-SY5Y/TrkA
   </value>
   <value>
    SHEP-21N
   </value>
   <value>
    SHEP-Tet21N
   </value>
   <value>
    SiHa
   </value>
   <value>
    Sk-Br-3
   </value>
   <value>
    Sk-Br-31
   </value>
   <value>
    SK-CO-1
   </value>
   <value>
    SK-ES-1
   </value>
   <value>
    SK-MEL-13
   </value>
   <value>
    SK-Mel-28
   </value>
   <value>
    Sk-Mel-28
   </value>
   <value>
    SK-MEL-31
   </value>
   <value>
    SK-MEL-5
   </value>
   <value>
    SK-N-AS
   </value>
   <value>
    SK-N-AS-NmycER
   </value>
   <value>
    SK-N-BE2(C)
   </value>
   <value>
    SK-N-F1
   </value>
   <value>
    SK-N-MC
   </value>
   <value>
    SK-N-SH
   </value>
   <value>
    SK23
   </value>
   <value>
    SKGT4
   </value>
   <value>
    SKM-1
   </value>
   <value>
    SKOV
   </value>
   <value>
    SKOV-3
   </value>
   <value>
    SKRC39
   </value>
   <value>
    SKRC45
   </value>
   <value>
    SKRC47
   </value>
   <value>
    SKRC54
   </value>
   <value>
    SKVCR 2.0
   </value>
   <value>
    SN12C
   </value>
   <value>
    SNK-6
   </value>
   <value>
    SNK1
   </value>
   <value>
    SNT-13
   </value>
   <value>
    SNT-15
   </value>
   <value>
    SNT-8
   </value>
   <value>
    SNU1
   </value>
   <value>
    SNU5
   </value>
   <value>
    SNU719
   </value>
   <value>
    Sosp-9607
   </value>
   <value>
    SR
   </value>
   <value>
    ST88-14
   </value>
   <value>
    SU-DHL-1
   </value>
   <value>
    SU-DHL-10
   </value>
   <value>
    SU-DHL-16
   </value>
   <value>
    SU-DHL-4
   </value>
   <value>
    SU-DHL-5
   </value>
   <value>
    SU-DHL-6
   </value>
   <value>
    SU-DHL-8
   </value>
   <value>
    SU86.86
   </value>
   <value>
    Susa
   </value>
   <value>
    SW 1783
   </value>
   <value>
    SW1116
   </value>
   <value>
    SW1463
   </value>
   <value>
    SW1573
   </value>
   <value>
    SW1990
   </value>
   <value>
    SW2
   </value>
   <value>
    SW403
   </value>
   <value>
    SW480
   </value>
   <value>
    SW527
   </value>
   <value>
    SW620
   </value>
   <value>
    T112D
   </value>
   <value>
    T265
   </value>
   <value>
    T3
   </value>
   <value>
    T3ES
   </value>
   <value>
    T47D
   </value>
   <value>
    T47D1
   </value>
   <value>
    T84
   </value>
   <value>
    T98G
   </value>
   <value>
    Takigawa
   </value>
   <value>
    TaY
   </value>
   <value>
    TaY-E10
   </value>
   <value>
    TC-252
   </value>
   <value>
    TEM2-5
   </value>
   <value>
    TEM4-18
   </value>
   <value>
    Tesi
   </value>
   <value>
    TF-1
   </value>
   <value>
    TGCT-833K
   </value>
   <value>
    TGCT-GCT27
   </value>
   <value>
    THP-1
   </value>
   <value>
    TIG-1
   </value>
   <value>
    TIG3 TERT/deltaB-RAF:ER
   </value>
   <value>
    TK
   </value>
   <value>
    TK6
   </value>
   <value>
    TMK1
   </value>
   <value>
    Toledo
   </value>
   <value>
    TOV112D
   </value>
   <value>
    TOV21G
   </value>
   <value>
    U-118 MG
   </value>
   <value>
    U-698-M
   </value>
   <value>
    U-937
   </value>
   <value>
    U1752
   </value>
   <value>
    U2-OS
   </value>
   <value>
    U251
   </value>
   <value>
    U266
   </value>
   <value>
    U343
   </value>
   <value>
    U373
   </value>
   <value>
    U87
   </value>
   <value>
    U87L4
   </value>
   <value>
    U87MG
   </value>
   <value>
    U87R4
   </value>
   <value>
    U937
   </value>
   <value>
    U937 NB4
   </value>
   <value>
    U937 PR-9
   </value>
   <value>
    U937T
   </value>
   <value>
    UACC-893
   </value>
   <value>
    UET-13
   </value>
   <value>
    UET-13TR-EWS/ERG
   </value>
   <value>
    UET-13TR-EWS/FLI1
   </value>
   <value>
    UMCL01-101
   </value>
   <value>
    UMRC2
   </value>
   <value>
    UMRC3
   </value>
   <value>
    UPN-1
   </value>
   <value>
    UROtsa
   </value>
   <value>
    UT-15
   </value>
   <value>
    UT-7
   </value>
   <value>
    UW-1
   </value>
   <value>
    VMRCLCD
   </value>
   <value>
    WI38
   </value>
   <value>
    WIBR1
   </value>
   <value>
    WIBR2
   </value>
   <value>
    WIBR3
   </value>
   <value>
    WIBR7
   </value>
   <value>
    WM-266-4
   </value>
   <value>
    WS1
   </value>
   <value>
    WSB
   </value>
   <value>
    WSU-FSCCL
   </value>
   <value>
    WSU-NHL
   </value>
   <value>
    WSUDLCL2
   </value>
   <value>
    XG
   </value>
   <value>
    YCC1
   </value>
   <value>
    YCC11
   </value>
   <value>
    YCC16
   </value>
   <value>
    YCC17
   </value>
   <value>
    YCC19
   </value>
   <value>
    YCC2
   </value>
   <value>
    YCC20
   </value>
   <value>
    YCC6
   </value>
   <value>
    YCC7
   </value>
   <value>
    YCC9
   </value>
   <value>
    YT-N
   </value>
   <value>
    Z138
   </value>
   <value>
    ZL25
   </value>
   <value>
    ZR-75
   </value>
   <value>
    ZR-75-1
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    cell type
   </category>
   <value>
    activated B-cell
   </value>
   <value>
    acute monocytic leukaemia cell line
   </value>
   <value>
    adipose-derived stem cell
   </value>
   <value>
    adrenocortical carcinoma cell line
   </value>
   <value>
    adult T-cell leukaemia cell line
   </value>
   <value>
    AIDS-NHL-derived cell line
   </value>
   <value>
    airway epithelial cell
   </value>
   <value>
    ALL cell line
   </value>
   <value>
    alveolar cell carcinoma cell line
   </value>
   <value>
    alveolar epithelial progenitor cell
   </value>
   <value>
    alveolar leukocyte
   </value>
   <value>
    alveolar macrophage
   </value>
   <value>
    AMKL cell line
   </value>
   <value>
    AML cell line
   </value>
   <value>
    amniocyte
   </value>
   <value>
    amnion cell line
   </value>
   <value>
    aortic vascular smooth muscle cell
   </value>
   <value>
    ascites cell
   </value>
   <value>
    astrocyte  derived from cell line H9
   </value>
   <value>
    ATL-derived cell line
   </value>
   <value>
    atypical ductal hyperplasia cell line
   </value>
   <value>
    B-cell
   </value>
   <value>
    B-cell derived cell line
   </value>
   <value>
    B-cell lymphoma cell line
   </value>
   <value>
    B-lymphoblastoid cell line
   </value>
   <value>
    B-lymphocyte
   </value>
   <value>
    B-lymphocyte cell line
   </value>
   <value>
    Barrett's syndrome cell line
   </value>
   <value>
    BDCA1+ dendritic cell
   </value>
   <value>
    BDCA3+ dendritic cell
   </value>
   <value>
    BJ-derived hIPS
   </value>
   <value>
    blast
   </value>
   <value>
    blast derived from cell line H9
   </value>
   <value>
    blast/proerythroblast
   </value>
   <value>
    blast/promonocyte
   </value>
   <value>
    blast/promyelocyte
   </value>
   <value>
    blasts and mononuclear cells
   </value>
   <value>
    blood vessel endothelial cell
   </value>
   <value>
    bone marrow derived cell line
   </value>
   <value>
    bone marrow stromal cell line
   </value>
   <value>
    bone sarcoma cell line
   </value>
   <value>
    brain cancer cell line
   </value>
   <value>
    breast cancer cell line
   </value>
   <value>
    breast cell line
   </value>
   <value>
    breast epithelial cell derived cell line
   </value>
   <value>
    breast tumor cell
   </value>
   <value>
    breast tumor cell line
   </value>
   <value>
    bronchial epithelial cell derived cell line
   </value>
   <value>
    bronchioalveolar carcinoma cell line
   </value>
   <value>
    bronchiole epithelial cell line
   </value>
   <value>
    Burkitt lymphoma cell line
   </value>
   <value>
    cancer cell lines
   </value>
   <value>
    CD133+ prostate epithelial cells
   </value>
   <value>
    CD133-/alpha2 integrin low prostate epithelial cells
   </value>
   <value>
    CD133-/aplha2 integrin low prostate epithelial cells
   </value>
   <value>
    CD138 plasma cell
   </value>
   <value>
    CD138+ plasma cell
   </value>
   <value>
    CD138+ selected plasma cells
   </value>
   <value>
    CD138-purified plasma cells
   </value>
   <value>
    CD138-selected cells
   </value>
   <value>
    CD14 cells
   </value>
   <value>
    CD14 positive mononuclear cell
   </value>
   <value>
    CD14+ CD16- monocyte
   </value>
   <value>
    CD14+ monocyte
   </value>
   <value>
    CD14-positive monocyte
   </value>
   <value>
    CD14low CD16+ monocyte
   </value>
   <value>
    CD15 cells
   </value>
   <value>
    CD16 negative mononuclear cell
   </value>
   <value>
    CD16 positive mononuclear cell
   </value>
   <value>
    CD16+ dendritic
   </value>
   <value>
    CD16+ monocyte
   </value>
   <value>
    CD16- monocyte
   </value>
   <value>
    CD19+ B-cell
   </value>
   <value>
    CD19+ cell
   </value>
   <value>
    cd19+ tumor cell
   </value>
   <value>
    CD1c+ dendritic cell
   </value>
   <value>
    CD21hi transitional B cell
   </value>
   <value>
    CD21lo transitional B cell
   </value>
   <value>
    CD3 cells
   </value>
   <value>
    CD3+ T-cell
   </value>
   <value>
    CD3-positive T cell
   </value>
   <value>
    CD34 positive mononuclear
   </value>
   <value>
    CD34+ cell
   </value>
   <value>
    CD34+ cells
   </value>
   <value>
    CD34+ haematopoietic stem cell
   </value>
   <value>
    CD34+ hematopoietic progenitor cell
   </value>
   <value>
    CD34+ progenitor cell, erythrocyte
   </value>
   <value>
    CD34+ progenitor cell, proerythroblast
   </value>
   <value>
    CD34+CD19+ pro-B-cell
   </value>
   <value>
    CD34-derived erythroid progenitors
   </value>
   <value>
    CD34-negative
   </value>
   <value>
    CD36+ erythroid progenitor cell
   </value>
   <value>
    CD4 positive T-cell
   </value>
   <value>
    CD4 T cell line
   </value>
   <value>
    CD4 T-cell
   </value>
   <value>
    CD4+ cell
   </value>
   <value>
    CD4+ T-cell
   </value>
   <value>
    CD41 negative portion
   </value>
   <value>
    CD41+ cord blood derived megakaryocytes
   </value>
   <value>
    CD4CD45RO T-cell
   </value>
   <value>
    CD8 positive T-cell
   </value>
   <value>
    CD8 T-cell
   </value>
   <value>
    CD8+ cell
   </value>
   <value>
    CD8+ central memory T cell
   </value>
   <value>
    CD8+ effector memory RA T cell
   </value>
   <value>
    CD8+ effector memory T cell
   </value>
   <value>
    CD8+ naive CD8 T cell
   </value>
   <value>
    CD8+ T-cell
   </value>
   <value>
    CD8+CD28+ T-cell
   </value>
   <value>
    CD8+CD28- T-cell
   </value>
   <value>
    cell line derived from HT1080
   </value>
   <value>
    cell line derived from primary cancer associated fibroblasts
   </value>
   <value>
    cell line derived from primary pancreatic ductal adenocarcinoma
   </value>
   <value>
    cell line mixture
   </value>
   <value>
    central memory T-cell
   </value>
   <value>
    centroblast
   </value>
   <value>
    centrocyte
   </value>
   <value>
    cervical carcinoma cell line
   </value>
   <value>
    chondrocyte
   </value>
   <value>
    chondrogenic progenitor cells
   </value>
   <value>
    chondrosarcoma cell line
   </value>
   <value>
    choroid
   </value>
   <value>
    chronic lymphocytic leukemia cell
   </value>
   <value>
    clear cell renal carcinoma cell line
   </value>
   <value>
    CLL cell line
   </value>
   <value>
    cloned fibroblast cell line
   </value>
   <value>
    CML cell line
   </value>
   <value>
    colon cancer stem cell
   </value>
   <value>
    colon fibroblast derived cell line
   </value>
   <value>
    colonic cancer cell line
   </value>
   <value>
    colonic epithelial cancer cell line
   </value>
   <value>
    colonic epithelial cell
   </value>
   <value>
    colorectal adenocarcinoma cell line
   </value>
   <value>
    colorectal cancer cell line
   </value>
   <value>
    coronary endothelial cell
   </value>
   <value>
    cumulus cell
   </value>
   <value>
    cutaneous T-cell lymphoma cell line
   </value>
   <value>
    dendritic cell
   </value>
   <value>
    dendritic cell derived from mature monocyte
   </value>
   <value>
    dental pulp stem cell
   </value>
   <value>
    dermal dendritic cell
   </value>
   <value>
    dermal fibroblast
   </value>
   <value>
    dermal microvascular endothelial cell line
   </value>
   <value>
    dermal microvascular lymphatic endothelial cell
   </value>
   <value>
    diffuse histiocytic lymphoma cell line
   </value>
   <value>
    diffuse large B-cell lymphoma cell
   </value>
   <value>
    diffuse large cell lymphoma cell line
   </value>
   <value>
    diffuse mixed lymphoma cell line
   </value>
   <value>
    DS-AMKL cell line
   </value>
   <value>
    EBV+ lymphoblastoid cell line
   </value>
   <value>
    EBV+ natural killer cell line
   </value>
   <value>
    EBV+ T-cell line
   </value>
   <value>
    EBV-immortalized B-cell line
   </value>
   <value>
    EBV-immortalized B-lymphoblastoid cell line
   </value>
   <value>
    EBV-transformed B-cell line
   </value>
   <value>
    EBV-transformed lymphoblastoid cell line
   </value>
   <value>
    EBV-transformed natural killer cell line
   </value>
   <value>
    effector memory T-cell
   </value>
   <value>
    embryoid body derived from cell line H9
   </value>
   <value>
    embryoid body derived from cell line hES-T3
   </value>
   <value>
    embryonal carcinoma cell line
   </value>
   <value>
    embryonic kidney cell line
   </value>
   <value>
    embryonic kidney derived cell line
   </value>
   <value>
    endometrial adenocarcinoma cell line
   </value>
   <value>
    endometrial cancer cell line
   </value>
   <value>
    endometrial cell
   </value>
   <value>
    endothelial cell
   </value>
   <value>
    endothelial cell differentiated from human umbilical cord blood derived-EPCs
   </value>
   <value>
    endothelial precursor cell derived from human umbilical cord blood
   </value>
   <value>
    eosinophilic cell line
   </value>
   <value>
    epidermal keratinocyte cell line
   </value>
   <value>
    epidermal melanocyte
   </value>
   <value>
    epidermoid carcinoma cell line
   </value>
   <value>
    epithelial cell
   </value>
   <value>
    epithelial cell line
   </value>
   <value>
    epithelium
   </value>
   <value>
    erythroblast
   </value>
   <value>
    erythrocyte
   </value>
   <value>
    erythroleukaemia cell line
   </value>
   <value>
    esophageal adenocarcinoma cell line
   </value>
   <value>
    esophageal carcinoma cell line
   </value>
   <value>
    esophageal epithelial cell
   </value>
   <value>
    esophageal squamous carcinoma cell line
   </value>
   <value>
    esophageal squamous cell
   </value>
   <value>
    esophageal squamous epithelium cell line
   </value>
   <value>
    esophagus
   </value>
   <value>
    Ewing family tumor cell line
   </value>
   <value>
    extranodal NK/T-cell lymphoma cell
   </value>
   <value>
    fetal cortex derived cell line
   </value>
   <value>
    fetal fibroblast
   </value>
   <value>
    fetal gamma-delta T-cell
   </value>
   <value>
    fetal lung fibroblast derived cell line
   </value>
   <value>
    fetal osteoblast derived cell line
   </value>
   <value>
    fetal retinal pigment epithelium
   </value>
   <value>
    fibroblast
   </value>
   <value>
    fibroblast cell line
   </value>
   <value>
    fibroblast cell lines pool
   </value>
   <value>
    fibroblast derived cell line
   </value>
   <value>
    fibroblast differentiated from H1
   </value>
   <value>
    fibroblast-derived iPSC
   </value>
   <value>
    fibroblast-like synovial cell
   </value>
   <value>
    fibroblastic cell line
   </value>
   <value>
    fibrosarcoma derived cell line
   </value>
   <value>
    forelimb leiomyosarcoma cell line
   </value>
   <value>
    foreskin fibroblast derived cell line
   </value>
   <value>
    foreskin-derived iPSC
   </value>
   <value>
    gamma-delta T-cell
   </value>
   <value>
    gastric adenocarcinoma cell line
   </value>
   <value>
    gastric adenocarcinoma cell lines
   </value>
   <value>
    gastric cancer cell line
   </value>
   <value>
    geminal center centroblast
   </value>
   <value>
    germinal center B-cell
   </value>
   <value>
    giant cell glioblatoma derived cell line
   </value>
   <value>
    gingival fibroblast
   </value>
   <value>
    gingival keratinocyte cell line
   </value>
   <value>
    glioblastoma cell line
   </value>
   <value>
    glioblastoma derived cell line
   </value>
   <value>
    glioblastoma derived neurosphere culture cell line
   </value>
   <value>
    glioblastoma stem-like cell line
   </value>
   <value>
    glioblastoma-derived stem cell
   </value>
   <value>
    glioma cell line
   </value>
   <value>
    glomerular podocyte
   </value>
   <value>
    granulopoietic cell
   </value>
   <value>
    granulosa cell
   </value>
   <value>
    head and neck cancer cell line
   </value>
   <value>
    head and neck squamous cell carcinoma cell line
   </value>
   <value>
    hematopoietic cell
   </value>
   <value>
    hematopoietic stem cell
   </value>
   <value>
    hematopoietic stem cell/progenitor cell
   </value>
   <value>
    hepatic stellate
   </value>
   <value>
    hepatocellular carcinoma cell line
   </value>
   <value>
    hepatocyte
   </value>
   <value>
    hepatoma cell line
   </value>
   <value>
    hESC
   </value>
   <value>
    hESC-derived endothelial cell
   </value>
   <value>
    HLA-DR negative T-cell
   </value>
   <value>
    HLA-DR+ T-cell
   </value>
   <value>
    Hodgkins lymphoma B-cell line
   </value>
   <value>
    Hodgkins lymphoma cell line
   </value>
   <value>
    hTERT-immortalized breast primary epithelial cell line
   </value>
   <value>
    hTERT-immortalized human mammary epithelial cell line
   </value>
   <value>
    human embryonic carcinoma cell
   </value>
   <value>
    human embryonic kidney cell
   </value>
   <value>
    human embryonic stem cell line
   </value>
   <value>
    human embryonic stem cell line (post hepatic differentiation)
   </value>
   <value>
    human umbilical cord lining epithelial cell
   </value>
   <value>
    human umbilical vein endothelial cell line
   </value>
   <value>
    human umbilical vein smooth muscle cell
   </value>
   <value>
    human vascular adventitial fibroblast
   </value>
   <value>
    huvec
   </value>
   <value>
    hypopharyngeal tumor cell line
   </value>
   <value>
    ileocecal carcinoma cell line
   </value>
   <value>
    ileum mucosa
   </value>
   <value>
    immature dendritic cell
   </value>
   <value>
    immature monocyte-derived dendritic cell
   </value>
   <value>
    immortalised T lymphocyte cell line
   </value>
   <value>
    immortalized B-cell
   </value>
   <value>
    immortalized bronchial epithelial cell
   </value>
   <value>
    immortalized bronchial epithelial cell line
   </value>
   <value>
    immortalized ovarian surface epithelial cell line
   </value>
   <value>
    immunoblastic large cell lymphoma cell line
   </value>
   <value>
    in vitro generated osteoclasts
   </value>
   <value>
    induced pluripotent stem cell line
   </value>
   <value>
    intermediate cell derived from dendritic cells
   </value>
   <value>
    intermediate cell derived from monocytes
   </value>
   <value>
    intestinal adenocarcinoma cell line
   </value>
   <value>
    intestinal epithelial cell line
   </value>
   <value>
    intestinal mucosa
   </value>
   <value>
    intestine epithelial cell
   </value>
   <value>
    iPSC
   </value>
   <value>
    iPSC cell line from cord blood mononuclear cell
   </value>
   <value>
    iPSC derived from cell line CCD-1079Sk
   </value>
   <value>
    iPSC derived from fibroblast
   </value>
   <value>
    iPSC derived from fibroblast cell line BJ
   </value>
   <value>
    iPSC derived from fibroblast cell line dH1CF
   </value>
   <value>
    iPSC derived from fibroblast cell line dH1F
   </value>
   <value>
    iPSC derived from fibroblast cell line IMR90
   </value>
   <value>
    iPSC derived from fibroblast cell line MRC-5
   </value>
   <value>
    iPSC derived from fibroblast cell line MRC-6
   </value>
   <value>
    iPSC derived from fibroblast cell line MRC-7
   </value>
   <value>
    iPSC derived from fibroblast cell line MRC-8
   </value>
   <value>
    iPSC derived from fibroblast cell line MRC-9
   </value>
   <value>
    iPSC derived from human adipose stem cells
   </value>
   <value>
    iPSC from bone marrow mononuclear cell
   </value>
   <value>
    iPSC from CML bone marrow mononuclear cell
   </value>
   <value>
    islet beta cell
   </value>
   <value>
    keratinocyte
   </value>
   <value>
    Langerhans cell
   </value>
   <value>
    large vessel endothelial cell derived from embryoid body
   </value>
   <value>
    leukaemia cell line
   </value>
   <value>
    leukemic lymphoblast
   </value>
   <value>
    leukocyte
   </value>
   <value>
    lipoma derived mesenchymal stem cell
   </value>
   <value>
    liposarcoma cell line
   </value>
   <value>
    liver mesenchymal tumor cell line
   </value>
   <value>
    luminal epithelial cell
   </value>
   <value>
    lung adenocarcinoma cell line
   </value>
   <value>
    lung cancer cell line
   </value>
   <value>
    lung fibroblast derived cell line
   </value>
   <value>
    lung squamous cell carcinoma cell line
   </value>
   <value>
    lung tissue-derived fibroblast
   </value>
   <value>
    lymphatic endothelial cell
   </value>
   <value>
    lymphoblast
   </value>
   <value>
    lymphoblast cell line
   </value>
   <value>
    lymphoblastoid cell line
   </value>
   <value>
    lymphocyte
   </value>
   <value>
    lymphocytic leukaemia cell line
   </value>
   <value>
    lymphoid cell
   </value>
   <value>
    lymphoid RNA reference
   </value>
   <value>
    lymphoma
   </value>
   <value>
    lymphoma cell
   </value>
   <value>
    lymphoma cell line
   </value>
   <value>
    macrophage
   </value>
   <value>
    malignant mesothelioma cell line
   </value>
   <value>
    malignant peripheral nerve sheath cell line
   </value>
   <value>
    malignant peripheral nerve sheath tumor cell line
   </value>
   <value>
    mammary epithelial cell
   </value>
   <value>
    mammary epithelial cell derived cell line
   </value>
   <value>
    mammary epithelial cell line
   </value>
   <value>
    mammary fibroblast derived cell line
   </value>
   <value>
    mammospheres derived from breast tumor
   </value>
   <value>
    mantle cell lymphoma cell line
   </value>
   <value>
    marrow stromal cell
   </value>
   <value>
    medulloblastoma cell line
   </value>
   <value>
    megakaryoblast
   </value>
   <value>
    megakaryoblastic leukaemia cell line
   </value>
   <value>
    megakaryocyte
   </value>
   <value>
    melanocyte
   </value>
   <value>
    melanoma cell line
   </value>
   <value>
    melanoma derived cell line
   </value>
   <value>
    memory B-cell
   </value>
   <value>
    mesenchymal progenitor cell line
   </value>
   <value>
    mesenchymal stem cell
   </value>
   <value>
    mesenchymal stem cell clone
   </value>
   <value>
    mesenchymal stem cell from iliac crest
   </value>
   <value>
    mesenchymal stem cell-derived adipocyte
   </value>
   <value>
    mesenchymal stem cell-derived stromal
   </value>
   <value>
    mesenchymal stem cell-derived stromal and adipocyte
   </value>
   <value>
    mesenchymal stromal cell
   </value>
   <value>
    mesendoderm/endoderm progenitor cell
   </value>
   <value>
    mesodermal precursor cell derived from hES cells line SA01
   </value>
   <value>
    mesodermal precursor cell derived from hES cells line VUB01
   </value>
   <value>
    mesodermal precursor cell derived from hES cells line VUB03_DM1
   </value>
   <value>
    mesothelioma cell line
   </value>
   <value>
    mesothelium cell line
   </value>
   <value>
    metamyelocyte/granulocyte
   </value>
   <value>
    metastatic breast cancer in bone
   </value>
   <value>
    metastatic breast cancer in brain
   </value>
   <value>
    metastatic breast cancer in lung
   </value>
   <value>
    metastatic clear-cell renal cell carcinoma in lung
   </value>
   <value>
    metastatic colorectal cancer in liver
   </value>
   <value>
    metastatic lung cancer in brain
   </value>
   <value>
    metastatic melanoma cell line
   </value>
   <value>
    metastatic midgut carcinoid in liver
   </value>
   <value>
    metastatic pancreatic cancer cell line
   </value>
   <value>
    metastatic prostate cancer cell line
   </value>
   <value>
    microvascular endothelial cell
   </value>
   <value>
    midgut carcinoid
   </value>
   <value>
    mixed somatic cell types
   </value>
   <value>
    monocyte
   </value>
   <value>
    monocyte-derived dendritic cell
   </value>
   <value>
    monocyte-derived macrophage
   </value>
   <value>
    monocyte/macrophage
   </value>
   <value>
    mononuclear cell
   </value>
   <value>
    multiple myeloma cell line
   </value>
   <value>
    multipotent stromal cell
   </value>
   <value>
    myelocyte/metamyelocyte
   </value>
   <value>
    myelodysplasia cell line
   </value>
   <value>
    myeloid cell
   </value>
   <value>
    myeloid monocytic cell
   </value>
   <value>
    myeloma cell line
   </value>
   <value>
    myoepithelial
   </value>
   <value>
    myoepithelial cells differentiated from hTERT-immortalized K5+K19- mammary epithelial cell
   </value>
   <value>
    myometrial cell
   </value>
   <value>
    naive B cell
   </value>
   <value>
    naive B-cell
   </value>
   <value>
    naive CD4+ T-cell
   </value>
   <value>
    naive T-cell
   </value>
   <value>
    nasopharingeal carcinoma cell line
   </value>
   <value>
    nasopharyngeal carcinoma cell line
   </value>
   <value>
    natural killer cell line
   </value>
   <value>
    natural killer leukaemia cell line
   </value>
   <value>
    neonatal foreskin-derived
   </value>
   <value>
    neural crest cell line
   </value>
   <value>
    neural epithelial cell from embryonic stem cell line H9
   </value>
   <value>
    neural progenitor cell from developing cortex
   </value>
   <value>
    neural progenitor cell from ventral midbrain
   </value>
   <value>
    neural progenitor cell line
   </value>
   <value>
    neural progenitor cells
   </value>
   <value>
    neuroblastic tumor cell
   </value>
   <value>
    neuroblastoma cell line
   </value>
   <value>
    neuroblastoma tumor cell
   </value>
   <value>
    neutrophil
   </value>
   <value>
    NK cell
   </value>
   <value>
    NK/T-cell lymphoma cell line
   </value>
   <value>
    nodal diffuse large B-cell lymphoma cell
   </value>
   <value>
    non-Hodgkin's lymphoma cell line
   </value>
   <value>
    non-Hodgkins lymphoma cell line
   </value>
   <value>
    non-small cell carcinoma cell line
   </value>
   <value>
    non-small cell lung adenocarcinoma cell line
   </value>
   <value>
    non-small cell lung cancer cell line
   </value>
   <value>
    non-small cell lung carcinoma cell line
   </value>
   <value>
    Norwalk virus replicon-bearing hepatoma cell line
   </value>
   <value>
    NSCLC cell line
   </value>
   <value>
    odontoblast
   </value>
   <value>
    oligoastrocytoma derived cell line
   </value>
   <value>
    oocyte
   </value>
   <value>
    oral keratinocyte
   </value>
   <value>
    osteoblast
   </value>
   <value>
    osteoclast derived from dendritic cells
   </value>
   <value>
    osteoclast derived from monocytes
   </value>
   <value>
    osteosarcoma cell line
   </value>
   <value>
    ovarian adenocarcinoma cell line
   </value>
   <value>
    ovarian cancer cell line
   </value>
   <value>
    ovarian carcinoma cell line
   </value>
   <value>
    ovarian serous carcinoma cell line
   </value>
   <value>
    pancreatic adenocarcinoma cell line
   </value>
   <value>
    pancreatic cancer cell line
   </value>
   <value>
    pancreatic carcinoma cell line
   </value>
   <value>
    pancreatic islet-like cell clusters derived from cell line T3ES
   </value>
   <value>
    periodontal ligament cell
   </value>
   <value>
    pharyngeal carcinoma cell line
   </value>
   <value>
    pharyngeal tumor cell line
   </value>
   <value>
    pituitary adenoma cell line
   </value>
   <value>
    placenta choriocarcinoma cell line
   </value>
   <value>
    plasma B-cell
   </value>
   <value>
    plasma cell
   </value>
   <value>
    plasmablast
   </value>
   <value>
    plasmacytoid dendritic cell
   </value>
   <value>
    polymorphonuclear leukocyte
   </value>
   <value>
    Pre-B leukaemia cell line
   </value>
   <value>
    precursor B-cell
   </value>
   <value>
    prenatal chorion villus cell
   </value>
   <value>
    primary fibroblast culture
   </value>
   <value>
    primary hematopoietic CD34+ cells
   </value>
   <value>
    primary T lymphocyte
   </value>
   <value>
    primitive neural epithelial cell from embryonic stem cell line H9
   </value>
   <value>
    promyelocyte
   </value>
   <value>
    prostate adenocarcinoma cell line
   </value>
   <value>
    prostate cancer cell line
   </value>
   <value>
    prostate cancer stem cell line
   </value>
   <value>
    prostate carcinoma cell line
   </value>
   <value>
    prostate epithelial cell
   </value>
   <value>
    prostate epithelial cell line
   </value>
   <value>
    prostate stromal cell
   </value>
   <value>
    prostatic cancer cell line
   </value>
   <value>
    proximal tubular epithelial cell
   </value>
   <value>
    pulmonary microvascular endothelial cell
   </value>
   <value>
    regulatory T-cell
   </value>
   <value>
    renal cancer cell line
   </value>
   <value>
    renal proximal tubular cell line
   </value>
   <value>
    renal proximal tubular epithelial cell
   </value>
   <value>
    retinal pigment epithelial cell
   </value>
   <value>
    retinal pigment epithelial cell line
   </value>
   <value>
    retinal pigment epithelium
   </value>
   <value>
    rhabdomyosarcoma cell
   </value>
   <value>
    rhabdomyosarcoma cell line
   </value>
   <value>
    scalp fibroblast
   </value>
   <value>
    skin derived fibroblast cell line
   </value>
   <value>
    skin fibroblast
   </value>
   <value>
    skin fibroblast cell line
   </value>
   <value>
    skin fibroblast derived cell line
   </value>
   <value>
    skin melanoma cell line
   </value>
   <value>
    small cell lung cancer cell line
   </value>
   <value>
    small cell lung carcinoma cell line
   </value>
   <value>
    smooth muscle cell
   </value>
   <value>
    squamous cell carcinoma cell line
   </value>
   <value>
    stem cell line
   </value>
   <value>
    stromal cell
   </value>
   <value>
    T-ALL cell
   </value>
   <value>
    T-ALL cell line
   </value>
   <value>
    T-cell
   </value>
   <value>
    T-cell and retinal pigment epithelial cell (co-cultured)
   </value>
   <value>
    T-cell leukaemia cell line
   </value>
   <value>
    T-cell line
   </value>
   <value>
    T-cell lymphoma cell line
   </value>
   <value>
    tarsal conjuntiva
   </value>
   <value>
    TCRVgamma9+ gamma delta T cells
   </value>
   <value>
    testicular diffuse large B-cell lymphoma tissue
   </value>
   <value>
    testicular germ-cell tumor cell line
   </value>
   <value>
    tracheal epithelial cell line
   </value>
   <value>
    transformed lymphocyte
   </value>
   <value>
    trophoblast cell line
   </value>
   <value>
    tumorigenic,hTERT-immortalized breast primary epithelial cell;
   </value>
   <value>
    tumorigenic,hTERT-immortalized human mammary epithelial cell;
   </value>
   <value>
    umbilical cord blood derived endothelial colony
   </value>
   <value>
    umbilical cord blood derived mesenchymal stem cell
   </value>
   <value>
    undifferentiated induced pluripotent stem cell
   </value>
   <value>
    universal human reference RNA
   </value>
   <value>
    unrestricted somatic stem cell
   </value>
   <value>
    urothelial
   </value>
   <value>
    urothelial cell line
   </value>
   <value>
    vascular endothelial cell
   </value>
   <value>
    vascular smooth muscle cell
   </value>
   <value>
    virus-transformed lung/bronchus epithelial cell line
   </value>
   <value>
    white blood cell
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    clinical history
   </category>
   <value>
    12 months of BETAFERON
   </value>
   <value>
    12 months of REBIF
   </value>
   <value>
    12 weeks after adalimumab therapy, good responder
   </value>
   <value>
    12 weeks after adalimumab therapy, moderate responder
   </value>
   <value>
    12 weeks after adalimumab therapy, poor responder
   </value>
   <value>
    16 years disease duration
   </value>
   <value>
    2 years disease duration
   </value>
   <value>
    24 months of BETAFERON
   </value>
   <value>
    24 months of REBIF
   </value>
   <value>
    24 years disease duration
   </value>
   <value>
    24h after GC-monotherapy initiation
   </value>
   <value>
    24h after prednisolon-administration
   </value>
   <value>
    3 months of BETAFERON
   </value>
   <value>
    3 months of REBIF
   </value>
   <value>
    6h after GC-monotherapy initiation
   </value>
   <value>
    6h after prednisolon-administration
   </value>
   <value>
    aborted triploid fetus
   </value>
   <value>
    active
   </value>
   <value>
    acute kidney transplant rejection
   </value>
   <value>
    acute stage
   </value>
   <value>
    adenocarcinoma of the colon
   </value>
   <value>
    adrenalectomy for renal cell carcinoma
   </value>
   <value>
    after ceasing to take immunosuppression drug
   </value>
   <value>
    after first infliximab treatment
   </value>
   <value>
    after methotrexate treatment
   </value>
   <value>
    after VAD support
   </value>
   <value>
    AML with t(8;21) or FAB M10
   </value>
   <value>
    AML with t(8;21) or FAB M11
   </value>
   <value>
    AML with t(8;21) or FAB M12
   </value>
   <value>
    AML with t(8;21) or FAB M13
   </value>
   <value>
    AML with t(8;21) or FAB M14
   </value>
   <value>
    AML with t(8;21) or FAB M15
   </value>
   <value>
    AML with t(8;21) or FAB M16
   </value>
   <value>
    AML with t(8;21) or FAB M17
   </value>
   <value>
    AML with t(8;21) or FAB M18
   </value>
   <value>
    AML with t(8;21) or FAB M19
   </value>
   <value>
    AML with t(8;21) or FAB M2
   </value>
   <value>
    AML with t(8;21) or FAB M3
   </value>
   <value>
    AML with t(8;21) or FAB M4
   </value>
   <value>
    AML with t(8;21) or FAB M5
   </value>
   <value>
    AML with t(8;21) or FAB M6
   </value>
   <value>
    AML with t(8;21) or FAB M7
   </value>
   <value>
    AML with t(8;21) or FAB M8
   </value>
   <value>
    AML with t(8;21) or FAB M9
   </value>
   <value>
    asymptomatic carrier
   </value>
   <value>
    bacterial endotoxin intravenously administered (inflammatory stimulus)
   </value>
   <value>
    bare metal cardiovascular stent
   </value>
   <value>
    baseline
   </value>
   <value>
    before first infliximab treatment
   </value>
   <value>
    before methotrexate treatment
   </value>
   <value>
    before VAD support
   </value>
   <value>
    biochemical pregnancy
   </value>
   <value>
    blast crisis
   </value>
   <value>
    bowel resection
   </value>
   <value>
    breast carcinoma, adjacent tissue
   </value>
   <value>
    breast reduction mammoplasty
   </value>
   <value>
    c9t11
   </value>
   <value>
    Calcineurin Inhibitor (Cyclosporine)-treated
   </value>
   <value>
    cancer recurrence
   </value>
   <value>
    Cause of death: heart attack
   </value>
   <value>
    Cause of death: heart failure
   </value>
   <value>
    Cause of death: myocardial infarction
   </value>
   <value>
    Cause of death: pancreatic cancer
   </value>
   <value>
    cells derived via NK Cell Activation and Expansion System
   </value>
   <value>
    central tumor
   </value>
   <value>
    cetuximab-resistant
   </value>
   <value>
    cetuximab-sensitive
   </value>
   <value>
    chemoradiotherapy
   </value>
   <value>
    Chemotherapy response: complete response
   </value>
   <value>
    Chemotherapy response: partial response
   </value>
   <value>
    Chemotherapy response: progressive disease
   </value>
   <value>
    Chemotherapy response: stable disease
   </value>
   <value>
    CHOP-treated
   </value>
   <value>
    CN-AML
   </value>
   <value>
    colorectal carcinoma, adjacent tissue
   </value>
   <value>
    complete continous remission
   </value>
   <value>
    constipation-predominant
   </value>
   <value>
    continuous complete remission
   </value>
   <value>
    control
   </value>
   <value>
    convalescent stage
   </value>
   <value>
    CsA monotherapy
   </value>
   <value>
    current smoker
   </value>
   <value>
    Cushing syndrome
   </value>
   <value>
    day of transplant
   </value>
   <value>
    death
   </value>
   <value>
    death unrelated
   </value>
   <value>
    dexamethasone treatment
   </value>
   <value>
    diarrhea-predominant
   </value>
   <value>
    Disease duration: 10 years; Cause of death: cachexia following swallowing disturbances
   </value>
   <value>
    Disease duration: 11 years; Cause of death: pneumonia in a dehydrated and cachexic patient
   </value>
   <value>
    Disease duration: 12 years; Cause of death: bronchopneumonia
   </value>
   <value>
    Disease duration: 12 years; Cause of death: sepsis, due to an urinary tract infection, and cachexia
   </value>
   <value>
    Disease duration: 13 years; Cause of death: cachexia and dehydration
   </value>
   <value>
    Disease duration: 14 years; Cause of death: infection of lungs
   </value>
   <value>
    Disease duration: 15 years; Cause of death: aspiration pneumonia
   </value>
   <value>
    Disease duration: 15 years; Cause of death: dehydration
   </value>
   <value>
    Disease duration: 16 years; Cause of death: acute cardiac arrest
   </value>
   <value>
    Disease duration: 2 years; Cause of death: euthanasia
   </value>
   <value>
    Disease duration: 3 years; Cause of death: pneumonia / cachexia
   </value>
   <value>
    Disease duration: 3 years; Cause of death: respiratory insufficience
   </value>
   <value>
    Disease duration: 4 years; Cause of death: complications secondary to a cerebro vasculair accident
   </value>
   <value>
    Disease duration: 4 years; Cause of death: septic with a urinary infection
   </value>
   <value>
    Disease duration: 6 years; Cause of death: bleeding of the stomach
   </value>
   <value>
    Disease duration: 6 years; Cause of death: myocardial infarction
   </value>
   <value>
    Disease duration: 6 years; Cause of death: pneumonia and cachexia by PSP
   </value>
   <value>
    Disease duration: 7 years; Cause of death: dehydration and vascular insufficiency
   </value>
   <value>
    Disease duration: 7 years; Cause of death: pulmonary arrest
   </value>
   <value>
    Disease duration: 7 years; Cause of death: unknown
   </value>
   <value>
    Disease duration: 8 years; Cause of death: aspiration pneumonia
   </value>
   <value>
    Disease duration: 8 years; Cause of death: cachexia and dehydration
   </value>
   <value>
    Disease duration: 8 years; Cause of death: lungdisorder with fever for 4 weeks
   </value>
   <value>
    Disease duration: 9 years; Cause of death: dehydration and respiratory insufficiency
   </value>
   <value>
    Disease duration: more than 7 years; Cause of death: general deterioration
   </value>
   <value>
    docosahexaenoic acid treatment
   </value>
   <value>
    early relapse
   </value>
   <value>
    early secretory phase
   </value>
   <value>
    elective termination
   </value>
   <value>
    endocrine-treated patient
   </value>
   <value>
    erosive gastritis, non-erosive site/Helicobacter pylori negative
   </value>
   <value>
    erosive gastritis, non-erosive site/Helicobacter pylori positive
   </value>
   <value>
    eutopic endometrium
   </value>
   <value>
    evidence of disease recurrence
   </value>
   <value>
    exposed to air
   </value>
   <value>
    exposed to wood smoke
   </value>
   <value>
    extended oligoarticular
   </value>
   <value>
    extra-intestinal manifestations;age at diagnosis under 25 years;not fibrostenotic;no fistula
   </value>
   <value>
    extra-intestinal manifestations;not fibrostenotic;age at diagnosis over 25 years;no fistula
   </value>
   <value>
    familial hyperplastic polyposis
   </value>
   <value>
    favorable prognosis
   </value>
   <value>
    fertile
   </value>
   <value>
    fibrosis
   </value>
   <value>
    fibrostenotic;extra-intestinal manifestations;age at diagnosis over 25 years;no fistula
   </value>
   <value>
    fibrostenotic;fistula;no extra-intestinal manifestations;age at diagnosis over 25 years
   </value>
   <value>
    fibrostenotic;no extra-intestinal manifestations;age at diagnosis over 25 years;no fistula
   </value>
   <value>
    first degree relative
   </value>
   <value>
    first occurrence of tumor
   </value>
   <value>
    first trimester
   </value>
   <value>
    first trimester of pregnancy
   </value>
   <value>
    fludarabine treatment
   </value>
   <value>
    former smoker
   </value>
   <value>
    free of disease after initial treatment
   </value>
   <value>
    free of disease after treatment for first relapse
   </value>
   <value>
    gastric tumor, adjacent tissue
   </value>
   <value>
    Gleason 6
   </value>
   <value>
    Gleason 7
   </value>
   <value>
    Gleason 7, patient was recieving hormone therapy
   </value>
   <value>
    Gleason 8/9
   </value>
   <value>
    glucocorticoids treatment
   </value>
   <value>
    Gram-Negative
   </value>
   <value>
    Gram-Positive
   </value>
   <value>
    Gram-positive and Gram-negative
   </value>
   <value>
    group A streptococcus
   </value>
   <value>
    group B streptococcus
   </value>
   <value>
    HBV, non-cancerous adjacent tissue
   </value>
   <value>
    hCMV-seropositive
   </value>
   <value>
    Helicobacter pylori negative
   </value>
   <value>
    Helicobacter pylori positive
   </value>
   <value>
    hemangioma, healthy tissue
   </value>
   <value>
    high grade muscle invasive tumor
   </value>
   <value>
    high grade superficial tumor
   </value>
   <value>
    high peak bone mass
   </value>
   <value>
    high reactive oxygen species
   </value>
   <value>
    high risk for ovarian cancer
   </value>
   <value>
    high risk of HLA
   </value>
   <value>
    high ZAP70 mRNA expression
   </value>
   <value>
    HIV suppression likely via direct contact (unrelated to CAF)
   </value>
   <value>
    HIV susceptible
   </value>
   <value>
    implantation failure
   </value>
   <value>
    in vitro fertilization
   </value>
   <value>
    inactive arthritis
   </value>
   <value>
    induction failure
   </value>
   <value>
    inflammation
   </value>
   <value>
    inhalation injury
   </value>
   <value>
    insulin resistant
   </value>
   <value>
    insulin sensitive
   </value>
   <value>
    intravenous immunoglobulin
   </value>
   <value>
    intravenous immunoglobulin and methylprednisolone
   </value>
   <value>
    inv(16)
   </value>
   <value>
    invasive
   </value>
   <value>
    invasive lobular carcinoma, normal tissue
   </value>
   <value>
    invasive tumor
   </value>
   <value>
    IPI prognostic score: high
   </value>
   <value>
    IPI prognostic score: high intermediate
   </value>
   <value>
    IPI prognostic score: low intermediate
   </value>
   <value>
    Johnsen score count 2: Sertoli Cell Only-Syndrome
   </value>
   <value>
    Johnsen score count 3.2: Sertoli cells and few spermatogonia
   </value>
   <value>
    Johnsen score count 5: no spermatids, many spermatocytes
   </value>
   <value>
    Johnsen score count 8: hypospermatogenesis - many early and elongated, few late spermatids
   </value>
   <value>
    keloid
   </value>
   <value>
    kit expression: high
   </value>
   <value>
    kit expression: low
   </value>
   <value>
    kit expression: MEDIUM
   </value>
   <value>
    lean
   </value>
   <value>
    leukaemia patient
   </value>
   <value>
    leukemia sample prior to therapy
   </value>
   <value>
    liver graft
   </value>
   <value>
    liver resection
   </value>
   <value>
    long course
   </value>
   <value>
    low differenciated
   </value>
   <value>
    low grade superficial tumor
   </value>
   <value>
    low malignancy potential
   </value>
   <value>
    low peak bone mass
   </value>
   <value>
    low reactive oxygen species
   </value>
   <value>
    low risk of HLA
   </value>
   <value>
    low ZAP70 mRNA expression
   </value>
   <value>
    lung cancer
   </value>
   <value>
    lung cancer patient
   </value>
   <value>
    lung cancer, adjacent tissue
   </value>
   <value>
    lung resection
   </value>
   <value>
    lymph node metastasis
   </value>
   <value>
    lymph node metastasis negative
   </value>
   <value>
    lymphoma death
   </value>
   <value>
    lymphoma patient, normal tissue
   </value>
   <value>
    M1
   </value>
   <value>
    M5
   </value>
   <value>
    malaria vaccinattion
   </value>
   <value>
    medication: Nil
   </value>
   <value>
    medication: olanzapine
   </value>
   <value>
    medication: thyroxine
   </value>
   <value>
    menstrual cycle phase: early secretory
   </value>
   <value>
    menstrual cycle phase: late secretory
   </value>
   <value>
    menstrual cycle phase: mid secretory
   </value>
   <value>
    menstrual cycle phase: proliferative
   </value>
   <value>
    menstrual cycle phase: unknown
   </value>
   <value>
    metastasis
   </value>
   <value>
    metastatic
   </value>
   <value>
    metastatic melanoma
   </value>
   <value>
    metastatic non-small cell adenocarcinoma patient, normal tissue
   </value>
   <value>
    mid secretory phase
   </value>
   <value>
    mild differentiated
   </value>
   <value>
    mild inflammation
   </value>
   <value>
    mixture
   </value>
   <value>
    MLL-rearrangement
   </value>
   <value>
    moderate inflammation
   </value>
   <value>
    multifocal lesion
   </value>
   <value>
    multilineage dysplasia
   </value>
   <value>
    multilineage dysplasia related changes
   </value>
   <value>
    myelodysplastic syndrome
   </value>
   <value>
    myelodysplastic syndrome patient, non-lesional tissue
   </value>
   <value>
    N/A
   </value>
   <value>
    n/a
   </value>
   <value>
    NA
   </value>
   <value>
    natural evolution (control)
   </value>
   <value>
    Neisseria
   </value>
   <value>
    never smoked
   </value>
   <value>
    no clinical treatment
   </value>
   <value>
    no evidence of disease
   </value>
   <value>
    no evidence of disease recurrence
   </value>
   <value>
    no extra-intestinal manifestations;age at diagnosis under 25 years;not fibrostenotic;no fistula
   </value>
   <value>
    no extra-intestinal manifestations;not fibrostenotic;age at diagnosis over 25 years;no fistula
   </value>
   <value>
    no hemodialysis
   </value>
   <value>
    no infection
   </value>
   <value>
    no inflamation
   </value>
   <value>
    no inflammation
   </value>
   <value>
    no inhalation injury
   </value>
   <value>
    no metastasis
   </value>
   <value>
    no previous melphalan isolated limb infusion/ILP
   </value>
   <value>
    no recurrence
   </value>
   <value>
    no rejection
   </value>
   <value>
    no relapse
   </value>
   <value>
    no response to chemiotherapy
   </value>
   <value>
    no response to Infliximab
   </value>
   <value>
    no response to radiotherapy
   </value>
   <value>
    no soluble CD8-suppression
   </value>
   <value>
    no surgery/post-radiotherapy/non-responder
   </value>
   <value>
    no surgery/post-radiotherapy/responder
   </value>
   <value>
    no surgery/pre-radiotherapy/non-responder
   </value>
   <value>
    no surgery/pre-radiotherapy/responder
   </value>
   <value>
    no therapy
   </value>
   <value>
    no treatement
   </value>
   <value>
    no treatment
   </value>
   <value>
    no VAD support
   </value>
   <value>
    nocturnal home hemodialysis
   </value>
   <value>
    non smoker
   </value>
   <value>
    non-invasive
   </value>
   <value>
    non-pregnant
   </value>
   <value>
    non-recurrent
   </value>
   <value>
    non-small cell adenocarcinoma/COPD patient, normal tissue
   </value>
   <value>
    non-small cell lung adenocarcinoma patient, normal tissue
   </value>
   <value>
    non-small cell squamous cell carcinoma patient, normal tissue
   </value>
   <value>
    non-smoker
   </value>
   <value>
    non-smoker/mechanical injury
   </value>
   <value>
    non-smoking
   </value>
   <value>
    non-survivor
   </value>
   <value>
    non-tolerant transplant recipient
   </value>
   <value>
    none
   </value>
   <value>
    normal karyotype
   </value>
   <value>
    normal scar
   </value>
   <value>
    not available
   </value>
   <value>
    not responsive to imatinib therapy
   </value>
   <value>
    not-inflamed
   </value>
   <value>
    not-pregnant
   </value>
   <value>
    obese
   </value>
   <value>
    obese/pioglitazone treated
   </value>
   <value>
    occasional smoker
   </value>
   <value>
    on immunosuppression
   </value>
   <value>
    oral cromoglycate treatment
   </value>
   <value>
    paclitaxel-eluting stent
   </value>
   <value>
    pancreatic cancer
   </value>
   <value>
    pancreatic tumor, adjacent tissue
   </value>
   <value>
    pancreatic tumor, normal adjacent tissue
   </value>
   <value>
    partial hepatectomy
   </value>
   <value>
    periodontitis, unaffected site
   </value>
   <value>
    persistent
   </value>
   <value>
    PKH26-positive
   </value>
   <value>
    placebo
   </value>
   <value>
    polyarticular juvenile idiopathic arthritis, clinical remission with medication
   </value>
   <value>
    polyarticular juvenile idiopathic arthritis, clinical remission without medication
   </value>
   <value>
    pool of RNAs from two siblings, female and male, affected with Setleis Syndrome
   </value>
   <value>
    poor prognosis
   </value>
   <value>
    post menopause
   </value>
   <value>
    post-gastric bypass
   </value>
   <value>
    post-menopausal
   </value>
   <value>
    post-operative off-pump coronary revascularization surgery
   </value>
   <value>
    post-operative on-pump coronary artery bypass grafting
   </value>
   <value>
    postmortem
   </value>
   <value>
    pre-gastric bypass
   </value>
   <value>
    pre-immobilization
   </value>
   <value>
    pre-operative heart
   </value>
   <value>
    pre-operative off-pump coronary revascularization surgery
   </value>
   <value>
    pre-operative on-pump coronary artery bypass grafting
   </value>
   <value>
    pre-therapy
   </value>
   <value>
    pre-transplant
   </value>
   <value>
    pregnant
   </value>
   <value>
    premortem
   </value>
   <value>
    preterm labor
   </value>
   <value>
    preterm no labor
   </value>
   <value>
    preterm spontaneous delivery
   </value>
   <value>
    previous melphalan isolated limb infusion
   </value>
   <value>
    previous vaccine tx
   </value>
   <value>
    primary human NK cells
   </value>
   <value>
    primary tumor relapse
   </value>
   <value>
    prior to GC-administration
   </value>
   <value>
    prior to treatment
   </value>
   <value>
    proband
   </value>
   <value>
    proliferative phase
   </value>
   <value>
    prostate cancer, adjacent tissue
   </value>
   <value>
    psoriasis, non lesional skin
   </value>
   <value>
    pustule former
   </value>
   <value>
    radiotherapy
   </value>
   <value>
    radiotherapy/temozolomide therapy
   </value>
   <value>
    Rapamycin-treated
   </value>
   <value>
    rapid early responder
   </value>
   <value>
    rapid early responder/continuous complete remission
   </value>
   <value>
    rapid early responder/relapse
   </value>
   <value>
    RCC, normal tissue
   </value>
   <value>
    Receiving treatment for first relapse
   </value>
   <value>
    recurrent
   </value>
   <value>
    recurrent miscarriage
   </value>
   <value>
    recurrent spontaneous abortion
   </value>
   <value>
    relapse
   </value>
   <value>
    remaining cytogenetics
   </value>
   <value>
    renal cell carcinoma
   </value>
   <value>
    resolver
   </value>
   <value>
    response to chemiotherapy
   </value>
   <value>
    response to Infliximab treatment
   </value>
   <value>
    response to radiotherapy
   </value>
   <value>
    responsive to imatinib therapy
   </value>
   <value>
    risk for VAP
   </value>
   <value>
    RRC patient, normal tissue
   </value>
   <value>
    second occurrence of tumor
   </value>
   <value>
    second occurrence of tumor/dendritic cell vaccination
   </value>
   <value>
    second trimester
   </value>
   <value>
    sedentary
   </value>
   <value>
    senescent (at the end of their in vitro life span)
   </value>
   <value>
    severe
   </value>
   <value>
    severe blunt trauma
   </value>
   <value>
    severe inflammation
   </value>
   <value>
    short course
   </value>
   <value>
    sister of Setleis patient
   </value>
   <value>
    site of relapse: brain
   </value>
   <value>
    site of relapse: brain and other
   </value>
   <value>
    site of relapse: local
   </value>
   <value>
    site of relapse: other
   </value>
   <value>
    slow early responder
   </value>
   <value>
    slow early responder/continuous complete remission
   </value>
   <value>
    slow early responder/relapse
   </value>
   <value>
    smoker
   </value>
   <value>
    smoker/mechanical injury
   </value>
   <value>
    smoker/no mechanical injury
   </value>
   <value>
    smoking
   </value>
   <value>
    smoking status not available
   </value>
   <value>
    sporadic hyperplastic polyposis
   </value>
   <value>
    SRL monotherapy
   </value>
   <value>
    stable kidney transplant
   </value>
   <value>
    staphylococcus aureus
   </value>
   <value>
    Streptococcus pneumoniae
   </value>
   <value>
    surgery/post-radiotherapy/non-responder
   </value>
   <value>
    surgery/post-radiotherapy/responder
   </value>
   <value>
    surgery/pre-radiotherapy/non-responder
   </value>
   <value>
    surgery/pre-radiotherapy/responder
   </value>
   <value>
    survival
   </value>
   <value>
    survivor
   </value>
   <value>
    t(15;17)
   </value>
   <value>
    t(7;12)
   </value>
   <value>
    t(8;21)
   </value>
   <value>
    t10c12
   </value>
   <value>
    Tacrolimus-treated
   </value>
   <value>
    tamoxifen treated
   </value>
   <value>
    temozolomide and radiotherapy
   </value>
   <value>
    term
   </value>
   <value>
    term labor
   </value>
   <value>
    term no labor
   </value>
   <value>
    term spontaneous delivery
   </value>
   <value>
    Th1 polarisation
   </value>
   <value>
    Th2 polarisation
   </value>
   <value>
    tolerant recipient
   </value>
   <value>
    tonsillectomy
   </value>
   <value>
    trained
   </value>
   <value>
    transplanted liver, 2 hours after reperfusion
   </value>
   <value>
    treated with 5-azacytidine, entinostat
   </value>
   <value>
    treated with atorvastatin
   </value>
   <value>
    treated with diclofenac (0 days)
   </value>
   <value>
    treated with diclofenac (10 days)
   </value>
   <value>
    treated with ECP
   </value>
   <value>
    treated with glatiramer acetate
   </value>
   <value>
    treated with indomethacin
   </value>
   <value>
    treated with interferon beta
   </value>
   <value>
    treated with Letrozole
   </value>
   <value>
    treated with placebo
   </value>
   <value>
    treated with placebo (0 days)
   </value>
   <value>
    treated with placebo (10 days)
   </value>
   <value>
    treated with simvastatin
   </value>
   <value>
    treatment: ampicillin/gentamicin
   </value>
   <value>
    treatment: cefazolin
   </value>
   <value>
    treatment: ceftriaxone/azithromycin
   </value>
   <value>
    treatment: ceftriaxone/clindamycin
   </value>
   <value>
    treatment: ceftriaxone/oseltamivir
   </value>
   <value>
    treatment: ceftriaxone/vancomycin
   </value>
   <value>
    treatment: ceftriaxone/vancomycin/oseltamivir
   </value>
   <value>
    treatment: clindamycin
   </value>
   <value>
    treatment: none
   </value>
   <value>
    treatment: oseltamivir
   </value>
   <value>
    treatment: oxacillin/clindamycin
   </value>
   <value>
    treatment: tamoxifen
   </value>
   <value>
    treatment: vancomycin
   </value>
   <value>
    treatment: vancomycin/rifampin
   </value>
   <value>
    triploid fetus
   </value>
   <value>
    trisomy 11
   </value>
   <value>
    trisomy 13
   </value>
   <value>
    trisomy 18
   </value>
   <value>
    trisomy 21
   </value>
   <value>
    trisomy 21/trisomy 3
   </value>
   <value>
    trisomy 8
   </value>
   <value>
    trisomy Y
   </value>
   <value>
    tubulovillous adenoma of the colon
   </value>
   <value>
    ulcer
   </value>
   <value>
    unaffected sister of Setleis patient
   </value>
   <value>
    unclassified
   </value>
   <value>
    undergoing fertility treatment
   </value>
   <value>
    uninfected site (control) from pustule former
   </value>
   <value>
    uninfected site (control) from resolver
   </value>
   <value>
    unknown cytogenetics
   </value>
   <value>
    unknown w.r.t. extra-intestinal manifestations;unknown w.r.t. fibrostenosis;unknown w.r.t. fistula;age unknown
   </value>
   <value>
    unknown w.r.t. fibrostenosis;extra-intestinal manifestations;age at diagnosis under 25 years;no fistula
   </value>
   <value>
    unknown w.r.t. fibrostenosis;fistula;no extra-intestinal manifestations;age at diagnosis under 25 years
   </value>
   <value>
    unrelated
   </value>
   <value>
    vasectomised
   </value>
   <value>
    week 1 after transplant
   </value>
   <value>
    week 12 after transplant
   </value>
   <value>
    week 2 after transplant
   </value>
   <value>
    week 4 after transplant
   </value>
   <value>
    week 8 after transplant
   </value>
   <value>
    With disease, after initial treatment
   </value>
   <value>
    young (in vitro age of early passage cells)
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    compound
   </category>
   <value>
    1,25-dihydroxyvitamin D3
   </value>
   <value>
    12-O-tetradecanoylphorbol-13-acetate
   </value>
   <value>
    17-(dimethylaminoethylamino)-17-demethoxygeldanamycin
   </value>
   <value>
    17-allylamino-17-demethoxygeldanamycin
   </value>
   <value>
    17-beta-estradiol
   </value>
   <value>
    17alpha-ethynyl estradiol
   </value>
   <value>
    17beta-estradiol
   </value>
   <value>
    1R-Chl
   </value>
   <value>
    4-hydroxytamoxifen
   </value>
   <value>
    4_-iodo-3,3,5-tripropyl-4-methoxy
   </value>
   <value>
    5-aza-2'-deoxycitidine and trychostatin A
   </value>
   <value>
    5-Aza-2'-deoxycytidine
   </value>
   <value>
    5-aza-2'-deoxycytidine
   </value>
   <value>
    5-Azacytidine
   </value>
   <value>
    5-azacytidine
   </value>
   <value>
    5-azacytidine and TSA
   </value>
   <value>
    Ac-26 peptide
   </value>
   <value>
    Ac4ManNLev
   </value>
   <value>
    acid
   </value>
   <value>
    actinomycin D
   </value>
   <value>
    actinomycin D after treatment with caffeine
   </value>
   <value>
    actinomycin D and caffeine after treatment with caffeine
   </value>
   <value>
    adenosine monophosphate
   </value>
   <value>
    advanced
   </value>
   <value>
    AFB1
   </value>
   <value>
    air
   </value>
   <value>
    AM580
   </value>
   <value>
    andrographis
   </value>
   <value>
    angiotensin II
   </value>
   <value>
    angiotensin II and cycloheximide
   </value>
   <value>
    Annexin 1
   </value>
   <value>
    anti-CD28 and anti-CD3
   </value>
   <value>
    anti-CD3 antibody
   </value>
   <value>
    anti-DC-SIGN antibody
   </value>
   <value>
    anti-FcgRIIB antibody
   </value>
   <value>
    antiIgM
   </value>
   <value>
    antimycin A
   </value>
   <value>
    apple extract enriched in (dp3.9)
   </value>
   <value>
    apple extract enriched in (dp3.9) + TNFalpha
   </value>
   <value>
    ARC
   </value>
   <value>
    arsenic trioxide
   </value>
   <value>
    asbestos
   </value>
   <value>
    ascorbic acid
   </value>
   <value>
    ascorbic acid 2-phosphate
   </value>
   <value>
    astragalus
   </value>
   <value>
    AuNP EGFP oligonucleotide complex
   </value>
   <value>
    azithromycin
   </value>
   <value>
    bafilomycin
   </value>
   <value>
    BaP
   </value>
   <value>
    basic fibroblast growth factor
   </value>
   <value>
    basic fibroblast growth factor amd tert-butylhydroperoxide
   </value>
   <value>
    basic fibroblast growth factor and tert-butylhydroperoxide
   </value>
   <value>
    BAY-43-9006
   </value>
   <value>
    benzo[a]pyrene diolepoxide
   </value>
   <value>
    bFGF
   </value>
   <value>
    bg-CAT
   </value>
   <value>
    Bicalutamide
   </value>
   <value>
    Bisphenol A
   </value>
   <value>
    blebbistatin
   </value>
   <value>
    BMP2
   </value>
   <value>
    bone morphogenetic protein 2
   </value>
   <value>
    bortezomib
   </value>
   <value>
    BrHPP/IL2
   </value>
   <value>
    buformin
   </value>
   <value>
    C1OH-Ac3ManNAc
   </value>
   <value>
    C1OH-But3GalNAc
   </value>
   <value>
    C1OH-But3GlcNAc
   </value>
   <value>
    C1OH-But3ManNAc
   </value>
   <value>
    C6OH-But3ManNAc
   </value>
   <value>
    cadmium
   </value>
   <value>
    caffeine
   </value>
   <value>
    caffeine+actinomycin D
   </value>
   <value>
    carbon monoxide gas
   </value>
   <value>
    carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone
   </value>
   <value>
    Carboplatin
   </value>
   <value>
    CD40L
   </value>
   <value>
    CdCl2
   </value>
   <value>
    cetuximab
   </value>
   <value>
    cigarette smoke condensate
   </value>
   <value>
    cis-9, trans-11 CLA
   </value>
   <value>
    cisplatin
   </value>
   <value>
    compound A
   </value>
   <value>
    compound B
   </value>
   <value>
    control
   </value>
   <value>
    control (DMSO)
   </value>
   <value>
    control (ethanol vehicle)
   </value>
   <value>
    control - untreated
   </value>
   <value>
    control antibody
   </value>
   <value>
    control DMEM
   </value>
   <value>
    control for AG1478 (without stimulus)
   </value>
   <value>
    control for U0126 (without stimulus)
   </value>
   <value>
    control MEM
   </value>
   <value>
    control mixture
   </value>
   <value>
    control peptide
   </value>
   <value>
    CsA
   </value>
   <value>
    curcumin
   </value>
   <value>
    Cxcl12
   </value>
   <value>
    Cxcl12 (SDF1)
   </value>
   <value>
    CXCL4
   </value>
   <value>
    Cxcr4
   </value>
   <value>
    cyckiheximide
   </value>
   <value>
    cytokine IL2
   </value>
   <value>
    cytokines IL17
   </value>
   <value>
    cytokines IL22
   </value>
   <value>
    darinaparsin
   </value>
   <value>
    dasatinib
   </value>
   <value>
    dasatinib + herceptin
   </value>
   <value>
    DCC-FBS
   </value>
   <value>
    DcR3
   </value>
   <value>
    decitabine
   </value>
   <value>
    deoxycholic acid
   </value>
   <value>
    desoxyferramine
   </value>
   <value>
    dexamethasone
   </value>
   <value>
    dexrazoxane
   </value>
   <value>
    DFO
   </value>
   <value>
    dihydrotestosterone
   </value>
   <value>
    dimethyl sulfoxide
   </value>
   <value>
    Diquat
   </value>
   <value>
    diterpene ester PEP008
   </value>
   <value>
    diterpene ester TPA
   </value>
   <value>
    DMSO
   </value>
   <value>
    DMSO (control)
   </value>
   <value>
    DMSO (vehicle)
   </value>
   <value>
    DMSO+TNFalpha
   </value>
   <value>
    docosahexaenoic acid
   </value>
   <value>
    Doxorubicin
   </value>
   <value>
    doxorubicin
   </value>
   <value>
    doxycyclin
   </value>
   <value>
    doxycycline
   </value>
   <value>
    doxycycline and TNF-alpha
   </value>
   <value>
    E2
   </value>
   <value>
    early
   </value>
   <value>
    echinomycin and DFO
   </value>
   <value>
    eicosapantaenoic acid
   </value>
   <value>
    Emdogain
   </value>
   <value>
    emetine
   </value>
   <value>
    emetine and actinomycin D
   </value>
   <value>
    enzastaurin
   </value>
   <value>
    epidermal growth factor
   </value>
   <value>
    epigallocatechin gallate
   </value>
   <value>
    EPO
   </value>
   <value>
    epoxomicin
   </value>
   <value>
    esophageal squamous cell carcinoma, normal tissue
   </value>
   <value>
    estradiol
   </value>
   <value>
    estradiol and medroxy progesterone acetate
   </value>
   <value>
    estrogen
   </value>
   <value>
    ethanol
   </value>
   <value>
    ethanol (control)
   </value>
   <value>
    ethanol (vehicle)
   </value>
   <value>
    FBS
   </value>
   <value>
    fenretinide
   </value>
   <value>
    ferucarbutran
   </value>
   <value>
    fine TiO2 and ultrafine Printex90
   </value>
   <value>
    FK228
   </value>
   <value>
    flubendazole
   </value>
   <value>
    flucloxacillin
   </value>
   <value>
    fluorouracil
   </value>
   <value>
    galectin-1
   </value>
   <value>
    gamma-secretase inhibitor DAPT
   </value>
   <value>
    GDC-0941
   </value>
   <value>
    gefitinib
   </value>
   <value>
    geldanamycin, IC50
   </value>
   <value>
    geldanamycin, IC51
   </value>
   <value>
    geldanamycin, IC52
   </value>
   <value>
    geldanamycin, IC53
   </value>
   <value>
    genistein
   </value>
   <value>
    genistein 20 micromolar
   </value>
   <value>
    gliadin
   </value>
   <value>
    glivec
   </value>
   <value>
    Gonal-F (recombinant FSH)
   </value>
   <value>
    granulocyte-colony stimulating factor
   </value>
   <value>
    growth hormone
   </value>
   <value>
    growth hormone (heregulin)
   </value>
   <value>
    H1152
   </value>
   <value>
    HBSS
   </value>
   <value>
    HDAC inhibitor
   </value>
   <value>
    HDAC inhibitor treatment
   </value>
   <value>
    Helicobacter pylori LPS
   </value>
   <value>
    hepatocyte growth factor
   </value>
   <value>
    herceptin
   </value>
   <value>
    heregulin
   </value>
   <value>
    heregulin and kinase inhibitor AG1478
   </value>
   <value>
    heregulin and kinase inhibitor U0126
   </value>
   <value>
    high dose 5-aza
   </value>
   <value>
    high dose IL2
   </value>
   <value>
    HisOH
   </value>
   <value>
    hlgG1
   </value>
   <value>
    HMB-PP
   </value>
   <value>
    hydrocortisone
   </value>
   <value>
    hydroxylated polybrominated diphenyl ethers
   </value>
   <value>
    iberin
   </value>
   <value>
    IFN gamma
   </value>
   <value>
    IFN-gamma
   </value>
   <value>
    IFNa
   </value>
   <value>
    IFNb-1a
   </value>
   <value>
    IFNg+TNF and rosiglitazone
   </value>
   <value>
    IFNg+TNF and vehicle
   </value>
   <value>
    IL-1-b, IL-6, TNF-a and PGE2
   </value>
   <value>
    IL-1beta
   </value>
   <value>
    IL-4 and anti-CD40
   </value>
   <value>
    IL1-beta and Actinom
   </value>
   <value>
    IL1beta
   </value>
   <value>
    inflammatory cytokines
   </value>
   <value>
    insulin
   </value>
   <value>
    interferon alpha
   </value>
   <value>
    interferon gamma
   </value>
   <value>
    interleukin 17
   </value>
   <value>
    interleukin 19
   </value>
   <value>
    interleukin 1b
   </value>
   <value>
    interleukin 20
   </value>
   <value>
    interleukin 22
   </value>
   <value>
    interleukin 24
   </value>
   <value>
    interleukin 26
   </value>
   <value>
    interleukin-2, interleukin-6, TNF-alpha or anti-CD3 antibodies
   </value>
   <value>
    interleukin-4 and rosiglitazone
   </value>
   <value>
    interleukin-4 and vehicle
   </value>
   <value>
    ionomycin
   </value>
   <value>
    isotype control antibody
   </value>
   <value>
    isotype control antibody plus LPS
   </value>
   <value>
    ivermectin
   </value>
   <value>
    keratinocyte growth factor
   </value>
   <value>
    kinase inhibitor AG1478
   </value>
   <value>
    kinase inhibitor U0126
   </value>
   <value>
    KINK-1
   </value>
   <value>
    Largazole
   </value>
   <value>
    leptin
   </value>
   <value>
    leukotriene B4
   </value>
   <value>
    leukotriene C4
   </value>
   <value>
    linoleic acid
   </value>
   <value>
    lipopeptide-bound HIV-1 gp120 V3 domain peptide
   </value>
   <value>
    lipopolysaccharide
   </value>
   <value>
    lipoprotein
   </value>
   <value>
    liposomal ATRA
   </value>
   <value>
    lipoxin A4
   </value>
   <value>
    lipoxin B4
   </value>
   <value>
    LMP-420
   </value>
   <value>
    low dose 5-aza
   </value>
   <value>
    low dose IL2
   </value>
   <value>
    low-density lipoprotein
   </value>
   <value>
    LPS
   </value>
   <value>
    LPS and air
   </value>
   <value>
    LPS and carbon monoxide
   </value>
   <value>
    LPS stimulated
   </value>
   <value>
    LTD4
   </value>
   <value>
    LY2109761
   </value>
   <value>
    LY2109761 and TGFb
   </value>
   <value>
    LY294002
   </value>
   <value>
    mannitol
   </value>
   <value>
    match polyamide, dexamethasone
   </value>
   <value>
    MCSF
   </value>
   <value>
    media
   </value>
   <value>
    Media + dexamethasone + absorbic acid
   </value>
   <value>
    Media + dexamethasone + absorbic acid + beta-glycerophosphate
   </value>
   <value>
    Media + dexamethasone + absorbic acid + beta-glycerophosphate + R568
   </value>
   <value>
    Media + dexamethasone + absorbic acid + beta-glycerophosphate + Vitamin D
   </value>
   <value>
    Media + dexamethasone + absorbic acid + beta-glycerophosphate + Zemplar
   </value>
   <value>
    medium with low LDL
   </value>
   <value>
    melphalan
   </value>
   <value>
    melphalan and temozolomide
   </value>
   <value>
    Menopur (hMG)
   </value>
   <value>
    mesalazine
   </value>
   <value>
    metastin-10
   </value>
   <value>
    metformin
   </value>
   <value>
    microgel iron oxide
   </value>
   <value>
    mifepristone, dexamethasone
   </value>
   <value>
    mismatch polyamide, dexamethasone
   </value>
   <value>
    mock (solvent)
   </value>
   <value>
    mock treated
   </value>
   <value>
    mock-treated
   </value>
   <value>
    N-methyl-N'-nitro-N-nitrosoguanidine
   </value>
   <value>
    Na2CrO4
   </value>
   <value>
    NC1153
   </value>
   <value>
    negative control
   </value>
   <value>
    nerve growth factor (NGF)
   </value>
   <value>
    neuropeptide S
   </value>
   <value>
    nicotine
   </value>
   <value>
    no cytokine
   </value>
   <value>
    nocodazole
   </value>
   <value>
    none
   </value>
   <value>
    NS398
   </value>
   <value>
    NSC76022
   </value>
   <value>
    oligofectamine with EGFP oligonucleotide
   </value>
   <value>
    oligofectamine without oligonucleotide
   </value>
   <value>
    oligomycin
   </value>
   <value>
    onconase
   </value>
   <value>
    orexin
   </value>
   <value>
    oxaliplatin
   </value>
   <value>
    oxidized LDL
   </value>
   <value>
    oxidized low-density lipoprotein
   </value>
   <value>
    PBS
   </value>
   <value>
    PBS (vehicle)
   </value>
   <value>
    PCB153
   </value>
   <value>
    PCB77
   </value>
   <value>
    PCI-5002
   </value>
   <value>
    PDGF-BB
   </value>
   <value>
    phenformin
   </value>
   <value>
    phenylsalicylihalamide
   </value>
   <value>
    phorbol ester
   </value>
   <value>
    phorbol ester and ionomycin
   </value>
   <value>
    phytohaemagglutinin
   </value>
   <value>
    PMA
   </value>
   <value>
    Poly(I:C)
   </value>
   <value>
    Polyamide 1
   </value>
   <value>
    polyamide 1and DFO
   </value>
   <value>
    Polyamide 2
   </value>
   <value>
    PPAR-alpha agonist GW7647
   </value>
   <value>
    PR-104A
   </value>
   <value>
    pre neoplastic lesion: cirrhoses
   </value>
   <value>
    pre neoplastic lesion: high-grade liver dysplasia
   </value>
   <value>
    pre neoplastic lesion: low-grade liver dysplasia
   </value>
   <value>
    pre-digested orange extract rich in flavanones
   </value>
   <value>
    Prima
   </value>
   <value>
    primary bile mixture
   </value>
   <value>
    prinixic acid
   </value>
   <value>
    pronase, collagenase
   </value>
   <value>
    protein farnesyltransferase inhibitor (FTI)
   </value>
   <value>
    protein inhibitor MK886
   </value>
   <value>
    pyrrole-imidazole polyamide
   </value>
   <value>
    pyrvinium pamoate
   </value>
   <value>
    quercetin
   </value>
   <value>
    R1881
   </value>
   <value>
    R547
   </value>
   <value>
    RAF inhibitor #1
   </value>
   <value>
    RAF inhibitor #2
   </value>
   <value>
    Rapa
   </value>
   <value>
    rapamycin
   </value>
   <value>
    recombinant granulocyte colony stimulating factor
   </value>
   <value>
    recombinant MAGP2
   </value>
   <value>
    resveratrol
   </value>
   <value>
    retinoic acid
   </value>
   <value>
    retinoid acid
   </value>
   <value>
    ricin
   </value>
   <value>
    rituximab
   </value>
   <value>
    rolipram
   </value>
   <value>
    Roscovitine
   </value>
   <value>
    rosiglitazone
   </value>
   <value>
    rosiglitazone and AGN193109
   </value>
   <value>
    rotenone
   </value>
   <value>
    RSL1 (inducing agent)
   </value>
   <value>
    SAHA
   </value>
   <value>
    sambucus
   </value>
   <value>
    Sangivamycin
   </value>
   <value>
    sapphyrin PCI-2050
   </value>
   <value>
    SB-431542
   </value>
   <value>
    SDF and Cxcr4
   </value>
   <value>
    serum amyloid A
   </value>
   <value>
    simvastatin
   </value>
   <value>
    SN38
   </value>
   <value>
    sodium orthovanadate and Na2CrO4
   </value>
   <value>
    solvent
   </value>
   <value>
    Sonazoid
   </value>
   <value>
    Sonazoid and ultrasound
   </value>
   <value>
    staurosporine
   </value>
   <value>
    steroid hormone DHT
   </value>
   <value>
    stimulated with IL-13
   </value>
   <value>
    STx1
   </value>
   <value>
    sulforaphane
   </value>
   <value>
    tBHP
   </value>
   <value>
    TCDD
   </value>
   <value>
    test compound CP-529414
   </value>
   <value>
    testosterone
   </value>
   <value>
    testosterone-BSA
   </value>
   <value>
    tetracycline
   </value>
   <value>
    tetradecylthioacetic acid
   </value>
   <value>
    TGF-beta
   </value>
   <value>
    TGF-beta1
   </value>
   <value>
    TGFb
   </value>
   <value>
    TGFb3
   </value>
   <value>
    TGFbeta
   </value>
   <value>
    thapsigargin
   </value>
   <value>
    tibolone
   </value>
   <value>
    TNF alpha
   </value>
   <value>
    TNF+IFNg
   </value>
   <value>
    TNF+IFNg+GW9508
   </value>
   <value>
    TNF+IFNg+terbutaline
   </value>
   <value>
    TNF-alpha
   </value>
   <value>
    TNF-alpha, IFN-gamma
   </value>
   <value>
    TNFalpha
   </value>
   <value>
    TNFalpha, IL1b, IL6 and PGE2
   </value>
   <value>
    trans-10, cis-12 CLA
   </value>
   <value>
    transforming growth factor beta 1
   </value>
   <value>
    transforming growth factor-beta
   </value>
   <value>
    treated
   </value>
   <value>
    treated with CDK-125
   </value>
   <value>
    treated with CDK-509
   </value>
   <value>
    treated with CDK-887
   </value>
   <value>
    treated with CNTO328 and IL-6
   </value>
   <value>
    treated with Flavopiridol
   </value>
   <value>
    treated with IL-6
   </value>
   <value>
    TREM1 antibody
   </value>
   <value>
    TREM1 antibody plus LPS
   </value>
   <value>
    trovafloxacin
   </value>
   <value>
    TSA
   </value>
   <value>
    tumor growth factor
   </value>
   <value>
    tumor necrosis and tumor growth factor
   </value>
   <value>
    tumor necrosis factor
   </value>
   <value>
    tumor necrosis factor alpha
   </value>
   <value>
    tumor necrosis factor and insulin
   </value>
   <value>
    tumor necrosis factor-alpha
   </value>
   <value>
    tunicamycin
   </value>
   <value>
    TX527
   </value>
   <value>
    TX528
   </value>
   <value>
    TX529
   </value>
   <value>
    TX530
   </value>
   <value>
    TX531
   </value>
   <value>
    ultrasound
   </value>
   <value>
    unknown
   </value>
   <value>
    unstimulated
   </value>
   <value>
    untreated
   </value>
   <value>
    untreated (control)
   </value>
   <value>
    urtica
   </value>
   <value>
    VAF347
   </value>
   <value>
    valproic acid
   </value>
   <value>
    vascular endothelial growth factor
   </value>
   <value>
    VEGF-A165
   </value>
   <value>
    vehicle
   </value>
   <value>
    vehicle (DMSO)
   </value>
   <value>
    vehicle - control
   </value>
   <value>
    vehicle control
   </value>
   <value>
    Vehicle-Control
   </value>
   <value>
    versipelostatin
   </value>
   <value>
    very advanced
   </value>
   <value>
    very early
   </value>
   <value>
    vitamin D
   </value>
   <value>
    vWF in HBSS
   </value>
   <value>
    water (mock)
   </value>
   <value>
    Wy14643
   </value>
   <value>
    Y27632
   </value>
   <value>
    zalypsis
   </value>
   <value>
    zinc
   </value>
   <value>
    ZnOAc2
   </value>
   <value>
    ZnOAc2 and PCI-5002
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    disease
   </category>
   <value>
    absense epilepsy
   </value>
   <value>
    active Crohn's disease
   </value>
   <value>
    active ulcerative colitis
   </value>
   <value>
    acute graft-versus-host disease
   </value>
   <value>
    acute lymphoblastic leukaemia
   </value>
   <value>
    acute malaria
   </value>
   <value>
    acute megakaryocytic leukaemia, Down syndrome
   </value>
   <value>
    acute monocytic leukaemia
   </value>
   <value>
    acute myeloid leukaemia
   </value>
   <value>
    acute promyelocytic leukaemia
   </value>
   <value>
    acyanotic Tetralogy of Fallot
   </value>
   <value>
    adenocarcinoma
   </value>
   <value>
    adenocarcinoma with spindle cell metaplasia
   </value>
   <value>
    adenoma
   </value>
   <value>
    adenoma with high-grade dysplasia
   </value>
   <value>
    adenomyosis
   </value>
   <value>
    adenosquamous carcinoma
   </value>
   <value>
    adrenocortical carcinoma
   </value>
   <value>
    adrenocortical tumor
   </value>
   <value>
    adult T-cell leukaemia
   </value>
   <value>
    AIDS-related non-Hodgkins lymphoma
   </value>
   <value>
    AIDS/activated B-cell-like diffuse large B-cell lymphoma
   </value>
   <value>
    AIDS/Burkitt lymphoma
   </value>
   <value>
    AIDS/DLBCL
   </value>
   <value>
    AIDS/GCB-DLBCL
   </value>
   <value>
    Alagille syndrome
   </value>
   <value>
    aldosterone-producing adenoma
   </value>
   <value>
    ALL
   </value>
   <value>
    ALL with hyperdiploid karyotype
   </value>
   <value>
    ALL with MLL rearrangement
   </value>
   <value>
    ALL with t(1, 19)
   </value>
   <value>
    ALL with t(12, 21)
   </value>
   <value>
    ALL without MLL rearrangement
   </value>
   <value>
    ALL/hyperdiploid karyotype
   </value>
   <value>
    allograft rejection
   </value>
   <value>
    alveolar cell carcinoma
   </value>
   <value>
    alveolar soft-part sarcoma
   </value>
   <value>
    Alzheimer's disease
   </value>
   <value>
    AMD
   </value>
   <value>
    AML with MLL rearrangement
   </value>
   <value>
    AML with normal karyotype and other abnormalities
   </value>
   <value>
    AML with t 11q23, MLL
   </value>
   <value>
    AML without MLL rearrangement
   </value>
   <value>
    AML(FAB-M0)
   </value>
   <value>
    AML-TLS
   </value>
   <value>
    AML/aberrant karyotype
   </value>
   <value>
    AML/chemotherapy-induced oral mucositis
   </value>
   <value>
    AML/MLL
   </value>
   <value>
    AML/other abnormalities
   </value>
   <value>
    anaplastic astrocytoma
   </value>
   <value>
    anaplastic carcinoma
   </value>
   <value>
    anaplastic large cell lymphoma
   </value>
   <value>
    angina/coronary atherosclerosis
   </value>
   <value>
    angioimmunoblastic T-cell lymphoma
   </value>
   <value>
    ankylosing spondylitis
   </value>
   <value>
    Apert syndrome
   </value>
   <value>
    apilocytic astrocytoma, juvenile pilocytic astrocytoma, or cystic cerebellar astrocytoma
   </value>
   <value>
    apocrine adenocarcinoma
   </value>
   <value>
    asthma
   </value>
   <value>
    asthma with exercise induced bronchoconstriction
   </value>
   <value>
    astrocytoma
   </value>
   <value>
    asymptomatic HIV-1 infection
   </value>
   <value>
    ATL
   </value>
   <value>
    atopic dermatitis
   </value>
   <value>
    atopy
   </value>
   <value>
    atrial fibrillation
   </value>
   <value>
    atypical carcinoid
   </value>
   <value>
    atypical ductal hyperplasia
   </value>
   <value>
    autism spectrum disorder
   </value>
   <value>
    autoimmune lymphoproliferative syndrome
   </value>
   <value>
    autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
   </value>
   <value>
    autosomal dominant monocytopenia
   </value>
   <value>
    B-ALL
   </value>
   <value>
    B-cell chronic lymphocytic leukaemia
   </value>
   <value>
    B-cell lymphoma
   </value>
   <value>
    bacteremia/suppurative arthritis/methicillin-resistant Staphylococcus aureus infection
   </value>
   <value>
    Barret's syndrome
   </value>
   <value>
    basal cell carcinoma
   </value>
   <value>
    basal-like breast cancer
   </value>
   <value>
    benign prostate tumor
   </value>
   <value>
    benign prostatic hyperplasia
   </value>
   <value>
    bilateral cryptorchid
   </value>
   <value>
    biliary atresia
   </value>
   <value>
    bipolar disorder
   </value>
   <value>
    birch pollen allergy
   </value>
   <value>
    bladder cancer
   </value>
   <value>
    bone sarcoma
   </value>
   <value>
    borderline tuberculoid leprosy
   </value>
   <value>
    BRCA1-deficient breast cancer
   </value>
   <value>
    breast adenocarcinoma
   </value>
   <value>
    breast cancer
   </value>
   <value>
    breast cancer, node metastasis
   </value>
   <value>
    breast carcinoma
   </value>
   <value>
    breast carcinoma/cystic change
   </value>
   <value>
    breast ductal adenocarcinoma
   </value>
   <value>
    breast ductal carcinoma
   </value>
   <value>
    breast fibrocystic disease
   </value>
   <value>
    breast medullary carcinoma
   </value>
   <value>
    breast metaplastic carcinoma
   </value>
   <value>
    breast squamous cell carcinoma
   </value>
   <value>
    Brief Psychotic Disorder
   </value>
   <value>
    bronchioalveolar carcinoma
   </value>
   <value>
    bronchopulmonary dysplasia
   </value>
   <value>
    Burkitt lymphoma
   </value>
   <value>
    burn
   </value>
   <value>
    c-ALL, Pre-B-ALL with t 9,22
   </value>
   <value>
    c-ALL, Pre-B-ALL without t 9,22
   </value>
   <value>
    cancer
   </value>
   <value>
    carcinoid
   </value>
   <value>
    carcinoma
   </value>
   <value>
    CCRCC
   </value>
   <value>
    cecum carcinoma
   </value>
   <value>
    celiac
   </value>
   <value>
    cervical adenocarcinoma
   </value>
   <value>
    cervical cancer
   </value>
   <value>
    cervical carcinoma
   </value>
   <value>
    childhood B-cell precursor ALL
   </value>
   <value>
    chondrosarcoma
   </value>
   <value>
    choroideremia
   </value>
   <value>
    chromophobe renal cell carcinoma
   </value>
   <value>
    chronic allograft nephropathy grade I
   </value>
   <value>
    chronic fatigue
   </value>
   <value>
    chronic graft versus host disease
   </value>
   <value>
    chronic Hodgkin's lymphoma
   </value>
   <value>
    chronic lymphocytic leukaemia
   </value>
   <value>
    chronic malaria
   </value>
   <value>
    chronic myelogenous leukaemia
   </value>
   <value>
    chronic myeloid leukaemia
   </value>
   <value>
    chronic rhinosinusitis
   </value>
   <value>
    clear-cell renal cell carcinoma
   </value>
   <value>
    clinically isolated syndrome
   </value>
   <value>
    CNS affected
   </value>
   <value>
    cocoon affected
   </value>
   <value>
    colon adenocarcinoma
   </value>
   <value>
    colon adenoma
   </value>
   <value>
    colon cancer
   </value>
   <value>
    colon carcinoma
   </value>
   <value>
    colon tumor
   </value>
   <value>
    colorectal adenocarcinoma
   </value>
   <value>
    colorectal adenoma
   </value>
   <value>
    colorectal cancer
   </value>
   <value>
    colorectal cancer - B
   </value>
   <value>
    colorectal cancer - CD
   </value>
   <value>
    colorectal carcinoma
   </value>
   <value>
    common ALL
   </value>
   <value>
    contralateral testicular aplasia
   </value>
   <value>
    conventional mantle cell lymphoma
   </value>
   <value>
    COPD
   </value>
   <value>
    COPD/emphysema
   </value>
   <value>
    COPD/giant bullae
   </value>
   <value>
    COPD/giant cell tumor
   </value>
   <value>
    COPD/non-small cell adenocarcinoma
   </value>
   <value>
    COPD/non-small cell squamous cell carcinoma
   </value>
   <value>
    Cornelia de Lange Syndrome
   </value>
   <value>
    corticosteroid resistant asthma
   </value>
   <value>
    corticosteroid sensitive asthma
   </value>
   <value>
    Crohn's disease
   </value>
   <value>
    Crohn's disease, non-inflamed site
   </value>
   <value>
    cutaneous T-cell lymphoma
   </value>
   <value>
    cystic fibrosis
   </value>
   <value>
    cystic fibrosis/chronic rhinosinusitis
   </value>
   <value>
    cytomegalovirus
   </value>
   <value>
    dedifferentiated liposarcoma
   </value>
   <value>
    desmoplastic cerebellar medulloblastoma
   </value>
   <value>
    Diamond-Blackfan Anemia
   </value>
   <value>
    diarrhea-irritable bowel syndrome
   </value>
   <value>
    differentiated liposarcoma
   </value>
   <value>
    diffuse glioma
   </value>
   <value>
    diffuse histiocytic lymphoma
   </value>
   <value>
    diffuse large B-cell lymphoma
   </value>
   <value>
    diffuse large cell lymphoma
   </value>
   <value>
    diffuse mixed lymphoma
   </value>
   <value>
    diffusely infiltrating astrocytic glioma
   </value>
   <value>
    dilated cardiomyopathy
   </value>
   <value>
    disease
   </value>
   <value>
    diseased (bleeding on probing)
   </value>
   <value>
    disseminated/methicillin-resistant Staphylococcus aureus infection
   </value>
   <value>
    disseminated/pneumonia/methicillin-sensitive Staphylococcus aureus infection
   </value>
   <value>
    dominant retinitis pigmentosa
   </value>
   <value>
    ductal carcinoma
   </value>
   <value>
    ductal carcinoma/lobular carcinoma
   </value>
   <value>
    ejaculatory azoospermia/cryptorchidism
   </value>
   <value>
    ejaculatory azoospermia/idiopathic infertility
   </value>
   <value>
    embryonic carcinoma
   </value>
   <value>
    encephalitis/influenza A infection
   </value>
   <value>
    endemic Burkitt lymphoma
   </value>
   <value>
    endometrial adenocarcinoma
   </value>
   <value>
    endometrial cancer
   </value>
   <value>
    endometrioid ovarian cancer
   </value>
   <value>
    endometriosis
   </value>
   <value>
    eosinophilic esophagitis
   </value>
   <value>
    eosinophilic leukaemia
   </value>
   <value>
    ependymoma
   </value>
   <value>
    epidermoid carcinoma
   </value>
   <value>
    epilepsy
   </value>
   <value>
    epitheloidal angiolipoma
   </value>
   <value>
    erosive gastritis
   </value>
   <value>
    erythroleukaemia
   </value>
   <value>
    esophageal adenocarcinoma
   </value>
   <value>
    esophageal squamous carcinoma
   </value>
   <value>
    esophageal squamous cell carcinoma
   </value>
   <value>
    Ewing's sarcoma
   </value>
   <value>
    extranodal NK/T-Cell lymphoma
   </value>
   <value>
    extranodal NK/T-cell lymphoma
   </value>
   <value>
    extranodal NK/T-Cell lymphoma derived cell line
   </value>
   <value>
    extraskeletal Ewing's sarcoma
   </value>
   <value>
    facial tumor
   </value>
   <value>
    facioscapulohumeral muscular dystrophy
   </value>
   <value>
    familial hypercholesterolemia
   </value>
   <value>
    familial hyperplastic polyposis
   </value>
   <value>
    fetal adenoma
   </value>
   <value>
    fever/influenza A infection
   </value>
   <value>
    fever/influenza B infection
   </value>
   <value>
    fever/upper respiratory infection/influenza A infection
   </value>
   <value>
    fever/upper respiratory infection/influenza B infection
   </value>
   <value>
    fibrocystic disease
   </value>
   <value>
    fibrosarcoma
   </value>
   <value>
    folicular lymphoma
   </value>
   <value>
    follicular adenoma
   </value>
   <value>
    follicular carcinoma
   </value>
   <value>
    follicular hyperplasia
   </value>
   <value>
    Freidriech's ataxia
   </value>
   <value>
    ganglioneuroblastoma
   </value>
   <value>
    ganglioneuroma
   </value>
   <value>
    gastric adenocarcinoma
   </value>
   <value>
    gastric cancer
   </value>
   <value>
    gastric carcinoma
   </value>
   <value>
    gastric papillary adenocarcinoma
   </value>
   <value>
    gastrointestinal stromal tumor
   </value>
   <value>
    germinoma
   </value>
   <value>
    germinoma/teratoma
   </value>
   <value>
    germioma/yolk sac tumor
   </value>
   <value>
    giant cell glioblastoma
   </value>
   <value>
    glioblastoma
   </value>
   <value>
    glioblastoma multiforme
   </value>
   <value>
    glioblastoma with EGFR amplification
   </value>
   <value>
    glioma
   </value>
   <value>
    gonadotrope tumor
   </value>
   <value>
    graft versus host disease
   </value>
   <value>
    graft-versus host disease
   </value>
   <value>
    graft-versus-host disease
   </value>
   <value>
    Graves' disease
   </value>
   <value>
    gulf war illness
   </value>
   <value>
    Haemophilus ducreyi infection
   </value>
   <value>
    hairy cell leukaemia
   </value>
   <value>
    HBV/hepatocellular carcinoma
   </value>
   <value>
    HCV
   </value>
   <value>
    HCV, hepatoma
   </value>
   <value>
    HCV/hepatocellular carcinoma
   </value>
   <value>
    head and neck cancer
   </value>
   <value>
    head and neck squamous cell carcinoma
   </value>
   <value>
    HeLa cell contamination
   </value>
   <value>
    hematoma
   </value>
   <value>
    hepatitis C virus-induced hepatocellular carcinoma
   </value>
   <value>
    hepatocellular carcinoma
   </value>
   <value>
    hepatoma
   </value>
   <value>
    her2+ breast cancer
   </value>
   <value>
    hereditary gingival fibromatosis
   </value>
   <value>
    hereditary spherocytosis
   </value>
   <value>
    high risk B-precurser ALL
   </value>
   <value>
    high-grade prostatic intraepithelial neoplasia
   </value>
   <value>
    highly invasive glioma
   </value>
   <value>
    hip arthroplasty
   </value>
   <value>
    HIV
   </value>
   <value>
    HIV-1
   </value>
   <value>
    Hodgkins lymphoma
   </value>
   <value>
    house dust mite allergy
   </value>
   <value>
    Huntington's disease
   </value>
   <value>
    Hutchinson-Gilford Progeria Syndrome
   </value>
   <value>
    hydrolethalus syndrome
   </value>
   <value>
    hyperplastic polyp
   </value>
   <value>
    hyperplastic polyposis syndrome
   </value>
   <value>
    hypertriglyceridemia
   </value>
   <value>
    hypopharynx squamous cell carcinoma
   </value>
   <value>
    ICA (appearance of autoantibodies against islet cells)
   </value>
   <value>
    idiopathic chronic fatigue
   </value>
   <value>
    idiopathic pulmonary arterial hypertension
   </value>
   <value>
    idipathic pulmonary fibrosis
   </value>
   <value>
    IFTA
   </value>
   <value>
    IFTA/inflammation
   </value>
   <value>
    ileocecal carcinoma
   </value>
   <value>
    immunoblastic large cell lymphoma
   </value>
   <value>
    immunodeficiency associated Burkitt lymphoma
   </value>
   <value>
    in-transit extremity melanoma
   </value>
   <value>
    indolent mantle cell lymphoma
   </value>
   <value>
    infiltrating ductal carcinoma
   </value>
   <value>
    infiltrating lobular carcinoma
   </value>
   <value>
    inflamed tonsil
   </value>
   <value>
    inflammation
   </value>
   <value>
    inflammatory bowel disease
   </value>
   <value>
    inflammatory lung disease
   </value>
   <value>
    interstitial cystitis
   </value>
   <value>
    intestinal adenocarcinoma
   </value>
   <value>
    intracranial arterial aneurysm (unruptured)
   </value>
   <value>
    invasive ductal carcinoma
   </value>
   <value>
    invasive ductal/lobular carcinoma
   </value>
   <value>
    irritable bowel syndrome
   </value>
   <value>
    ischemic cardiomyopathy
   </value>
   <value>
    Job's syndrome
   </value>
   <value>
    juvenile idiopathic arthritis
   </value>
   <value>
    juvenile myelomonocytic leukaemia
   </value>
   <value>
    Kaposi's sarcoma
   </value>
   <value>
    Kawasaki disease
   </value>
   <value>
    kidney carcinoma
   </value>
   <value>
    kidney transplant recipient
   </value>
   <value>
    large cell lung cancer
   </value>
   <value>
    large cell lymphoma
   </value>
   <value>
    large cell neuroendocrine carcinoma
   </value>
   <value>
    larynx squamous cell carcinoma
   </value>
   <value>
    leiomyoma
   </value>
   <value>
    leiomyosarcoma
   </value>
   <value>
    lepromatous leprosy
   </value>
   <value>
    leukaemia
   </value>
   <value>
    leukemic-state lymphoma
   </value>
   <value>
    lipoma
   </value>
   <value>
    liposarcoma
   </value>
   <value>
    liver adenoma
   </value>
   <value>
    liver mesenchymal tumor
   </value>
   <value>
    lobular carcinoma
   </value>
   <value>
    lung adenocarcinoma
   </value>
   <value>
    lung anaplastic carcinoma
   </value>
   <value>
    lung cancer
   </value>
   <value>
    lung cancer (pathology not available)
   </value>
   <value>
    lung carcinoma
   </value>
   <value>
    lung fibrosarcoma
   </value>
   <value>
    lung squamous cell carcinoma
   </value>
   <value>
    lymph node metastasis
   </value>
   <value>
    lymphocytic leukaemia
   </value>
   <value>
    lymphoid neoplasm
   </value>
   <value>
    lymphoma
   </value>
   <value>
    malignant Burkitt's lymphoma
   </value>
   <value>
    malignant melanoma
   </value>
   <value>
    malignant mesothelioma
   </value>
   <value>
    malignant non-Hodgkin's lymphoma
   </value>
   <value>
    malignant peripheral nerve sheath tumor
   </value>
   <value>
    malignant pheochromocytoma
   </value>
   <value>
    malignant pluripotent embryonal carcinoma
   </value>
   <value>
    malignant testicular teratoma
   </value>
   <value>
    MALT lymphoma
   </value>
   <value>
    mantle cell lymphoma
   </value>
   <value>
    MCI
   </value>
   <value>
    medulloblastoma
   </value>
   <value>
    melanoma
   </value>
   <value>
    meningioma
   </value>
   <value>
    meningococcal sepsis
   </value>
   <value>
    mental retardation or developmental delay
   </value>
   <value>
    mesothelioma
   </value>
   <value>
    metastatic CCRCC
   </value>
   <value>
    metastatic colorectal cancer in liver
   </value>
   <value>
    metastatic gastrointestinal stromal tumor in liver
   </value>
   <value>
    metastatic kidney carcinoma in liver
   </value>
   <value>
    metastatic mammary carcinoma in liver
   </value>
   <value>
    metastatic melanoma
   </value>
   <value>
    metastatic prostate cancer
   </value>
   <value>
    metastatic stomach cancer in liver
   </value>
   <value>
    midgut carcinoid
   </value>
   <value>
    mild chronic allograft nephropathy
   </value>
   <value>
    mixture
   </value>
   <value>
    MLL
   </value>
   <value>
    MLL rearrangement
   </value>
   <value>
    moderate chronic allograft nephropathy
   </value>
   <value>
    moderately differentiated head and neck squamous cell carcinoma
   </value>
   <value>
    monoclonal gammopathy of undetermined significance
   </value>
   <value>
    monoclonal gammopathy of unknown significance
   </value>
   <value>
    morbidly obese
   </value>
   <value>
    mucinous adenocarcinoma
   </value>
   <value>
    mucoepidermoid lung cancer
   </value>
   <value>
    mucoid ductal carcinoma
   </value>
   <value>
    Muenke syndrome
   </value>
   <value>
    multiple myeloma
   </value>
   <value>
    multiple sclerosis
   </value>
   <value>
    multiple sclerosis or clinically isolated syndrome
   </value>
   <value>
    muscular dystrophy
   </value>
   <value>
    mycosis fungoide (cutaneus T-cell lymphoma)
   </value>
   <value>
    mycosis fungoides
   </value>
   <value>
    myelodisplastic syndrome
   </value>
   <value>
    myelodysplasia
   </value>
   <value>
    myelodysplastic syndrome
   </value>
   <value>
    myelodysplastic syndrome/refractory anemia
   </value>
   <value>
    myelodysplastic syndrome/refractory anemia with excess blasts
   </value>
   <value>
    myelodysplastic syndrome/refractory anemia with ringed sideroblasts
   </value>
   <value>
    myeloma
   </value>
   <value>
    myxoid liposarcoma
   </value>
   <value>
    myxoid round cell liposarcoma
   </value>
   <value>
    nasopharingeal carcinoma
   </value>
   <value>
    nasopharyngeal carcinoma
   </value>
   <value>
    nasopharyngeal squamous cell carcinoma
   </value>
   <value>
    neuroaxonal injury in cerebral palsy patient
   </value>
   <value>
    neuroblastoma
   </value>
   <value>
    neuroblastoma (Ewing sarcoma)
   </value>
   <value>
    neuroepithelioma
   </value>
   <value>
    neuromuscular pain
   </value>
   <value>
    nickel allergy
   </value>
   <value>
    Nijmegen breakage syndrome
   </value>
   <value>
    NK leukaemia
   </value>
   <value>
    NK/T-cell lymphoma
   </value>
   <value>
    no rejection
   </value>
   <value>
    nodal diffuse large B-cell lymphoma
   </value>
   <value>
    nodal peripheral T-cell lymphoma
   </value>
   <value>
    nodular goiter
   </value>
   <value>
    nodular lymphocyte predominant Hodgkin's lymphoma
   </value>
   <value>
    nodular melanoma
   </value>
   <value>
    non active Crohn's disease
   </value>
   <value>
    non-active ulcerative colitis
   </value>
   <value>
    non-basal like breast cancer
   </value>
   <value>
    non-Hodgkins lymphoma
   </value>
   <value>
    non-inflammatory bowel disease
   </value>
   <value>
    non-inflammatory neurological disease
   </value>
   <value>
    non-invasive glioma
   </value>
   <value>
    non-small cell lung cancer
   </value>
   <value>
    nonsyndromic sagittal synostosis
   </value>
   <value>
    normal
   </value>
   <value>
    NSCLC
   </value>
   <value>
    null cell tumor
   </value>
   <value>
    obesity
   </value>
   <value>
    obstruction
   </value>
   <value>
    oculo-facio-cardio-dental syndrome
   </value>
   <value>
    oligoarticular juvenile idiopathic arthritis
   </value>
   <value>
    oligoastrocytoma
   </value>
   <value>
    oligoastrocytoma (grade 3) with EGFR amplification
   </value>
   <value>
    oligodendroglioma
   </value>
   <value>
    oligodendroglioma (grade 3) with 1p19q codeletion
   </value>
   <value>
    oligodendroglioma (grade 3) with EGFR amplification
   </value>
   <value>
    oral cavity squamous cell carcinoma
   </value>
   <value>
    organ donor
   </value>
   <value>
    oropharynx squamous cell carcinoma
   </value>
   <value>
    osteoarthritis
   </value>
   <value>
    osteomyelitis
   </value>
   <value>
    osteomyelitis/bacteremia/methicillin-resistant Staphylococcus aureus infection
   </value>
   <value>
    osteomyelitis/suppurative arthritis/methicillin-resistant Staphylococcus aureus infection
   </value>
   <value>
    osteosarcoma
   </value>
   <value>
    ovarian adenocarcinoma
   </value>
   <value>
    ovarian cancer
   </value>
   <value>
    ovarian carcinoma
   </value>
   <value>
    ovarian papillary serous adenocarcinoma
   </value>
   <value>
    ovarian serous carcinoma
   </value>
   <value>
    ovary carcinoma
   </value>
   <value>
    pancreatic adenocarcinoma
   </value>
   <value>
    pancreatic cancer
   </value>
   <value>
    pancreatic carcinoma
   </value>
   <value>
    pancreatic ductal adenocarcinoma
   </value>
   <value>
    papillary carcinoma
   </value>
   <value>
    papillary serous ovarian adenocarcinoma
   </value>
   <value>
    papillary thyroid cancer
   </value>
   <value>
    parathyroid tumour
   </value>
   <value>
    Parkinson's disease
   </value>
   <value>
    pediatric acute leukaemia
   </value>
   <value>
    pediatric T-ALL
   </value>
   <value>
    pediatric-high grade glioma/anaplastic astrocytoma
   </value>
   <value>
    pediatric-high grade glioma/anaplastic oligodendroglioma
   </value>
   <value>
    pediatric-high grade glioma/glioblastoma
   </value>
   <value>
    pediatric-high grade glioma/glioblastoma variant
   </value>
   <value>
    pediatric-high grade glioma/pleomorphic xanthoastrocytoma
   </value>
   <value>
    periodontitis
   </value>
   <value>
    peripheral T-cell lymphoma
   </value>
   <value>
    pharyngeal carcinoma
   </value>
   <value>
    Pick's disease
   </value>
   <value>
    pilocytic astrocytoma
   </value>
   <value>
    pituitary adenoma
   </value>
   <value>
    pituitary adenoma predisposition
   </value>
   <value>
    pituitary tumor
   </value>
   <value>
    placenta choriocarcinoma
   </value>
   <value>
    pleomorphic liposarcoma
   </value>
   <value>
    pneumonia/bacteremia/S. Pneumoniae infection
   </value>
   <value>
    pneumonia/empyema/S. Pneumoniae infection
   </value>
   <value>
    pneumonia/influenza A infection
   </value>
   <value>
    polyarticular juvenile idiopathic arthritis
   </value>
   <value>
    polycystic ovary syndrome
   </value>
   <value>
    poorly differentiated head and neck squamous cell carcinoma
   </value>
   <value>
    post-transplant
   </value>
   <value>
    pre B-ALL
   </value>
   <value>
    Pre-B-ALL/c-ALL
   </value>
   <value>
    pre-diabetes
   </value>
   <value>
    pre-transplant
   </value>
   <value>
    precursor B-cell acute lymphoblastic leukaemia
   </value>
   <value>
    preeclampsia
   </value>
   <value>
    previous malaria infection
   </value>
   <value>
    primary breast tumor
   </value>
   <value>
    primary glioblastoma
   </value>
   <value>
    primary prostate cancer
   </value>
   <value>
    primary unilateral non-metastatic breast cancer
   </value>
   <value>
    Pro-B-ALL
   </value>
   <value>
    Pro-B-ALL with t 11q23, MLL
   </value>
   <value>
    Pro-B-ALL/MLL
   </value>
   <value>
    progressive multiple sclerosis
   </value>
   <value>
    Progressive supranuclear palsy
   </value>
   <value>
    prolapse
   </value>
   <value>
    prostate adenocarcinoma
   </value>
   <value>
    prostate cancer
   </value>
   <value>
    prostate carcinoma
   </value>
   <value>
    psoriasis
   </value>
   <value>
    pulmonary arterial hypertension
   </value>
   <value>
    pulmonary MALT lymphoma
   </value>
   <value>
    pulmonary tuberculosis
   </value>
   <value>
    RCC
   </value>
   <value>
    recessive retinitis pigmentosa
   </value>
   <value>
    rectal adenocarcinoma
   </value>
   <value>
    recurrent glioblastoma
   </value>
   <value>
    recurrent glioblastoma multiforme
   </value>
   <value>
    renal adenocarcinoma
   </value>
   <value>
    renal cancer
   </value>
   <value>
    renal carcinoma
   </value>
   <value>
    renal cell carcinoma
   </value>
   <value>
    renal clear cell carcinoma
   </value>
   <value>
    renal disease
   </value>
   <value>
    renal oncocytoma
   </value>
   <value>
    Rett syndrome
   </value>
   <value>
    rhabdomyosarcoma
   </value>
   <value>
    rheumatoid arthriris
   </value>
   <value>
    rheumatoid arthritis
   </value>
   <value>
    Roberts syndrome
   </value>
   <value>
    sarcoidosis
   </value>
   <value>
    sarcoma
   </value>
   <value>
    schizophrenia
   </value>
   <value>
    schyzophrenia
   </value>
   <value>
    scleroderma with pulmonary hypertension
   </value>
   <value>
    scleroderma without pulmonary hypertension
   </value>
   <value>
    sepsis
   </value>
   <value>
    septic arthritis/osteomyelitis/bacteremia/methicillin-sensitive Staphylococcus aureus infection
   </value>
   <value>
    septic patient
   </value>
   <value>
    septic shock
   </value>
   <value>
    serous borderline ovarian cancer
   </value>
   <value>
    serous epithelial ovarian cancer
   </value>
   <value>
    Setleis syndrome
   </value>
   <value>
    severe chronic allograft nephropathy
   </value>
   <value>
    Sezary syndrome
   </value>
   <value>
    sickle cell anaemia
   </value>
   <value>
    Sjogren syndrome
   </value>
   <value>
    small cell lung cancer
   </value>
   <value>
    small cell lung carcinoma
   </value>
   <value>
    Soetre-Chotzen syndrome
   </value>
   <value>
    soft tissue sarcoma
   </value>
   <value>
    spina bifida
   </value>
   <value>
    spinal muscular atrophy
   </value>
   <value>
    splenic marginal zone lymphoma
   </value>
   <value>
    sporadic Burkitt lymphoma
   </value>
   <value>
    squamous cell carcinoma
   </value>
   <value>
    squamous cell lung carcinoma
   </value>
   <value>
    Stevens-Johnson syndrome/toxic epidermal necrolysis
   </value>
   <value>
    stress incontinence
   </value>
   <value>
    subclinical interstitial fibrosis
   </value>
   <value>
    subependymal giant cell astrocytoma
   </value>
   <value>
    systemic inflammatory response syndrome
   </value>
   <value>
    systemic inflammatory response syndrome resolved
   </value>
   <value>
    systemic juvenile idiopathic arthritis
   </value>
   <value>
    T-ALL
   </value>
   <value>
    T-cell leukaemia
   </value>
   <value>
    T-cell lymphoma
   </value>
   <value>
    T-cell/histiocyte rich B-cell lymphoma
   </value>
   <value>
    T-LGL lymphocytosis
   </value>
   <value>
    teratoma/germ cell tumor
   </value>
   <value>
    teratoma/yolk sac tumor
   </value>
   <value>
    testicular diffuse large B-cell lymphoma
   </value>
   <value>
    testicular germ-cell tumor
   </value>
   <value>
    thalassemia
   </value>
   <value>
    thanatophoric dysplasia
   </value>
   <value>
    Thompson disease, grade 1
   </value>
   <value>
    Thompson disease, grade 1/2
   </value>
   <value>
    Thompson disease, grade 3
   </value>
   <value>
    Thompson disease, grade 4
   </value>
   <value>
    tongue squamous cell carcinoma
   </value>
   <value>
    trachoma
   </value>
   <value>
    tuberous sclerosis
   </value>
   <value>
    tumorigenic
   </value>
   <value>
    type 1 diabetes
   </value>
   <value>
    type 1 diabetes clinical onset
   </value>
   <value>
    type 1 diabetes longstanding
   </value>
   <value>
    type 1 diabetes recent onset
   </value>
   <value>
    type 2 diabetes
   </value>
   <value>
    type 2 diabetes mellitus
   </value>
   <value>
    ulcerative colitis
   </value>
   <value>
    ulcerative colitis with inflammation
   </value>
   <value>
    ulcerative colitis without inflammation
   </value>
   <value>
    undifferentiated bone sarcoma
   </value>
   <value>
    undifferentiated sarcoma
   </value>
   <value>
    undifferentiated soft tissue sarcoma
   </value>
   <value>
    unilateral cryptorchid
   </value>
   <value>
    unknown
   </value>
   <value>
    Usher syndrome
   </value>
   <value>
    uterine fibroid
   </value>
   <value>
    uterine leiomyoma
   </value>
   <value>
    vessel ischemic heart disease
   </value>
   <value>
    villitis
   </value>
   <value>
    vulvar intraepithelial neoplasia
   </value>
   <value>
    Waldenstrom Macroglobulinemia
   </value>
   <value>
    Waldenstršms macroglobulinemia
   </value>
   <value>
    well differentiated head and neck squamous cell carcinoma
   </value>
   <value>
    well-differentiated soft tissue sarcoma
   </value>
   <value>
    Williams-Beuren Syndrome
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    genotype
   </category>
   <value>
    (dominant negative Egr)/EGFP infected SH-SY5Y/TrkA
   </value>
   <value>
    12G FEZL-overexpressed
   </value>
   <value>
    1b
   </value>
   <value>
    46(X,Y)
   </value>
   <value>
    ACO1 overexpression
   </value>
   <value>
    Ad-GFP
   </value>
   <value>
    Ad-GFP infected
   </value>
   <value>
    Ad-GFP-1 alpha infected
   </value>
   <value>
    Ad-HER2-ki (kinase inactive)
   </value>
   <value>
    Ad-HER2-wt (wild type)
   </value>
   <value>
    AHI-1/sh4 vector
   </value>
   <value>
    AML1-ETO
   </value>
   <value>
    AML1-ETO fusion gene transduction
   </value>
   <value>
    aneuploidy
   </value>
   <value>
    annexin receptor ALXR
   </value>
   <value>
    B2som
   </value>
   <value>
    Basp
   </value>
   <value>
    BMPR2 mutation
   </value>
   <value>
    BRAF Mutant
   </value>
   <value>
    BRAF Mutant; NRAS wildtype
   </value>
   <value>
    BRAF wildtype; NRAS mutant
   </value>
   <value>
    BRAF wildtype; NRAS wildtype
   </value>
   <value>
    BRG1 and T_R-II vectors
   </value>
   <value>
    C/EBPbeta-2 overexpression
   </value>
   <value>
    CACNA1E transfection
   </value>
   <value>
    CAT expression
   </value>
   <value>
    CBFbeta-MYH11
   </value>
   <value>
    Cdh1 shRNA  knockdown
   </value>
   <value>
    CEBP (transfect)
   </value>
   <value>
    CEBPA expression silenced
   </value>
   <value>
    CEBPA mutation
   </value>
   <value>
    CEBPA wildtype
   </value>
   <value>
    CLL 11q deletion high zap IGHV unmutated
   </value>
   <value>
    CLL 13q deletion low zap IGHV mutated
   </value>
   <value>
    CLL 17p deletion high zap IGHV unmutated
   </value>
   <value>
    CLL 17p deletion low zap IGHV mutated
   </value>
   <value>
    CLL normal karyotype low zap IGHV mutated
   </value>
   <value>
    CLL trisomy 12 high zap IGHV unmutated
   </value>
   <value>
    CLL trisomy 12 low zap IGHV mutated
   </value>
   <value>
    clone TERT5 transfected with TERT
   </value>
   <value>
    clone TERT6 transfected with TERT
   </value>
   <value>
    clone TERT8 transfected with TERT
   </value>
   <value>
    constitutively-active RhoA mutant (G14V)
   </value>
   <value>
    control
   </value>
   <value>
    control decoy
   </value>
   <value>
    control miRNA
   </value>
   <value>
    control retrovirus
   </value>
   <value>
    control transduced
   </value>
   <value>
    control transfected
   </value>
   <value>
    control vector
   </value>
   <value>
    CTNNB1 mutation: 232G&gt;GA | D32D/N, TP53 mutation: negative
   </value>
   <value>
    CTNNB1 mutation: 232G&gt;GA,p.D32D/N, TP53 mutation: negative
   </value>
   <value>
    CTNNB1 mutation: 232G&gt;GT | D32D/Y, TP53 mutation: negative
   </value>
   <value>
    CTNNB1 mutation: 233A&gt;AG,p.D32D/G, TP53 mutation: negative
   </value>
   <value>
    CTNNB1 mutation: 233A&gt;AT | D32D/V, TP53 mutation: negative
   </value>
   <value>
    CTNNB1 mutation: 234_245het_delCTCTGGAATCCA, TP53 mutation: negative
   </value>
   <value>
    CTNNB1 mutation: 235T&gt;TC | S33S/P, TP53 mutation: negative
   </value>
   <value>
    CTNNB1 mutation: 236C&gt;CT | S33S/F, TP53 mutation: 256G&gt;GT | R249R/S
   </value>
   <value>
    CTNNB1 mutation: 236C&gt;CT,p.S33S/F, TP53 mutation: negative
   </value>
   <value>
    CTNNB1 mutation: 247T&gt;TG | S37S/A, TP53 mutation: negative
   </value>
   <value>
    CTNNB1 mutation: 248C&gt;CG | S37S/C, TP53 mutation: negative
   </value>
   <value>
    CTNNB1 mutation: 248C&gt;CT | S37S/F, TP53 mutation: negative
   </value>
   <value>
    CTNNB1 mutation: 271T&gt;TG,p.S45S/A, TP53 mutation: negative
   </value>
   <value>
    CTNNB1 mutation: negative, TP53 mutation: 284G&gt;GT | D259D/Y
   </value>
   <value>
    CTNNB1 mutation: negative, TP53 mutation: 344A&gt;AC | Q144Q/P
   </value>
   <value>
    CTNNB1 mutation: negative, TP53 mutation: 364C&gt;CA | P151P/T
   </value>
   <value>
    CTNNB1 mutation: negative, TP53 mutation: 366A&gt;AG,Y205Y/C
   </value>
   <value>
    CTNNB1 mutation: negative, TP53 mutation: 386G&gt;GT | R158R/L
   </value>
   <value>
    CTNNB1 mutation: negative, TP53 mutation: negative
   </value>
   <value>
    CTNNB1 mutation: negative, TP53 mutation: not available
   </value>
   <value>
    CTNNB1 mutation: negative, TP53 mutation:249_250het_insGAATC
   </value>
   <value>
    CTNNB1 mutation: not available, TP53 mutation: negative
   </value>
   <value>
    CTNNB1 mutation: not available, TP53 mutation: not available
   </value>
   <value>
    D374Y-PCSK9 gain of function
   </value>
   <value>
    DBA deletion
   </value>
   <value>
    DBA Deletion 1
   </value>
   <value>
    delta CS construct
   </value>
   <value>
    derived using lentiviral factor
   </value>
   <value>
    derived using minicircle DNA
   </value>
   <value>
    dipeptidylpeptidase III
   </value>
   <value>
    direct delivery of reprogramming proteins
   </value>
   <value>
    DNMT3a R882 mutant
   </value>
   <value>
    DNMT3a R882 wild type
   </value>
   <value>
    dominant negative CLIM induction
   </value>
   <value>
    DomNeg1-encoding retroviral vector
   </value>
   <value>
    EBNA2 expression
   </value>
   <value>
    EC-specific VE-cadherin promoter driving GFP
   </value>
   <value>
    EGFP infected SH-SY5Y/TrkA
   </value>
   <value>
    ELMOD2 over-expression
   </value>
   <value>
    empty
   </value>
   <value>
    empty pGEX-4T-327 vector
   </value>
   <value>
    empty pSG213 vector
   </value>
   <value>
    empty pSGMtNeo vector
   </value>
   <value>
    empty retroviral vector
   </value>
   <value>
    empty vector
   </value>
   <value>
    empty vector control
   </value>
   <value>
    empty vector control with GFP
   </value>
   <value>
    empty vector transfected
   </value>
   <value>
    ESCO2 mutation
   </value>
   <value>
    estrogen deprived
   </value>
   <value>
    estrogen receptor alpha mutation: positive; PIK3CA mutation: negative
   </value>
   <value>
    estrogen receptor alpha mutation: positive; PIK3CA mutation: positive
   </value>
   <value>
    EWS/NOR1-overexpressing
   </value>
   <value>
    expressing an actively mutated hHSF1
   </value>
   <value>
    expressing chicken HSF1
   </value>
   <value>
    expressing conditional EBNA3C
   </value>
   <value>
    expressing HTLV-I p30
   </value>
   <value>
    expressing PLZF-RARa
   </value>
   <value>
    ezrin- knockdown
   </value>
   <value>
    Flag vector
   </value>
   <value>
    Flag-p53 SA
   </value>
   <value>
    Flag-p53 wild type
   </value>
   <value>
    FLT3-ITD absent
   </value>
   <value>
    FLT3-ITD present
   </value>
   <value>
    FOXP3-tet-off
   </value>
   <value>
    GAM overexpression
   </value>
   <value>
    gefitinib resistant
   </value>
   <value>
    gene fusion: API2-MALT1
   </value>
   <value>
    gene fusion: IgH-MALT1
   </value>
   <value>
    gene knock out
   </value>
   <value>
    GFP and MIST1 transfected, GFP sorted
   </value>
   <value>
    GFP control
   </value>
   <value>
    GFP expressing lentivirus
   </value>
   <value>
    GFP integrated
   </value>
   <value>
    GFP virus
   </value>
   <value>
    GFP-cmatr3
   </value>
   <value>
    GSTM1 null
   </value>
   <value>
    GSTM1 positive
   </value>
   <value>
    HA-tagged AML1/ETO
   </value>
   <value>
    HA-tagged PRDM5
   </value>
   <value>
    HCV replicon
   </value>
   <value>
    HER2 amplification
   </value>
   <value>
    HER2 mutation: negative
   </value>
   <value>
    HER2 mutation: positive
   </value>
   <value>
    heterozygous familial hypercholesterolemia
   </value>
   <value>
    heterozygous LDLR mutant
   </value>
   <value>
    hIMP Dmut transfection
   </value>
   <value>
    hIMP1 wt transfection
   </value>
   <value>
    hMOF knock-down
   </value>
   <value>
    HNF4a2 mutant C106R
   </value>
   <value>
    HNF4a2 mutant R154X
   </value>
   <value>
    HNF4a2 wild type
   </value>
   <value>
    homozygous familial hypercholesterolemia
   </value>
   <value>
    homozygous for the Q119X mutation in the TWIST2 gene
   </value>
   <value>
    homozygous LDLR mutant
   </value>
   <value>
    HPV E6/E7/hTERT transfected
   </value>
   <value>
    HRas overexpression
   </value>
   <value>
    hypotriploid
   </value>
   <value>
    ICSBP1: allele 11
   </value>
   <value>
    ICSBP1: allele 13
   </value>
   <value>
    ICSBP1: allele 33
   </value>
   <value>
    IGF1R-overexpressed
   </value>
   <value>
    IKK2kd-transfected
   </value>
   <value>
    immortalized by transduction with human papilloma virus 16 E6/E7 genes
   </value>
   <value>
    infected with Bmi-1-expressing retrovirus; superinfected with E6 expressing retrovirus
   </value>
   <value>
    infected with Bmi-1-expressing retrovirus; superinfected with E6(Delta)118-122 expressing retrovirus
   </value>
   <value>
    infected with Bmi-1-expressing retrovirus; superinfected with LXSN-rexpressing (control) retrovirus
   </value>
   <value>
    infection with retrovirus containing IKKB-gene
   </value>
   <value>
    infection with retrovirus containing NIK-gene
   </value>
   <value>
    IT15 CAG repeats: 15/50
   </value>
   <value>
    IT15 CAG repeats: 17/45
   </value>
   <value>
    IT15 CAG repeats: 17/47
   </value>
   <value>
    IT15 CAG repeats: 18/43
   </value>
   <value>
    IT15 CAG repeats: 26/47
   </value>
   <value>
    JAG1 mutation
   </value>
   <value>
    Jag1 retrovirus infected
   </value>
   <value>
    JAK1 mutated
   </value>
   <value>
    JAK1 wild type
   </value>
   <value>
    KIT mutation: Exon 11
   </value>
   <value>
    KIT mutation: Exon 9
   </value>
   <value>
    KIT mutation: wild type
   </value>
   <value>
    KIT mutation; PDGFRA wild type
   </value>
   <value>
    KIT wild type; PDGFRA mutation
   </value>
   <value>
    KIT wild type; PDGFRA wild type
   </value>
   <value>
    KLF1 p.K288X/wild type
   </value>
   <value>
    LacZ transduced (control)
   </value>
   <value>
    lentiviral transduction
   </value>
   <value>
    lentivirus for GFP and luciferase expression (control)
   </value>
   <value>
    lentivirus for GFP and SOX2 expression
   </value>
   <value>
    LMNA E161K (gene mutation)
   </value>
   <value>
    LMNA wild type
   </value>
   <value>
    LMP1
   </value>
   <value>
    Luc RNAi-Day0 ES cells (lentivirus infected)
   </value>
   <value>
    MeCP2 decoy
   </value>
   <value>
    MEK1 overexpression
   </value>
   <value>
    MEK5/CA transduced
   </value>
   <value>
    miR-124 overexpression
   </value>
   <value>
    miR-130b transfection
   </value>
   <value>
    miR-145 transfectant
   </value>
   <value>
    miR-155 knock down
   </value>
   <value>
    miR-7 precursor
   </value>
   <value>
    miR-99a transfection
   </value>
   <value>
    miR-NC negative control precursor
   </value>
   <value>
    miR206 transfected
   </value>
   <value>
    miR221 transfected
   </value>
   <value>
    miR222 transfected
   </value>
   <value>
    miR26a
   </value>
   <value>
    MLL-AF9
   </value>
   <value>
    mock
   </value>
   <value>
    mock transfectant
   </value>
   <value>
    mock transfected
   </value>
   <value>
    mock-transduced
   </value>
   <value>
    mock-transfected
   </value>
   <value>
    modified-RNA (synthetic mRNA with GFP)
   </value>
   <value>
    mutant-p53 depleted
   </value>
   <value>
    mutated gene (MECP2)
   </value>
   <value>
    MYCN amplification; 1p deletion; 11q wild type; 17q amplification
   </value>
   <value>
    MYCN wild type; 1p deletion; 11q deletion; 17q amplification
   </value>
   <value>
    MYCN wild type; 1p deletion; 11q wild type; 17q amplification
   </value>
   <value>
    MYCN wild type; 1p wild type; 11q deletion; 17q amplification
   </value>
   <value>
    MYCN wild type; 1p wild type; 11q deletion; 17q wild type
   </value>
   <value>
    MYCN wild type; 1p wild type; 11q wild type; 17q amplification
   </value>
   <value>
    MYCN wild type; 1p wild type; 11q wild type; 17q wild type
   </value>
   <value>
    MYCN wild type; 1p wild type; 11q wild type; gain: mixed
   </value>
   <value>
    MYCN-tet-off
   </value>
   <value>
    MYCN: amplified
   </value>
   <value>
    MYCN: single copy
   </value>
   <value>
    naive
   </value>
   <value>
    negative control transfection
   </value>
   <value>
    NESG1 overexpression
   </value>
   <value>
    NFKB &amp; CEBP (transfect)
   </value>
   <value>
    NFKB (transfect)
   </value>
   <value>
    NICD
   </value>
   <value>
    NIPBL mutation: cDNA 1444_1447delAGAG / Frameshift
   </value>
   <value>
    NIPBL mutation: cDNA 1546_1547insG / Frameshift
   </value>
   <value>
    NIPBL mutation: cDNA 1902_1903insA / Frameshift
   </value>
   <value>
    NIPBL mutation: cDNA 1934delA / Nonsense
   </value>
   <value>
    NIPBL mutation: cDNA 2449_2450insG / Frameshift
   </value>
   <value>
    NIPBL mutation: cDNA 2494C&gt;T / nonsense
   </value>
   <value>
    NIPBL mutation: cDNA 2969delG / Frameshift
   </value>
   <value>
    NIPBL mutation: cDNA 3048_3051delATTA / Frameshift
   </value>
   <value>
    NIPBL mutation: cDNA 4002_4005del4
   </value>
   <value>
    NIPBL mutation: cDNA 4193C&gt;G / Nonsense
   </value>
   <value>
    NIPBL mutation: cDNA 4606C&gt;T / Nonsense
   </value>
   <value>
    NIPBL mutation: cDNA 5167C&gt;T / Nonsense
   </value>
   <value>
    NIPBL mutation: cDNA 6407insA / Frameshift
   </value>
   <value>
    NIPBL mutation: cDNA 742_743delCT / Frameshift
   </value>
   <value>
    NIPBL mutation: cDNA 961delA / Frameshift
   </value>
   <value>
    NKX2-8 overexpression
   </value>
   <value>
    no aberration
   </value>
   <value>
    no genetic modification
   </value>
   <value>
    non-integrating oriP/EBNA1-based episomal vectors
   </value>
   <value>
    none
   </value>
   <value>
    NOR1-overexpressing
   </value>
   <value>
    normal
   </value>
   <value>
    Norwalk virus replicon-harboring cells
   </value>
   <value>
    not available
   </value>
   <value>
    NOTCH 1 mutation
   </value>
   <value>
    Notch1 L1601P+deltaP
   </value>
   <value>
    Notch1-IC expression
   </value>
   <value>
    Notch2-IC expression
   </value>
   <value>
    NPM1 mutated, normal karyotype
   </value>
   <value>
    NPM1 mutated, other chromosomal aberrations
   </value>
   <value>
    NPM1 wild type, normal karyotype
   </value>
   <value>
    NPSR1-A transfected
   </value>
   <value>
    NS1 transduced
   </value>
   <value>
    over-expressing GFP
   </value>
   <value>
    over-expressing LOX-1
   </value>
   <value>
    over-expression of MycER
   </value>
   <value>
    over-expression RASSF1C
   </value>
   <value>
    overexpressing NF-C2
   </value>
   <value>
    overexpressing STOX1
   </value>
   <value>
    p-delta-MT-Myc
   </value>
   <value>
    p-delta-MT-Zip
   </value>
   <value>
    p190
   </value>
   <value>
    p210
   </value>
   <value>
    p53 deficient
   </value>
   <value>
    p53 expressing DLD-1
   </value>
   <value>
    p53 null
   </value>
   <value>
    p53-His273 mutated
   </value>
   <value>
    p73 over-expression
   </value>
   <value>
    PAX9 overexpression
   </value>
   <value>
    pEGZ-transfected (empty vector)
   </value>
   <value>
    PKA RI-alpha over expression
   </value>
   <value>
    pMIGR-Bcl11b-EGFP (BCL11B overexpression)
   </value>
   <value>
    pMIGR-EGFP (control)
   </value>
   <value>
    pMSCV-vector
   </value>
   <value>
    point mutation in the VHL gene
   </value>
   <value>
    PPARg receptor mutation: C114R
   </value>
   <value>
    PPARg receptor mutation: C131Y
   </value>
   <value>
    pQCXIH vector
   </value>
   <value>
    pQCXIH-YAP-S94A
   </value>
   <value>
    pQCXIH-YAP-W1W2
   </value>
   <value>
    pQCXIH-YAP-wild type
   </value>
   <value>
    PRF1 protective haplotype: AGA/AG
   </value>
   <value>
    PRVCMV empty vector (mock)
   </value>
   <value>
    PRVCMVCD9
   </value>
   <value>
    PSG5 (control)
   </value>
   <value>
    pSIN-MCS
   </value>
   <value>
    pSIN-MCS-KSCluster
   </value>
   <value>
    rat-glucocorticoid-receptor transfected
   </value>
   <value>
    Retrotransfected by Cox2 Vector
   </value>
   <value>
    Retrotransfected by Empty Vector
   </value>
   <value>
    retroviral transfection of reprogramming genes
   </value>
   <value>
    retroviral vector MSCV
   </value>
   <value>
    retroviral vector MSCVPURaMyc
   </value>
   <value>
    retrovirus expressing MyoD~E heterodimers
   </value>
   <value>
    RhoA-T37A mutant
   </value>
   <value>
    RNA derived
   </value>
   <value>
    sequestosome 1 overexpression
   </value>
   <value>
    Set8_deltaPIP2
   </value>
   <value>
    SF91m3 oncoretrovirus
   </value>
   <value>
    SF91neo oncoretrovirus
   </value>
   <value>
    sFRP1 encoding vector
   </value>
   <value>
    sh2B-raf (doxycycline inducible)
   </value>
   <value>
    shB-Raf (doxycycline inducible)
   </value>
   <value>
    shGFP
   </value>
   <value>
    si-GL2 transfection
   </value>
   <value>
    siGAM
   </value>
   <value>
    SOX2 expression construct
   </value>
   <value>
    SOX7 over-expression
   </value>
   <value>
    stable GFP
   </value>
   <value>
    stably expressing HPV16 E6
   </value>
   <value>
    stably expressing HPV16 E7
   </value>
   <value>
    stably expressing S33Y beta-catenin
   </value>
   <value>
    STK3 overexpression
   </value>
   <value>
    TAp63 alpha wt
   </value>
   <value>
    TAp63Q540L alpha mutant
   </value>
   <value>
    temperature sensitive gene for SV40 T-antigen insertion
   </value>
   <value>
    Tmprss6 mutant
   </value>
   <value>
    Tmprss6 wild type
   </value>
   <value>
    TOP-GFP transduced/high Wnt
   </value>
   <value>
    TOP-GFP transduced/low Wnt
   </value>
   <value>
    transduced using lentivirus containing the the triple fusion reporter gene fluc-mrfp-ttk
   </value>
   <value>
    transduced with a Snail over-expressing vector
   </value>
   <value>
    transduced with a Snail over-expressing vector.
   </value>
   <value>
    transduced with an empty vector
   </value>
   <value>
    transduced with empty vector (backbone of the virus)
   </value>
   <value>
    transduced with GFP
   </value>
   <value>
    transduced with lenti 1+3
   </value>
   <value>
    transduced with lentivirus containing siRNA agaisnt GFP
   </value>
   <value>
    transduced with RFP
   </value>
   <value>
    transduction (&amp;#916NGFR+/NeoR+)
   </value>
   <value>
    transduction of hTERT
   </value>
   <value>
    transduction of hTERT, HPVE6
   </value>
   <value>
    transduction of hTERT, HPVE6, HPVE7
   </value>
   <value>
    transduction of hTERT, HPVE6, HPVE7, SV40t
   </value>
   <value>
    transduction of hTERT, HPVE6, HPVE7, SV40t, hRas
   </value>
   <value>
    transfected with a dimerization deficient Glucocorticoid-receptor-mutant
   </value>
   <value>
    transfected with a plasmid coding for Staufen2-HA
   </value>
   <value>
    transfected with AllStar (negative control)
   </value>
   <value>
    transfected with an inducible DKK1 expression vector
   </value>
   <value>
    transfected with an inducible MYCN expression vector
   </value>
   <value>
    transfected with androgen receptor
   </value>
   <value>
    transfected with CEACAM1-S double-A mutant
   </value>
   <value>
    transfected with CEACAM1-S wild-type
   </value>
   <value>
    transfected with control plasmid (pcDNAI/Neo)
   </value>
   <value>
    transfected with control vector pcDNA3.1/V5/HisA
   </value>
   <value>
    transfected with Dmimic
   </value>
   <value>
    transfected with empty vecto
   </value>
   <value>
    transfected with empty vector
   </value>
   <value>
    transfected with exon 4 mutant of surfactant protein C
   </value>
   <value>
    transfected with FUGW-146a overexpressign vector
   </value>
   <value>
    transfected with full-length human CA 9 cDNA / pcDNA3.0 DNA construct
   </value>
   <value>
    transfected with HIPK2
   </value>
   <value>
    transfected with L 188Q mutant of surfactant protein C
   </value>
   <value>
    transfected with miR-200c
   </value>
   <value>
    transfected with miR-34a
   </value>
   <value>
    transfected with negative control pre-miRNA
   </value>
   <value>
    transfected with NmycER expression vector
   </value>
   <value>
    transfected with Parvin-beta (long isoform) cloned into the pcDNA3.1 Myc-His (clone B) plasmid
   </value>
   <value>
    transfected with pcDNA3.1 empty vector
   </value>
   <value>
    transfected with pcDNA3.1 Myc-His plasmid (control)
   </value>
   <value>
    transfected with pHA-HIF1a(dODD) vector
   </value>
   <value>
    transfected with pIRES-TGFBR1-HA-FLAG
   </value>
   <value>
    transfected with pIRESpuro3
   </value>
   <value>
    transfected with pIRESpuro3_EpCAM
   </value>
   <value>
    transfected with plasmid containing control GFP
   </value>
   <value>
    transfected with plasmid containing wild type PML-RAR_ cDNA (pEGFP-PR2VR)
   </value>
   <value>
    transfected with plasmid containing wild type PML-RAR_ cDNA (pEGFP-PRWT)
   </value>
   <value>
    transfected with plasmid encoding HCaRG
   </value>
   <value>
    transfected with pmiRNA expressing miR-155
   </value>
   <value>
    transfected with pmiRNA expressing miR-K12-11
   </value>
   <value>
    transfected with pre-miR-145
   </value>
   <value>
    transfected with pRTS-CA-IKK2
   </value>
   <value>
    transfected with pRTS-GFP
   </value>
   <value>
    transfected with Qmimic
   </value>
   <value>
    transfected with scrambled negative control
   </value>
   <value>
    transfected with shRNA constructs (si1340) against LEDGF transcript (PSIP1 gene)
   </value>
   <value>
    transfected with the Bmi1 expression vector pcDNA3-Bmi1
   </value>
   <value>
    transfected with the Twist1 expression vector pFLAG-Twist1
   </value>
   <value>
    transfected with vFLIP/K13
   </value>
   <value>
    transfected with wild-type surfactant protein C
   </value>
   <value>
    transformed with FUGW-FF3 containing eGFP as vector control
   </value>
   <value>
    transiently transfected with human RB
   </value>
   <value>
    transiently transfected with human RB and mouse SMYD2
   </value>
   <value>
    transiently transfected with mouse SMYD2
   </value>
   <value>
    translocation t(11;19)
   </value>
   <value>
    translocation t(4;11)
   </value>
   <value>
    translocation t(9;11)
   </value>
   <value>
    translocation(11;18)
   </value>
   <value>
    translocation: t(11;14)(q13;q32)
   </value>
   <value>
    TTF1 overexpression
   </value>
   <value>
    UET-13 transfectant
   </value>
   <value>
    uninduced SOX9
   </value>
   <value>
    untransfected
   </value>
   <value>
    USF1-overexpression
   </value>
   <value>
    V600E BRAF mutant
   </value>
   <value>
    vector containing miR-15a/16-1
   </value>
   <value>
    vector control
   </value>
   <value>
    vector expressing BCR/ABL1
   </value>
   <value>
    vector expressing BCR/FGFR1
   </value>
   <value>
    vector expressing GFP (MIG control)
   </value>
   <value>
    vector expressing ZMYM2/FGFR1
   </value>
   <value>
    vector transfection
   </value>
   <value>
    vehicle control
   </value>
   <value>
    viral derived
   </value>
   <value>
    virus integration
   </value>
   <value>
    WASF3 knockdown
   </value>
   <value>
    wild type
   </value>
   <value>
    wild type (empty vector)
   </value>
   <value>
    wild type (mock transfected)
   </value>
   <value>
    wild type for TWIST2
   </value>
   <value>
    wild type genotype
   </value>
   <value>
    wild type RhoA immortalized
   </value>
   <value>
    wild type, transcomplemented with an OriP base EBNA3C expression vector
   </value>
   <value>
    wild type/wild type
   </value>
   <value>
    wild-type full-length Notch1
   </value>
   <value>
    with PCI-Neo stable integration
   </value>
   <value>
    Wt-Set8b
   </value>
   <value>
    WT1 mutation
   </value>
   <value>
    XBP1 overexpression
   </value>
   <value>
    XX;AA
   </value>
   <value>
    XXX;AAA
   </value>
   <value>
    XY;AA
   </value>
   <value>
    XYY;AAA
   </value>
   <value>
    YAP
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    growth condition
   </category>
   <value>
    0h after induction
   </value>
   <value>
    10 ng/ml LPS in media
   </value>
   <value>
    1h after induction
   </value>
   <value>
    2-deoxyglucose
   </value>
   <value>
    2D
   </value>
   <value>
    2D monolayer with EGF and insulin
   </value>
   <value>
    2D monolayer without EGF and insulin
   </value>
   <value>
    2D/bovine type I collagen
   </value>
   <value>
    36 hours cysteine deprivation followed by 6 hours cysteine abundance
   </value>
   <value>
    3D
   </value>
   <value>
    3D Matrigel culture
   </value>
   <value>
    3D/bovine type I collagen
   </value>
   <value>
    3h after induction
   </value>
   <value>
    42 hours cysteine abundance
   </value>
   <value>
    42 hours cysteine deprivation
   </value>
   <value>
    7h after induction
   </value>
   <value>
    9h after induction
   </value>
   <value>
    A. fumigatus condia in media
   </value>
   <value>
    absence of tetracycline
   </value>
   <value>
    acidosis
   </value>
   <value>
    acrolein (0h)
   </value>
   <value>
    acrolein (1h)
   </value>
   <value>
    acrolein (2h)
   </value>
   <value>
    acrolein (4h)
   </value>
   <value>
    ActinomycinD
   </value>
   <value>
    activated
   </value>
   <value>
    activated/IL-2 withdrawal for 24h
   </value>
   <value>
    adherent culture
   </value>
   <value>
    air-exposed (mock)
   </value>
   <value>
    air-oxidized PAPC
   </value>
   <value>
    Anaplasma phagocytophilum infected
   </value>
   <value>
    androgen deficient media
   </value>
   <value>
    androgen deprivation
   </value>
   <value>
    androgen deprivation + Etoposide
   </value>
   <value>
    androgen deprivation + Merbarone
   </value>
   <value>
    Angiopoietin-1
   </value>
   <value>
    antibodies against LN-332 chains in media
   </value>
   <value>
    antiCD3/28 bead activation
   </value>
   <value>
    Aspergillus fumigatus-infected
   </value>
   <value>
    autologous T-cell co-cultured
   </value>
   <value>
    Bacillus anthracis spores
   </value>
   <value>
    before treatment
   </value>
   <value>
    Borrelia burgdorferi
   </value>
   <value>
    brain-derived neurotrophic factor
   </value>
   <value>
    breast tumor conditioned media
   </value>
   <value>
    Candida albicans
   </value>
   <value>
    Candida albicans strain CAN34 co-cultured
   </value>
   <value>
    Candida albicans strain M199 co-cultured
   </value>
   <value>
    Candida albicans strain SC5314 co-cultured
   </value>
   <value>
    CD14-postive monocytes
   </value>
   <value>
    CD3 activation
   </value>
   <value>
    CD3-CD28 activation
   </value>
   <value>
    chemically defined feeder-free medium
   </value>
   <value>
    chemically defined medium supplemented with activin and FGF
   </value>
   <value>
    chemically defined medium supplemented with FGF2 and SB431542
   </value>
   <value>
    cigarette smoke
   </value>
   <value>
    cigarette smoke condensate
   </value>
   <value>
    co-culture with airway epithelial cells
   </value>
   <value>
    co-culture with nurse-like cells
   </value>
   <value>
    co-cultured with 1205Lu melanoma cells
   </value>
   <value>
    co-cultured with A549 cells
   </value>
   <value>
    co-cultured with blood components
   </value>
   <value>
    co-cultured with blood components and HT-29
   </value>
   <value>
    co-cultured with blood components and LS180
   </value>
   <value>
    co-cultured with bone marrow stromal cell line HS-5
   </value>
   <value>
    co-cultured with breast cancer associated fibroblasts
   </value>
   <value>
    co-cultured with dendritic cells
   </value>
   <value>
    co-cultured with HMEC-1 cells
   </value>
   <value>
    co-cultured with HT-29
   </value>
   <value>
    co-cultured with HUVEC cells
   </value>
   <value>
    co-cultured with LPS-stimulated cDCs
   </value>
   <value>
    co-cultured with LS180
   </value>
   <value>
    co-cultured with non-stimulated cDCs
   </value>
   <value>
    co-cultured with normal breast fibroblasts
   </value>
   <value>
    co-cultured with R848-stimulated cDCs
   </value>
   <value>
    co-cultured with retinal pigment epithelial cell
   </value>
   <value>
    co-cultured with SK-MES-1 cells
   </value>
   <value>
    complete media
   </value>
   <value>
    complete medium
   </value>
   <value>
    Compound 76
   </value>
   <value>
    conditioned medium from NSCLC
   </value>
   <value>
    conditioned medium from NSCLC hypoxia
   </value>
   <value>
    confluent quiescence
   </value>
   <value>
    control
   </value>
   <value>
    control adenovirus
   </value>
   <value>
    control conditions
   </value>
   <value>
    control infected
   </value>
   <value>
    control without parasites
   </value>
   <value>
    cooked broccoli
   </value>
   <value>
    Cryptosporidium infection
   </value>
   <value>
    CsA
   </value>
   <value>
    cultured
   </value>
   <value>
    cultured alone
   </value>
   <value>
    cultured in 3D polystyrene scaffolds
   </value>
   <value>
    cultured on Matrigel-coated six-well plates
   </value>
   <value>
    cultured on Plastic six-well plates
   </value>
   <value>
    cultured with ultrafine air pollutant particles
   </value>
   <value>
    cycloheximide
   </value>
   <value>
    DHT stimulation
   </value>
   <value>
    differentiated as embryoid bodies
   </value>
   <value>
    differentiated M01
   </value>
   <value>
    differentiated M02
   </value>
   <value>
    differentiating medium
   </value>
   <value>
    differentiation from adipocyte
   </value>
   <value>
    differentiation from chondrocyte
   </value>
   <value>
    differentiation from osteoblast
   </value>
   <value>
    dihydrotestosterone
   </value>
   <value>
    dimethyl sulfoxide
   </value>
   <value>
    directly activated
   </value>
   <value>
    DMEM
   </value>
   <value>
    DMSO
   </value>
   <value>
    DMSO control
   </value>
   <value>
    DOHV-infected
   </value>
   <value>
    E2
   </value>
   <value>
    E3
   </value>
   <value>
    E4
   </value>
   <value>
    E5
   </value>
   <value>
    E6
   </value>
   <value>
    E7
   </value>
   <value>
    EGF stimulation
   </value>
   <value>
    eGFP/VSVG
   </value>
   <value>
    EGM-2 medium in dense culture
   </value>
   <value>
    elongated cells
   </value>
   <value>
    Epstein-Barr virus
   </value>
   <value>
    erythrocytes infected with Plasmodium falciparum ItG
   </value>
   <value>
    erythroid unilineage culture
   </value>
   <value>
    estrogen deprieved, tamoxifen containing media
   </value>
   <value>
    EV71 infection
   </value>
   <value>
    expanded cell culture
   </value>
   <value>
    exposed to air (mock)
   </value>
   <value>
    exposed to commensal Escherichia coli strain MG1655
   </value>
   <value>
    exposed to PD/CH/FK/Lif
   </value>
   <value>
    exposed to smoke
   </value>
   <value>
    exposed to tobacco condensate
   </value>
   <value>
    exposed to uropathogenic Escherichia coli strain UTI89
   </value>
   <value>
    fetal bovine serum
   </value>
   <value>
    FGF stimulation
   </value>
   <value>
    fluid flow-induced shear stress
   </value>
   <value>
    Francisella tularensis novicida
   </value>
   <value>
    Francisella tularensis Schu S4
   </value>
   <value>
    freshly isolated cells
   </value>
   <value>
    fully spread/starve media
   </value>
   <value>
    fully spread/VEGF exposure
   </value>
   <value>
    gamma radiation
   </value>
   <value>
    GBS in LB medium
   </value>
   <value>
    GFP labeled
   </value>
   <value>
    glucose free medium
   </value>
   <value>
    glucose starvation
   </value>
   <value>
    GM-CSF stimulation
   </value>
   <value>
    granulocytic unilineage culture
   </value>
   <value>
    grown alone
   </value>
   <value>
    grown to confluence
   </value>
   <value>
    H5N1 influenza virus
   </value>
   <value>
    healthy-control sera
   </value>
   <value>
    heat shock
   </value>
   <value>
    heat stress
   </value>
   <value>
    heat treatment
   </value>
   <value>
    hepatic differentiation
   </value>
   <value>
    hepatitis C virus infection
   </value>
   <value>
    herpes simplex virus G207
   </value>
   <value>
    hES medium supplemented with activin A
   </value>
   <value>
    HGF stimulation
   </value>
   <value>
    HHV8-infected
   </value>
   <value>
    HIV-1 Env-Nef-/VSVG
   </value>
   <value>
    HIV-1 Env-Nef-Vpr-/VSVG
   </value>
   <value>
    house dust mite
   </value>
   <value>
    HRV-16 rhinovirus
   </value>
   <value>
    HS27a stromal cell line conditioned medium
   </value>
   <value>
    HT+ media
   </value>
   <value>
    HT- media
   </value>
   <value>
    HTLV-positive
   </value>
   <value>
    HTLV-positive, in vitro transformed
   </value>
   <value>
    human serum
   </value>
   <value>
    hypoxia
   </value>
   <value>
    IgG in media
   </value>
   <value>
    IL-2 starvation + IL-15 activation
   </value>
   <value>
    IL-2 starvation + IL-2 activation
   </value>
   <value>
    IL-2 starvation + IL-21 activation
   </value>
   <value>
    IL-2 starvation + Jak3 inhibitor + IL-2 activation
   </value>
   <value>
    IL-2 starvation + medium
   </value>
   <value>
    IL-2 starvation + pan-Jak inhibitor + IL-2 activation
   </value>
   <value>
    IL4 and dexamethasone
   </value>
   <value>
    IL4 only
   </value>
   <value>
    in vitro cell cultivation
   </value>
   <value>
    incubated overnight
   </value>
   <value>
    incubated with IgG- and C3bi-coated latex beads
   </value>
   <value>
    incubated without IgG- and C3bi-coated latex beads
   </value>
   <value>
    incubation with B. animalis subsp. lactis BB-12
   </value>
   <value>
    incubator control
   </value>
   <value>
    infected Adenovirus control
   </value>
   <value>
    infected Adenovirus HLX
   </value>
   <value>
    infected with HIV
   </value>
   <value>
    infected with human metapneumovirus
   </value>
   <value>
    infected with Streptococcus pneumoniae serotype 19F strain G54 (wild type)
   </value>
   <value>
    infected with Streptococcus pneumoniae serotype 19F strain G54 delta-cps
   </value>
   <value>
    infected with Streptococcus pneumoniae serotype 2 capsular polysaccharides
   </value>
   <value>
    infected with Streptococcus pneumoniae serotype 2 strain D39 (wild type)
   </value>
   <value>
    infected with Streptococcus pneumoniae serotype 2 strain D39 delta-cps
   </value>
   <value>
    infected with Streptococcus pneumoniae serotype 2 strain D39 delta-cps (low dosage)
   </value>
   <value>
    infected with Streptococcus pneumoniae serotype 4 strain TIGR4 (wild type)
   </value>
   <value>
    infected with Streptococcus pneumoniae serotype 4 strain TIGR4 delta-cps
   </value>
   <value>
    inflammatory stimulus (SMM)
   </value>
   <value>
    influenza A virus
   </value>
   <value>
    insulin
   </value>
   <value>
    Interferon-gamma
   </value>
   <value>
    interleukin 2 deprivation
   </value>
   <value>
    iPS derivation
   </value>
   <value>
    Kaposi's sarcoma-associated herpesvirus
   </value>
   <value>
    keratinocyte cell conditioned medium
   </value>
   <value>
    keratinocyte growth medium
   </value>
   <value>
    KSHV-infected
   </value>
   <value>
    lactic acidosis
   </value>
   <value>
    lactic acidosis and hypoxia
   </value>
   <value>
    lactic lactosis
   </value>
   <value>
    lactosis
   </value>
   <value>
    laminar shear stress
   </value>
   <value>
    latex beads
   </value>
   <value>
    LB-medium
   </value>
   <value>
    Leishmania chagasi infected
   </value>
   <value>
    Leishmania chagasi infected and autologous T-cell co-cultured
   </value>
   <value>
    lethal toxin of Bacillus anthracis
   </value>
   <value>
    leucin free medium
   </value>
   <value>
    listeriolysin
   </value>
   <value>
    long term strogen deprived
   </value>
   <value>
    LPS
   </value>
   <value>
    LSP and heat shock
   </value>
   <value>
    McCoys 5A Medium + L-glutamine
   </value>
   <value>
    mechanical stretch
   </value>
   <value>
    mechanical stretch plus LPS
   </value>
   <value>
    mechanical stretch plus TNFa
   </value>
   <value>
    media only
   </value>
   <value>
    medium
   </value>
   <value>
    medium with BMP4
   </value>
   <value>
    medium with BMP4 and inhibitors
   </value>
   <value>
    MEF feeder
   </value>
   <value>
    MEF-conditioned medium
   </value>
   <value>
    megakaryocytic unilineage culture
   </value>
   <value>
    MEM media (control)
   </value>
   <value>
    microtubule bound
   </value>
   <value>
    mineralisation
   </value>
   <value>
    mock cytokine stimulated
   </value>
   <value>
    mock infected
   </value>
   <value>
    mock infection
   </value>
   <value>
    mock-infected
   </value>
   <value>
    mono-cultured
   </value>
   <value>
    monocytic unilineage culture
   </value>
   <value>
    monolayer
   </value>
   <value>
    MSCV-empty retrovirus with high Myc expression
   </value>
   <value>
    MSCV-empty retrovirus with low Myc expression
   </value>
   <value>
    MSCV-Lin28B retrovirus with high Myc expression
   </value>
   <value>
    MSCV-Lin28B retrovirus with low Myc expression
   </value>
   <value>
    Mycobacterium tuberculosis H37Rv whole cell lysate
   </value>
   <value>
    na•ve M01
   </value>
   <value>
    na•ve M02
   </value>
   <value>
    negative control
   </value>
   <value>
    Newcastle disease virus infected
   </value>
   <value>
    NIM811
   </value>
   <value>
    no activation
   </value>
   <value>
    no CD14-positive monocytes
   </value>
   <value>
    no co-culture
   </value>
   <value>
    no infection
   </value>
   <value>
    no stress
   </value>
   <value>
    no treatment
   </value>
   <value>
    non strained
   </value>
   <value>
    non-infected
   </value>
   <value>
    none
   </value>
   <value>
    normal
   </value>
   <value>
    normal growth
   </value>
   <value>
    normoxia
   </value>
   <value>
    not infected
   </value>
   <value>
    not stimulated
   </value>
   <value>
    NSC-mixed
   </value>
   <value>
    oxidative stress
   </value>
   <value>
    P. Gingivalis infected
   </value>
   <value>
    p53 expressing adenovirus
   </value>
   <value>
    PAPC
   </value>
   <value>
    PDAC/CAF coculture
   </value>
   <value>
    PGE2-DC maturation
   </value>
   <value>
    phorbol 12-myristate 13-acetate
   </value>
   <value>
    poliovirus infection
   </value>
   <value>
    poly(I:C)-DC maturation
   </value>
   <value>
    pool of two control cell lines (GM00037 and from a normal donor)
   </value>
   <value>
    pooled
   </value>
   <value>
    pooled from 6 healthy donors
   </value>
   <value>
    pooled/loaded with lysates from AML product
   </value>
   <value>
    pooled/loaded with mRNA and lysates from AML product
   </value>
   <value>
    pooled/loaded with mRNA from AML product
   </value>
   <value>
    pooled/loaded with tumor product
   </value>
   <value>
    pooled/unloaded
   </value>
   <value>
    PR8 influenza virus
   </value>
   <value>
    presence of tetracycline
   </value>
   <value>
    primay culture
   </value>
   <value>
    proliferating medium
   </value>
   <value>
    pSin co-culture
   </value>
   <value>
    pSin-DLL4 co-culture
   </value>
   <value>
    pSin-JAG1 co-culture
   </value>
   <value>
    Q10 preincubated
   </value>
   <value>
    Q10H2 preincubated
   </value>
   <value>
    radiation
   </value>
   <value>
    ras-induced senescence
   </value>
   <value>
    RB-PAPC
   </value>
   <value>
    recent-onset type I diabetes sera
   </value>
   <value>
    redifferentiated cell culture
   </value>
   <value>
    resting
   </value>
   <value>
    restricted in spreading/starve media
   </value>
   <value>
    restricted in spreading/VEGF exposure
   </value>
   <value>
    retinoic acid
   </value>
   <value>
    retinoic acid differentiation
   </value>
   <value>
    rhinovirus infected
   </value>
   <value>
    rounded cells
   </value>
   <value>
    S. aureus
   </value>
   <value>
    saline
   </value>
   <value>
    SARS-CoV-infected
   </value>
   <value>
    SDF stimulation
   </value>
   <value>
    senescent
   </value>
   <value>
    serum free
   </value>
   <value>
    serum stimulated
   </value>
   <value>
    serum-containing medium
   </value>
   <value>
    serum-depleted medium
   </value>
   <value>
    serum-free medium
   </value>
   <value>
    smoke
   </value>
   <value>
    smoke and radiation
   </value>
   <value>
    sphere culture
   </value>
   <value>
    spheroid
   </value>
   <value>
    staphylococcal superantigen SEB
   </value>
   <value>
    staphylococcal superantigen SEI
   </value>
   <value>
    Staphylococcus aureus strain 252
   </value>
   <value>
    starvation-induced autophagy
   </value>
   <value>
    static stress
   </value>
   <value>
    steady state
   </value>
   <value>
    stem-cell medium
   </value>
   <value>
    stimulated
   </value>
   <value>
    stimulated for osteogenic induction
   </value>
   <value>
    strained
   </value>
   <value>
    Streptcoccus suis 2 strain SC19
   </value>
   <value>
    Streptococcus gordonii
   </value>
   <value>
    stromal co-culture
   </value>
   <value>
    T3HDF feeder
   </value>
   <value>
    T3HDF-conditioned medium
   </value>
   <value>
    TAp73beta expressing adenovirus
   </value>
   <value>
    TNFa
   </value>
   <value>
    tobacco smoke condensate
   </value>
   <value>
    total extract
   </value>
   <value>
    trophoblast conditioned medium
   </value>
   <value>
    Trypanosoma cruzi-infected
   </value>
   <value>
    tunicamycin
   </value>
   <value>
    uninduced
   </value>
   <value>
    uninfected
   </value>
   <value>
    uninfected (control)
   </value>
   <value>
    unstimulated
   </value>
   <value>
    untreated
   </value>
   <value>
    UVA-1-irradiated
   </value>
   <value>
    vaccinia virus -ADAR/E3L
   </value>
   <value>
    vaccinia virus delE3L
   </value>
   <value>
    vaccinia virus delK3L
   </value>
   <value>
    vaccinia virus E3L Y48A
   </value>
   <value>
    vaccinia virus E3Ldel26C
   </value>
   <value>
    vaccinia virus E3Ldel7C
   </value>
   <value>
    vehicle
   </value>
   <value>
    VHL reconstituted
   </value>
   <value>
    virulence-attenuated Entamoeba histolytica
   </value>
   <value>
    virulent Entamoeba histolytica
   </value>
   <value>
    water
   </value>
   <value>
    with serum
   </value>
   <value>
    without stroma
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    metastatic tissue
   </category>
   <value>
    -
   </value>
   <value>
    ascites
   </value>
   <value>
    bone
   </value>
   <value>
    bone marrow
   </value>
   <value>
    brain
   </value>
   <value>
    colorectal
   </value>
   <value>
    left supraclavicular lymph node
   </value>
   <value>
    liver
   </value>
   <value>
    lung
   </value>
   <value>
    lung, bone marrow
   </value>
   <value>
    lymph node
   </value>
   <value>
    malignant pleural effusion
   </value>
   <value>
    not applicable
   </value>
   <value>
    pericardial effusion
   </value>
   <value>
    peritoneal cavity
   </value>
   <value>
    peritoneal effusion
   </value>
   <value>
    pleural effusion
   </value>
   <value>
    skin
   </value>
   <value>
    soft tissue
   </value>
   <value>
    supra-orbital area
   </value>
   <value>
    tonsil
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism part
   </category>
   <value>
    -
   </value>
   <value>
    abdomen
   </value>
   <value>
    abdominal fat
   </value>
   <value>
    accumbens
   </value>
   <value>
    adipose tissue
   </value>
   <value>
    adrenal gland
   </value>
   <value>
    adrenal gland cortex
   </value>
   <value>
    adrenal medulla
   </value>
   <value>
    alveolus
   </value>
   <value>
    amnion
   </value>
   <value>
    amniotic mesoderm
   </value>
   <value>
    amygdala
   </value>
   <value>
    aorta
   </value>
   <value>
    artery
   </value>
   <value>
    articular cartilage
   </value>
   <value>
    ascending colon
   </value>
   <value>
    biceps
   </value>
   <value>
    biceps brachii
   </value>
   <value>
    bladder
   </value>
   <value>
    blood
   </value>
   <value>
    blood from allogeneic stem cell transplantation
   </value>
   <value>
    bone
   </value>
   <value>
    bone marrow
   </value>
   <value>
    bone marrow or peripheral blood
   </value>
   <value>
    bone marrow/stroma
   </value>
   <value>
    bone, iliac crest
   </value>
   <value>
    bone, lumbar spinal laminae
   </value>
   <value>
    brain
   </value>
   <value>
    brain cortex
   </value>
   <value>
    brain reference
   </value>
   <value>
    breast
   </value>
   <value>
    breast duct
   </value>
   <value>
    breast organelle
   </value>
   <value>
    bronchiole
   </value>
   <value>
    bronchus
   </value>
   <value>
    bronchus or trachea
   </value>
   <value>
    buffy coat
   </value>
   <value>
    cartilage
   </value>
   <value>
    cecum
   </value>
   <value>
    cerebellum
   </value>
   <value>
    cerebral cortex
   </value>
   <value>
    cerebrum
   </value>
   <value>
    cervix
   </value>
   <value>
    chorion villus
   </value>
   <value>
    choroid
   </value>
   <value>
    colon
   </value>
   <value>
    colon cecum
   </value>
   <value>
    conjunctiva
   </value>
   <value>
    connective tissue
   </value>
   <value>
    cord blood
   </value>
   <value>
    coronary artery
   </value>
   <value>
    corpus callosum
   </value>
   <value>
    cultured skin substitute
   </value>
   <value>
    decidua
   </value>
   <value>
    decidua basalis
   </value>
   <value>
    deltoid
   </value>
   <value>
    dermis
   </value>
   <value>
    descending colon
   </value>
   <value>
    dorsal root ganglion
   </value>
   <value>
    dorsolateral prefrontal cortex
   </value>
   <value>
    duodenum
   </value>
   <value>
    embryo
   </value>
   <value>
    embryonic testis
   </value>
   <value>
    endometrium
   </value>
   <value>
    endometrium/ovary
   </value>
   <value>
    entorhinal cortex
   </value>
   <value>
    esophagus
   </value>
   <value>
    extremity
   </value>
   <value>
    fallopian tube
   </value>
   <value>
    fat
   </value>
   <value>
    femoral condyle and tibial plateau
   </value>
   <value>
    femur
   </value>
   <value>
    fetal cartilage
   </value>
   <value>
    fetal cortex
   </value>
   <value>
    fetal intestine
   </value>
   <value>
    fetal kidney
   </value>
   <value>
    fetal lung
   </value>
   <value>
    fibroblast
   </value>
   <value>
    foot
   </value>
   <value>
    fore limb
   </value>
   <value>
    forearm
   </value>
   <value>
    forearm epidermis
   </value>
   <value>
    foreskin
   </value>
   <value>
    frontal cortex
   </value>
   <value>
    frontal cortex/hippocampus
   </value>
   <value>
    frontal lobe
   </value>
   <value>
    ganglia
   </value>
   <value>
    gastrointestinal scraped-off mucosa
   </value>
   <value>
    gingiva
   </value>
   <value>
    gingival papillae
   </value>
   <value>
    globus pallidus
   </value>
   <value>
    gluteal fat
   </value>
   <value>
    gum
   </value>
   <value>
    head and neck
   </value>
   <value>
    heart
   </value>
   <value>
    heart atrial appendage
   </value>
   <value>
    heart atrium
   </value>
   <value>
    heart right ventricle
   </value>
   <value>
    heart ventricle
   </value>
   <value>
    hind limb
   </value>
   <value>
    hippocampus
   </value>
   <value>
    humerus
   </value>
   <value>
    hypopharynx
   </value>
   <value>
    hypothalamus
   </value>
   <value>
    ileum
   </value>
   <value>
    inguinal lymph node
   </value>
   <value>
    internal trunk
   </value>
   <value>
    Intervertebral disc
   </value>
   <value>
    intestine
   </value>
   <value>
    iris
   </value>
   <value>
    islet of Langerhans
   </value>
   <value>
    jejunal mucosa
   </value>
   <value>
    jejunum
   </value>
   <value>
    joint synovium
   </value>
   <value>
    kidney
   </value>
   <value>
    kidney allograft
   </value>
   <value>
    kidney cortex
   </value>
   <value>
    kidney medulla
   </value>
   <value>
    knee
   </value>
   <value>
    left ventricle
   </value>
   <value>
    LIMA artery
   </value>
   <value>
    liver
   </value>
   <value>
    lung
   </value>
   <value>
    lung/bronchus
   </value>
   <value>
    lymph node
   </value>
   <value>
    lymph nodes
   </value>
   <value>
    MALT lymphoma
   </value>
   <value>
    mammary gland
   </value>
   <value>
    medial temporal lobe
   </value>
   <value>
    medulla
   </value>
   <value>
    melanoma tumor
   </value>
   <value>
    metastatic kidney
   </value>
   <value>
    metastatic melanoma
   </value>
   <value>
    metastatic renal cell carcinoma in lung
   </value>
   <value>
    midbrain
   </value>
   <value>
    muscle
   </value>
   <value>
    myocardial tissue
   </value>
   <value>
    myometrium
   </value>
   <value>
    nasal pharynx
   </value>
   <value>
    nasopharyngeal region
   </value>
   <value>
    nasopharynx
   </value>
   <value>
    neck nodule
   </value>
   <value>
    nipple
   </value>
   <value>
    no data
   </value>
   <value>
    nodose nucleus
   </value>
   <value>
    nose
   </value>
   <value>
    occipital lobe
   </value>
   <value>
    oocyte
   </value>
   <value>
    oral cavity
   </value>
   <value>
    oral mucosa
   </value>
   <value>
    oropharynx
   </value>
   <value>
    ovary
   </value>
   <value>
    pancreas
   </value>
   <value>
    pancreatic islet
   </value>
   <value>
    paravertebral muscle
   </value>
   <value>
    parietal lobe
   </value>
   <value>
    penis
   </value>
   <value>
    penis foreskin
   </value>
   <value>
    pericardial effusion
   </value>
   <value>
    pericardium
   </value>
   <value>
    peripheral blood
   </value>
   <value>
    peripheral blood and bone marrow
   </value>
   <value>
    peripheral blood or tonsil
   </value>
   <value>
    peripheral nerve sheath
   </value>
   <value>
    peritoneum
   </value>
   <value>
    pharyngeal mucosa
   </value>
   <value>
    pituitary
   </value>
   <value>
    pituitary gland
   </value>
   <value>
    placenta
   </value>
   <value>
    pleura
   </value>
   <value>
    pleural fluid
   </value>
   <value>
    pons
   </value>
   <value>
    postcentral gyrus
   </value>
   <value>
    posterior fossa
   </value>
   <value>
    prefrontal cortex
   </value>
   <value>
    primary breast tumor
   </value>
   <value>
    prostate
   </value>
   <value>
    prostate gland
   </value>
   <value>
    pulmonary artery
   </value>
   <value>
    putamen
   </value>
   <value>
    rectum
   </value>
   <value>
    renal medulla
   </value>
   <value>
    retina
   </value>
   <value>
    root apical papilla
   </value>
   <value>
    salivary gland
   </value>
   <value>
    saphenous vein
   </value>
   <value>
    seminal vesicle
   </value>
   <value>
    seminiferous tubule
   </value>
   <value>
    sigmoid colon
   </value>
   <value>
    sigmoid colon mucosa
   </value>
   <value>
    sigmoideum
   </value>
   <value>
    skeletal muscle
   </value>
   <value>
    skin
   </value>
   <value>
    small airways
   </value>
   <value>
    small intestine
   </value>
   <value>
    spinal cord
   </value>
   <value>
    spleen
   </value>
   <value>
    sputum
   </value>
   <value>
    stomach
   </value>
   <value>
    stomach cardiac
   </value>
   <value>
    stomach fundus
   </value>
   <value>
    stomach pyloric
   </value>
   <value>
    substantia nigra
   </value>
   <value>
    substantia nigra pars compacta
   </value>
   <value>
    subthalamic nucleus
   </value>
   <value>
    superior frontal gyrus
   </value>
   <value>
    synovial fluid
   </value>
   <value>
    synovial membrane
   </value>
   <value>
    temporal lobe
   </value>
   <value>
    testis
   </value>
   <value>
    thalamus
   </value>
   <value>
    thigh
   </value>
   <value>
    third molar
   </value>
   <value>
    thorax
   </value>
   <value>
    thymus
   </value>
   <value>
    thyroid
   </value>
   <value>
    thyroid gland
   </value>
   <value>
    tibia
   </value>
   <value>
    tongue
   </value>
   <value>
    tongue main corpus
   </value>
   <value>
    tongue superior with papillae
   </value>
   <value>
    tonsil
   </value>
   <value>
    trabecular bone
   </value>
   <value>
    trachea
   </value>
   <value>
    trans-iliacal bone
   </value>
   <value>
    trigeminal ganglion
   </value>
   <value>
    trunk neural crest
   </value>
   <value>
    trunk wall
   </value>
   <value>
    umbilical cord
   </value>
   <value>
    umbilical cord blood
   </value>
   <value>
    umbilical vein
   </value>
   <value>
    universal human reference
   </value>
   <value>
    urethra
   </value>
   <value>
    urothelium
   </value>
   <value>
    uterus
   </value>
   <value>
    vagina
   </value>
   <value>
    vastus lateralis
   </value>
   <value>
    vastus lateralis (knee)
   </value>
   <value>
    ventral tegmental area
   </value>
   <value>
    vestibular nuclei
   </value>
   <value>
    vestibular nuclei superior
   </value>
   <value>
    vestibular nucleus
   </value>
   <value>
    villus tree
   </value>
   <value>
    vulva
   </value>
   <value>
    well-differentiated bronchial airway
   </value>
   <value>
    whole blood
   </value>
   <value>
    whole embryo without liver
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    phenotype
   </category>
   <value>
    5-FU resistant
   </value>
   <value>
    adherent
   </value>
   <value>
    CD133+
   </value>
   <value>
    CD133-
   </value>
   <value>
    cisplatin-resistant
   </value>
   <value>
    cisplatin-sensitive
   </value>
   <value>
    doxycycline-mediated repression of FOXP3
   </value>
   <value>
    estrogen resistant
   </value>
   <value>
    ET-743 resistant
   </value>
   <value>
    expression of FOXP3
   </value>
   <value>
    expression of MYCN transgene
   </value>
   <value>
    GC-resistant subclone of 697 cells
   </value>
   <value>
    GC-resistant subclone of CCRF-CEM
   </value>
   <value>
    GC-sensitive
   </value>
   <value>
    GC-sensitive subclone of CCRF-CEM
   </value>
   <value>
    glucocorticoid resistant
   </value>
   <value>
    glucocorticoid sensitive
   </value>
   <value>
    herceptin-resistant
   </value>
   <value>
    high Myc expression
   </value>
   <value>
    high PD-1 expression
   </value>
   <value>
    Li-Fraumeni syndrome mutation carriers
   </value>
   <value>
    low Myc expression
   </value>
   <value>
    methotrexate-resistant
   </value>
   <value>
    methotrexate-sensitive
   </value>
   <value>
    naive
   </value>
   <value>
    neurosphere-like
   </value>
   <value>
    no Myc expression
   </value>
   <value>
    normal
   </value>
   <value>
    normoglycaemic
   </value>
   <value>
    oxaliplatin resistant
   </value>
   <value>
    parental
   </value>
   <value>
    PLX4032 resistant
   </value>
   <value>
    PLX4032 sensitive
   </value>
   <value>
    SN38 sensitive
   </value>
   <value>
    standard immunotherapy
   </value>
   <value>
    Tetracycline-mediated repression of MYCN transgene
   </value>
   <value>
    tolerant
   </value>
   <value>
    vincristine-resistant derivative
   </value>
   <value>
    vincristine-sensitive
   </value>
   <value>
    wild type
   </value>
   <value>
    zalapsis resistant
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    RNAi
   </category>
   <value>
    25 miRNAs siRNA
   </value>
   <value>
    Alk shRNA
   </value>
   <value>
    allStar-transfected
   </value>
   <value>
    androgen receptor siRNA
   </value>
   <value>
    anti-Evi1 transfected
   </value>
   <value>
    anti-miR-155-LNA
   </value>
   <value>
    AP-2 gamma targetting siRNA
   </value>
   <value>
    APE1 RNAi
   </value>
   <value>
    AR-shRNA
   </value>
   <value>
    Asf1a
   </value>
   <value>
    Asf1a+Asf1b
   </value>
   <value>
    Asf1b
   </value>
   <value>
    BAHD1 siRNA
   </value>
   <value>
    BCL11A siRNA
   </value>
   <value>
    Bmi-1 Mel-18 shRNA
   </value>
   <value>
    Bmi-1 shRNA
   </value>
   <value>
    Bmi1-shRNA
   </value>
   <value>
    BRCA1 RNAi
   </value>
   <value>
    c-MYC knockdown
   </value>
   <value>
    cdr2 siRNA-treated
   </value>
   <value>
    CDX1 siRNA
   </value>
   <value>
    CDX2 knockdown
   </value>
   <value>
    CNOT7 + non-targeting (siRNA mediated)
   </value>
   <value>
    CNOT7+CNOT8 (siRNA mediated)
   </value>
   <value>
    CNOT8 + non-targeting (siRNA mediated)
   </value>
   <value>
    control
   </value>
   <value>
    control esiRNA
   </value>
   <value>
    control for ESR1 siRNA
   </value>
   <value>
    control for mir-221/222 inhibitor
   </value>
   <value>
    control for mir-221/222 mimic
   </value>
   <value>
    control pre-miR
   </value>
   <value>
    control shRNA
   </value>
   <value>
    Control siRNA
   </value>
   <value>
    control siRNA
   </value>
   <value>
    control siRNA-treated
   </value>
   <value>
    control transfected
   </value>
   <value>
    control vector
   </value>
   <value>
    control vector(pRS-IRES-GFP/pmig)
   </value>
   <value>
    control-IP IMP1
   </value>
   <value>
    CS1 expression vector
   </value>
   <value>
    CS1 shRNA
   </value>
   <value>
    CXCR4 shRNA I
   </value>
   <value>
    CXCR4 shRNA II
   </value>
   <value>
    cyclin T1 shRNA
   </value>
   <value>
    DGCR8 siRNA
   </value>
   <value>
    Dharmacon control
   </value>
   <value>
    Drosha siRNA
   </value>
   <value>
    Egr-3 siRNA #1
   </value>
   <value>
    Egr-3 siRNA #2
   </value>
   <value>
    empty pSM2 vector, shRNA targeting GFP
   </value>
   <value>
    empty vector
   </value>
   <value>
    empty vector (control)
   </value>
   <value>
    empty vector control
   </value>
   <value>
    enforced miR-34a expression
   </value>
   <value>
    ESR1 siRNA
   </value>
   <value>
    ESR1 siRNA control
   </value>
   <value>
    expressing DUSP1 siRNA
   </value>
   <value>
    expression construct for BGAL (control)
   </value>
   <value>
    EZH2 shRNA
   </value>
   <value>
    ezrin RNAi
   </value>
   <value>
    FAKsiRNA
   </value>
   <value>
    FAM33 siRNA r(CGA UUU AAA UAU AUG UAC A)dTdT
   </value>
   <value>
    FAM33 siRNA r(GGC UGG AAU AUG AAA UCA A)dTdT
   </value>
   <value>
    Fas shRNA4 knock-out
   </value>
   <value>
    FAS shRNA6 knock-out
   </value>
   <value>
    FGF-AS siRNA
   </value>
   <value>
    FLAG-IP IMP1
   </value>
   <value>
    FLAP silencing
   </value>
   <value>
    FLI1 siRNA
   </value>
   <value>
    FOXF2 siRNA
   </value>
   <value>
    FoxM1 siRNA
   </value>
   <value>
    Gfi-1B RNAi
   </value>
   <value>
    GFP siRNA
   </value>
   <value>
    GPR54-specific siRNA
   </value>
   <value>
    H1015 ASCL1 siRNA
   </value>
   <value>
    H1033 ASCL1 siRNA
   </value>
   <value>
    H938 ASCL1 siRNA
   </value>
   <value>
    HIF-2a shRNAi
   </value>
   <value>
    HIV1 VLP transfection
   </value>
   <value>
    HIVGFP(G)
   </value>
   <value>
    HIVGFP(G) + SIVVLP(G)
   </value>
   <value>
    HNRPA2B1 construct
   </value>
   <value>
    HZ4 expression construct
   </value>
   <value>
    IGF2BP1, IGF2BP2, IGF2BP3 siRNA
   </value>
   <value>
    infected with shGFP (control)
   </value>
   <value>
    infected with shQk-2
   </value>
   <value>
    infected with shQk-5
   </value>
   <value>
    LacZ (control)
   </value>
   <value>
    LKO control lentivirus
   </value>
   <value>
    LRPPRC siRNA
   </value>
   <value>
    LSD1 siRNA
   </value>
   <value>
    luciferase shRNA
   </value>
   <value>
    media-only control
   </value>
   <value>
    Mel-18 shRNA
   </value>
   <value>
    meT-a/meT-as
   </value>
   <value>
    meT-s/as
   </value>
   <value>
    miR-124 transfection
   </value>
   <value>
    mir-221/222 inhibitor
   </value>
   <value>
    mir-221/222 mimic
   </value>
   <value>
    miR-30a-3p siRNA duplex
   </value>
   <value>
    miR-34a LNA inhibitor
   </value>
   <value>
    miR-7 transfection
   </value>
   <value>
    MLV VLP transfection
   </value>
   <value>
    mock
   </value>
   <value>
    mock transfection
   </value>
   <value>
    mock-transfected
   </value>
   <value>
    native cell line
   </value>
   <value>
    negative control
   </value>
   <value>
    negative control shRNA
   </value>
   <value>
    negative control siRNA
   </value>
   <value>
    NMNAT1 shRNA
   </value>
   <value>
    no siRNA
   </value>
   <value>
    non targeted control
   </value>
   <value>
    non-effective shRNA cassette against GFP
   </value>
   <value>
    non-sense SiRNA
   </value>
   <value>
    non-silencing control siRNA
   </value>
   <value>
    non-specific siRNA control
   </value>
   <value>
    non-targeting (siRNA mediated)
   </value>
   <value>
    non-targeting control siRNA
   </value>
   <value>
    non-targeting negative control siRNA (luciferase)
   </value>
   <value>
    non-targeting shRNA-transduced (control)
   </value>
   <value>
    non-targeting siRNA
   </value>
   <value>
    non-targetting siRNA control
   </value>
   <value>
    none
   </value>
   <value>
    NR2F2 siRNA
   </value>
   <value>
    p16-transfected
   </value>
   <value>
    p63-depleted (shRNA)
   </value>
   <value>
    PAPGEF3-antisense transcript siRNA knockdown
   </value>
   <value>
    PAR-1 shRNA-transduced
   </value>
   <value>
    pBabe (vector control)
   </value>
   <value>
    pBabe puro (control vector)
   </value>
   <value>
    pBabe-ErbB2 (ERBB2 over-expression)
   </value>
   <value>
    pCMV-Script
   </value>
   <value>
    pCMV-Script (control)
   </value>
   <value>
    PIK3CB-6340
   </value>
   <value>
    PIK3CB-6340 mock
   </value>
   <value>
    pKLO beta-catenin shRNA
   </value>
   <value>
    pKLO GFP control
   </value>
   <value>
    PLKO control
   </value>
   <value>
    pLPC 12S E1A (viral protein Adenovirus)
   </value>
   <value>
    pLPC wt E7 (viral protein HPV16 E7)
   </value>
   <value>
    pLPCX (empty vector)
   </value>
   <value>
    POU5F1 siRNA-1
   </value>
   <value>
    POU5F1 siRNA-2
   </value>
   <value>
    POU5F1 specific siRNA-1
   </value>
   <value>
    POU5F1 specific siRNA-2
   </value>
   <value>
    pRC/CMV expression vector
   </value>
   <value>
    pre-miR-17
   </value>
   <value>
    Prox1 siRNA
   </value>
   <value>
    Prox1/NR2F2 siRNA
   </value>
   <value>
    pSilencer
   </value>
   <value>
    pSM2 retroviral vector
   </value>
   <value>
    QKI siRNA
   </value>
   <value>
    RB shRNA
   </value>
   <value>
    RISC-free siRNA
   </value>
   <value>
    s/as
   </value>
   <value>
    s/as mock
   </value>
   <value>
    s/meT-as
   </value>
   <value>
    SCRAM transfected
   </value>
   <value>
    scramble siRNA
   </value>
   <value>
    scramble siRNA(control)
   </value>
   <value>
    scramble-LNA
   </value>
   <value>
    scrambled control
   </value>
   <value>
    scrambled RNA
   </value>
   <value>
    scrambled siRNA sequence
   </value>
   <value>
    SCY1-like 1 esiRNA
   </value>
   <value>
    SDHB siRNA
   </value>
   <value>
    sh HuR
   </value>
   <value>
    shCTL transfection
   </value>
   <value>
    shGFP
   </value>
   <value>
    shGFP control
   </value>
   <value>
    shLuc+ (with expression of short hairpin RNA)
   </value>
   <value>
    shLuc- (without expression of short hairpin RNA)
   </value>
   <value>
    shNKX3.1 transfection
   </value>
   <value>
    shp53
   </value>
   <value>
    shRHAU+ (with expression of short hairpin RNA)
   </value>
   <value>
    shRHAU- (without expression of short hairpin RNA)
   </value>
   <value>
    shRNA expression vector against Luc
   </value>
   <value>
    shRNA expression vector against TAK1
   </value>
   <value>
    shRNA targeting CBFA2T3
   </value>
   <value>
    shRNA targeting CBFA2T3 and IKKb(EE)
   </value>
   <value>
    shRNA targeting IKKb(EE)
   </value>
   <value>
    shRNAs against CD146
   </value>
   <value>
    shTAL1 transfection
   </value>
   <value>
    shYY1 control lentivirus
   </value>
   <value>
    shYY1shYY2 control lentivirus
   </value>
   <value>
    shYY2 control lentivirus
   </value>
   <value>
    si Control
   </value>
   <value>
    si-EZH2
   </value>
   <value>
    si-EZH2&amp;EZH2sr
   </value>
   <value>
    si-EZH2&amp;T350Asr
   </value>
   <value>
    si463 (vIRF-3 knockdown)
   </value>
   <value>
    si716s (vIRF-3 knockdown)
   </value>
   <value>
    siControl (siCon) and siGFP (Dharmacon)
   </value>
   <value>
    sidroshaB-transfected
   </value>
   <value>
    sidroshaC-transfected
   </value>
   <value>
    siGFP-transfected
   </value>
   <value>
    siGNE-transfected
   </value>
   <value>
    siHDAC5 transfected
   </value>
   <value>
    siHOTAIR-transfected
   </value>
   <value>
    siLincIRX5-transfected
   </value>
   <value>
    siLincZFP161-transfected
   </value>
   <value>
    siN (control siRNA)
   </value>
   <value>
    siNs (control siRNA)
   </value>
   <value>
    siRNA against CDK4
   </value>
   <value>
    siRNA against Cyclin D1
   </value>
   <value>
    siRNA against GFP
   </value>
   <value>
    siRNA against HIF-1a
   </value>
   <value>
    siRNA Control
   </value>
   <value>
    siRNA control
   </value>
   <value>
    siRNA duplex against NME2
   </value>
   <value>
    siRNA for RIP140
   </value>
   <value>
    siRNA oligonucleotide against cyclophilin
   </value>
   <value>
    siRNA oligonucleotide against Lamin A/C (control)
   </value>
   <value>
    siRNA oligonucleotide against RhoBTB2
   </value>
   <value>
    siRNA specific for optineurin
   </value>
   <value>
    siRNA specific for PIPKIalpha
   </value>
   <value>
    siRNA specific for StarPap
   </value>
   <value>
    siRNA Stau1
   </value>
   <value>
    siRNA targeting MITF
   </value>
   <value>
    siRNA targeting PAX3
   </value>
   <value>
    siRNA-mediated CDC7 inhibition
   </value>
   <value>
    siRNA-mediated HNF4alpha and HNF4gamma double knockdown
   </value>
   <value>
    siRNA-mediated SRA depletion
   </value>
   <value>
    siRNA: mock
   </value>
   <value>
    siRNA: SCAI
   </value>
   <value>
    siRNAs against firefly luciferase
   </value>
   <value>
    siRNAs against human IRF4
   </value>
   <value>
    siTOP1
   </value>
   <value>
    siTUG1-transfected
   </value>
   <value>
    siVFp(-992)
   </value>
   <value>
    siVFp(-992)m1
   </value>
   <value>
    SIVVLP(G)
   </value>
   <value>
    Stat3 siRNA
   </value>
   <value>
    Stat5a/b siRNA
   </value>
   <value>
    TFAP2A siRNA
   </value>
   <value>
    TFAP2C siRNA
   </value>
   <value>
    TIA-1 and TIAR siRNA
   </value>
   <value>
    TIA-1 siRNA
   </value>
   <value>
    TIAR siRNA
   </value>
   <value>
    transduced with a control shRNA
   </value>
   <value>
    transduced with an shRNA targeting STK33
   </value>
   <value>
    transfected by antisense hsa-miR-221
   </value>
   <value>
    transfected by antisense hsa-miR-222
   </value>
   <value>
    transfected with an shControl construct
   </value>
   <value>
    transfected with control siRNA
   </value>
   <value>
    transfected with miR-1 duplex
   </value>
   <value>
    transfected with miR-155 duplex
   </value>
   <value>
    transfected with miR-210, miR-338-3p, miR-33a and miR-451
   </value>
   <value>
    transfected with miR-338-3p and miR-451
   </value>
   <value>
    transfected with shBAP1 #1 construct
   </value>
   <value>
    transfected with shBAP1 #2 construct
   </value>
   <value>
    transfected with siHX
   </value>
   <value>
    transfected with siRNA for Pirin knock-down
   </value>
   <value>
    transfection reagent alone
   </value>
   <value>
    transfection reagents without any siRNAs
   </value>
   <value>
    transfection with 5nM anti-PCSK9 siRNA
   </value>
   <value>
    transfection with 5nM M13 DNA oligonucleotide
   </value>
   <value>
    transfection with 5nM UA31D4 Adaptor + 5nM UA31E Adaptor oligonucleotides
   </value>
   <value>
    transfection without oligonucleotides
   </value>
   <value>
    untreated
   </value>
   <value>
    vector control
   </value>
   <value>
    vector expressing 10 KHSV
   </value>
   <value>
    vector only
   </value>
   <value>
    vector plasmid
   </value>
   <value>
    wild type
   </value>
   <value>
    WT1 siRNA
   </value>
   <value>
    XIAP shRNA
   </value>
   <value>
    YAP shRNA(pRS-IRES-GFP-YAP/pmig-YAP)
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    stimulus
   </category>
   <value>
    24h post-exercise
   </value>
   <value>
    3 kiwi fruits per day
   </value>
   <value>
    4h post-exercise
   </value>
   <value>
    aCD3+aCD28 mAb
   </value>
   <value>
    anitoxidant rich diet - 1/3 total caloric intake
   </value>
   <value>
    arsenic exposed mother
   </value>
   <value>
    biopsy taken after 2 years on gluten free diet
   </value>
   <value>
    biopsy taken at diagnosis of celiac disease
   </value>
   <value>
    continuous exposure to magnetic field with no recovery
   </value>
   <value>
    continuous exposure to magnetic field with one day recovery
   </value>
   <value>
    control
   </value>
   <value>
    control diet
   </value>
   <value>
    control with 8 weeks of relaxation response practice
   </value>
   <value>
    diesel exhaust exposure
   </value>
   <value>
    exercise
   </value>
   <value>
    exercise training
   </value>
   <value>
    exercise: 0m
   </value>
   <value>
    exercise: 20m
   </value>
   <value>
    exercise: 30m
   </value>
   <value>
    exercise: 60m
   </value>
   <value>
    exposed to magnetic field on day 6
   </value>
   <value>
    fasted patient
   </value>
   <value>
    feeding trial with protein intake
   </value>
   <value>
    filtered air exposure
   </value>
   <value>
    gluten-free diet
   </value>
   <value>
    hCG ovarian stimulation
   </value>
   <value>
    intermittent mechanical stress
   </value>
   <value>
    long-term practitioner of daily relaxation response practice
   </value>
   <value>
    nickel exposed
   </value>
   <value>
    no exposure to magnetic field
   </value>
   <value>
    none
   </value>
   <value>
    resting state
   </value>
   <value>
    rFSH ovarian stimulation
   </value>
   <value>
    treatment: broccoli
   </value>
   <value>
    treatment: none
   </value>
   <value>
    treatment: not applicable
   </value>
   <value>
    treatment: peas
   </value>
   <value>
    western equine encephalitis virus
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    tissue supergroup
   </category>
   <value>
    acute myeloid leukemia sample
   </value>
   <value>
    adipose tissue
   </value>
   <value>
    adrenal cortex
   </value>
   <value>
    adrenal gland/cortex
   </value>
   <value>
    amnion
   </value>
   <value>
    annulus fibrosus
   </value>
   <value>
    articular cartilage
   </value>
   <value>
    biceps
   </value>
   <value>
    blood
   </value>
   <value>
    bone
   </value>
   <value>
    bone marrow
   </value>
   <value>
    brain
   </value>
   <value>
    breast
   </value>
   <value>
    breast epithelium
   </value>
   <value>
    breast reduction mammoplasty tissue explant
   </value>
   <value>
    breast tumor
   </value>
   <value>
    breast tumor explant
   </value>
   <value>
    bronchial epithelium
   </value>
   <value>
    bronchoalveolar lavage
   </value>
   <value>
    bronchus
   </value>
   <value>
    buccal mucosa
   </value>
   <value>
    cecum
   </value>
   <value>
    central nervous system DLBCL
   </value>
   <value>
    cerebellum
   </value>
   <value>
    cervix
   </value>
   <value>
    colon
   </value>
   <value>
    colon tumor
   </value>
   <value>
    colonic mucosa
   </value>
   <value>
    colorectal
   </value>
   <value>
    colorectal mucosa
   </value>
   <value>
    connective tissue
   </value>
   <value>
    cord blood
   </value>
   <value>
    coronary
   </value>
   <value>
    corpus callosum
   </value>
   <value>
    cortex/proximal tubule
   </value>
   <value>
    cultured epidermis
   </value>
   <value>
    cultured erythroid progenitor
   </value>
   <value>
    dorsal root ganglion
   </value>
   <value>
    embryonic cortex
   </value>
   <value>
    embryonic kidney
   </value>
   <value>
    embryonic liver
   </value>
   <value>
    embryonic osteoblast
   </value>
   <value>
    endometrium
   </value>
   <value>
    engineered neural tissue
   </value>
   <value>
    epidermis
   </value>
   <value>
    epididymis body segment
   </value>
   <value>
    epididymis head segment
   </value>
   <value>
    epididymis tail segment
   </value>
   <value>
    esophageal epithelium
   </value>
   <value>
    esophagus
   </value>
   <value>
    fetal cortex
   </value>
   <value>
    fetal lung
   </value>
   <value>
    fibroblast
   </value>
   <value>
    forearm
   </value>
   <value>
    gastric tissue
   </value>
   <value>
    gastrointestinal tissue
   </value>
   <value>
    head and neck
   </value>
   <value>
    hematopoietic and lymphoid
   </value>
   <value>
    ileal mucosa
   </value>
   <value>
    ileum
   </value>
   <value>
    inner cell mass
   </value>
   <value>
    intracranial pediatric germ cell tumor
   </value>
   <value>
    kidney
   </value>
   <value>
    liver
   </value>
   <value>
    liver sinusoidal endothelium
   </value>
   <value>
    lung
   </value>
   <value>
    lung/bronchus
   </value>
   <value>
    lymphoblastoid
   </value>
   <value>
    lymphoid
   </value>
   <value>
    lymphoma tissue
   </value>
   <value>
    main corpus
   </value>
   <value>
    mammary epithelium
   </value>
   <value>
    mammary gland
   </value>
   <value>
    meniscal tissue
   </value>
   <value>
    mesothelium
   </value>
   <value>
    metastatic RCC
   </value>
   <value>
    nasal
   </value>
   <value>
    nasopharingeal
   </value>
   <value>
    nasopharingeal tissue
   </value>
   <value>
    nasopharyngeal
   </value>
   <value>
    neonatal dermal fibroblast
   </value>
   <value>
    neuroblastic tumor
   </value>
   <value>
    nucleus pulpsus
   </value>
   <value>
    omental adipose tissue
   </value>
   <value>
    oral cavity
   </value>
   <value>
    oral mucosa
   </value>
   <value>
    ovary
   </value>
   <value>
    pancreas
   </value>
   <value>
    pancreatic islet
   </value>
   <value>
    parathyroid tissue
   </value>
   <value>
    pericardial fluid
   </value>
   <value>
    peripheral blood
   </value>
   <value>
    peritoneal effusion
   </value>
   <value>
    pharyngeal mucosa
   </value>
   <value>
    placenta
   </value>
   <value>
    pleura
   </value>
   <value>
    pleural effusion
   </value>
   <value>
    pleural fluid
   </value>
   <value>
    primary clear-cell renal cell carcinoma
   </value>
   <value>
    prostate
   </value>
   <value>
    pulmonary MALT lymphoma tissue
   </value>
   <value>
    pulmonary metastasis of clear-cell renal cell carcinoma
   </value>
   <value>
    renal tumor
   </value>
   <value>
    retina
   </value>
   <value>
    sarcomatiod
   </value>
   <value>
    sinus mucosa
   </value>
   <value>
    skin
   </value>
   <value>
    soft tissue
   </value>
   <value>
    soft tissue sarcoma
   </value>
   <value>
    spleen
   </value>
   <value>
    stomach
   </value>
   <value>
    subcutaneous adipose tissue
   </value>
   <value>
    synovial tissue
   </value>
   <value>
    testicular diffuse large B-cell lymphoma tissue
   </value>
   <value>
    testis
   </value>
   <value>
    thigh
   </value>
   <value>
    tongue
   </value>
   <value>
    trachea
   </value>
   <value>
    trunk neural crest
   </value>
   <value>
    umbilical cord
   </value>
   <value>
    umbilical vein
   </value>
   <value>
    urothelium
   </value>
   <value>
    uterus
   </value>
   <value>
    vastus lateralis
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    cell line
   </name>
   <value>
    (pool of 16 cancer cell lines)
   </value>
   <value>
    04-147
   </value>
   <value>
    10
   </value>
   <value>
    1089 luminal
   </value>
   <value>
    10A
   </value>
   <value>
    11
   </value>
   <value>
    11A
   </value>
   <value>
    1205-Lu
   </value>
   <value>
    184B5 MeM
   </value>
   <value>
    1Cc8
   </value>
   <value>
    22Rv1
   </value>
   <value>
    36M2
   </value>
   <value>
    5-8F
   </value>
   <value>
    527MEL
   </value>
   <value>
    6-10B
   </value>
   <value>
    624MEL
   </value>
   <value>
    697
   </value>
   <value>
    6a
   </value>
   <value>
    76N
   </value>
   <value>
    76N RhoA
   </value>
   <value>
    786-O
   </value>
   <value>
    786-VHL
   </value>
   <value>
    8226/S
   </value>
   <value>
    888MEL
   </value>
   <value>
    8d
   </value>
   <value>
    90-8
   </value>
   <value>
    92,1
   </value>
   <value>
    928MEL
   </value>
   <value>
    9A
   </value>
   <value>
    A02
   </value>
   <value>
    A04
   </value>
   <value>
    A06
   </value>
   <value>
    A1
   </value>
   <value>
    A11
   </value>
   <value>
    A13
   </value>
   <value>
    A15
   </value>
   <value>
    A172
   </value>
   <value>
    A2058
   </value>
   <value>
    A2780
   </value>
   <value>
    A3-Kawakami
   </value>
   <value>
    A375
   </value>
   <value>
    A375M2
   </value>
   <value>
    A375P
   </value>
   <value>
    A375SM
   </value>
   <value>
    A427
   </value>
   <value>
    A431
   </value>
   <value>
    A4_Fukada
   </value>
   <value>
    A549
   </value>
   <value>
    A6
   </value>
   <value>
    ABC1
   </value>
   <value>
    abl
   </value>
   <value>
    AF6
   </value>
   <value>
    AG04147
   </value>
   <value>
    AG05416
   </value>
   <value>
    AG06237
   </value>
   <value>
    AG07139
   </value>
   <value>
    AG07307
   </value>
   <value>
    AG08046
   </value>
   <value>
    AG08048
   </value>
   <value>
    AG09699
   </value>
   <value>
    AG09877
   </value>
   <value>
    AG10049
   </value>
   <value>
    AG10941
   </value>
   <value>
    AG11364
   </value>
   <value>
    AG11696
   </value>
   <value>
    AG11726
   </value>
   <value>
    AG13066
   </value>
   <value>
    AG13145
   </value>
   <value>
    AG13150
   </value>
   <value>
    AG14446
   </value>
   <value>
    AGS
   </value>
   <value>
    AGS and MKN-45
   </value>
   <value>
    AMO-1
   </value>
   <value>
    ANBL-6
   </value>
   <value>
    ARPE-19
   </value>
   <value>
    AsPC-1
   </value>
   <value>
    AU565
   </value>
   <value>
    Awells
   </value>
   <value>
    AZ521
   </value>
   <value>
    B41
   </value>
   <value>
    BattP12
   </value>
   <value>
    BC-3
   </value>
   <value>
    BCN
   </value>
   <value>
    BCWM1
   </value>
   <value>
    BE(2)-C
   </value>
   <value>
    BEAS-2B
   </value>
   <value>
    BJ
   </value>
   <value>
    BJ1
   </value>
   <value>
    BJAB
   </value>
   <value>
    BL
   </value>
   <value>
    BPLER
   </value>
   <value>
    BT-474
   </value>
   <value>
    BT-474-EI
   </value>
   <value>
    BT-483
   </value>
   <value>
    BT-549
   </value>
   <value>
    BT-5491
   </value>
   <value>
    BT/HerR0.2D clone (Her2-positive BT474)
   </value>
   <value>
    BT/HerR0.2J clone (Her2-positive BT474)
   </value>
   <value>
    BT/HerR1.0C clone (Her2-positive BT474)
   </value>
   <value>
    BT/HerR1.0E clone (Her2-positive BT474)
   </value>
   <value>
    BxPC-3
   </value>
   <value>
    C-32
   </value>
   <value>
    C1
   </value>
   <value>
    C32
   </value>
   <value>
    C33-A
   </value>
   <value>
    C4-2
   </value>
   <value>
    C7H2
   </value>
   <value>
    C7H2-R10E7
   </value>
   <value>
    C7H2-R19E5
   </value>
   <value>
    C7H2-R19E7
   </value>
   <value>
    C7H2-R19F2
   </value>
   <value>
    C7H2-R3B5
   </value>
   <value>
    C7H2-R9C10
   </value>
   <value>
    C7H2-S10
   </value>
   <value>
    C7H2-S11
   </value>
   <value>
    C7H2-S12
   </value>
   <value>
    C7H2-S15
   </value>
   <value>
    C7H2-S2
   </value>
   <value>
    C7H2-S27
   </value>
   <value>
    C7H2-S27(ZR)
   </value>
   <value>
    CA1
   </value>
   <value>
    CA2
   </value>
   <value>
    Caco-2
   </value>
   <value>
    Caki-1
   </value>
   <value>
    CAL-120
   </value>
   <value>
    CAL-1201
   </value>
   <value>
    CAL-148
   </value>
   <value>
    CAL-51
   </value>
   <value>
    CAL-851
   </value>
   <value>
    Calu-1
   </value>
   <value>
    Calu-3
   </value>
   <value>
    Calu-3 subclone 2B4
   </value>
   <value>
    Calu-6
   </value>
   <value>
    CAMA-1
   </value>
   <value>
    Caov-3
   </value>
   <value>
    Capan-1
   </value>
   <value>
    Capan-2
   </value>
   <value>
    CCD-1079Sk
   </value>
   <value>
    CCD-1108SK
   </value>
   <value>
    CCD-13Lu
   </value>
   <value>
    CCD-16Lu
   </value>
   <value>
    CCD-18Co
   </value>
   <value>
    CCD-19Lu
   </value>
   <value>
    CCD-25Lu
   </value>
   <value>
    CCD-29Lu
   </value>
   <value>
    CCD-8Lu
   </value>
   <value>
    CCRF-CEM
   </value>
   <value>
    CCRF-CEM-c1
   </value>
   <value>
    CCRF-CEM-C7R1
   </value>
   <value>
    CEM
   </value>
   <value>
    CFPAC
   </value>
   <value>
    CFT-2
   </value>
   <value>
    CI-1
   </value>
   <value>
    CJM
   </value>
   <value>
    CL-11
   </value>
   <value>
    CL-40
   </value>
   <value>
    CL1-5
   </value>
   <value>
    CLS145
   </value>
   <value>
    CMK
   </value>
   <value>
    CNE2
   </value>
   <value>
    CNMel
   </value>
   <value>
    COLO-201
   </value>
   <value>
    COLO-205
   </value>
   <value>
    Colo-206
   </value>
   <value>
    Colo-320 DM
   </value>
   <value>
    Colo-320 HSR
   </value>
   <value>
    Colo-357
   </value>
   <value>
    Colo-678
   </value>
   <value>
    COLO-704
   </value>
   <value>
    Colo-741
   </value>
   <value>
    Colo-829
   </value>
   <value>
    Con1
   </value>
   <value>
    CP-A hTERT
   </value>
   <value>
    CRL-2054
   </value>
   <value>
    CRMel
   </value>
   <value>
    CS-1
   </value>
   <value>
    CS-1/ER
   </value>
   <value>
    CS-1/PR
   </value>
   <value>
    CWR22Rv1
   </value>
   <value>
    CX-1
   </value>
   <value>
    D01
   </value>
   <value>
    D04
   </value>
   <value>
    D05
   </value>
   <value>
    D08
   </value>
   <value>
    D10
   </value>
   <value>
    D11
   </value>
   <value>
    D14
   </value>
   <value>
    D17
   </value>
   <value>
    D20
   </value>
   <value>
    D22
   </value>
   <value>
    D24
   </value>
   <value>
    D25
   </value>
   <value>
    D28
   </value>
   <value>
    D29
   </value>
   <value>
    D32
   </value>
   <value>
    D35
   </value>
   <value>
    D36
   </value>
   <value>
    D38
   </value>
   <value>
    D40
   </value>
   <value>
    D41
   </value>
   <value>
    DAOY
   </value>
   <value>
    DB
   </value>
   <value>
    DBTRG-05MG
   </value>
   <value>
    Detroit 551
   </value>
   <value>
    Detroit 562
   </value>
   <value>
    dH1F
   </value>
   <value>
    DLD-1
   </value>
   <value>
    DM175
   </value>
   <value>
    DM366
   </value>
   <value>
    DM368
   </value>
   <value>
    DM382
   </value>
   <value>
    DM391
   </value>
   <value>
    DM401p
   </value>
   <value>
    DM414
   </value>
   <value>
    DM422
   </value>
   <value>
    DM424
   </value>
   <value>
    DM425
   </value>
   <value>
    DM440
   </value>
   <value>
    DM443
   </value>
   <value>
    DM451
   </value>
   <value>
    DM459
   </value>
   <value>
    DM467
   </value>
   <value>
    DM497
   </value>
   <value>
    DM555
   </value>
   <value>
    DM578
   </value>
   <value>
    DM589
   </value>
   <value>
    DM59
   </value>
   <value>
    DM598
   </value>
   <value>
    DM6
   </value>
   <value>
    DM602
   </value>
   <value>
    DM608
   </value>
   <value>
    DM636
   </value>
   <value>
    DM643
   </value>
   <value>
    DM646
   </value>
   <value>
    DM711
   </value>
   <value>
    DM733
   </value>
   <value>
    DM738
   </value>
   <value>
    DM745
   </value>
   <value>
    DM751
   </value>
   <value>
    DM779
   </value>
   <value>
    DM787
   </value>
   <value>
    DM792
   </value>
   <value>
    DM798
   </value>
   <value>
    DM806
   </value>
   <value>
    DM833
   </value>
   <value>
    DM868
   </value>
   <value>
    DoHH2
   </value>
   <value>
    DU145
   </value>
   <value>
    DU4475
   </value>
   <value>
    EBC1
   </value>
   <value>
    EBV-LCL 721
   </value>
   <value>
    EC109
   </value>
   <value>
    EES-1
   </value>
   <value>
    EFM19
   </value>
   <value>
    EFM192A
   </value>
   <value>
    EFO21
   </value>
   <value>
    EKVX
   </value>
   <value>
    Eol1
   </value>
   <value>
    EREB2-5
   </value>
   <value>
    ES-2
   </value>
   <value>
    EVSA
   </value>
   <value>
    FaDu
   </value>
   <value>
    Farage
   </value>
   <value>
    FarageX1
   </value>
   <value>
    FG
   </value>
   <value>
    fibroblast derived cell line
   </value>
   <value>
    FL
   </value>
   <value>
    FU-OV-1
   </value>
   <value>
    Fu97
   </value>
   <value>
    G111
   </value>
   <value>
    G112
   </value>
   <value>
    G118
   </value>
   <value>
    G120
   </value>
   <value>
    G121
   </value>
   <value>
    G122
   </value>
   <value>
    G124
   </value>
   <value>
    G130
   </value>
   <value>
    G140
   </value>
   <value>
    G141
   </value>
   <value>
    G142
   </value>
   <value>
    G144-NS
   </value>
   <value>
    G166-NS
   </value>
   <value>
    G174-NS
   </value>
   <value>
    G179-NS
   </value>
   <value>
    G22
   </value>
   <value>
    G28T
   </value>
   <value>
    G361
   </value>
   <value>
    G44
   </value>
   <value>
    G59
   </value>
   <value>
    G61
   </value>
   <value>
    G63
   </value>
   <value>
    G84
   </value>
   <value>
    G96
   </value>
   <value>
    GBS6
   </value>
   <value>
    GI-LI-N
   </value>
   <value>
    GI-ME-N
   </value>
   <value>
    GliNS1
   </value>
   <value>
    GliNS2
   </value>
   <value>
    GM
   </value>
   <value>
    GM00144
   </value>
   <value>
    GM01652C
   </value>
   <value>
    GM02036A
   </value>
   <value>
    GM02767
   </value>
   <value>
    GM03348E
   </value>
   <value>
    GM03349C
   </value>
   <value>
    GM03377
   </value>
   <value>
    GM04981
   </value>
   <value>
    GM06944
   </value>
   <value>
    GM06985
   </value>
   <value>
    GM06993
   </value>
   <value>
    GM06994
   </value>
   <value>
    GM07000
   </value>
   <value>
    GM07022
   </value>
   <value>
    GM07034
   </value>
   <value>
    GM07055
   </value>
   <value>
    GM07056
   </value>
   <value>
    GM07345
   </value>
   <value>
    GM07357
   </value>
   <value>
    GM08398A
   </value>
   <value>
    GM11829
   </value>
   <value>
    GM11830
   </value>
   <value>
    GM11831
   </value>
   <value>
    GM11832
   </value>
   <value>
    GM11839
   </value>
   <value>
    GM11840
   </value>
   <value>
    GM11881
   </value>
   <value>
    GM11882
   </value>
   <value>
    GM11992
   </value>
   <value>
    GM11993
   </value>
   <value>
    GM11994
   </value>
   <value>
    GM11995
   </value>
   <value>
    GM12003
   </value>
   <value>
    GM12004
   </value>
   <value>
    GM12005
   </value>
   <value>
    GM12006
   </value>
   <value>
    GM12043
   </value>
   <value>
    GM12044
   </value>
   <value>
    GM12056
   </value>
   <value>
    GM12057
   </value>
   <value>
    GM12144
   </value>
   <value>
    GM12145
   </value>
   <value>
    GM12146
   </value>
   <value>
    GM12154
   </value>
   <value>
    GM12155
   </value>
   <value>
    GM12156
   </value>
   <value>
    GM12234
   </value>
   <value>
    GM12236
   </value>
   <value>
    GM12239
   </value>
   <value>
    GM12248
   </value>
   <value>
    GM12249
   </value>
   <value>
    GM12264
   </value>
   <value>
    GM12716
   </value>
   <value>
    GM12717
   </value>
   <value>
    GM12750
   </value>
   <value>
    GM12751
   </value>
   <value>
    GM12760
   </value>
   <value>
    GM12761
   </value>
   <value>
    GM12762
   </value>
   <value>
    GM12763
   </value>
   <value>
    GM12812
   </value>
   <value>
    GM12813
   </value>
   <value>
    GM12814
   </value>
   <value>
    GM12815
   </value>
   <value>
    GM12872
   </value>
   <value>
    GM12873
   </value>
   <value>
    GM12874
   </value>
   <value>
    GM12875
   </value>
   <value>
    GM12891
   </value>
   <value>
    GM12892
   </value>
   <value>
    GM14381
   </value>
   <value>
    GM14382
   </value>
   <value>
    GM14405
   </value>
   <value>
    GM14406
   </value>
   <value>
    GM14408
   </value>
   <value>
    GM14409
   </value>
   <value>
    GM14414
   </value>
   <value>
    GM14417
   </value>
   <value>
    GM14432
   </value>
   <value>
    GM14433
   </value>
   <value>
    GM14439
   </value>
   <value>
    GM14440
   </value>
   <value>
    GM14447
   </value>
   <value>
    GM14448
   </value>
   <value>
    GM14452
   </value>
   <value>
    GM14453
   </value>
   <value>
    GM14454
   </value>
   <value>
    GM14455
   </value>
   <value>
    GM14464
   </value>
   <value>
    GM14465
   </value>
   <value>
    GM14467
   </value>
   <value>
    GM14468
   </value>
   <value>
    GM14474
   </value>
   <value>
    GM14475
   </value>
   <value>
    GM14476
   </value>
   <value>
    GM14477
   </value>
   <value>
    GM14478
   </value>
   <value>
    GM14479
   </value>
   <value>
    GM14480
   </value>
   <value>
    GM14481
   </value>
   <value>
    GM14501
   </value>
   <value>
    GM14502
   </value>
   <value>
    GM14503
   </value>
   <value>
    GM14504
   </value>
   <value>
    GM14506
   </value>
   <value>
    GM14507
   </value>
   <value>
    GM14508
   </value>
   <value>
    GM14509
   </value>
   <value>
    GM14520
   </value>
   <value>
    GM14521
   </value>
   <value>
    GM14532
   </value>
   <value>
    GM14533
   </value>
   <value>
    GM14535
   </value>
   <value>
    GM14536
   </value>
   <value>
    GM14568
   </value>
   <value>
    GM14569
   </value>
   <value>
    GM14581
   </value>
   <value>
    GM14582
   </value>
   <value>
    GM14583
   </value>
   <value>
    GM14584
   </value>
   <value>
    GM15029
   </value>
   <value>
    GM15036
   </value>
   <value>
    GM15038
   </value>
   <value>
    GM15056
   </value>
   <value>
    GM15061
   </value>
   <value>
    GM15072
   </value>
   <value>
    GM15144
   </value>
   <value>
    GM15213
   </value>
   <value>
    GM15215
   </value>
   <value>
    GM15216
   </value>
   <value>
    GM15221
   </value>
   <value>
    GM15223
   </value>
   <value>
    GM15224
   </value>
   <value>
    GM15226
   </value>
   <value>
    GM15227
   </value>
   <value>
    GM15236
   </value>
   <value>
    GM15242
   </value>
   <value>
    GM15245
   </value>
   <value>
    GM15268
   </value>
   <value>
    GM15324
   </value>
   <value>
    GM15385
   </value>
   <value>
    GM15386
   </value>
   <value>
    GM15510
   </value>
   <value>
    GM15590
   </value>
   <value>
    GM15850
   </value>
   <value>
    GM15851
   </value>
   <value>
    GM17102
   </value>
   <value>
    GM17103
   </value>
   <value>
    GM17104
   </value>
   <value>
    GM17105
   </value>
   <value>
    GM17106
   </value>
   <value>
    GM17107
   </value>
   <value>
    GM17108
   </value>
   <value>
    GM17109
   </value>
   <value>
    GM17110
   </value>
   <value>
    GM17111
   </value>
   <value>
    GM17112
   </value>
   <value>
    GM17113
   </value>
   <value>
    GM17114
   </value>
   <value>
    GM17115
   </value>
   <value>
    GM17116
   </value>
   <value>
    GM17117
   </value>
   <value>
    GM17118
   </value>
   <value>
    GM17119
   </value>
   <value>
    GM17121
   </value>
   <value>
    GM17122
   </value>
   <value>
    GM17124
   </value>
   <value>
    GM17125
   </value>
   <value>
    GM17126
   </value>
   <value>
    GM17127
   </value>
   <value>
    GM17129
   </value>
   <value>
    GM17130
   </value>
   <value>
    GM17131
   </value>
   <value>
    GM17132
   </value>
   <value>
    GM17133
   </value>
   <value>
    GM17134
   </value>
   <value>
    GM17135
   </value>
   <value>
    GM17136
   </value>
   <value>
    GM17137
   </value>
   <value>
    GM17138
   </value>
   <value>
    GM17139
   </value>
   <value>
    GM17140
   </value>
   <value>
    GM17141
   </value>
   <value>
    GM17142
   </value>
   <value>
    GM17143
   </value>
   <value>
    GM17144
   </value>
   <value>
    GM17145
   </value>
   <value>
    GM17146
   </value>
   <value>
    GM17147
   </value>
   <value>
    GM17148
   </value>
   <value>
    GM17149
   </value>
   <value>
    GM17150
   </value>
   <value>
    GM17154
   </value>
   <value>
    GM17155
   </value>
   <value>
    GM17156
   </value>
   <value>
    GM17157
   </value>
   <value>
    GM17158
   </value>
   <value>
    GM17159
   </value>
   <value>
    GM17160
   </value>
   <value>
    GM17161
   </value>
   <value>
    GM17162
   </value>
   <value>
    GM17163
   </value>
   <value>
    GM17164
   </value>
   <value>
    GM17165
   </value>
   <value>
    GM17166
   </value>
   <value>
    GM17167
   </value>
   <value>
    GM17168
   </value>
   <value>
    GM17170
   </value>
   <value>
    GM17171
   </value>
   <value>
    GM17172
   </value>
   <value>
    GM17176
   </value>
   <value>
    GM17177
   </value>
   <value>
    GM17179
   </value>
   <value>
    GM17180
   </value>
   <value>
    GM17181
   </value>
   <value>
    GM17182
   </value>
   <value>
    GM17183
   </value>
   <value>
    GM17184
   </value>
   <value>
    GM17185
   </value>
   <value>
    GM17186
   </value>
   <value>
    GM17187
   </value>
   <value>
    GM17188
   </value>
   <value>
    GM17189
   </value>
   <value>
    GM17190
   </value>
   <value>
    GM17192
   </value>
   <value>
    GM17196
   </value>
   <value>
    GM17197
   </value>
   <value>
    GM17198
   </value>
   <value>
    GM17199
   </value>
   <value>
    GM17201
   </value>
   <value>
    GM17202
   </value>
   <value>
    GM17203
   </value>
   <value>
    GM17204
   </value>
   <value>
    GM17205
   </value>
   <value>
    GM17206
   </value>
   <value>
    GM17207
   </value>
   <value>
    GM17208
   </value>
   <value>
    GM17209
   </value>
   <value>
    GM17210
   </value>
   <value>
    GM17211
   </value>
   <value>
    GM17212
   </value>
   <value>
    GM17213
   </value>
   <value>
    GM17214
   </value>
   <value>
    GM17215
   </value>
   <value>
    GM17216
   </value>
   <value>
    GM17217
   </value>
   <value>
    GM17218
   </value>
   <value>
    GM17220
   </value>
   <value>
    GM17221
   </value>
   <value>
    GM17222
   </value>
   <value>
    GM17223
   </value>
   <value>
    GM17224
   </value>
   <value>
    GM17225
   </value>
   <value>
    GM17226
   </value>
   <value>
    GM17227
   </value>
   <value>
    GM17228
   </value>
   <value>
    GM17229
   </value>
   <value>
    GM17230
   </value>
   <value>
    GM17231
   </value>
   <value>
    GM17232
   </value>
   <value>
    GM17233
   </value>
   <value>
    GM17234
   </value>
   <value>
    GM17235
   </value>
   <value>
    GM17236
   </value>
   <value>
    GM17237
   </value>
   <value>
    GM17238
   </value>
   <value>
    GM17239
   </value>
   <value>
    GM17240
   </value>
   <value>
    GM17241
   </value>
   <value>
    GM17242
   </value>
   <value>
    GM17243
   </value>
   <value>
    GM17244
   </value>
   <value>
    GM17245
   </value>
   <value>
    GM17246
   </value>
   <value>
    GM17247
   </value>
   <value>
    GM17248
   </value>
   <value>
    GM17249
   </value>
   <value>
    GM17250
   </value>
   <value>
    GM17251
   </value>
   <value>
    GM17252
   </value>
   <value>
    GM17253
   </value>
   <value>
    GM17254
   </value>
   <value>
    GM17255
   </value>
   <value>
    GM17256
   </value>
   <value>
    GM17257
   </value>
   <value>
    GM17258
   </value>
   <value>
    GM17259
   </value>
   <value>
    GM17260
   </value>
   <value>
    GM17261
   </value>
   <value>
    GM17263
   </value>
   <value>
    GM17264
   </value>
   <value>
    GM17265
   </value>
   <value>
    GM17266
   </value>
   <value>
    GM17267
   </value>
   <value>
    GM17268
   </value>
   <value>
    GM17269
   </value>
   <value>
    GM17270
   </value>
   <value>
    GM17272
   </value>
   <value>
    GM17274
   </value>
   <value>
    GM17275
   </value>
   <value>
    GM17276
   </value>
   <value>
    GM17278
   </value>
   <value>
    GM17281
   </value>
   <value>
    GM17282
   </value>
   <value>
    GM17283
   </value>
   <value>
    GM17284
   </value>
   <value>
    GM17285
   </value>
   <value>
    GM17286
   </value>
   <value>
    GM17288
   </value>
   <value>
    GM17290
   </value>
   <value>
    GM17733
   </value>
   <value>
    GM17734
   </value>
   <value>
    GM17735
   </value>
   <value>
    GM17736
   </value>
   <value>
    GM17737
   </value>
   <value>
    GM17738
   </value>
   <value>
    GM17739
   </value>
   <value>
    GM17741
   </value>
   <value>
    GM17742
   </value>
   <value>
    GM17743
   </value>
   <value>
    GM17744
   </value>
   <value>
    GM17745
   </value>
   <value>
    GM17746
   </value>
   <value>
    GM17747
   </value>
   <value>
    GM17749
   </value>
   <value>
    GM17752
   </value>
   <value>
    GM17753
   </value>
   <value>
    GM17754
   </value>
   <value>
    GM17755
   </value>
   <value>
    GM17757
   </value>
   <value>
    GM17759
   </value>
   <value>
    GM17761
   </value>
   <value>
    GM17762
   </value>
   <value>
    GM17764
   </value>
   <value>
    GM17765
   </value>
   <value>
    GM17766
   </value>
   <value>
    GM17767
   </value>
   <value>
    GM17768
   </value>
   <value>
    GM17769
   </value>
   <value>
    GM17770
   </value>
   <value>
    GM17771
   </value>
   <value>
    GM17773
   </value>
   <value>
    GM17774
   </value>
   <value>
    GM17775
   </value>
   <value>
    GM17776
   </value>
   <value>
    GM17779
   </value>
   <value>
    GM17780
   </value>
   <value>
    GM17782
   </value>
   <value>
    GM17783
   </value>
   <value>
    GM17785
   </value>
   <value>
    GM17787
   </value>
   <value>
    GM17789
   </value>
   <value>
    GM17790
   </value>
   <value>
    GM17791
   </value>
   <value>
    GM17792
   </value>
   <value>
    GM17793
   </value>
   <value>
    GM17794
   </value>
   <value>
    GM17795
   </value>
   <value>
    GM17796
   </value>
   <value>
    GM17797
   </value>
   <value>
    GM17798
   </value>
   <value>
    GM17799
   </value>
   <value>
    GM17800
   </value>
   <value>
    GM17801
   </value>
   <value>
    GM17802
   </value>
   <value>
    GM17803
   </value>
   <value>
    GM17804
   </value>
   <value>
    GM17805
   </value>
   <value>
    GM17806
   </value>
   <value>
    GM17807
   </value>
   <value>
    GM17808
   </value>
   <value>
    GM17809
   </value>
   <value>
    GM17810
   </value>
   <value>
    GM17811
   </value>
   <value>
    GM17812
   </value>
   <value>
    GM17814
   </value>
   <value>
    GM17815
   </value>
   <value>
    GM17816
   </value>
   <value>
    GM17817
   </value>
   <value>
    GM17818
   </value>
   <value>
    GM17823
   </value>
   <value>
    GM17825
   </value>
   <value>
    GM17826
   </value>
   <value>
    GM17828
   </value>
   <value>
    GM17833
   </value>
   <value>
    GM17835
   </value>
   <value>
    GM17838
   </value>
   <value>
    GM2036A
   </value>
   <value>
    GM5659
   </value>
   <value>
    GOTO
   </value>
   <value>
    Granta-519
   </value>
   <value>
    GS-1
   </value>
   <value>
    GS-10
   </value>
   <value>
    GS-11
   </value>
   <value>
    GS-12
   </value>
   <value>
    GS-2
   </value>
   <value>
    GS-3
   </value>
   <value>
    GS-3 clone
   </value>
   <value>
    GS-4
   </value>
   <value>
    GS-5
   </value>
   <value>
    GS-6
   </value>
   <value>
    GS-7
   </value>
   <value>
    GS-7 clone
   </value>
   <value>
    GS-8
   </value>
   <value>
    GS-9
   </value>
   <value>
    H1
   </value>
   <value>
    H1112
   </value>
   <value>
    H1155
   </value>
   <value>
    H125
   </value>
   <value>
    H13B
   </value>
   <value>
    H1435
   </value>
   <value>
    H1437
   </value>
   <value>
    H14A
   </value>
   <value>
    H1568
   </value>
   <value>
    H157
   </value>
   <value>
    H1618
   </value>
   <value>
    H1650
   </value>
   <value>
    H1651
   </value>
   <value>
    H1666
   </value>
   <value>
    H1703
   </value>
   <value>
    H1781
   </value>
   <value>
    H1793
   </value>
   <value>
    H1819
   </value>
   <value>
    H1838
   </value>
   <value>
    H187
   </value>
   <value>
    H1993
   </value>
   <value>
    H1L
   </value>
   <value>
    H2009
   </value>
   <value>
    H2030
   </value>
   <value>
    H209
   </value>
   <value>
    H2122
   </value>
   <value>
    H2126
   </value>
   <value>
    H226
   </value>
   <value>
    H23
   </value>
   <value>
    H2347
   </value>
   <value>
    H2405
   </value>
   <value>
    H292
   </value>
   <value>
    H295R
   </value>
   <value>
    H322c
   </value>
   <value>
    H322T
   </value>
   <value>
    H358
   </value>
   <value>
    H4
   </value>
   <value>
    H441
   </value>
   <value>
    H446
   </value>
   <value>
    H460
   </value>
   <value>
    H520
   </value>
   <value>
    H522
   </value>
   <value>
    H526
   </value>
   <value>
    H596
   </value>
   <value>
    H647
   </value>
   <value>
    H650
   </value>
   <value>
    H661
   </value>
   <value>
    H69
   </value>
   <value>
    H720
   </value>
   <value>
    H82
   </value>
   <value>
    H838
   </value>
   <value>
    H9
   </value>
   <value>
    H9-derived
   </value>
   <value>
    H929
   </value>
   <value>
    HaCaT
   </value>
   <value>
    HANK
   </value>
   <value>
    hBEC
   </value>
   <value>
    HBEC2
   </value>
   <value>
    HBEC2-E
   </value>
   <value>
    HBEC2-KT
   </value>
   <value>
    HBEC3
   </value>
   <value>
    HBEC3-ET
   </value>
   <value>
    HBEC3-KT
   </value>
   <value>
    HBEC4
   </value>
   <value>
    HBEC4-KT
   </value>
   <value>
    HBEC5-KT
   </value>
   <value>
    HBL-2
   </value>
   <value>
    HCC-1008
   </value>
   <value>
    HCC-1143
   </value>
   <value>
    HCC-1395
   </value>
   <value>
    HCC-1396
   </value>
   <value>
    HCC-1402
   </value>
   <value>
    HCC-1419
   </value>
   <value>
    HCC-1428
   </value>
   <value>
    HCC-1500
   </value>
   <value>
    HCC-1569
   </value>
   <value>
    HCC-1599
   </value>
   <value>
    HCC-1806
   </value>
   <value>
    HCC-1937
   </value>
   <value>
    HCC-1954
   </value>
   <value>
    HCC-202
   </value>
   <value>
    HCC-2218
   </value>
   <value>
    HCC-38
   </value>
   <value>
    HCC-70
   </value>
   <value>
    HCT-116
   </value>
   <value>
    HCT-15
   </value>
   <value>
    HCT-29
   </value>
   <value>
    HCT-8
   </value>
   <value>
    HCT-8Sa
   </value>
   <value>
    HD90/FE07-142-L1
   </value>
   <value>
    HDLM-2
   </value>
   <value>
    HDQP1
   </value>
   <value>
    Hec50
   </value>
   <value>
    Hec50co
   </value>
   <value>
    HEK-293
   </value>
   <value>
    HEK-293 clone
   </value>
   <value>
    HEK-293-2C6
   </value>
   <value>
    HEK-293H
   </value>
   <value>
    HEK-293T
   </value>
   <value>
    HEK-TLR2
   </value>
   <value>
    HeLa
   </value>
   <value>
    HeLa clone
   </value>
   <value>
    HeLa-S3
   </value>
   <value>
    Hep-3B
   </value>
   <value>
    HepaRG
   </value>
   <value>
    HepG2
   </value>
   <value>
    HepG2/C3A
   </value>
   <value>
    hES-T3
   </value>
   <value>
    hESC BG01
   </value>
   <value>
    hESC BG03
   </value>
   <value>
    HET-1A
   </value>
   <value>
    HeyA8
   </value>
   <value>
    hf240-NS
   </value>
   <value>
    hf286-NS
   </value>
   <value>
    hf289-NS
   </value>
   <value>
    HFF1
   </value>
   <value>
    hFOB
   </value>
   <value>
    HG23
   </value>
   <value>
    HGADFN003
   </value>
   <value>
    HGADFN127
   </value>
   <value>
    HGADFN155
   </value>
   <value>
    HGADFN167
   </value>
   <value>
    HGADFN188
   </value>
   <value>
    HGC-27
   </value>
   <value>
    HIGK
   </value>
   <value>
    hiPS
   </value>
   <value>
    hiPS 17914 line E
   </value>
   <value>
    hiPS 17914 line G
   </value>
   <value>
    hiPS 3975
   </value>
   <value>
    hiPS line 1
   </value>
   <value>
    hiPS line 18
   </value>
   <value>
    hiPS line 2
   </value>
   <value>
    HK-2
   </value>
   <value>
    HK-Hep1
   </value>
   <value>
    HL60
   </value>
   <value>
    HLF-A
   </value>
   <value>
    HME
   </value>
   <value>
    HMEC
   </value>
   <value>
    HMF3A
   </value>
   <value>
    HMLER
   </value>
   <value>
    HOP18
   </value>
   <value>
    HOP62
   </value>
   <value>
    HOP92
   </value>
   <value>
    Hotz
   </value>
   <value>
    HP75
   </value>
   <value>
    HPAC
   </value>
   <value>
    HPAF-II
   </value>
   <value>
    HS181
   </value>
   <value>
    HS27a
   </value>
   <value>
    Hs294T
   </value>
   <value>
    HS5
   </value>
   <value>
    HS578T
   </value>
   <value>
    HS683
   </value>
   <value>
    Hs683
   </value>
   <value>
    Hs695T
   </value>
   <value>
    Hs746T
   </value>
   <value>
    HS766t
   </value>
   <value>
    HSB2
   </value>
   <value>
    HSC-3
   </value>
   <value>
    HSF1
   </value>
   <value>
    HT
   </value>
   <value>
    HT-29
   </value>
   <value>
    HT1080
   </value>
   <value>
    HT144
   </value>
   <value>
    HT29 CL.16E
   </value>
   <value>
    HT55
   </value>
   <value>
    HTB-58
   </value>
   <value>
    hTERT-immortalized BPEC
   </value>
   <value>
    HTETOP
   </value>
   <value>
    HTR8
   </value>
   <value>
    Hues9
   </value>
   <value>
    Huh7
   </value>
   <value>
    Huh7.5
   </value>
   <value>
    HuPT3
   </value>
   <value>
    HuT-102
   </value>
   <value>
    HuT-78
   </value>
   <value>
    huvec
   </value>
   <value>
    I83E95
   </value>
   <value>
    IGROV
   </value>
   <value>
    IGROV-1
   </value>
   <value>
    IM-9
   </value>
   <value>
    IM-95
   </value>
   <value>
    IMC-1
   </value>
   <value>
    IMR-32
   </value>
   <value>
    IMR-32-DKK1
   </value>
   <value>
    IMR90
   </value>
   <value>
    IOSE
   </value>
   <value>
    iPSC 15
   </value>
   <value>
    iPSC 1i
   </value>
   <value>
    iPSC 1M
   </value>
   <value>
    iPSC 4
   </value>
   <value>
    iPSC 9
   </value>
   <value>
    iPSC clone 3975.4
   </value>
   <value>
    iPSC clone IMR9.4
   </value>
   <value>
    iPSC T4
   </value>
   <value>
    Ishikawa
   </value>
   <value>
    Ishikawa H
   </value>
   <value>
    Ist1
   </value>
   <value>
    JEG-3
   </value>
   <value>
    JeKo-1
   </value>
   <value>
    Jeko-1
   </value>
   <value>
    JIM3
   </value>
   <value>
    Jurkat
   </value>
   <value>
    Jurkat/IM-9/Raji/THP-1
   </value>
   <value>
    K562
   </value>
   <value>
    KAI3
   </value>
   <value>
    Karpas-1106P
   </value>
   <value>
    Karpas-422
   </value>
   <value>
    KG1
   </value>
   <value>
    KHYG1
   </value>
   <value>
    Kit225
   </value>
   <value>
    KM12
   </value>
   <value>
    KMH2
   </value>
   <value>
    KMS11
   </value>
   <value>
    KMS12
   </value>
   <value>
    KNS62
   </value>
   <value>
    KPL-1
   </value>
   <value>
    KPL-4
   </value>
   <value>
    KTCL 140
   </value>
   <value>
    KTCL 26
   </value>
   <value>
    KYSE-140
   </value>
   <value>
    L-1236
   </value>
   <value>
    L-428
   </value>
   <value>
    L-540
   </value>
   <value>
    L3.6pl
   </value>
   <value>
    LAN-1
   </value>
   <value>
    LB84-1
   </value>
   <value>
    LI90
   </value>
   <value>
    line 18
   </value>
   <value>
    line1
   </value>
   <value>
    line2
   </value>
   <value>
    LL24
   </value>
   <value>
    LL47
   </value>
   <value>
    LL86
   </value>
   <value>
    LM1
   </value>
   <value>
    LM2
   </value>
   <value>
    LN18
   </value>
   <value>
    LN215
   </value>
   <value>
    LN229
   </value>
   <value>
    LN235
   </value>
   <value>
    LN319
   </value>
   <value>
    LN340
   </value>
   <value>
    LN382
   </value>
   <value>
    LN443
   </value>
   <value>
    LN444
   </value>
   <value>
    LN464
   </value>
   <value>
    LNCaP
   </value>
   <value>
    LNCaP late passage (LP50)
   </value>
   <value>
    LNZ308
   </value>
   <value>
    LOVO
   </value>
   <value>
    LOX-IMVI
   </value>
   <value>
    LP1
   </value>
   <value>
    LS1034
   </value>
   <value>
    LS174T
   </value>
   <value>
    LS180
   </value>
   <value>
    LS2 derived
   </value>
   <value>
    LXFL529
   </value>
   <value>
    M059J
   </value>
   <value>
    M059K
   </value>
   <value>
    M12
   </value>
   <value>
    M202
   </value>
   <value>
    M202R1
   </value>
   <value>
    M29
   </value>
   <value>
    Malme-3M
   </value>
   <value>
    MC116
   </value>
   <value>
    MCF-10A
   </value>
   <value>
    MCF-10A MycER
   </value>
   <value>
    MCF-10F
   </value>
   <value>
    MCF-7
   </value>
   <value>
    MCF-7-14
   </value>
   <value>
    MCF-7-DN-CLIM-TetOff
   </value>
   <value>
    MCF-7-FR
   </value>
   <value>
    MCF-7-G11TamR
   </value>
   <value>
    MCF-7:2A
   </value>
   <value>
    MCF-7:5C
   </value>
   <value>
    MCF-7R4
   </value>
   <value>
    MCH58
   </value>
   <value>
    MDA-MB-134VI
   </value>
   <value>
    MDA-MB-157
   </value>
   <value>
    MDA-MB-175
   </value>
   <value>
    MDA-MB-231
   </value>
   <value>
    MDA-MB-361
   </value>
   <value>
    MDA-MB-415
   </value>
   <value>
    MDA-MB-435
   </value>
   <value>
    MDA-MB-436
   </value>
   <value>
    MDA-MB-453
   </value>
   <value>
    MDA-MB-468
   </value>
   <value>
    MDA-MB-468GFP-LN
   </value>
   <value>
    MDST8
   </value>
   <value>
    ME180
   </value>
   <value>
    ME181
   </value>
   <value>
    ME182
   </value>
   <value>
    ME183
   </value>
   <value>
    ME184
   </value>
   <value>
    ME185
   </value>
   <value>
    MEG-01
   </value>
   <value>
    Met5A
   </value>
   <value>
    MeWo
   </value>
   <value>
    MFM-223
   </value>
   <value>
    MHH-PREB-1
   </value>
   <value>
    MIA PaCa2
   </value>
   <value>
    Mino
   </value>
   <value>
    MKN-1
   </value>
   <value>
    MKN-28
   </value>
   <value>
    MKN-45
   </value>
   <value>
    MKN-7
   </value>
   <value>
    MKN-74
   </value>
   <value>
    MkTBr
   </value>
   <value>
    ML-4
   </value>
   <value>
    ML-5
   </value>
   <value>
    ML-8
   </value>
   <value>
    ML-9
   </value>
   <value>
    MM.1R
   </value>
   <value>
    MM.1S
   </value>
   <value>
    MM.1s
   </value>
   <value>
    MM127
   </value>
   <value>
    MM170
   </value>
   <value>
    MM200
   </value>
   <value>
    MM229
   </value>
   <value>
    MM253
   </value>
   <value>
    MM329
   </value>
   <value>
    MM370
   </value>
   <value>
    MM383
   </value>
   <value>
    MM386
   </value>
   <value>
    MM415
   </value>
   <value>
    MM426
   </value>
   <value>
    MM455
   </value>
   <value>
    MM466
   </value>
   <value>
    MM473
   </value>
   <value>
    MM485
   </value>
   <value>
    MM537
   </value>
   <value>
    MM540
   </value>
   <value>
    MM548
   </value>
   <value>
    MM576
   </value>
   <value>
    MM595
   </value>
   <value>
    MM603
   </value>
   <value>
    MM608
   </value>
   <value>
    MM622
   </value>
   <value>
    MM648
   </value>
   <value>
    MM649
   </value>
   <value>
    MM96L
   </value>
   <value>
    MOLT-3
   </value>
   <value>
    MOLT4
   </value>
   <value>
    MonoMac 6
   </value>
   <value>
    Mpanc-96
   </value>
   <value>
    MRC-5
   </value>
   <value>
    MSK-Leuk1
   </value>
   <value>
    MT-1
   </value>
   <value>
    MT-2
   </value>
   <value>
    MT-3
   </value>
   <value>
    MT-4
   </value>
   <value>
    N1
   </value>
   <value>
    N2
   </value>
   <value>
    N3
   </value>
   <value>
    N4
   </value>
   <value>
    N5
   </value>
   <value>
    Namalwa
   </value>
   <value>
    NAN
   </value>
   <value>
    NB4
   </value>
   <value>
    NB69
   </value>
   <value>
    NB9
   </value>
   <value>
    NCI-H1299
   </value>
   <value>
    NCI-N87
   </value>
   <value>
    NCR-EW2
   </value>
   <value>
    NCR-EW3
   </value>
   <value>
    NGP
   </value>
   <value>
    NHDF 17914
   </value>
   <value>
    NHDF1
   </value>
   <value>
    NK-YS
   </value>
   <value>
    NK92
   </value>
   <value>
    NOMO-1
   </value>
   <value>
    Nor-P1
   </value>
   <value>
    NPC 5-8F
   </value>
   <value>
    NPrEC
   </value>
   <value>
    NRS-1
   </value>
   <value>
    NT-1
   </value>
   <value>
    NT2/D1
   </value>
   <value>
    NU-DHL-1
   </value>
   <value>
    NU-DUL-1
   </value>
   <value>
    NUGC3
   </value>
   <value>
    NUGC4
   </value>
   <value>
    NZM12
   </value>
   <value>
    NZM15
   </value>
   <value>
    OCI AML2
   </value>
   <value>
    Oci-Ly-19
   </value>
   <value>
    OCM-1
   </value>
   <value>
    OCUB-M
   </value>
   <value>
    OCUM1
   </value>
   <value>
    OPM1
   </value>
   <value>
    OPM2
   </value>
   <value>
    OV90
   </value>
   <value>
    OVCA429
   </value>
   <value>
    OVCAR-8
   </value>
   <value>
    OVCAR3
   </value>
   <value>
    P493-6
   </value>
   <value>
    Panc 1
   </value>
   <value>
    Panc 10.05
   </value>
   <value>
    Panc 2.03
   </value>
   <value>
    Panc 2.13
   </value>
   <value>
    Panc 3.03
   </value>
   <value>
    Panc 3.27
   </value>
   <value>
    Panc 4.03
   </value>
   <value>
    Panc 5.04
   </value>
   <value>
    Panc 8.13
   </value>
   <value>
    PaTu8902
   </value>
   <value>
    PaTu8988s
   </value>
   <value>
    PaTu8988t
   </value>
   <value>
    PC-3
   </value>
   <value>
    PC-3MM2
   </value>
   <value>
    PCSC-1
   </value>
   <value>
    PCSC-2
   </value>
   <value>
    PCSC-3
   </value>
   <value>
    PDB
   </value>
   <value>
    PDB1lox_17
   </value>
   <value>
    PDB1lox_21
   </value>
   <value>
    PDB1lox_22
   </value>
   <value>
    PDB1lox_5
   </value>
   <value>
    PEER
   </value>
   <value>
    Pfeiffer
   </value>
   <value>
    PGF
   </value>
   <value>
    PL45
   </value>
   <value>
    PLC-PRL
   </value>
   <value>
    PLC/PRF/5
   </value>
   <value>
    PLC8024
   </value>
   <value>
    pMIP3 line 3
   </value>
   <value>
    PreB 697 R4G4
   </value>
   <value>
    PRMel
   </value>
   <value>
    PSN1
   </value>
   <value>
    Ptci
   </value>
   <value>
    R11
   </value>
   <value>
    R18
   </value>
   <value>
    R28
   </value>
   <value>
    R43
   </value>
   <value>
    R46
   </value>
   <value>
    R8
   </value>
   <value>
    Raji
   </value>
   <value>
    Ramos
   </value>
   <value>
    RC-K8
   </value>
   <value>
    RCC4
   </value>
   <value>
    RD-ES
   </value>
   <value>
    REC-1
   </value>
   <value>
    Reh
   </value>
   <value>
    ReNCell
   </value>
   <value>
    RERF-LC-AD1
   </value>
   <value>
    RERF-LC-KJ
   </value>
   <value>
    RERF-LC-MS
   </value>
   <value>
    RERF-LC-OK
   </value>
   <value>
    RerfGC1B
   </value>
   <value>
    RI-1
   </value>
   <value>
    RKO
   </value>
   <value>
    RKOAS451
   </value>
   <value>
    RL
   </value>
   <value>
    round5 A2780
   </value>
   <value>
    RPMI-7951
   </value>
   <value>
    RPMI-8226
   </value>
   <value>
    RWPE1
   </value>
   <value>
    S462
   </value>
   <value>
    SA01
   </value>
   <value>
    SACHI
   </value>
   <value>
    SAOS
   </value>
   <value>
    Saos-2
   </value>
   <value>
    SC-1
   </value>
   <value>
    SCC-3
   </value>
   <value>
    SCC1
   </value>
   <value>
    SCC4
   </value>
   <value>
    SCC47
   </value>
   <value>
    SCC74A
   </value>
   <value>
    SCCH-196
   </value>
   <value>
    SCH
   </value>
   <value>
    Sez-4
   </value>
   <value>
    SF268
   </value>
   <value>
    SF539
   </value>
   <value>
    SF763
   </value>
   <value>
    SH-EP2
   </value>
   <value>
    SH-SY5Y
   </value>
   <value>
    SH-SY5Y-A
   </value>
   <value>
    SH-SY5Y-E
   </value>
   <value>
    SH-SY5Y/TrkA
   </value>
   <value>
    SHEP-21N
   </value>
   <value>
    SHEP-Tet21N
   </value>
   <value>
    SiHa
   </value>
   <value>
    Sk-Br-3
   </value>
   <value>
    Sk-Br-31
   </value>
   <value>
    SK-CO-1
   </value>
   <value>
    SK-ES-1
   </value>
   <value>
    SK-MEL-13
   </value>
   <value>
    SK-Mel-28
   </value>
   <value>
    Sk-Mel-28
   </value>
   <value>
    SK-MEL-31
   </value>
   <value>
    SK-MEL-5
   </value>
   <value>
    SK-N-AS
   </value>
   <value>
    SK-N-AS-NmycER
   </value>
   <value>
    SK-N-BE2(C)
   </value>
   <value>
    SK-N-F1
   </value>
   <value>
    SK-N-MC
   </value>
   <value>
    SK-N-SH
   </value>
   <value>
    SK23
   </value>
   <value>
    SKGT4
   </value>
   <value>
    SKM-1
   </value>
   <value>
    SKOV
   </value>
   <value>
    SKOV-3
   </value>
   <value>
    SKRC39
   </value>
   <value>
    SKRC45
   </value>
   <value>
    SKRC47
   </value>
   <value>
    SKRC54
   </value>
   <value>
    SKVCR 2.0
   </value>
   <value>
    SN12C
   </value>
   <value>
    SNK-6
   </value>
   <value>
    SNK1
   </value>
   <value>
    SNT-13
   </value>
   <value>
    SNT-15
   </value>
   <value>
    SNT-8
   </value>
   <value>
    SNU1
   </value>
   <value>
    SNU5
   </value>
   <value>
    SNU719
   </value>
   <value>
    Sosp-9607
   </value>
   <value>
    SR
   </value>
   <value>
    ST88-14
   </value>
   <value>
    SU-DHL-1
   </value>
   <value>
    SU-DHL-10
   </value>
   <value>
    SU-DHL-16
   </value>
   <value>
    SU-DHL-4
   </value>
   <value>
    SU-DHL-5
   </value>
   <value>
    SU-DHL-6
   </value>
   <value>
    SU-DHL-8
   </value>
   <value>
    SU86.86
   </value>
   <value>
    Susa
   </value>
   <value>
    SW 1783
   </value>
   <value>
    SW1116
   </value>
   <value>
    SW1463
   </value>
   <value>
    SW1573
   </value>
   <value>
    SW1990
   </value>
   <value>
    SW2
   </value>
   <value>
    SW403
   </value>
   <value>
    SW480
   </value>
   <value>
    SW527
   </value>
   <value>
    SW620
   </value>
   <value>
    T112D
   </value>
   <value>
    T265
   </value>
   <value>
    T3
   </value>
   <value>
    T3ES
   </value>
   <value>
    T47D
   </value>
   <value>
    T47D1
   </value>
   <value>
    T84
   </value>
   <value>
    T98G
   </value>
   <value>
    Takigawa
   </value>
   <value>
    TaY
   </value>
   <value>
    TaY-E10
   </value>
   <value>
    TC-252
   </value>
   <value>
    TEM2-5
   </value>
   <value>
    TEM4-18
   </value>
   <value>
    Tesi
   </value>
   <value>
    TF-1
   </value>
   <value>
    TGCT-833K
   </value>
   <value>
    TGCT-GCT27
   </value>
   <value>
    THP-1
   </value>
   <value>
    TIG-1
   </value>
   <value>
    TIG3 TERT/deltaB-RAF:ER
   </value>
   <value>
    TK
   </value>
   <value>
    TK6
   </value>
   <value>
    TMK1
   </value>
   <value>
    Toledo
   </value>
   <value>
    TOV112D
   </value>
   <value>
    TOV21G
   </value>
   <value>
    U-118 MG
   </value>
   <value>
    U-698-M
   </value>
   <value>
    U-937
   </value>
   <value>
    U1752
   </value>
   <value>
    U2-OS
   </value>
   <value>
    U251
   </value>
   <value>
    U266
   </value>
   <value>
    U343
   </value>
   <value>
    U373
   </value>
   <value>
    U87
   </value>
   <value>
    U87L4
   </value>
   <value>
    U87MG
   </value>
   <value>
    U87R4
   </value>
   <value>
    U937
   </value>
   <value>
    U937 NB4
   </value>
   <value>
    U937 PR-9
   </value>
   <value>
    U937T
   </value>
   <value>
    UACC-893
   </value>
   <value>
    UET-13
   </value>
   <value>
    UET-13TR-EWS/ERG
   </value>
   <value>
    UET-13TR-EWS/FLI1
   </value>
   <value>
    UMCL01-101
   </value>
   <value>
    UMRC2
   </value>
   <value>
    UMRC3
   </value>
   <value>
    UPN-1
   </value>
   <value>
    UROtsa
   </value>
   <value>
    UT-15
   </value>
   <value>
    UT-7
   </value>
   <value>
    UW-1
   </value>
   <value>
    VMRCLCD
   </value>
   <value>
    WI38
   </value>
   <value>
    WIBR1
   </value>
   <value>
    WIBR2
   </value>
   <value>
    WIBR3
   </value>
   <value>
    WIBR7
   </value>
   <value>
    WM-266-4
   </value>
   <value>
    WS1
   </value>
   <value>
    WSB
   </value>
   <value>
    WSU-FSCCL
   </value>
   <value>
    WSU-NHL
   </value>
   <value>
    WSUDLCL2
   </value>
   <value>
    XG
   </value>
   <value>
    YCC1
   </value>
   <value>
    YCC11
   </value>
   <value>
    YCC16
   </value>
   <value>
    YCC17
   </value>
   <value>
    YCC19
   </value>
   <value>
    YCC2
   </value>
   <value>
    YCC20
   </value>
   <value>
    YCC6
   </value>
   <value>
    YCC7
   </value>
   <value>
    YCC9
   </value>
   <value>
    YT-N
   </value>
   <value>
    Z138
   </value>
   <value>
    ZL25
   </value>
   <value>
    ZR-75
   </value>
   <value>
    ZR-75-1
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    cell type
   </name>
   <value>
    activated B-cell
   </value>
   <value>
    acute monocytic leukaemia cell line
   </value>
   <value>
    adipose-derived stem cell
   </value>
   <value>
    adrenocortical carcinoma cell line
   </value>
   <value>
    adult T-cell leukaemia cell line
   </value>
   <value>
    AIDS-NHL-derived cell line
   </value>
   <value>
    airway epithelial cell
   </value>
   <value>
    ALL cell line
   </value>
   <value>
    alveolar cell carcinoma cell line
   </value>
   <value>
    alveolar epithelial progenitor cell
   </value>
   <value>
    alveolar leukocyte
   </value>
   <value>
    alveolar macrophage
   </value>
   <value>
    AMKL cell line
   </value>
   <value>
    AML cell line
   </value>
   <value>
    amniocyte
   </value>
   <value>
    amnion cell line
   </value>
   <value>
    aortic vascular smooth muscle cell
   </value>
   <value>
    ascites cell
   </value>
   <value>
    astrocyte  derived from cell line H9
   </value>
   <value>
    ATL-derived cell line
   </value>
   <value>
    atypical ductal hyperplasia cell line
   </value>
   <value>
    B-cell
   </value>
   <value>
    B-cell derived cell line
   </value>
   <value>
    B-cell lymphoma cell line
   </value>
   <value>
    B-lymphoblastoid cell line
   </value>
   <value>
    B-lymphocyte
   </value>
   <value>
    B-lymphocyte cell line
   </value>
   <value>
    Barrett's syndrome cell line
   </value>
   <value>
    BDCA1+ dendritic cell
   </value>
   <value>
    BDCA3+ dendritic cell
   </value>
   <value>
    BJ-derived hIPS
   </value>
   <value>
    blast
   </value>
   <value>
    blast derived from cell line H9
   </value>
   <value>
    blast/proerythroblast
   </value>
   <value>
    blast/promonocyte
   </value>
   <value>
    blast/promyelocyte
   </value>
   <value>
    blasts and mononuclear cells
   </value>
   <value>
    blood vessel endothelial cell
   </value>
   <value>
    bone marrow derived cell line
   </value>
   <value>
    bone marrow stromal cell line
   </value>
   <value>
    bone sarcoma cell line
   </value>
   <value>
    brain cancer cell line
   </value>
   <value>
    breast cancer cell line
   </value>
   <value>
    breast cell line
   </value>
   <value>
    breast epithelial cell derived cell line
   </value>
   <value>
    breast tumor cell
   </value>
   <value>
    breast tumor cell line
   </value>
   <value>
    bronchial epithelial cell derived cell line
   </value>
   <value>
    bronchioalveolar carcinoma cell line
   </value>
   <value>
    bronchiole epithelial cell line
   </value>
   <value>
    Burkitt lymphoma cell line
   </value>
   <value>
    cancer cell lines
   </value>
   <value>
    CD133+ prostate epithelial cells
   </value>
   <value>
    CD133-/alpha2 integrin low prostate epithelial cells
   </value>
   <value>
    CD133-/aplha2 integrin low prostate epithelial cells
   </value>
   <value>
    CD138 plasma cell
   </value>
   <value>
    CD138+ plasma cell
   </value>
   <value>
    CD138+ selected plasma cells
   </value>
   <value>
    CD138-purified plasma cells
   </value>
   <value>
    CD138-selected cells
   </value>
   <value>
    CD14 cells
   </value>
   <value>
    CD14 positive mononuclear cell
   </value>
   <value>
    CD14+ CD16- monocyte
   </value>
   <value>
    CD14+ monocyte
   </value>
   <value>
    CD14-positive monocyte
   </value>
   <value>
    CD14low CD16+ monocyte
   </value>
   <value>
    CD15 cells
   </value>
   <value>
    CD16 negative mononuclear cell
   </value>
   <value>
    CD16 positive mononuclear cell
   </value>
   <value>
    CD16+ dendritic
   </value>
   <value>
    CD16+ monocyte
   </value>
   <value>
    CD16- monocyte
   </value>
   <value>
    CD19+ B-cell
   </value>
   <value>
    CD19+ cell
   </value>
   <value>
    cd19+ tumor cell
   </value>
   <value>
    CD1c+ dendritic cell
   </value>
   <value>
    CD21hi transitional B cell
   </value>
   <value>
    CD21lo transitional B cell
   </value>
   <value>
    CD3 cells
   </value>
   <value>
    CD3+ T-cell
   </value>
   <value>
    CD3-positive T cell
   </value>
   <value>
    CD34 positive mononuclear
   </value>
   <value>
    CD34+ cell
   </value>
   <value>
    CD34+ cells
   </value>
   <value>
    CD34+ haematopoietic stem cell
   </value>
   <value>
    CD34+ hematopoietic progenitor cell
   </value>
   <value>
    CD34+ progenitor cell, erythrocyte
   </value>
   <value>
    CD34+ progenitor cell, proerythroblast
   </value>
   <value>
    CD34+CD19+ pro-B-cell
   </value>
   <value>
    CD34-derived erythroid progenitors
   </value>
   <value>
    CD34-negative
   </value>
   <value>
    CD36+ erythroid progenitor cell
   </value>
   <value>
    CD4 positive T-cell
   </value>
   <value>
    CD4 T cell line
   </value>
   <value>
    CD4 T-cell
   </value>
   <value>
    CD4+ cell
   </value>
   <value>
    CD4+ T-cell
   </value>
   <value>
    CD41 negative portion
   </value>
   <value>
    CD41+ cord blood derived megakaryocytes
   </value>
   <value>
    CD4CD45RO T-cell
   </value>
   <value>
    CD8 positive T-cell
   </value>
   <value>
    CD8 T-cell
   </value>
   <value>
    CD8+ cell
   </value>
   <value>
    CD8+ central memory T cell
   </value>
   <value>
    CD8+ effector memory RA T cell
   </value>
   <value>
    CD8+ effector memory T cell
   </value>
   <value>
    CD8+ naive CD8 T cell
   </value>
   <value>
    CD8+ T-cell
   </value>
   <value>
    CD8+CD28+ T-cell
   </value>
   <value>
    CD8+CD28- T-cell
   </value>
   <value>
    cell line derived from HT1080
   </value>
   <value>
    cell line derived from primary cancer associated fibroblasts
   </value>
   <value>
    cell line derived from primary pancreatic ductal adenocarcinoma
   </value>
   <value>
    cell line mixture
   </value>
   <value>
    central memory T-cell
   </value>
   <value>
    centroblast
   </value>
   <value>
    centrocyte
   </value>
   <value>
    cervical carcinoma cell line
   </value>
   <value>
    chondrocyte
   </value>
   <value>
    chondrogenic progenitor cells
   </value>
   <value>
    chondrosarcoma cell line
   </value>
   <value>
    choroid
   </value>
   <value>
    chronic lymphocytic leukemia cell
   </value>
   <value>
    clear cell renal carcinoma cell line
   </value>
   <value>
    CLL cell line
   </value>
   <value>
    cloned fibroblast cell line
   </value>
   <value>
    CML cell line
   </value>
   <value>
    colon cancer stem cell
   </value>
   <value>
    colon fibroblast derived cell line
   </value>
   <value>
    colonic cancer cell line
   </value>
   <value>
    colonic epithelial cancer cell line
   </value>
   <value>
    colonic epithelial cell
   </value>
   <value>
    colorectal adenocarcinoma cell line
   </value>
   <value>
    colorectal cancer cell line
   </value>
   <value>
    coronary endothelial cell
   </value>
   <value>
    cumulus cell
   </value>
   <value>
    cutaneous T-cell lymphoma cell line
   </value>
   <value>
    dendritic cell
   </value>
   <value>
    dendritic cell derived from mature monocyte
   </value>
   <value>
    dental pulp stem cell
   </value>
   <value>
    dermal dendritic cell
   </value>
   <value>
    dermal fibroblast
   </value>
   <value>
    dermal microvascular endothelial cell line
   </value>
   <value>
    dermal microvascular lymphatic endothelial cell
   </value>
   <value>
    diffuse histiocytic lymphoma cell line
   </value>
   <value>
    diffuse large B-cell lymphoma cell
   </value>
   <value>
    diffuse large cell lymphoma cell line
   </value>
   <value>
    diffuse mixed lymphoma cell line
   </value>
   <value>
    DS-AMKL cell line
   </value>
   <value>
    EBV+ lymphoblastoid cell line
   </value>
   <value>
    EBV+ natural killer cell line
   </value>
   <value>
    EBV+ T-cell line
   </value>
   <value>
    EBV-immortalized B-cell line
   </value>
   <value>
    EBV-immortalized B-lymphoblastoid cell line
   </value>
   <value>
    EBV-transformed B-cell line
   </value>
   <value>
    EBV-transformed lymphoblastoid cell line
   </value>
   <value>
    EBV-transformed natural killer cell line
   </value>
   <value>
    effector memory T-cell
   </value>
   <value>
    embryoid body derived from cell line H9
   </value>
   <value>
    embryoid body derived from cell line hES-T3
   </value>
   <value>
    embryonal carcinoma cell line
   </value>
   <value>
    embryonic kidney cell line
   </value>
   <value>
    embryonic kidney derived cell line
   </value>
   <value>
    endometrial adenocarcinoma cell line
   </value>
   <value>
    endometrial cancer cell line
   </value>
   <value>
    endometrial cell
   </value>
   <value>
    endothelial cell
   </value>
   <value>
    endothelial cell differentiated from human umbilical cord blood derived-EPCs
   </value>
   <value>
    endothelial precursor cell derived from human umbilical cord blood
   </value>
   <value>
    eosinophilic cell line
   </value>
   <value>
    epidermal keratinocyte cell line
   </value>
   <value>
    epidermal melanocyte
   </value>
   <value>
    epidermoid carcinoma cell line
   </value>
   <value>
    epithelial cell
   </value>
   <value>
    epithelial cell line
   </value>
   <value>
    epithelium
   </value>
   <value>
    erythroblast
   </value>
   <value>
    erythrocyte
   </value>
   <value>
    erythroleukaemia cell line
   </value>
   <value>
    esophageal adenocarcinoma cell line
   </value>
   <value>
    esophageal carcinoma cell line
   </value>
   <value>
    esophageal epithelial cell
   </value>
   <value>
    esophageal squamous carcinoma cell line
   </value>
   <value>
    esophageal squamous cell
   </value>
   <value>
    esophageal squamous epithelium cell line
   </value>
   <value>
    esophagus
   </value>
   <value>
    Ewing family tumor cell line
   </value>
   <value>
    extranodal NK/T-cell lymphoma cell
   </value>
   <value>
    fetal cortex derived cell line
   </value>
   <value>
    fetal fibroblast
   </value>
   <value>
    fetal gamma-delta T-cell
   </value>
   <value>
    fetal lung fibroblast derived cell line
   </value>
   <value>
    fetal osteoblast derived cell line
   </value>
   <value>
    fetal retinal pigment epithelium
   </value>
   <value>
    fibroblast
   </value>
   <value>
    fibroblast cell line
   </value>
   <value>
    fibroblast cell lines pool
   </value>
   <value>
    fibroblast derived cell line
   </value>
   <value>
    fibroblast differentiated from H1
   </value>
   <value>
    fibroblast-derived iPSC
   </value>
   <value>
    fibroblast-like synovial cell
   </value>
   <value>
    fibroblastic cell line
   </value>
   <value>
    fibrosarcoma derived cell line
   </value>
   <value>
    forelimb leiomyosarcoma cell line
   </value>
   <value>
    foreskin fibroblast derived cell line
   </value>
   <value>
    foreskin-derived iPSC
   </value>
   <value>
    gamma-delta T-cell
   </value>
   <value>
    gastric adenocarcinoma cell line
   </value>
   <value>
    gastric adenocarcinoma cell lines
   </value>
   <value>
    gastric cancer cell line
   </value>
   <value>
    geminal center centroblast
   </value>
   <value>
    germinal center B-cell
   </value>
   <value>
    giant cell glioblatoma derived cell line
   </value>
   <value>
    gingival fibroblast
   </value>
   <value>
    gingival keratinocyte cell line
   </value>
   <value>
    glioblastoma cell line
   </value>
   <value>
    glioblastoma derived cell line
   </value>
   <value>
    glioblastoma derived neurosphere culture cell line
   </value>
   <value>
    glioblastoma stem-like cell line
   </value>
   <value>
    glioblastoma-derived stem cell
   </value>
   <value>
    glioma cell line
   </value>
   <value>
    glomerular podocyte
   </value>
   <value>
    granulopoietic cell
   </value>
   <value>
    granulosa cell
   </value>
   <value>
    head and neck cancer cell line
   </value>
   <value>
    head and neck squamous cell carcinoma cell line
   </value>
   <value>
    hematopoietic cell
   </value>
   <value>
    hematopoietic stem cell
   </value>
   <value>
    hematopoietic stem cell/progenitor cell
   </value>
   <value>
    hepatic stellate
   </value>
   <value>
    hepatocellular carcinoma cell line
   </value>
   <value>
    hepatocyte
   </value>
   <value>
    hepatoma cell line
   </value>
   <value>
    hESC
   </value>
   <value>
    hESC-derived endothelial cell
   </value>
   <value>
    HLA-DR negative T-cell
   </value>
   <value>
    HLA-DR+ T-cell
   </value>
   <value>
    Hodgkins lymphoma B-cell line
   </value>
   <value>
    Hodgkins lymphoma cell line
   </value>
   <value>
    hTERT-immortalized breast primary epithelial cell line
   </value>
   <value>
    hTERT-immortalized human mammary epithelial cell line
   </value>
   <value>
    human embryonic carcinoma cell
   </value>
   <value>
    human embryonic kidney cell
   </value>
   <value>
    human embryonic stem cell line
   </value>
   <value>
    human embryonic stem cell line (post hepatic differentiation)
   </value>
   <value>
    human umbilical cord lining epithelial cell
   </value>
   <value>
    human umbilical vein endothelial cell line
   </value>
   <value>
    human umbilical vein smooth muscle cell
   </value>
   <value>
    human vascular adventitial fibroblast
   </value>
   <value>
    huvec
   </value>
   <value>
    hypopharyngeal tumor cell line
   </value>
   <value>
    ileocecal carcinoma cell line
   </value>
   <value>
    ileum mucosa
   </value>
   <value>
    immature dendritic cell
   </value>
   <value>
    immature monocyte-derived dendritic cell
   </value>
   <value>
    immortalised T lymphocyte cell line
   </value>
   <value>
    immortalized B-cell
   </value>
   <value>
    immortalized bronchial epithelial cell
   </value>
   <value>
    immortalized bronchial epithelial cell line
   </value>
   <value>
    immortalized ovarian surface epithelial cell line
   </value>
   <value>
    immunoblastic large cell lymphoma cell line
   </value>
   <value>
    in vitro generated osteoclasts
   </value>
   <value>
    induced pluripotent stem cell line
   </value>
   <value>
    intermediate cell derived from dendritic cells
   </value>
   <value>
    intermediate cell derived from monocytes
   </value>
   <value>
    intestinal adenocarcinoma cell line
   </value>
   <value>
    intestinal epithelial cell line
   </value>
   <value>
    intestinal mucosa
   </value>
   <value>
    intestine epithelial cell
   </value>
   <value>
    iPSC
   </value>
   <value>
    iPSC cell line from cord blood mononuclear cell
   </value>
   <value>
    iPSC derived from cell line CCD-1079Sk
   </value>
   <value>
    iPSC derived from fibroblast
   </value>
   <value>
    iPSC derived from fibroblast cell line BJ
   </value>
   <value>
    iPSC derived from fibroblast cell line dH1CF
   </value>
   <value>
    iPSC derived from fibroblast cell line dH1F
   </value>
   <value>
    iPSC derived from fibroblast cell line IMR90
   </value>
   <value>
    iPSC derived from fibroblast cell line MRC-5
   </value>
   <value>
    iPSC derived from fibroblast cell line MRC-6
   </value>
   <value>
    iPSC derived from fibroblast cell line MRC-7
   </value>
   <value>
    iPSC derived from fibroblast cell line MRC-8
   </value>
   <value>
    iPSC derived from fibroblast cell line MRC-9
   </value>
   <value>
    iPSC derived from human adipose stem cells
   </value>
   <value>
    iPSC from bone marrow mononuclear cell
   </value>
   <value>
    iPSC from CML bone marrow mononuclear cell
   </value>
   <value>
    islet beta cell
   </value>
   <value>
    keratinocyte
   </value>
   <value>
    Langerhans cell
   </value>
   <value>
    large vessel endothelial cell derived from embryoid body
   </value>
   <value>
    leukaemia cell line
   </value>
   <value>
    leukemic lymphoblast
   </value>
   <value>
    leukocyte
   </value>
   <value>
    lipoma derived mesenchymal stem cell
   </value>
   <value>
    liposarcoma cell line
   </value>
   <value>
    liver mesenchymal tumor cell line
   </value>
   <value>
    luminal epithelial cell
   </value>
   <value>
    lung adenocarcinoma cell line
   </value>
   <value>
    lung cancer cell line
   </value>
   <value>
    lung fibroblast derived cell line
   </value>
   <value>
    lung squamous cell carcinoma cell line
   </value>
   <value>
    lung tissue-derived fibroblast
   </value>
   <value>
    lymphatic endothelial cell
   </value>
   <value>
    lymphoblast
   </value>
   <value>
    lymphoblast cell line
   </value>
   <value>
    lymphoblastoid cell line
   </value>
   <value>
    lymphocyte
   </value>
   <value>
    lymphocytic leukaemia cell line
   </value>
   <value>
    lymphoid cell
   </value>
   <value>
    lymphoid RNA reference
   </value>
   <value>
    lymphoma
   </value>
   <value>
    lymphoma cell
   </value>
   <value>
    lymphoma cell line
   </value>
   <value>
    macrophage
   </value>
   <value>
    malignant mesothelioma cell line
   </value>
   <value>
    malignant peripheral nerve sheath cell line
   </value>
   <value>
    malignant peripheral nerve sheath tumor cell line
   </value>
   <value>
    mammary epithelial cell
   </value>
   <value>
    mammary epithelial cell derived cell line
   </value>
   <value>
    mammary epithelial cell line
   </value>
   <value>
    mammary fibroblast derived cell line
   </value>
   <value>
    mammospheres derived from breast tumor
   </value>
   <value>
    mantle cell lymphoma cell line
   </value>
   <value>
    marrow stromal cell
   </value>
   <value>
    medulloblastoma cell line
   </value>
   <value>
    megakaryoblast
   </value>
   <value>
    megakaryoblastic leukaemia cell line
   </value>
   <value>
    megakaryocyte
   </value>
   <value>
    melanocyte
   </value>
   <value>
    melanoma cell line
   </value>
   <value>
    melanoma derived cell line
   </value>
   <value>
    memory B-cell
   </value>
   <value>
    mesenchymal progenitor cell line
   </value>
   <value>
    mesenchymal stem cell
   </value>
   <value>
    mesenchymal stem cell clone
   </value>
   <value>
    mesenchymal stem cell from iliac crest
   </value>
   <value>
    mesenchymal stem cell-derived adipocyte
   </value>
   <value>
    mesenchymal stem cell-derived stromal
   </value>
   <value>
    mesenchymal stem cell-derived stromal and adipocyte
   </value>
   <value>
    mesenchymal stromal cell
   </value>
   <value>
    mesendoderm/endoderm progenitor cell
   </value>
   <value>
    mesodermal precursor cell derived from hES cells line SA01
   </value>
   <value>
    mesodermal precursor cell derived from hES cells line VUB01
   </value>
   <value>
    mesodermal precursor cell derived from hES cells line VUB03_DM1
   </value>
   <value>
    mesothelioma cell line
   </value>
   <value>
    mesothelium cell line
   </value>
   <value>
    metamyelocyte/granulocyte
   </value>
   <value>
    metastatic breast cancer in bone
   </value>
   <value>
    metastatic breast cancer in brain
   </value>
   <value>
    metastatic breast cancer in lung
   </value>
   <value>
    metastatic clear-cell renal cell carcinoma in lung
   </value>
   <value>
    metastatic colorectal cancer in liver
   </value>
   <value>
    metastatic lung cancer in brain
   </value>
   <value>
    metastatic melanoma cell line
   </value>
   <value>
    metastatic midgut carcinoid in liver
   </value>
   <value>
    metastatic pancreatic cancer cell line
   </value>
   <value>
    metastatic prostate cancer cell line
   </value>
   <value>
    microvascular endothelial cell
   </value>
   <value>
    midgut carcinoid
   </value>
   <value>
    mixed somatic cell types
   </value>
   <value>
    monocyte
   </value>
   <value>
    monocyte-derived dendritic cell
   </value>
   <value>
    monocyte-derived macrophage
   </value>
   <value>
    monocyte/macrophage
   </value>
   <value>
    mononuclear cell
   </value>
   <value>
    multiple myeloma cell line
   </value>
   <value>
    multipotent stromal cell
   </value>
   <value>
    myelocyte/metamyelocyte
   </value>
   <value>
    myelodysplasia cell line
   </value>
   <value>
    myeloid cell
   </value>
   <value>
    myeloid monocytic cell
   </value>
   <value>
    myeloma cell line
   </value>
   <value>
    myoepithelial
   </value>
   <value>
    myoepithelial cells differentiated from hTERT-immortalized K5+K19- mammary epithelial cell
   </value>
   <value>
    myometrial cell
   </value>
   <value>
    naive B cell
   </value>
   <value>
    naive B-cell
   </value>
   <value>
    naive CD4+ T-cell
   </value>
   <value>
    naive T-cell
   </value>
   <value>
    nasopharingeal carcinoma cell line
   </value>
   <value>
    nasopharyngeal carcinoma cell line
   </value>
   <value>
    natural killer cell line
   </value>
   <value>
    natural killer leukaemia cell line
   </value>
   <value>
    neonatal foreskin-derived
   </value>
   <value>
    neural crest cell line
   </value>
   <value>
    neural epithelial cell from embryonic stem cell line H9
   </value>
   <value>
    neural progenitor cell from developing cortex
   </value>
   <value>
    neural progenitor cell from ventral midbrain
   </value>
   <value>
    neural progenitor cell line
   </value>
   <value>
    neural progenitor cells
   </value>
   <value>
    neuroblastic tumor cell
   </value>
   <value>
    neuroblastoma cell line
   </value>
   <value>
    neuroblastoma tumor cell
   </value>
   <value>
    neutrophil
   </value>
   <value>
    NK cell
   </value>
   <value>
    NK/T-cell lymphoma cell line
   </value>
   <value>
    nodal diffuse large B-cell lymphoma cell
   </value>
   <value>
    non-Hodgkin's lymphoma cell line
   </value>
   <value>
    non-Hodgkins lymphoma cell line
   </value>
   <value>
    non-small cell carcinoma cell line
   </value>
   <value>
    non-small cell lung adenocarcinoma cell line
   </value>
   <value>
    non-small cell lung cancer cell line
   </value>
   <value>
    non-small cell lung carcinoma cell line
   </value>
   <value>
    Norwalk virus replicon-bearing hepatoma cell line
   </value>
   <value>
    NSCLC cell line
   </value>
   <value>
    odontoblast
   </value>
   <value>
    oligoastrocytoma derived cell line
   </value>
   <value>
    oocyte
   </value>
   <value>
    oral keratinocyte
   </value>
   <value>
    osteoblast
   </value>
   <value>
    osteoclast derived from dendritic cells
   </value>
   <value>
    osteoclast derived from monocytes
   </value>
   <value>
    osteosarcoma cell line
   </value>
   <value>
    ovarian adenocarcinoma cell line
   </value>
   <value>
    ovarian cancer cell line
   </value>
   <value>
    ovarian carcinoma cell line
   </value>
   <value>
    ovarian serous carcinoma cell line
   </value>
   <value>
    pancreatic adenocarcinoma cell line
   </value>
   <value>
    pancreatic cancer cell line
   </value>
   <value>
    pancreatic carcinoma cell line
   </value>
   <value>
    pancreatic islet-like cell clusters derived from cell line T3ES
   </value>
   <value>
    periodontal ligament cell
   </value>
   <value>
    pharyngeal carcinoma cell line
   </value>
   <value>
    pharyngeal tumor cell line
   </value>
   <value>
    pituitary adenoma cell line
   </value>
   <value>
    placenta choriocarcinoma cell line
   </value>
   <value>
    plasma B-cell
   </value>
   <value>
    plasma cell
   </value>
   <value>
    plasmablast
   </value>
   <value>
    plasmacytoid dendritic cell
   </value>
   <value>
    polymorphonuclear leukocyte
   </value>
   <value>
    Pre-B leukaemia cell line
   </value>
   <value>
    precursor B-cell
   </value>
   <value>
    prenatal chorion villus cell
   </value>
   <value>
    primary fibroblast culture
   </value>
   <value>
    primary hematopoietic CD34+ cells
   </value>
   <value>
    primary T lymphocyte
   </value>
   <value>
    primitive neural epithelial cell from embryonic stem cell line H9
   </value>
   <value>
    promyelocyte
   </value>
   <value>
    prostate adenocarcinoma cell line
   </value>
   <value>
    prostate cancer cell line
   </value>
   <value>
    prostate cancer stem cell line
   </value>
   <value>
    prostate carcinoma cell line
   </value>
   <value>
    prostate epithelial cell
   </value>
   <value>
    prostate epithelial cell line
   </value>
   <value>
    prostate stromal cell
   </value>
   <value>
    prostatic cancer cell line
   </value>
   <value>
    proximal tubular epithelial cell
   </value>
   <value>
    pulmonary microvascular endothelial cell
   </value>
   <value>
    regulatory T-cell
   </value>
   <value>
    renal cancer cell line
   </value>
   <value>
    renal proximal tubular cell line
   </value>
   <value>
    renal proximal tubular epithelial cell
   </value>
   <value>
    retinal pigment epithelial cell
   </value>
   <value>
    retinal pigment epithelial cell line
   </value>
   <value>
    retinal pigment epithelium
   </value>
   <value>
    rhabdomyosarcoma cell
   </value>
   <value>
    rhabdomyosarcoma cell line
   </value>
   <value>
    scalp fibroblast
   </value>
   <value>
    skin derived fibroblast cell line
   </value>
   <value>
    skin fibroblast
   </value>
   <value>
    skin fibroblast cell line
   </value>
   <value>
    skin fibroblast derived cell line
   </value>
   <value>
    skin melanoma cell line
   </value>
   <value>
    small cell lung cancer cell line
   </value>
   <value>
    small cell lung carcinoma cell line
   </value>
   <value>
    smooth muscle cell
   </value>
   <value>
    squamous cell carcinoma cell line
   </value>
   <value>
    stem cell line
   </value>
   <value>
    stromal cell
   </value>
   <value>
    T-ALL cell
   </value>
   <value>
    T-ALL cell line
   </value>
   <value>
    T-cell
   </value>
   <value>
    T-cell and retinal pigment epithelial cell (co-cultured)
   </value>
   <value>
    T-cell leukaemia cell line
   </value>
   <value>
    T-cell line
   </value>
   <value>
    T-cell lymphoma cell line
   </value>
   <value>
    tarsal conjuntiva
   </value>
   <value>
    TCRVgamma9+ gamma delta T cells
   </value>
   <value>
    testicular diffuse large B-cell lymphoma tissue
   </value>
   <value>
    testicular germ-cell tumor cell line
   </value>
   <value>
    tracheal epithelial cell line
   </value>
   <value>
    transformed lymphocyte
   </value>
   <value>
    trophoblast cell line
   </value>
   <value>
    tumorigenic,hTERT-immortalized breast primary epithelial cell;
   </value>
   <value>
    tumorigenic,hTERT-immortalized human mammary epithelial cell;
   </value>
   <value>
    umbilical cord blood derived endothelial colony
   </value>
   <value>
    umbilical cord blood derived mesenchymal stem cell
   </value>
   <value>
    undifferentiated induced pluripotent stem cell
   </value>
   <value>
    universal human reference RNA
   </value>
   <value>
    unrestricted somatic stem cell
   </value>
   <value>
    urothelial
   </value>
   <value>
    urothelial cell line
   </value>
   <value>
    vascular endothelial cell
   </value>
   <value>
    vascular smooth muscle cell
   </value>
   <value>
    virus-transformed lung/bronchus epithelial cell line
   </value>
   <value>
    white blood cell
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    disease
   </name>
   <value>
    absense epilepsy
   </value>
   <value>
    active Crohn's disease
   </value>
   <value>
    active ulcerative colitis
   </value>
   <value>
    acute graft-versus-host disease
   </value>
   <value>
    acute lymphoblastic leukaemia
   </value>
   <value>
    acute malaria
   </value>
   <value>
    acute megakaryocytic leukaemia, Down syndrome
   </value>
   <value>
    acute monocytic leukaemia
   </value>
   <value>
    acute myeloid leukaemia
   </value>
   <value>
    acute promyelocytic leukaemia
   </value>
   <value>
    acyanotic Tetralogy of Fallot
   </value>
   <value>
    adenocarcinoma
   </value>
   <value>
    adenocarcinoma with spindle cell metaplasia
   </value>
   <value>
    adenoma
   </value>
   <value>
    adenoma with high-grade dysplasia
   </value>
   <value>
    adenomyosis
   </value>
   <value>
    adenosquamous carcinoma
   </value>
   <value>
    adrenocortical carcinoma
   </value>
   <value>
    adrenocortical tumor
   </value>
   <value>
    adult T-cell leukaemia
   </value>
   <value>
    AIDS-related non-Hodgkins lymphoma
   </value>
   <value>
    AIDS/activated B-cell-like diffuse large B-cell lymphoma
   </value>
   <value>
    AIDS/Burkitt lymphoma
   </value>
   <value>
    AIDS/DLBCL
   </value>
   <value>
    AIDS/GCB-DLBCL
   </value>
   <value>
    Alagille syndrome
   </value>
   <value>
    aldosterone-producing adenoma
   </value>
   <value>
    ALL
   </value>
   <value>
    ALL with hyperdiploid karyotype
   </value>
   <value>
    ALL with MLL rearrangement
   </value>
   <value>
    ALL with t(1, 19)
   </value>
   <value>
    ALL with t(12, 21)
   </value>
   <value>
    ALL without MLL rearrangement
   </value>
   <value>
    ALL/hyperdiploid karyotype
   </value>
   <value>
    allograft rejection
   </value>
   <value>
    alveolar cell carcinoma
   </value>
   <value>
    alveolar soft-part sarcoma
   </value>
   <value>
    Alzheimer's disease
   </value>
   <value>
    AMD
   </value>
   <value>
    AML with MLL rearrangement
   </value>
   <value>
    AML with normal karyotype and other abnormalities
   </value>
   <value>
    AML with t 11q23, MLL
   </value>
   <value>
    AML without MLL rearrangement
   </value>
   <value>
    AML(FAB-M0)
   </value>
   <value>
    AML-TLS
   </value>
   <value>
    AML/aberrant karyotype
   </value>
   <value>
    AML/chemotherapy-induced oral mucositis
   </value>
   <value>
    AML/MLL
   </value>
   <value>
    AML/other abnormalities
   </value>
   <value>
    anaplastic astrocytoma
   </value>
   <value>
    anaplastic carcinoma
   </value>
   <value>
    anaplastic large cell lymphoma
   </value>
   <value>
    angina/coronary atherosclerosis
   </value>
   <value>
    angioimmunoblastic T-cell lymphoma
   </value>
   <value>
    ankylosing spondylitis
   </value>
   <value>
    Apert syndrome
   </value>
   <value>
    apilocytic astrocytoma, juvenile pilocytic astrocytoma, or cystic cerebellar astrocytoma
   </value>
   <value>
    apocrine adenocarcinoma
   </value>
   <value>
    asthma
   </value>
   <value>
    asthma with exercise induced bronchoconstriction
   </value>
   <value>
    astrocytoma
   </value>
   <value>
    asymptomatic HIV-1 infection
   </value>
   <value>
    ATL
   </value>
   <value>
    atopic dermatitis
   </value>
   <value>
    atopy
   </value>
   <value>
    atrial fibrillation
   </value>
   <value>
    atypical carcinoid
   </value>
   <value>
    atypical ductal hyperplasia
   </value>
   <value>
    autism spectrum disorder
   </value>
   <value>
    autoimmune lymphoproliferative syndrome
   </value>
   <value>
    autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
   </value>
   <value>
    autosomal dominant monocytopenia
   </value>
   <value>
    B-ALL
   </value>
   <value>
    B-cell chronic lymphocytic leukaemia
   </value>
   <value>
    B-cell lymphoma
   </value>
   <value>
    bacteremia/suppurative arthritis/methicillin-resistant Staphylococcus aureus infection
   </value>
   <value>
    Barret's syndrome
   </value>
   <value>
    basal cell carcinoma
   </value>
   <value>
    basal-like breast cancer
   </value>
   <value>
    benign prostate tumor
   </value>
   <value>
    benign prostatic hyperplasia
   </value>
   <value>
    bilateral cryptorchid
   </value>
   <value>
    biliary atresia
   </value>
   <value>
    bipolar disorder
   </value>
   <value>
    birch pollen allergy
   </value>
   <value>
    bladder cancer
   </value>
   <value>
    bone sarcoma
   </value>
   <value>
    borderline tuberculoid leprosy
   </value>
   <value>
    BRCA1-deficient breast cancer
   </value>
   <value>
    breast adenocarcinoma
   </value>
   <value>
    breast cancer
   </value>
   <value>
    breast cancer, node metastasis
   </value>
   <value>
    breast carcinoma
   </value>
   <value>
    breast carcinoma/cystic change
   </value>
   <value>
    breast ductal adenocarcinoma
   </value>
   <value>
    breast ductal carcinoma
   </value>
   <value>
    breast fibrocystic disease
   </value>
   <value>
    breast medullary carcinoma
   </value>
   <value>
    breast metaplastic carcinoma
   </value>
   <value>
    breast squamous cell carcinoma
   </value>
   <value>
    Brief Psychotic Disorder
   </value>
   <value>
    bronchioalveolar carcinoma
   </value>
   <value>
    bronchopulmonary dysplasia
   </value>
   <value>
    Burkitt lymphoma
   </value>
   <value>
    burn
   </value>
   <value>
    c-ALL, Pre-B-ALL with t 9,22
   </value>
   <value>
    c-ALL, Pre-B-ALL without t 9,22
   </value>
   <value>
    cancer
   </value>
   <value>
    carcinoid
   </value>
   <value>
    carcinoma
   </value>
   <value>
    CCRCC
   </value>
   <value>
    cecum carcinoma
   </value>
   <value>
    celiac
   </value>
   <value>
    cervical adenocarcinoma
   </value>
   <value>
    cervical cancer
   </value>
   <value>
    cervical carcinoma
   </value>
   <value>
    childhood B-cell precursor ALL
   </value>
   <value>
    chondrosarcoma
   </value>
   <value>
    choroideremia
   </value>
   <value>
    chromophobe renal cell carcinoma
   </value>
   <value>
    chronic allograft nephropathy grade I
   </value>
   <value>
    chronic fatigue
   </value>
   <value>
    chronic graft versus host disease
   </value>
   <value>
    chronic Hodgkin's lymphoma
   </value>
   <value>
    chronic lymphocytic leukaemia
   </value>
   <value>
    chronic malaria
   </value>
   <value>
    chronic myelogenous leukaemia
   </value>
   <value>
    chronic myeloid leukaemia
   </value>
   <value>
    chronic rhinosinusitis
   </value>
   <value>
    clear-cell renal cell carcinoma
   </value>
   <value>
    clinically isolated syndrome
   </value>
   <value>
    CNS affected
   </value>
   <value>
    cocoon affected
   </value>
   <value>
    colon adenocarcinoma
   </value>
   <value>
    colon adenoma
   </value>
   <value>
    colon cancer
   </value>
   <value>
    colon carcinoma
   </value>
   <value>
    colon tumor
   </value>
   <value>
    colorectal adenocarcinoma
   </value>
   <value>
    colorectal adenoma
   </value>
   <value>
    colorectal cancer
   </value>
   <value>
    colorectal cancer - B
   </value>
   <value>
    colorectal cancer - CD
   </value>
   <value>
    colorectal carcinoma
   </value>
   <value>
    common ALL
   </value>
   <value>
    contralateral testicular aplasia
   </value>
   <value>
    conventional mantle cell lymphoma
   </value>
   <value>
    COPD
   </value>
   <value>
    COPD/emphysema
   </value>
   <value>
    COPD/giant bullae
   </value>
   <value>
    COPD/giant cell tumor
   </value>
   <value>
    COPD/non-small cell adenocarcinoma
   </value>
   <value>
    COPD/non-small cell squamous cell carcinoma
   </value>
   <value>
    Cornelia de Lange Syndrome
   </value>
   <value>
    corticosteroid resistant asthma
   </value>
   <value>
    corticosteroid sensitive asthma
   </value>
   <value>
    Crohn's disease
   </value>
   <value>
    Crohn's disease, non-inflamed site
   </value>
   <value>
    cutaneous T-cell lymphoma
   </value>
   <value>
    cystic fibrosis
   </value>
   <value>
    cystic fibrosis/chronic rhinosinusitis
   </value>
   <value>
    cytomegalovirus
   </value>
   <value>
    dedifferentiated liposarcoma
   </value>
   <value>
    desmoplastic cerebellar medulloblastoma
   </value>
   <value>
    Diamond-Blackfan Anemia
   </value>
   <value>
    diarrhea-irritable bowel syndrome
   </value>
   <value>
    differentiated liposarcoma
   </value>
   <value>
    diffuse glioma
   </value>
   <value>
    diffuse histiocytic lymphoma
   </value>
   <value>
    diffuse large B-cell lymphoma
   </value>
   <value>
    diffuse large cell lymphoma
   </value>
   <value>
    diffuse mixed lymphoma
   </value>
   <value>
    diffusely infiltrating astrocytic glioma
   </value>
   <value>
    dilated cardiomyopathy
   </value>
   <value>
    disease
   </value>
   <value>
    diseased (bleeding on probing)
   </value>
   <value>
    disseminated/methicillin-resistant Staphylococcus aureus infection
   </value>
   <value>
    disseminated/pneumonia/methicillin-sensitive Staphylococcus aureus infection
   </value>
   <value>
    dominant retinitis pigmentosa
   </value>
   <value>
    ductal carcinoma
   </value>
   <value>
    ductal carcinoma/lobular carcinoma
   </value>
   <value>
    ejaculatory azoospermia/cryptorchidism
   </value>
   <value>
    ejaculatory azoospermia/idiopathic infertility
   </value>
   <value>
    embryonic carcinoma
   </value>
   <value>
    encephalitis/influenza A infection
   </value>
   <value>
    endemic Burkitt lymphoma
   </value>
   <value>
    endometrial adenocarcinoma
   </value>
   <value>
    endometrial cancer
   </value>
   <value>
    endometrioid ovarian cancer
   </value>
   <value>
    endometriosis
   </value>
   <value>
    eosinophilic esophagitis
   </value>
   <value>
    eosinophilic leukaemia
   </value>
   <value>
    ependymoma
   </value>
   <value>
    epidermoid carcinoma
   </value>
   <value>
    epilepsy
   </value>
   <value>
    epitheloidal angiolipoma
   </value>
   <value>
    erosive gastritis
   </value>
   <value>
    erythroleukaemia
   </value>
   <value>
    esophageal adenocarcinoma
   </value>
   <value>
    esophageal squamous carcinoma
   </value>
   <value>
    esophageal squamous cell carcinoma
   </value>
   <value>
    Ewing's sarcoma
   </value>
   <value>
    extranodal NK/T-Cell lymphoma
   </value>
   <value>
    extranodal NK/T-cell lymphoma
   </value>
   <value>
    extranodal NK/T-Cell lymphoma derived cell line
   </value>
   <value>
    extraskeletal Ewing's sarcoma
   </value>
   <value>
    facial tumor
   </value>
   <value>
    facioscapulohumeral muscular dystrophy
   </value>
   <value>
    familial hypercholesterolemia
   </value>
   <value>
    familial hyperplastic polyposis
   </value>
   <value>
    fetal adenoma
   </value>
   <value>
    fever/influenza A infection
   </value>
   <value>
    fever/influenza B infection
   </value>
   <value>
    fever/upper respiratory infection/influenza A infection
   </value>
   <value>
    fever/upper respiratory infection/influenza B infection
   </value>
   <value>
    fibrocystic disease
   </value>
   <value>
    fibrosarcoma
   </value>
   <value>
    folicular lymphoma
   </value>
   <value>
    follicular adenoma
   </value>
   <value>
    follicular carcinoma
   </value>
   <value>
    follicular hyperplasia
   </value>
   <value>
    Freidriech's ataxia
   </value>
   <value>
    ganglioneuroblastoma
   </value>
   <value>
    ganglioneuroma
   </value>
   <value>
    gastric adenocarcinoma
   </value>
   <value>
    gastric cancer
   </value>
   <value>
    gastric carcinoma
   </value>
   <value>
    gastric papillary adenocarcinoma
   </value>
   <value>
    gastrointestinal stromal tumor
   </value>
   <value>
    germinoma
   </value>
   <value>
    germinoma/teratoma
   </value>
   <value>
    germioma/yolk sac tumor
   </value>
   <value>
    giant cell glioblastoma
   </value>
   <value>
    glioblastoma
   </value>
   <value>
    glioblastoma multiforme
   </value>
   <value>
    glioblastoma with EGFR amplification
   </value>
   <value>
    glioma
   </value>
   <value>
    gonadotrope tumor
   </value>
   <value>
    graft versus host disease
   </value>
   <value>
    graft-versus host disease
   </value>
   <value>
    graft-versus-host disease
   </value>
   <value>
    Graves' disease
   </value>
   <value>
    gulf war illness
   </value>
   <value>
    Haemophilus ducreyi infection
   </value>
   <value>
    hairy cell leukaemia
   </value>
   <value>
    HBV/hepatocellular carcinoma
   </value>
   <value>
    HCV
   </value>
   <value>
    HCV, hepatoma
   </value>
   <value>
    HCV/hepatocellular carcinoma
   </value>
   <value>
    head and neck cancer
   </value>
   <value>
    head and neck squamous cell carcinoma
   </value>
   <value>
    HeLa cell contamination
   </value>
   <value>
    hematoma
   </value>
   <value>
    hepatitis C virus-induced hepatocellular carcinoma
   </value>
   <value>
    hepatocellular carcinoma
   </value>
   <value>
    hepatoma
   </value>
   <value>
    her2+ breast cancer
   </value>
   <value>
    hereditary gingival fibromatosis
   </value>
   <value>
    hereditary spherocytosis
   </value>
   <value>
    high risk B-precurser ALL
   </value>
   <value>
    high-grade prostatic intraepithelial neoplasia
   </value>
   <value>
    highly invasive glioma
   </value>
   <value>
    hip arthroplasty
   </value>
   <value>
    HIV
   </value>
   <value>
    HIV-1
   </value>
   <value>
    Hodgkins lymphoma
   </value>
   <value>
    house dust mite allergy
   </value>
   <value>
    Huntington's disease
   </value>
   <value>
    Hutchinson-Gilford Progeria Syndrome
   </value>
   <value>
    hydrolethalus syndrome
   </value>
   <value>
    hyperplastic polyp
   </value>
   <value>
    hyperplastic polyposis syndrome
   </value>
   <value>
    hypertriglyceridemia
   </value>
   <value>
    hypopharynx squamous cell carcinoma
   </value>
   <value>
    ICA (appearance of autoantibodies against islet cells)
   </value>
   <value>
    idiopathic chronic fatigue
   </value>
   <value>
    idiopathic pulmonary arterial hypertension
   </value>
   <value>
    idipathic pulmonary fibrosis
   </value>
   <value>
    IFTA
   </value>
   <value>
    IFTA/inflammation
   </value>
   <value>
    ileocecal carcinoma
   </value>
   <value>
    immunoblastic large cell lymphoma
   </value>
   <value>
    immunodeficiency associated Burkitt lymphoma
   </value>
   <value>
    in-transit extremity melanoma
   </value>
   <value>
    indolent mantle cell lymphoma
   </value>
   <value>
    infiltrating ductal carcinoma
   </value>
   <value>
    infiltrating lobular carcinoma
   </value>
   <value>
    inflamed tonsil
   </value>
   <value>
    inflammation
   </value>
   <value>
    inflammatory bowel disease
   </value>
   <value>
    inflammatory lung disease
   </value>
   <value>
    interstitial cystitis
   </value>
   <value>
    intestinal adenocarcinoma
   </value>
   <value>
    intracranial arterial aneurysm (unruptured)
   </value>
   <value>
    invasive ductal carcinoma
   </value>
   <value>
    invasive ductal/lobular carcinoma
   </value>
   <value>
    irritable bowel syndrome
   </value>
   <value>
    ischemic cardiomyopathy
   </value>
   <value>
    Job's syndrome
   </value>
   <value>
    juvenile idiopathic arthritis
   </value>
   <value>
    juvenile myelomonocytic leukaemia
   </value>
   <value>
    Kaposi's sarcoma
   </value>
   <value>
    Kawasaki disease
   </value>
   <value>
    kidney carcinoma
   </value>
   <value>
    kidney transplant recipient
   </value>
   <value>
    large cell lung cancer
   </value>
   <value>
    large cell lymphoma
   </value>
   <value>
    large cell neuroendocrine carcinoma
   </value>
   <value>
    larynx squamous cell carcinoma
   </value>
   <value>
    leiomyoma
   </value>
   <value>
    leiomyosarcoma
   </value>
   <value>
    lepromatous leprosy
   </value>
   <value>
    leukaemia
   </value>
   <value>
    leukemic-state lymphoma
   </value>
   <value>
    lipoma
   </value>
   <value>
    liposarcoma
   </value>
   <value>
    liver adenoma
   </value>
   <value>
    liver mesenchymal tumor
   </value>
   <value>
    lobular carcinoma
   </value>
   <value>
    lung adenocarcinoma
   </value>
   <value>
    lung anaplastic carcinoma
   </value>
   <value>
    lung cancer
   </value>
   <value>
    lung cancer (pathology not available)
   </value>
   <value>
    lung carcinoma
   </value>
   <value>
    lung fibrosarcoma
   </value>
   <value>
    lung squamous cell carcinoma
   </value>
   <value>
    lymph node metastasis
   </value>
   <value>
    lymphocytic leukaemia
   </value>
   <value>
    lymphoid neoplasm
   </value>
   <value>
    lymphoma
   </value>
   <value>
    malignant Burkitt's lymphoma
   </value>
   <value>
    malignant melanoma
   </value>
   <value>
    malignant mesothelioma
   </value>
   <value>
    malignant non-Hodgkin's lymphoma
   </value>
   <value>
    malignant peripheral nerve sheath tumor
   </value>
   <value>
    malignant pheochromocytoma
   </value>
   <value>
    malignant pluripotent embryonal carcinoma
   </value>
   <value>
    malignant testicular teratoma
   </value>
   <value>
    MALT lymphoma
   </value>
   <value>
    mantle cell lymphoma
   </value>
   <value>
    MCI
   </value>
   <value>
    medulloblastoma
   </value>
   <value>
    melanoma
   </value>
   <value>
    meningioma
   </value>
   <value>
    meningococcal sepsis
   </value>
   <value>
    mental retardation or developmental delay
   </value>
   <value>
    mesothelioma
   </value>
   <value>
    metastatic CCRCC
   </value>
   <value>
    metastatic colorectal cancer in liver
   </value>
   <value>
    metastatic gastrointestinal stromal tumor in liver
   </value>
   <value>
    metastatic kidney carcinoma in liver
   </value>
   <value>
    metastatic mammary carcinoma in liver
   </value>
   <value>
    metastatic melanoma
   </value>
   <value>
    metastatic prostate cancer
   </value>
   <value>
    metastatic stomach cancer in liver
   </value>
   <value>
    midgut carcinoid
   </value>
   <value>
    mild chronic allograft nephropathy
   </value>
   <value>
    mixture
   </value>
   <value>
    MLL
   </value>
   <value>
    MLL rearrangement
   </value>
   <value>
    moderate chronic allograft nephropathy
   </value>
   <value>
    moderately differentiated head and neck squamous cell carcinoma
   </value>
   <value>
    monoclonal gammopathy of undetermined significance
   </value>
   <value>
    monoclonal gammopathy of unknown significance
   </value>
   <value>
    morbidly obese
   </value>
   <value>
    mucinous adenocarcinoma
   </value>
   <value>
    mucoepidermoid lung cancer
   </value>
   <value>
    mucoid ductal carcinoma
   </value>
   <value>
    Muenke syndrome
   </value>
   <value>
    multiple myeloma
   </value>
   <value>
    multiple sclerosis
   </value>
   <value>
    multiple sclerosis or clinically isolated syndrome
   </value>
   <value>
    muscular dystrophy
   </value>
   <value>
    mycosis fungoide (cutaneus T-cell lymphoma)
   </value>
   <value>
    mycosis fungoides
   </value>
   <value>
    myelodisplastic syndrome
   </value>
   <value>
    myelodysplasia
   </value>
   <value>
    myelodysplastic syndrome
   </value>
   <value>
    myelodysplastic syndrome/refractory anemia
   </value>
   <value>
    myelodysplastic syndrome/refractory anemia with excess blasts
   </value>
   <value>
    myelodysplastic syndrome/refractory anemia with ringed sideroblasts
   </value>
   <value>
    myeloma
   </value>
   <value>
    myxoid liposarcoma
   </value>
   <value>
    myxoid round cell liposarcoma
   </value>
   <value>
    nasopharingeal carcinoma
   </value>
   <value>
    nasopharyngeal carcinoma
   </value>
   <value>
    nasopharyngeal squamous cell carcinoma
   </value>
   <value>
    neuroaxonal injury in cerebral palsy patient
   </value>
   <value>
    neuroblastoma
   </value>
   <value>
    neuroblastoma (Ewing sarcoma)
   </value>
   <value>
    neuroepithelioma
   </value>
   <value>
    neuromuscular pain
   </value>
   <value>
    nickel allergy
   </value>
   <value>
    Nijmegen breakage syndrome
   </value>
   <value>
    NK leukaemia
   </value>
   <value>
    NK/T-cell lymphoma
   </value>
   <value>
    no rejection
   </value>
   <value>
    nodal diffuse large B-cell lymphoma
   </value>
   <value>
    nodal peripheral T-cell lymphoma
   </value>
   <value>
    nodular goiter
   </value>
   <value>
    nodular lymphocyte predominant Hodgkin's lymphoma
   </value>
   <value>
    nodular melanoma
   </value>
   <value>
    non active Crohn's disease
   </value>
   <value>
    non-active ulcerative colitis
   </value>
   <value>
    non-basal like breast cancer
   </value>
   <value>
    non-Hodgkins lymphoma
   </value>
   <value>
    non-inflammatory bowel disease
   </value>
   <value>
    non-inflammatory neurological disease
   </value>
   <value>
    non-invasive glioma
   </value>
   <value>
    non-small cell lung cancer
   </value>
   <value>
    nonsyndromic sagittal synostosis
   </value>
   <value>
    normal
   </value>
   <value>
    NSCLC
   </value>
   <value>
    null cell tumor
   </value>
   <value>
    obesity
   </value>
   <value>
    obstruction
   </value>
   <value>
    oculo-facio-cardio-dental syndrome
   </value>
   <value>
    oligoarticular juvenile idiopathic arthritis
   </value>
   <value>
    oligoastrocytoma
   </value>
   <value>
    oligoastrocytoma (grade 3) with EGFR amplification
   </value>
   <value>
    oligodendroglioma
   </value>
   <value>
    oligodendroglioma (grade 3) with 1p19q codeletion
   </value>
   <value>
    oligodendroglioma (grade 3) with EGFR amplification
   </value>
   <value>
    oral cavity squamous cell carcinoma
   </value>
   <value>
    organ donor
   </value>
   <value>
    oropharynx squamous cell carcinoma
   </value>
   <value>
    osteoarthritis
   </value>
   <value>
    osteomyelitis
   </value>
   <value>
    osteomyelitis/bacteremia/methicillin-resistant Staphylococcus aureus infection
   </value>
   <value>
    osteomyelitis/suppurative arthritis/methicillin-resistant Staphylococcus aureus infection
   </value>
   <value>
    osteosarcoma
   </value>
   <value>
    ovarian adenocarcinoma
   </value>
   <value>
    ovarian cancer
   </value>
   <value>
    ovarian carcinoma
   </value>
   <value>
    ovarian papillary serous adenocarcinoma
   </value>
   <value>
    ovarian serous carcinoma
   </value>
   <value>
    ovary carcinoma
   </value>
   <value>
    pancreatic adenocarcinoma
   </value>
   <value>
    pancreatic cancer
   </value>
   <value>
    pancreatic carcinoma
   </value>
   <value>
    pancreatic ductal adenocarcinoma
   </value>
   <value>
    papillary carcinoma
   </value>
   <value>
    papillary serous ovarian adenocarcinoma
   </value>
   <value>
    papillary thyroid cancer
   </value>
   <value>
    parathyroid tumour
   </value>
   <value>
    Parkinson's disease
   </value>
   <value>
    pediatric acute leukaemia
   </value>
   <value>
    pediatric T-ALL
   </value>
   <value>
    pediatric-high grade glioma/anaplastic astrocytoma
   </value>
   <value>
    pediatric-high grade glioma/anaplastic oligodendroglioma
   </value>
   <value>
    pediatric-high grade glioma/glioblastoma
   </value>
   <value>
    pediatric-high grade glioma/glioblastoma variant
   </value>
   <value>
    pediatric-high grade glioma/pleomorphic xanthoastrocytoma
   </value>
   <value>
    periodontitis
   </value>
   <value>
    peripheral T-cell lymphoma
   </value>
   <value>
    pharyngeal carcinoma
   </value>
   <value>
    Pick's disease
   </value>
   <value>
    pilocytic astrocytoma
   </value>
   <value>
    pituitary adenoma
   </value>
   <value>
    pituitary adenoma predisposition
   </value>
   <value>
    pituitary tumor
   </value>
   <value>
    placenta choriocarcinoma
   </value>
   <value>
    pleomorphic liposarcoma
   </value>
   <value>
    pneumonia/bacteremia/S. Pneumoniae infection
   </value>
   <value>
    pneumonia/empyema/S. Pneumoniae infection
   </value>
   <value>
    pneumonia/influenza A infection
   </value>
   <value>
    polyarticular juvenile idiopathic arthritis
   </value>
   <value>
    polycystic ovary syndrome
   </value>
   <value>
    poorly differentiated head and neck squamous cell carcinoma
   </value>
   <value>
    post-transplant
   </value>
   <value>
    pre B-ALL
   </value>
   <value>
    Pre-B-ALL/c-ALL
   </value>
   <value>
    pre-diabetes
   </value>
   <value>
    pre-transplant
   </value>
   <value>
    precursor B-cell acute lymphoblastic leukaemia
   </value>
   <value>
    preeclampsia
   </value>
   <value>
    previous malaria infection
   </value>
   <value>
    primary breast tumor
   </value>
   <value>
    primary glioblastoma
   </value>
   <value>
    primary prostate cancer
   </value>
   <value>
    primary unilateral non-metastatic breast cancer
   </value>
   <value>
    Pro-B-ALL
   </value>
   <value>
    Pro-B-ALL with t 11q23, MLL
   </value>
   <value>
    Pro-B-ALL/MLL
   </value>
   <value>
    progressive multiple sclerosis
   </value>
   <value>
    Progressive supranuclear palsy
   </value>
   <value>
    prolapse
   </value>
   <value>
    prostate adenocarcinoma
   </value>
   <value>
    prostate cancer
   </value>
   <value>
    prostate carcinoma
   </value>
   <value>
    psoriasis
   </value>
   <value>
    pulmonary arterial hypertension
   </value>
   <value>
    pulmonary MALT lymphoma
   </value>
   <value>
    pulmonary tuberculosis
   </value>
   <value>
    RCC
   </value>
   <value>
    recessive retinitis pigmentosa
   </value>
   <value>
    rectal adenocarcinoma
   </value>
   <value>
    recurrent glioblastoma
   </value>
   <value>
    recurrent glioblastoma multiforme
   </value>
   <value>
    renal adenocarcinoma
   </value>
   <value>
    renal cancer
   </value>
   <value>
    renal carcinoma
   </value>
   <value>
    renal cell carcinoma
   </value>
   <value>
    renal clear cell carcinoma
   </value>
   <value>
    renal disease
   </value>
   <value>
    renal oncocytoma
   </value>
   <value>
    Rett syndrome
   </value>
   <value>
    rhabdomyosarcoma
   </value>
   <value>
    rheumatoid arthriris
   </value>
   <value>
    rheumatoid arthritis
   </value>
   <value>
    Roberts syndrome
   </value>
   <value>
    sarcoidosis
   </value>
   <value>
    sarcoma
   </value>
   <value>
    schizophrenia
   </value>
   <value>
    schyzophrenia
   </value>
   <value>
    scleroderma with pulmonary hypertension
   </value>
   <value>
    scleroderma without pulmonary hypertension
   </value>
   <value>
    sepsis
   </value>
   <value>
    septic arthritis/osteomyelitis/bacteremia/methicillin-sensitive Staphylococcus aureus infection
   </value>
   <value>
    septic patient
   </value>
   <value>
    septic shock
   </value>
   <value>
    serous borderline ovarian cancer
   </value>
   <value>
    serous epithelial ovarian cancer
   </value>
   <value>
    Setleis syndrome
   </value>
   <value>
    severe chronic allograft nephropathy
   </value>
   <value>
    Sezary syndrome
   </value>
   <value>
    sickle cell anaemia
   </value>
   <value>
    Sjogren syndrome
   </value>
   <value>
    small cell lung cancer
   </value>
   <value>
    small cell lung carcinoma
   </value>
   <value>
    Soetre-Chotzen syndrome
   </value>
   <value>
    soft tissue sarcoma
   </value>
   <value>
    spina bifida
   </value>
   <value>
    spinal muscular atrophy
   </value>
   <value>
    splenic marginal zone lymphoma
   </value>
   <value>
    sporadic Burkitt lymphoma
   </value>
   <value>
    squamous cell carcinoma
   </value>
   <value>
    squamous cell lung carcinoma
   </value>
   <value>
    Stevens-Johnson syndrome/toxic epidermal necrolysis
   </value>
   <value>
    stress incontinence
   </value>
   <value>
    subclinical interstitial fibrosis
   </value>
   <value>
    subependymal giant cell astrocytoma
   </value>
   <value>
    systemic inflammatory response syndrome
   </value>
   <value>
    systemic inflammatory response syndrome resolved
   </value>
   <value>
    systemic juvenile idiopathic arthritis
   </value>
   <value>
    T-ALL
   </value>
   <value>
    T-cell leukaemia
   </value>
   <value>
    T-cell lymphoma
   </value>
   <value>
    T-cell/histiocyte rich B-cell lymphoma
   </value>
   <value>
    T-LGL lymphocytosis
   </value>
   <value>
    teratoma/germ cell tumor
   </value>
   <value>
    teratoma/yolk sac tumor
   </value>
   <value>
    testicular diffuse large B-cell lymphoma
   </value>
   <value>
    testicular germ-cell tumor
   </value>
   <value>
    thalassemia
   </value>
   <value>
    thanatophoric dysplasia
   </value>
   <value>
    Thompson disease, grade 1
   </value>
   <value>
    Thompson disease, grade 1/2
   </value>
   <value>
    Thompson disease, grade 3
   </value>
   <value>
    Thompson disease, grade 4
   </value>
   <value>
    tongue squamous cell carcinoma
   </value>
   <value>
    trachoma
   </value>
   <value>
    tuberous sclerosis
   </value>
   <value>
    tumorigenic
   </value>
   <value>
    type 1 diabetes
   </value>
   <value>
    type 1 diabetes clinical onset
   </value>
   <value>
    type 1 diabetes longstanding
   </value>
   <value>
    type 1 diabetes recent onset
   </value>
   <value>
    type 2 diabetes
   </value>
   <value>
    type 2 diabetes mellitus
   </value>
   <value>
    ulcerative colitis
   </value>
   <value>
    ulcerative colitis with inflammation
   </value>
   <value>
    ulcerative colitis without inflammation
   </value>
   <value>
    undifferentiated bone sarcoma
   </value>
   <value>
    undifferentiated sarcoma
   </value>
   <value>
    undifferentiated soft tissue sarcoma
   </value>
   <value>
    unilateral cryptorchid
   </value>
   <value>
    unknown
   </value>
   <value>
    Usher syndrome
   </value>
   <value>
    uterine fibroid
   </value>
   <value>
    uterine leiomyoma
   </value>
   <value>
    vessel ischemic heart disease
   </value>
   <value>
    villitis
   </value>
   <value>
    vulvar intraepithelial neoplasia
   </value>
   <value>
    Waldenstrom Macroglobulinemia
   </value>
   <value>
    Waldenstršms macroglobulinemia
   </value>
   <value>
    well differentiated head and neck squamous cell carcinoma
   </value>
   <value>
    well-differentiated soft tissue sarcoma
   </value>
   <value>
    Williams-Beuren Syndrome
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    0
   </reportersequencescore>
   <protocolscore>
    1
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    4
   </overallscore>
  </miamescores>
  <id>
   537522
  </id>
  <accession>
   E-MTAB-3732
  </accession>
  <name>
   A comprehensive human expression map
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2015-07-23
  </releasedate>
  <submissiondate>
   2015-05-23
  </submissiondate>
  <lastupdatedate>
   2016-04-01
  </lastupdatedate>
  <samples>
   27887
  </samples>
  <assays>
   27871
  </assays>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    1
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    1
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bibliography>
   <authors>
    Aurora Torrente, Margus Lukk, Vincent Xue, Helen Parkinson, Johan Rung, Alvis Brazma
   </authors>
   <title>
    Identification of Cancer Related Genes Using a Comprehensive Map of Human Gene Expression
   </title>
   <doi>
    10.1371/journal.pone.0157484
   </doi>
   <issue>
    6
   </issue>
   <pages>
    e0157484
   </pages>
   <publication>
    PLOS ONE
   </publication>
   <volume>
    11
   </volume>
   <year>
    2016
   </year>
  </bibliography>
  <provider>
   <contact>
    Aurora Torrente
   </contact>
   <role>
    submitter
   </role>
   <email>
    aurora@ebi.ac.uk
   </email>
  </provider>
  <experimentdesign>
   array specific design
  </experimentdesign>
  <experimentdesign>
   cell type comparison design
  </experimentdesign>
  <experimentdesign>
   disease state design
  </experimentdesign>
  <experimentdesign>
   organism part comparison design
  </experimentdesign>
  <description>
   <id>
   </id>
   <text>
    A compiled human gene expression, ontology-annotated dataset from publicly available data including 27887 Affymetrix HG-U133Plus2 arrays, filtered for quality control. The dataset contains samples from healthy individuals, from individuals with disease (including cancer) and cell lines.
   </text>
  </description>
  <protocol>
   <id>
    1195142
   </id>
   <accession>
    P-MTAB-45988
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <fgem available="true" name="E-MTAB-3732.processed.1.zip">
   </fgem>
   <idf name="E-MTAB-3732.idf.txt">
   </idf>
   <sdrf name="E-MTAB-3732.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="false">
  </processeddatafiles>
  <sampleattribute>
   <category>
    clinical history
   </category>
   <value>
    high risk of developing placental complications
   </value>
   <value>
    low risk of developing placental complications
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism part
   </category>
   <value>
    placental vilous
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    clinical history
   </name>
   <value>
    high risk of developing placental complications
   </value>
   <value>
    low risk of developing placental complications
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    1
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    0
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    4
   </overallscore>
  </miamescores>
  <id>
   517862
  </id>
  <accession>
   E-MTAB-3265
  </accession>
  <name>
   Transcription profiling by array of placental vilous tissues from women with high or low risks of developing placental complications during pregnancy
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2015-07-22
  </releasedate>
  <submissiondate>
   2010-04-19
  </submissiondate>
  <lastupdatedate>
   2015-01-23
  </lastupdatedate>
  <samples>
   22
  </samples>
  <assays>
   22
  </assays>
  <arraydesign>
   <id>
    13379
   </id>
   <accession>
    A-MEXP-1171
   </accession>
   <name>
    Illumina HumanHT-12 v3.0 Expression BeadChip
   </name>
   <count>
    22
   </count>
   <legacy_id>
    1633174974
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawDataMatrix
   </name>
   <bioassaydatacubes>
    1
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawDataMatrix
   </dataformat>
   <bioassays>
    1
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Ken Laing
   </contact>
   <role>
    submitter
   </role>
   <email>
    klaing@sgul.ac.uk
   </email>
  </provider>
  <experimentdesign>
   clinical history design
  </experimentdesign>
  <description>
   <id>
   </id>
   <text>
    High uterine artery Doppler (UtAD) resistance indices (RI), indicative of poor uterine blood flow, have been shown to be predictive of placental complications of pregnancy such as pre-eclampsia (PE), fetal growth restriction (FGR) and stillbirth. A comparative analysis of gene expression in High vs normal risk pregnancies in placental tissue from first trimester was undertaken. Patients were stratified by their risk of developing placental complications as determined by Doppler resistance indices. High-resistance cases were defined as those with bilateral uterine diastolic notches and a mean RI &gt;95th percentile whilst Normal-resistance cases had a mean RI of &lt;95th percentile. A direct comparison of gene expression in Placental villous tissue obtained folowing terminations at of 9 to 14 weeks gestation.
   </text>
  </description>
  <protocol>
   <id>
    1107429
   </id>
   <accession>
    P-MTAB-43016
   </accession>
  </protocol>
  <protocol>
   <id>
    1107430
   </id>
   <accession>
    P-MTAB-43015
   </accession>
  </protocol>
  <protocol>
   <id>
    1107431
   </id>
   <accession>
    P-MTAB-43014
   </accession>
  </protocol>
  <protocol>
   <id>
    1107433
   </id>
   <accession>
    P-MTAB-43013
   </accession>
  </protocol>
  <protocol>
   <id>
    1107432
   </id>
   <accession>
    P-MTAB-43012
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-MTAB-3265.raw.1.zip">
   </raw>
   <idf name="E-MTAB-3265.idf.txt">
   </idf>
   <sdrf name="E-MTAB-3265.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    cell line
   </category>
   <value>
    HUVEC cell line
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    disease
   </category>
   <value>
    mild preeclampsia
   </value>
   <value>
    normal
   </value>
   <value>
    severe preeclampsia
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    pool
   </category>
   <value>
    RNA pooled from 2 independent cultures of cells exposed to plasma from women with mild preeclampsia
   </value>
   <value>
    RNA pooled from 3 independent cultures of cells exposed to plasma from women with severe preeclampsia
   </value>
   <value>
    RNA pooled from 5 independent cultures of cells exposed to plasma from normal pregnant women
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    disease
   </name>
   <value>
    mild preeclampsia
   </value>
   <value>
    normal
   </value>
   <value>
    severe preeclampsia
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    4
   </overallscore>
  </miamescores>
  <id>
   519113
  </id>
  <accession>
   E-MTAB-3348
  </accession>
  <name>
   Long term exposure of HUVEC to plasma from preeclamptic versus normal pregnancies
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2015-06-29
  </releasedate>
  <submissiondate>
   2012-03-22
  </submissiondate>
  <lastupdatedate>
   2015-02-23
  </lastupdatedate>
  <samples>
   4
  </samples>
  <assays>
   4
  </assays>
  <arraydesign>
   <id>
    17485
   </id>
   <accession>
    A-MEXP-2102
   </accession>
   <name>
    Agilent 028004 SurePrint G3 Human GE 8x60K Microarray
   </name>
   <count>
    4
   </count>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    4
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    4
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    1
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    1
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bibliography>
   <accession>
    24738702
   </accession>
  </bibliography>
  <bibliography>
   <accession>
    24120378
   </accession>
  </bibliography>
  <provider>
   <contact>
    Daniel VAIMAN
   </contact>
   <role>
    submitter
   </role>
   <email>
    daniel.vaiman@inserm.fr
   </email>
  </provider>
  <experimentdesign>
   case control design
  </experimentdesign>
  <description>
   <id>
   </id>
   <text>
    Plasma from pregnant women were applied three days in three steps to HUVEC cells. RNAs were isolated and prepared. Four pools of RNAs were obtained, two of them from cells exposed to preeclamptic plasma (2 and 3, corresponding to mild and severe preeclampsia, respectively) and two from cells exposed to normal plasma from pregnant women (five and five).
   </text>
  </description>
  <protocol>
   <id>
    1114176
   </id>
   <accession>
    P-MTAB-43461
   </accession>
  </protocol>
  <protocol>
   <id>
    1114175
   </id>
   <accession>
    P-MTAB-43462
   </accession>
  </protocol>
  <protocol>
   <id>
    1114174
   </id>
   <accession>
    P-MTAB-43463
   </accession>
  </protocol>
  <protocol>
   <id>
    1114173
   </id>
   <accession>
    P-MTAB-43464
   </accession>
  </protocol>
  <protocol>
   <id>
    1114171
   </id>
   <accession>
    P-MTAB-43465
   </accession>
  </protocol>
  <protocol>
   <id>
    1114170
   </id>
   <accession>
    P-MTAB-43466
   </accession>
  </protocol>
  <protocol>
   <id>
    1114172
   </id>
   <accession>
    P-MTAB-43467
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-MTAB-3348.raw.1.zip">
   </raw>
   <fgem available="true" name="E-MTAB-3348.processed.1.zip">
   </fgem>
   <idf name="E-MTAB-3348.idf.txt">
   </idf>
   <sdrf name="E-MTAB-3348.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="false">
  </processeddatafiles>
  <sampleattribute>
   <category>
    age of donor
   </category>
   <value>
    18 year
   </value>
   <value>
    21 year
   </value>
   <value>
    23 year
   </value>
   <value>
    26 year
   </value>
   <value>
    27 year
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    cell type
   </category>
   <value>
    macrophage
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    RNA interference
   </category>
   <value>
    siRNA CD74
   </value>
   <value>
    siRNA non-targeting
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    sex
   </category>
   <value>
    female
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    stimulus
   </category>
   <value>
    IL-4
   </value>
   <value>
    none
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    RNA interference
   </name>
   <value>
    siRNA CD74
   </value>
   <value>
    siRNA non-targeting
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    0
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    3
   </overallscore>
  </miamescores>
  <id>
   518672
  </id>
  <accession>
   E-MTAB-3309
  </accession>
  <name>
   Transcription profiling of human blood monocyte-derived macrophages that were non- or IL-4-activated and treated with small interfering RNA against CD74 (siRNA CD74) or non-targeting siRNA (siRNA non-targeting)
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2015-04-29
  </releasedate>
  <submissiondate>
   2013-11-27
  </submissiondate>
  <lastupdatedate>
   2015-02-11
  </lastupdatedate>
  <samples>
   24
  </samples>
  <assays>
   24
  </assays>
  <arraydesign>
   <id>
    21185
   </id>
   <accession>
    A-MEXP-2210
   </accession>
   <name>
    Illumina HumanHT-12_V4_0_R1_15002873_B
   </name>
   <count>
    24
   </count>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    24
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    24
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bibliography>
   <authors>
    Lukasz Przybyl, MS; Nadine Haase, PhD; Michaela Golic, MD; Julianna Rugor, MS; Maria Emilia Solano, PhD; Petra Clara Arck, PhD; Martin Gauster, PhD; Berthold Huppertz, PhD; Christoph Emontzpohl, Christian Stoppe, MD; JÌ_rgen Bernhagen, PhD; Herbert Schulz, PhD; Arndt Heuser, MD; Meryam Sugulle, MD; Friedrich C Luft, MD; Anne Cathrine Staff, MD; Dominik N MÌ_ller, PhD; Ralf Dechend, MD, Florian Herse, PhD
   </authors>
   <title>
    Dysregulated CD74 in macrophage-trophoblast interactions and the pathogenesis of preeclampsia
   </title>
   <status>
    in preparation
   </status>
  </bibliography>
  <provider>
   <contact>
    Lukasz Przybyl
   </contact>
   <role>
    submitter investigator experiment performer
   </role>
   <email>
    lukasz.przybyl@charite.de
   </email>
  </provider>
  <experimentdesign>
   genetic modification design
  </experimentdesign>
  <experimentdesign>
   genotype design
  </experimentdesign>
  <description>
   <id>
   </id>
   <text>
    Preeclampsia is a disease of pregnant women, which is characterized by hypertension, proteinuria and chronic inflammation. There is a growing body of evidence that cause of preeclampsia lies within immunological aspect of pregnancy. This study aimed to analyze the role of CD74 in preeclampsia with a focus on its influence on communication between placental macrophages (Hofbauer cells) and trophoblasts. We have found CD74 to be highly dysregulated in preeclamptic placenta by real-time RT-PCR and Western blot methods. We identified Hofbauer cells to express the highest levels of CD74 in placenta by immunofluorescence and flow cytometry and that CD74 in preeclamptic Hofbauer cells is lower than in controls. We have performed a transcriptome analysis on human blood monocyte-derived macrophages that were non- or IL-4-activated and treated with small interfering RNA against CD74 (siRNA CD74) or non-targeting siRNA (siRNA non-targeting) as control.
   </text>
  </description>
  <protocol>
   <id>
    1112060
   </id>
   <accession>
    P-MTAB-43265
   </accession>
  </protocol>
  <protocol>
   <id>
    1112061
   </id>
   <accession>
    P-MTAB-43264
   </accession>
  </protocol>
  <protocol>
   <id>
    1112063
   </id>
   <accession>
    P-MTAB-43263
   </accession>
  </protocol>
  <protocol>
   <id>
    1112062
   </id>
   <accession>
    P-MTAB-43262
   </accession>
  </protocol>
  <protocol>
   <id>
    1112057
   </id>
   <accession>
    P-MTAB-43268
   </accession>
  </protocol>
  <protocol>
   <id>
    1112058
   </id>
   <accession>
    P-MTAB-43267
   </accession>
  </protocol>
  <protocol>
   <id>
    1112059
   </id>
   <accession>
    P-MTAB-43266
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-MTAB-3309.raw.1.zip">
   </raw>
   <idf name="E-MTAB-3309.idf.txt">
   </idf>
   <sdrf name="E-MTAB-3309.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="false">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    cell id
   </category>
   <value>
    CTL #10
   </value>
   <value>
    CTL #2
   </value>
   <value>
    CTL #3
   </value>
   <value>
    CTL #4
   </value>
   <value>
    CTL #5
   </value>
   <value>
    CTL #6
   </value>
   <value>
    CTL #7
   </value>
   <value>
    CTL #8
   </value>
   <value>
    CTL #9
   </value>
   <value>
    PE A
   </value>
   <value>
    PE B
   </value>
   <value>
    PE C
   </value>
   <value>
    PE D
   </value>
   <value>
    PE F
   </value>
   <value>
    PE G
   </value>
   <value>
    PE H
   </value>
   <value>
    PE I
   </value>
   <value>
    PE J
   </value>
   <value>
    PE K
   </value>
   <value>
    PE L
   </value>
   <value>
    PE M
   </value>
   <value>
    PE N
   </value>
   <value>
    PE O
   </value>
   <value>
    PE P
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    cell type
   </category>
   <value>
    umbilical cord fibroblast
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    diagnosis
   </category>
   <value>
   </value>
   <value>
    healthy
   </value>
   <value>
    preeclampsia
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    passage #
   </category>
   <value>
    1
   </value>
   <value>
    2
   </value>
   <value>
    3
   </value>
   <value>
    4
   </value>
   <value>
    5
   </value>
   <value>
    6
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    CELL ID
   </name>
   <value>
    CTL #10
   </value>
   <value>
    CTL #2
   </value>
   <value>
    CTL #3
   </value>
   <value>
    CTL #4
   </value>
   <value>
    CTL #5
   </value>
   <value>
    CTL #6
   </value>
   <value>
    CTL #7
   </value>
   <value>
    CTL #8
   </value>
   <value>
    CTL #9
   </value>
   <value>
    PE A
   </value>
   <value>
    PE B
   </value>
   <value>
    PE C
   </value>
   <value>
    PE D
   </value>
   <value>
    PE F
   </value>
   <value>
    PE G
   </value>
   <value>
    PE H
   </value>
   <value>
    PE I
   </value>
   <value>
    PE J
   </value>
   <value>
    PE K
   </value>
   <value>
    PE L
   </value>
   <value>
    PE M
   </value>
   <value>
    PE N
   </value>
   <value>
    PE O
   </value>
   <value>
    PE P
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    DIAGNOSIS
   </name>
   <value>
    healthy
   </value>
   <value>
    not specified
   </value>
   <value>
    preeclampsia
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    PASSAGE #
   </name>
   <value>
    1
   </value>
   <value>
    2
   </value>
   <value>
    3
   </value>
   <value>
    4
   </value>
   <value>
    5
   </value>
   <value>
    6
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    4
   </overallscore>
  </miamescores>
  <id>
   507591
  </id>
  <accession>
   E-GEOD-54400
  </accession>
  <secondaryaccession>
   GSE54400
  </secondaryaccession>
  <name>
   Transcriptome analysis of human umbilical cord fibroblasts from babies whose mother experienced preeclampsia
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2014-08-31
  </releasedate>
  <lastupdatedate>
   2014-10-06
  </lastupdatedate>
  <samples>
   47
  </samples>
  <assays>
   47
  </assays>
  <arraydesign>
   <id>
    7604
   </id>
   <accession>
    A-GEOD-10558
   </accession>
   <name>
    Illumina HumanHT-12 V4.0 expression beadchip
   </name>
   <count>
    47
   </count>
   <legacy_id>
    2501282336
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    47
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    47
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    47
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    47
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Danny Schust
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Michael R Roberts
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Toshihiko Ezashi
   </contact>
   <role>
    submitter
   </role>
   <email>
    ezashit@missouri.edu
   </email>
  </provider>
  <provider>
   <contact>
    Toshihiko Ezashi
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Penghua Yang
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    In pregnancies involving preeclampsia (PE), there is evidence that the fetal-placental unit is under oxidative stress. Here we examined primary cell lines generated from umbilical cords (UC) delivered by mothers who had either a normal pregnancy or experienced early onset PE to determine whether the two had distinguishable phenotypes. While all UC provided outgrowths when established in 4 % O2, success was less assured for PE cords under ambient (20 % O2) conditions (P &lt; 0.05). Moreover, proliferation rates of established PE lines, although similar to controls in 4 % O2, were significantly lower in 20 % O2.  PE lines grown in 4 % O2 were also more susceptible to the pro-oxidant diethylmaleate than control lines, and unlike controls, were not protected by glutathione. Transcriptome profiling revealed only a few differentially regulated genes between PE lines and controls in 4 % O2 conditions, but confirmed the more severely stressed phenotype of the PE lines under 20 % O2. We conclude that the primary UC cell lines generated from PE births maintain a susceptibility to oxidative stress that is stable over many cell divisions, but whether the basis of this vulnerability is genetic or epigenetic remains unclear. RNA was isolated from early passages (&lt; p5) of UC fibroblast lines (15 PE and 9 CTL lines, grown in T25 flasks) when they reached ~90% confluency in 4 % O2 conditions. In order to collect RNA from cells under 20 % O2, cell lines at either p 4, 5, or 6 were switched from 4 % O2 conditions to 20 % O2 conditions when they were approximately 20 % confluent. When they reached ~90% confluency (generally 2 days in 4 %  O2 and 3-4 days in 20 % O2 conditions), medium was removed and RNA STAT60  (I ml; Tel-Test, Friendswood, TX) was immediately added to each T25 flask and RNA extracted by following the manufacturer’s instructions. The samples of RNA were submitted to University Texas Southwestern Medical Center Microarray Core Facility (
    <a href="https://microarray.swmed.edu/" target="_blank">
     https://microarray.swmed.edu/
    </a>
    ) and microarray analysis performed with Illumina HumanHT-12 v4 expression BeadChips. Raw intensity data were background subtracted by using BeadStudio software and analyzed further by GeneSpring 12.6 software (Agilent Technologies Inc., Santa Clara CA), according to the advanced workflow protocol: percentile shift and filter by flags (detected).
   </text>
  </description>
  <protocol>
   <id>
    1087761
   </id>
   <accession>
    P-GSE54400-3
   </accession>
  </protocol>
  <protocol>
   <id>
    1087760
   </id>
   <accession>
    P-GSE54400-4
   </accession>
  </protocol>
  <protocol>
   <id>
    1087759
   </id>
   <accession>
    P-GSE54400-5
   </accession>
  </protocol>
  <protocol>
   <id>
    1087758
   </id>
   <accession>
    P-GSE54400-6
   </accession>
  </protocol>
  <protocol>
   <id>
    1087756
   </id>
   <accession>
    P-GSE54400-7
   </accession>
  </protocol>
  <protocol>
   <id>
    1087762
   </id>
   <accession>
    P-GSE54400-2
   </accession>
  </protocol>
  <protocol>
   <id>
    1087757
   </id>
   <accession>
    P-GSE54400-1
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <fgem available="true" name="E-GEOD-54400.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-54400.idf.txt">
   </idf>
   <sdrf name="E-GEOD-54400.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="false">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    diastolic bp &lt;20 weeks mmhg
   </category>
   <value>
    58
   </value>
   <value>
    60
   </value>
   <value>
    61
   </value>
   <value>
    62
   </value>
   <value>
    63
   </value>
   <value>
    64
   </value>
   <value>
    65
   </value>
   <value>
    66
   </value>
   <value>
    67
   </value>
   <value>
    68
   </value>
   <value>
    69
   </value>
   <value>
    70
   </value>
   <value>
    71
   </value>
   <value>
    72
   </value>
   <value>
    73
   </value>
   <value>
    75
   </value>
   <value>
    76
   </value>
   <value>
    77
   </value>
   <value>
    78
   </value>
   <value>
    79
   </value>
   <value>
    80
   </value>
   <value>
    84
   </value>
   <value>
    n/a
   </value>
   <value>
    na
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    diastolic bp at delivery mmhg
   </category>
   <value>
    100
   </value>
   <value>
    102
   </value>
   <value>
    108
   </value>
   <value>
    113
   </value>
   <value>
    115
   </value>
   <value>
    61
   </value>
   <value>
    63
   </value>
   <value>
    64
   </value>
   <value>
    65
   </value>
   <value>
    66
   </value>
   <value>
    67
   </value>
   <value>
    68
   </value>
   <value>
    70
   </value>
   <value>
    71
   </value>
   <value>
    72
   </value>
   <value>
    74
   </value>
   <value>
    76
   </value>
   <value>
    80
   </value>
   <value>
    85
   </value>
   <value>
    86
   </value>
   <value>
    87
   </value>
   <value>
    88
   </value>
   <value>
    91
   </value>
   <value>
    92
   </value>
   <value>
    94
   </value>
   <value>
    95
   </value>
   <value>
    96
   </value>
   <value>
    97
   </value>
   <value>
    98
   </value>
   <value>
    99
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    fetal sex
   </category>
   <value>
    female
   </value>
   <value>
    male
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    gestational age at delivery weeks
   </category>
   <value>
    27.71
   </value>
   <value>
    28.14
   </value>
   <value>
    29.29
   </value>
   <value>
    29.71
   </value>
   <value>
    31.43
   </value>
   <value>
    32.57
   </value>
   <value>
    33.29
   </value>
   <value>
    33.71
   </value>
   <value>
    34.43
   </value>
   <value>
    34.71
   </value>
   <value>
    35.00
   </value>
   <value>
    36.57
   </value>
   <value>
    36.86
   </value>
   <value>
    37.14
   </value>
   <value>
    37.29
   </value>
   <value>
    37.57
   </value>
   <value>
    37.71
   </value>
   <value>
    37.86
   </value>
   <value>
    38.00
   </value>
   <value>
    38.29
   </value>
   <value>
    38.86
   </value>
   <value>
    39.00
   </value>
   <value>
    39.14
   </value>
   <value>
    39.29
   </value>
   <value>
    39.43
   </value>
   <value>
    39.57
   </value>
   <value>
    39.71
   </value>
   <value>
    39.86
   </value>
   <value>
    40.00
   </value>
   <value>
    40.14
   </value>
   <value>
    40.57
   </value>
   <value>
    40.71
   </value>
   <value>
    40.86
   </value>
   <value>
    41.14
   </value>
   <value>
    41.43
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    jury
   </category>
   <value>
    4
   </value>
   <value>
    4.1
   </value>
   <value>
    4.3
   </value>
   <value>
    4.4
   </value>
   <value>
    4.5
   </value>
   <value>
    6
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    maternal age years
   </category>
   <value>
    17.77
   </value>
   <value>
    17.88
   </value>
   <value>
    18.71
   </value>
   <value>
    18.78
   </value>
   <value>
    19.22
   </value>
   <value>
    19.33
   </value>
   <value>
    19.61
   </value>
   <value>
    19.63
   </value>
   <value>
    20.34
   </value>
   <value>
    20.53
   </value>
   <value>
    21.84
   </value>
   <value>
    22.00
   </value>
   <value>
    23.04
   </value>
   <value>
    25.88
   </value>
   <value>
    25.95
   </value>
   <value>
    26.26
   </value>
   <value>
    26.46
   </value>
   <value>
    27.30
   </value>
   <value>
    27.49
   </value>
   <value>
    27.78
   </value>
   <value>
    28.33
   </value>
   <value>
    28.62
   </value>
   <value>
    29.16
   </value>
   <value>
    29.94
   </value>
   <value>
    30.10
   </value>
   <value>
    30.74
   </value>
   <value>
    31.30
   </value>
   <value>
    31.69
   </value>
   <value>
    31.83
   </value>
   <value>
    31.92
   </value>
   <value>
    32.31
   </value>
   <value>
    32.45
   </value>
   <value>
    32.65
   </value>
   <value>
    32.84
   </value>
   <value>
    32.87
   </value>
   <value>
    33.02
   </value>
   <value>
    33.17
   </value>
   <value>
    33.31
   </value>
   <value>
    33.49
   </value>
   <value>
    35.10
   </value>
   <value>
    35.43
   </value>
   <value>
    35.93
   </value>
   <value>
    36.81
   </value>
   <value>
    37.32
   </value>
   <value>
    37.62
   </value>
   <value>
    39.31
   </value>
   <value>
    43.11
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    maternal race
   </category>
   <value>
    Black
   </value>
   <value>
    Nat Amer
   </value>
   <value>
    White
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    nulliparous
   </category>
   <value>
    0
   </value>
   <value>
    1
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism part
   </category>
   <value>
    placenta
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    pre-pregancy bmi
   </category>
   <value>
    18.28
   </value>
   <value>
    19.65
   </value>
   <value>
    19.78
   </value>
   <value>
    20.40
   </value>
   <value>
    20.47
   </value>
   <value>
    20.53
   </value>
   <value>
    20.64
   </value>
   <value>
    21.03
   </value>
   <value>
    21.08
   </value>
   <value>
    21.28
   </value>
   <value>
    21.30
   </value>
   <value>
    21.34
   </value>
   <value>
    21.46
   </value>
   <value>
    21.68
   </value>
   <value>
    21.79
   </value>
   <value>
    21.99
   </value>
   <value>
    22.19
   </value>
   <value>
    22.26
   </value>
   <value>
    22.72
   </value>
   <value>
    23.08
   </value>
   <value>
    23.22
   </value>
   <value>
    23.45
   </value>
   <value>
    23.77
   </value>
   <value>
    24.33
   </value>
   <value>
    24.50
   </value>
   <value>
    24.94
   </value>
   <value>
    24.99
   </value>
   <value>
    25.01
   </value>
   <value>
    25.11
   </value>
   <value>
    25.74
   </value>
   <value>
    25.85
   </value>
   <value>
    25.88
   </value>
   <value>
    25.92
   </value>
   <value>
    26.68
   </value>
   <value>
    26.85
   </value>
   <value>
    27.86
   </value>
   <value>
    28.21
   </value>
   <value>
    28.30
   </value>
   <value>
    28.85
   </value>
   <value>
    29.24
   </value>
   <value>
    30.18
   </value>
   <value>
    31.13
   </value>
   <value>
    32.52
   </value>
   <value>
    32.56
   </value>
   <value>
    35.94
   </value>
   <value>
    36.39
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    systolic bp &lt;20 weeks mmhg
   </category>
   <value>
    100
   </value>
   <value>
    101
   </value>
   <value>
    103
   </value>
   <value>
    104
   </value>
   <value>
    105
   </value>
   <value>
    107
   </value>
   <value>
    108
   </value>
   <value>
    109
   </value>
   <value>
    110
   </value>
   <value>
    112
   </value>
   <value>
    113
   </value>
   <value>
    114
   </value>
   <value>
    115
   </value>
   <value>
    118
   </value>
   <value>
    119
   </value>
   <value>
    120
   </value>
   <value>
    122
   </value>
   <value>
    123
   </value>
   <value>
    124
   </value>
   <value>
    125
   </value>
   <value>
    126
   </value>
   <value>
    127
   </value>
   <value>
    133
   </value>
   <value>
    134
   </value>
   <value>
    135
   </value>
   <value>
    n/a
   </value>
   <value>
    na
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    systolic bp at delivery mmhg
   </category>
   <value>
    102
   </value>
   <value>
    110
   </value>
   <value>
    114
   </value>
   <value>
    115
   </value>
   <value>
    117
   </value>
   <value>
    118
   </value>
   <value>
    121
   </value>
   <value>
    122
   </value>
   <value>
    124
   </value>
   <value>
    128
   </value>
   <value>
    129
   </value>
   <value>
    130
   </value>
   <value>
    133
   </value>
   <value>
    134
   </value>
   <value>
    137
   </value>
   <value>
    138
   </value>
   <value>
    139
   </value>
   <value>
    140
   </value>
   <value>
    141
   </value>
   <value>
    142
   </value>
   <value>
    144
   </value>
   <value>
    146
   </value>
   <value>
    147
   </value>
   <value>
    152
   </value>
   <value>
    153
   </value>
   <value>
    154
   </value>
   <value>
    156
   </value>
   <value>
    157
   </value>
   <value>
    158
   </value>
   <value>
    159
   </value>
   <value>
    160
   </value>
   <value>
    162
   </value>
   <value>
    164
   </value>
   <value>
    168
   </value>
   <value>
    98
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    uric acid mg/dl
   </category>
   <value>
    2.59999990463257
   </value>
   <value>
    3.09999990463257
   </value>
   <value>
    4
   </value>
   <value>
    4.9
   </value>
   <value>
    5
   </value>
   <value>
    5.5
   </value>
   <value>
    5.6
   </value>
   <value>
    5.69999980926514
   </value>
   <value>
    5.8
   </value>
   <value>
    5.9
   </value>
   <value>
    6
   </value>
   <value>
    6.4
   </value>
   <value>
    6.6
   </value>
   <value>
    7.1
   </value>
   <value>
    7.8
   </value>
   <value>
    8.2
   </value>
   <value>
    n/a
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    DIASTOLIC BP &lt;20 WEEKS MMHG
   </name>
   <value>
    58
   </value>
   <value>
    60
   </value>
   <value>
    61
   </value>
   <value>
    62
   </value>
   <value>
    63
   </value>
   <value>
    64
   </value>
   <value>
    65
   </value>
   <value>
    66
   </value>
   <value>
    67
   </value>
   <value>
    68
   </value>
   <value>
    69
   </value>
   <value>
    70
   </value>
   <value>
    71
   </value>
   <value>
    72
   </value>
   <value>
    73
   </value>
   <value>
    75
   </value>
   <value>
    76
   </value>
   <value>
    77
   </value>
   <value>
    78
   </value>
   <value>
    79
   </value>
   <value>
    80
   </value>
   <value>
    84
   </value>
   <value>
    n/a
   </value>
   <value>
    na
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    DIASTOLIC BP AT DELIVERY MMHG
   </name>
   <value>
    100
   </value>
   <value>
    102
   </value>
   <value>
    108
   </value>
   <value>
    113
   </value>
   <value>
    115
   </value>
   <value>
    61
   </value>
   <value>
    63
   </value>
   <value>
    64
   </value>
   <value>
    65
   </value>
   <value>
    66
   </value>
   <value>
    67
   </value>
   <value>
    68
   </value>
   <value>
    70
   </value>
   <value>
    71
   </value>
   <value>
    72
   </value>
   <value>
    74
   </value>
   <value>
    76
   </value>
   <value>
    80
   </value>
   <value>
    85
   </value>
   <value>
    86
   </value>
   <value>
    87
   </value>
   <value>
    88
   </value>
   <value>
    91
   </value>
   <value>
    92
   </value>
   <value>
    94
   </value>
   <value>
    95
   </value>
   <value>
    96
   </value>
   <value>
    97
   </value>
   <value>
    98
   </value>
   <value>
    99
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    FETAL SEX
   </name>
   <value>
    female
   </value>
   <value>
    male
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    GESTATIONAL AGE AT DELIVERY WEEKS
   </name>
   <value>
    27.71
   </value>
   <value>
    28.14
   </value>
   <value>
    29.29
   </value>
   <value>
    29.71
   </value>
   <value>
    31.43
   </value>
   <value>
    32.57
   </value>
   <value>
    33.29
   </value>
   <value>
    33.71
   </value>
   <value>
    34.43
   </value>
   <value>
    34.71
   </value>
   <value>
    35.00
   </value>
   <value>
    36.57
   </value>
   <value>
    36.86
   </value>
   <value>
    37.14
   </value>
   <value>
    37.29
   </value>
   <value>
    37.57
   </value>
   <value>
    37.71
   </value>
   <value>
    37.86
   </value>
   <value>
    38.00
   </value>
   <value>
    38.29
   </value>
   <value>
    38.86
   </value>
   <value>
    39.00
   </value>
   <value>
    39.14
   </value>
   <value>
    39.29
   </value>
   <value>
    39.43
   </value>
   <value>
    39.57
   </value>
   <value>
    39.71
   </value>
   <value>
    39.86
   </value>
   <value>
    40.00
   </value>
   <value>
    40.14
   </value>
   <value>
    40.57
   </value>
   <value>
    40.71
   </value>
   <value>
    40.86
   </value>
   <value>
    41.14
   </value>
   <value>
    41.43
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    JURY
   </name>
   <value>
    4
   </value>
   <value>
    4.1
   </value>
   <value>
    4.3
   </value>
   <value>
    4.4
   </value>
   <value>
    4.5
   </value>
   <value>
    6
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    MATERNAL AGE YEARS
   </name>
   <value>
    17.77
   </value>
   <value>
    17.88
   </value>
   <value>
    18.71
   </value>
   <value>
    18.78
   </value>
   <value>
    19.22
   </value>
   <value>
    19.33
   </value>
   <value>
    19.61
   </value>
   <value>
    19.63
   </value>
   <value>
    20.34
   </value>
   <value>
    20.53
   </value>
   <value>
    21.84
   </value>
   <value>
    22.00
   </value>
   <value>
    23.04
   </value>
   <value>
    25.88
   </value>
   <value>
    25.95
   </value>
   <value>
    26.26
   </value>
   <value>
    26.46
   </value>
   <value>
    27.30
   </value>
   <value>
    27.49
   </value>
   <value>
    27.78
   </value>
   <value>
    28.33
   </value>
   <value>
    28.62
   </value>
   <value>
    29.16
   </value>
   <value>
    29.94
   </value>
   <value>
    30.10
   </value>
   <value>
    30.74
   </value>
   <value>
    31.30
   </value>
   <value>
    31.69
   </value>
   <value>
    31.83
   </value>
   <value>
    31.92
   </value>
   <value>
    32.31
   </value>
   <value>
    32.45
   </value>
   <value>
    32.65
   </value>
   <value>
    32.84
   </value>
   <value>
    32.87
   </value>
   <value>
    33.02
   </value>
   <value>
    33.17
   </value>
   <value>
    33.31
   </value>
   <value>
    33.49
   </value>
   <value>
    35.10
   </value>
   <value>
    35.43
   </value>
   <value>
    35.93
   </value>
   <value>
    36.81
   </value>
   <value>
    37.32
   </value>
   <value>
    37.62
   </value>
   <value>
    39.31
   </value>
   <value>
    43.11
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    MATERNAL RACE
   </name>
   <value>
    Black
   </value>
   <value>
    Nat Amer
   </value>
   <value>
    White
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    NULLIPAROUS
   </name>
   <value>
    0
   </value>
   <value>
    1
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    PRE-PREGANCY BMI
   </name>
   <value>
    18.28
   </value>
   <value>
    19.65
   </value>
   <value>
    19.78
   </value>
   <value>
    20.40
   </value>
   <value>
    20.47
   </value>
   <value>
    20.53
   </value>
   <value>
    20.64
   </value>
   <value>
    21.03
   </value>
   <value>
    21.08
   </value>
   <value>
    21.28
   </value>
   <value>
    21.30
   </value>
   <value>
    21.34
   </value>
   <value>
    21.46
   </value>
   <value>
    21.68
   </value>
   <value>
    21.79
   </value>
   <value>
    21.99
   </value>
   <value>
    22.19
   </value>
   <value>
    22.26
   </value>
   <value>
    22.72
   </value>
   <value>
    23.08
   </value>
   <value>
    23.22
   </value>
   <value>
    23.45
   </value>
   <value>
    23.77
   </value>
   <value>
    24.33
   </value>
   <value>
    24.50
   </value>
   <value>
    24.94
   </value>
   <value>
    24.99
   </value>
   <value>
    25.01
   </value>
   <value>
    25.11
   </value>
   <value>
    25.74
   </value>
   <value>
    25.85
   </value>
   <value>
    25.88
   </value>
   <value>
    25.92
   </value>
   <value>
    26.68
   </value>
   <value>
    26.85
   </value>
   <value>
    27.86
   </value>
   <value>
    28.21
   </value>
   <value>
    28.30
   </value>
   <value>
    28.85
   </value>
   <value>
    29.24
   </value>
   <value>
    30.18
   </value>
   <value>
    31.13
   </value>
   <value>
    32.52
   </value>
   <value>
    32.56
   </value>
   <value>
    35.94
   </value>
   <value>
    36.39
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    SYSTOLIC BP &lt;20 WEEKS MMHG
   </name>
   <value>
    100
   </value>
   <value>
    101
   </value>
   <value>
    103
   </value>
   <value>
    104
   </value>
   <value>
    105
   </value>
   <value>
    107
   </value>
   <value>
    108
   </value>
   <value>
    109
   </value>
   <value>
    110
   </value>
   <value>
    112
   </value>
   <value>
    113
   </value>
   <value>
    114
   </value>
   <value>
    115
   </value>
   <value>
    118
   </value>
   <value>
    119
   </value>
   <value>
    120
   </value>
   <value>
    122
   </value>
   <value>
    123
   </value>
   <value>
    124
   </value>
   <value>
    125
   </value>
   <value>
    126
   </value>
   <value>
    127
   </value>
   <value>
    133
   </value>
   <value>
    134
   </value>
   <value>
    135
   </value>
   <value>
    n/a
   </value>
   <value>
    na
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    SYSTOLIC BP AT DELIVERY MMHG
   </name>
   <value>
    102
   </value>
   <value>
    110
   </value>
   <value>
    114
   </value>
   <value>
    115
   </value>
   <value>
    117
   </value>
   <value>
    118
   </value>
   <value>
    121
   </value>
   <value>
    122
   </value>
   <value>
    124
   </value>
   <value>
    128
   </value>
   <value>
    129
   </value>
   <value>
    130
   </value>
   <value>
    133
   </value>
   <value>
    134
   </value>
   <value>
    137
   </value>
   <value>
    138
   </value>
   <value>
    139
   </value>
   <value>
    140
   </value>
   <value>
    141
   </value>
   <value>
    142
   </value>
   <value>
    144
   </value>
   <value>
    146
   </value>
   <value>
    147
   </value>
   <value>
    152
   </value>
   <value>
    153
   </value>
   <value>
    154
   </value>
   <value>
    156
   </value>
   <value>
    157
   </value>
   <value>
    158
   </value>
   <value>
    159
   </value>
   <value>
    160
   </value>
   <value>
    162
   </value>
   <value>
    164
   </value>
   <value>
    168
   </value>
   <value>
    98
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    URIC ACID MG/DL
   </name>
   <value>
    2.59999990463257
   </value>
   <value>
    3.09999990463257
   </value>
   <value>
    4
   </value>
   <value>
    4.9
   </value>
   <value>
    5
   </value>
   <value>
    5.5
   </value>
   <value>
    5.6
   </value>
   <value>
    5.69999980926514
   </value>
   <value>
    5.8
   </value>
   <value>
    5.9
   </value>
   <value>
    6
   </value>
   <value>
    6.4
   </value>
   <value>
    6.6
   </value>
   <value>
    7.1
   </value>
   <value>
    7.8
   </value>
   <value>
    8.2
   </value>
   <value>
    n/a
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    4
   </overallscore>
  </miamescores>
  <id>
   470399
  </id>
  <accession>
   E-GEOD-59274
  </accession>
  <secondaryaccession>
   GSE59274
  </secondaryaccession>
  <name>
   Comprehensive Analysis of Preeclampsia-Associated DNA Methylation in the Placenta
  </name>
  <experimenttype>
   methylation profiling by array
  </experimenttype>
  <releasedate>
   2014-07-12
  </releasedate>
  <lastupdatedate>
   2014-07-14
  </lastupdatedate>
  <samples>
   48
  </samples>
  <assays>
   48
  </assays>
  <arraydesign>
   <id>
    6828
   </id>
   <accession>
    A-GEOD-8490
   </accession>
   <name>
    Illumina HumanMethylation27 BeadChip (HumanMethylation27_270596_v.1.2)
   </name>
   <count>
    48
   </count>
   <legacy_id>
    2102792432
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    48
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    48
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    48
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    48
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    David G. Peters
   </contact>
   <role>
    submitter
   </role>
   <email>
    david.peters@mail.hgen.pitt.edu
   </email>
  </provider>
  <provider>
   <contact>
    David Peters
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    Background: A small number of recent reports have suggested that altered placental DNA methylation may be associated with early onset preeclampsia. It is important that further studies be undertaken to confirm and develop these findings. We therefore undertook a systematic analysis of DNA methylation patterns in placental tissue from 24 women with preeclampsia and 24 with uncomplicated pregnancy outcome.   Methods: We analyzed the DNA methylation status of approximately 27,000 CpG sites in placental tissues in a massively parallel fashion using an oligonucleotide microarray. Follow up analysis of DNA methylation at specific CpG loci was performed using the Epityper MassArray approach and high-throughput bisulfite sequencing.  Results: Preeclampsia-specific DNA methylation changes were identified in placental tissue samples irrespective of gestational age of delivery. In addition, we identified a group of CpG sites within specific gene sequences that were only altered in early onset-preeclampsia (EOPET) although these DNA methylation changes did not correlate with altered mRNA transcription. We found evidence that fetal gender influences DNA methylation at autosomal loci but could find no clear association between DNA methylation and gestational age.   Conclusion: Preeclampsia is associated with altered placental DNA methylation. Fetal gender should be carefully considered during the design of future studies in which placental DNA is analyzed at the level of DNA methylation. Further large-scale analyses of preeclampsia-associated DNA methylation are necessary. Bisulphite converted DNA from the 48 samples were hybridized to the Illumina Infinium 27k Human Methylation Beadchip v1.2
   </text>
  </description>
  <protocol>
   <id>
    1044140
   </id>
   <accession>
    P-GSE59274-5
   </accession>
  </protocol>
  <protocol>
   <id>
    1044143
   </id>
   <accession>
    P-GSE59274-2
   </accession>
  </protocol>
  <protocol>
   <id>
    1044139
   </id>
   <accession>
    P-GSE59274-1
   </accession>
  </protocol>
  <protocol>
   <id>
    1044141
   </id>
   <accession>
    P-GSE59274-4
   </accession>
  </protocol>
  <protocol>
   <id>
    1044142
   </id>
   <accession>
    P-GSE59274-3
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <fgem available="true" name="E-GEOD-59274.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-59274.idf.txt">
   </idf>
   <sdrf name="E-GEOD-59274.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="false">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    disease state
   </category>
   <value>
    normal
   </value>
   <value>
    preeclampsia
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    gestational classification
   </category>
   <value>
    Preterm
   </value>
   <value>
    Term
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism part
   </category>
   <value>
    placenta
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    DISEASE STATE
   </name>
   <value>
    normal
   </value>
   <value>
    preeclampsia
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    GESTATIONAL CLASSIFICATION
   </name>
   <value>
    Preterm
   </value>
   <value>
    Term
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    0
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    3
   </overallscore>
  </miamescores>
  <id>
   444302
  </id>
  <accession>
   E-GEOD-57767
  </accession>
  <secondaryaccession>
   GSE57767
  </secondaryaccession>
  <name>
   Epigenome analysis of normal and preeclamptic placenta samples
  </name>
  <experimenttype>
   methylation profiling by array
  </experimenttype>
  <releasedate>
   2014-05-20
  </releasedate>
  <lastupdatedate>
   2014-05-25
  </lastupdatedate>
  <samples>
   45
  </samples>
  <assays>
   45
  </assays>
  <arraydesign>
   <id>
    19396
   </id>
   <accession>
    A-GEOD-13534
   </accession>
   <name>
    Illumina HumanMethylation450 BeadChip (HumanMethylation450_15017482_v.1.1)
   </name>
   <count>
    45
   </count>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    45
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    45
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    45
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    45
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Lauren Anton
   </contact>
   <role>
    submitter
   </role>
   <email>
    lanton@mail.med.upenn.edu
   </email>
  </provider>
  <provider>
   <contact>
    Michal A Elovitz
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Lauren Anton
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    Preeclampsia (PE), a hypertensive disorder of pregnancy, is hypothesized to be associated with, if not mechanistically related to abnormal placental function. However, the exact mechanisms regulating the pathogenesis of PE remain unclear. While many studies have investigated changes in gene expression in the PE placenta, the role of epigenetics in PE associated placental dysfunction remains unclear.  Using the genome-wide Illumina Infinium Methylation 450 BeadChip array, we analyzed gene-specific alterations in DNA methylation in placental biopsies collected from normal pregnant women delivering at term (n=14), with term PE (≥37 weeks; n=19) or with preterm PE (&lt;37 weeks, n=12).  Of the 485,582 gene loci on the array, compared to controls, 229 loci were differentially methylated in PE placentas and 3411 loci were differentially methylated in preterm PE (step up p-value &lt;0.05 and &gt;5% methylation difference). Functional annotation of the differentially methylated genes in preterm PE placentas revealed a 32 gene cluster in the cadherin and cell adhesion functional groups (Benjamini p&lt;0.00001). Hypermethylation of CDH11 (p=0.0143), COL5A1 (p=0.0127) and TNF (p=0.0098) and hypomethylation of NCAM1 (p=0.0158) was associated with altered mRNA expression in preterm PE placentas. These studies demonstrate aberrant methylation, correlating with disease severity, in PE placentas. Bisulphite converted DNA from the 45 samples were hybridised to the Illumina Infinium 450k Human Methylation Beadchip v1.2
   </text>
  </description>
  <protocol>
   <id>
    1017142
   </id>
   <accession>
    P-GSE57767-29
   </accession>
  </protocol>
  <protocol>
   <id>
    1017141
   </id>
   <accession>
    P-GSE57767-28
   </accession>
  </protocol>
  <protocol>
   <id>
    1017140
   </id>
   <accession>
    P-GSE57767-27
   </accession>
  </protocol>
  <protocol>
   <id>
    1017139
   </id>
   <accession>
    P-GSE57767-26
   </accession>
  </protocol>
  <protocol>
   <id>
    1017134
   </id>
   <accession>
    P-GSE57767-21
   </accession>
  </protocol>
  <protocol>
   <id>
    1017133
   </id>
   <accession>
    P-GSE57767-20
   </accession>
  </protocol>
  <protocol>
   <id>
    1017138
   </id>
   <accession>
    P-GSE57767-25
   </accession>
  </protocol>
  <protocol>
   <id>
    1017137
   </id>
   <accession>
    P-GSE57767-24
   </accession>
  </protocol>
  <protocol>
   <id>
    1017136
   </id>
   <accession>
    P-GSE57767-23
   </accession>
  </protocol>
  <protocol>
   <id>
    1017135
   </id>
   <accession>
    P-GSE57767-22
   </accession>
  </protocol>
  <protocol>
   <id>
    1017144
   </id>
   <accession>
    P-GSE57767-31
   </accession>
  </protocol>
  <protocol>
   <id>
    1017145
   </id>
   <accession>
    P-GSE57767-32
   </accession>
  </protocol>
  <protocol>
   <id>
    1017143
   </id>
   <accession>
    P-GSE57767-30
   </accession>
  </protocol>
  <protocol>
   <id>
    1017148
   </id>
   <accession>
    P-GSE57767-35
   </accession>
  </protocol>
  <protocol>
   <id>
    1017149
   </id>
   <accession>
    P-GSE57767-36
   </accession>
  </protocol>
  <protocol>
   <id>
    1017146
   </id>
   <accession>
    P-GSE57767-33
   </accession>
  </protocol>
  <protocol>
   <id>
    1017147
   </id>
   <accession>
    P-GSE57767-34
   </accession>
  </protocol>
  <protocol>
   <id>
    1017152
   </id>
   <accession>
    P-GSE57767-39
   </accession>
  </protocol>
  <protocol>
   <id>
    1017115
   </id>
   <accession>
    P-GSE57767-1
   </accession>
  </protocol>
  <protocol>
   <id>
    1017150
   </id>
   <accession>
    P-GSE57767-37
   </accession>
  </protocol>
  <protocol>
   <id>
    1017151
   </id>
   <accession>
    P-GSE57767-38
   </accession>
  </protocol>
  <protocol>
   <id>
    1017121
   </id>
   <accession>
    P-GSE57767-8
   </accession>
  </protocol>
  <protocol>
   <id>
    1017129
   </id>
   <accession>
    P-GSE57767-16
   </accession>
  </protocol>
  <protocol>
   <id>
    1017122
   </id>
   <accession>
    P-GSE57767-9
   </accession>
  </protocol>
  <protocol>
   <id>
    1017128
   </id>
   <accession>
    P-GSE57767-15
   </accession>
  </protocol>
  <protocol>
   <id>
    1017158
   </id>
   <accession>
    P-GSE57767-6
   </accession>
  </protocol>
  <protocol>
   <id>
    1017131
   </id>
   <accession>
    P-GSE57767-18
   </accession>
  </protocol>
  <protocol>
   <id>
    1017120
   </id>
   <accession>
    P-GSE57767-7
   </accession>
  </protocol>
  <protocol>
   <id>
    1017130
   </id>
   <accession>
    P-GSE57767-17
   </accession>
  </protocol>
  <protocol>
   <id>
    1017118
   </id>
   <accession>
    P-GSE57767-4
   </accession>
  </protocol>
  <protocol>
   <id>
    1017119
   </id>
   <accession>
    P-GSE57767-5
   </accession>
  </protocol>
  <protocol>
   <id>
    1017132
   </id>
   <accession>
    P-GSE57767-19
   </accession>
  </protocol>
  <protocol>
   <id>
    1017116
   </id>
   <accession>
    P-GSE57767-2
   </accession>
  </protocol>
  <protocol>
   <id>
    1017117
   </id>
   <accession>
    P-GSE57767-3
   </accession>
  </protocol>
  <protocol>
   <id>
    1017123
   </id>
   <accession>
    P-GSE57767-10
   </accession>
  </protocol>
  <protocol>
   <id>
    1017125
   </id>
   <accession>
    P-GSE57767-12
   </accession>
  </protocol>
  <protocol>
   <id>
    1017124
   </id>
   <accession>
    P-GSE57767-11
   </accession>
  </protocol>
  <protocol>
   <id>
    1017127
   </id>
   <accession>
    P-GSE57767-14
   </accession>
  </protocol>
  <protocol>
   <id>
    1017126
   </id>
   <accession>
    P-GSE57767-13
   </accession>
  </protocol>
  <protocol>
   <id>
    1017153
   </id>
   <accession>
    P-GSE57767-40
   </accession>
  </protocol>
  <protocol>
   <id>
    1017154
   </id>
   <accession>
    P-GSE57767-41
   </accession>
  </protocol>
  <protocol>
   <id>
    1017155
   </id>
   <accession>
    P-GSE57767-42
   </accession>
  </protocol>
  <protocol>
   <id>
    1017156
   </id>
   <accession>
    P-GSE57767-43
   </accession>
  </protocol>
  <protocol>
   <id>
    1017157
   </id>
   <accession>
    P-GSE57767-44
   </accession>
  </protocol>
  <protocol>
   <id>
    1017113
   </id>
   <accession>
    P-GSE57767-45
   </accession>
  </protocol>
  <protocol>
   <id>
    1017161
   </id>
   <accession>
    P-GSE57767-46
   </accession>
  </protocol>
  <protocol>
   <id>
    1017160
   </id>
   <accession>
    P-GSE57767-47
   </accession>
  </protocol>
  <protocol>
   <id>
    1017159
   </id>
   <accession>
    P-GSE57767-48
   </accession>
  </protocol>
  <protocol>
   <id>
    1017114
   </id>
   <accession>
    P-GSE57767-49
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <fgem available="true" name="E-GEOD-57767.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-57767.idf.txt">
   </idf>
   <sdrf name="E-GEOD-57767.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    age
   </category>
   <value>
    21
   </value>
   <value>
    23
   </value>
   <value>
    25
   </value>
   <value>
    26
   </value>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    30
   </value>
   <value>
    31
   </value>
   <value>
    32
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
   <value>
    40
   </value>
   <value>
    43
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    disease status
   </category>
   <value>
    healthy
   </value>
   <value>
    preeclampsia
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    gestational age weeks
   </category>
   <value>
    16
   </value>
   <value>
    18
   </value>
   <value>
    23
   </value>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    31
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    35
   </value>
   <value>
    36
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
   <value>
    40
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    matching
   </category>
   <value>
    A
   </value>
   <value>
    B
   </value>
   <value>
    C
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism part
   </category>
   <value>
    blood
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    severity
   </category>
   <value>
    NA
   </value>
   <value>
    NS
   </value>
   <value>
    S
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    AGE
   </name>
   <value>
    21
   </value>
   <value>
    23
   </value>
   <value>
    25
   </value>
   <value>
    26
   </value>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    30
   </value>
   <value>
    31
   </value>
   <value>
    32
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
   <value>
    40
   </value>
   <value>
    43
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    DISEASE STATUS
   </name>
   <value>
    healthy
   </value>
   <value>
    preeclampsia
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    GESTATIONAL AGE WEEKS
   </name>
   <value>
    16
   </value>
   <value>
    18
   </value>
   <value>
    23
   </value>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    31
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    35
   </value>
   <value>
    36
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
   <value>
    40
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    MATCHING
   </name>
   <value>
    A
   </value>
   <value>
    B
   </value>
   <value>
    C
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    SEVERITY
   </name>
   <value>
    NA
   </value>
   <value>
    NS
   </value>
   <value>
    S
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    1
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    5
   </overallscore>
  </miamescores>
  <id>
   443293
  </id>
  <accession>
   E-GEOD-48424
  </accession>
  <secondaryaccession>
   GSE48424
  </secondaryaccession>
  <name>
   Severe preeclampsia: new blood circulating biomarkers
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2014-05-14
  </releasedate>
  <lastupdatedate>
   2014-06-03
  </lastupdatedate>
  <samples>
   36
  </samples>
  <assays>
   36
  </assays>
  <arraydesign>
   <id>
    11853
   </id>
   <accession>
    A-AGIL-28
   </accession>
   <name>
    Agilent Whole Human Genome Microarray 4x44K 014850 G4112F (85 cols x 532 rows)
   </name>
   <count>
    36
   </count>
   <legacy_id>
    1316855037
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    36
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    36
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    36
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    36
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    36
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    36
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bibliography>
   <accession>
    24349325
   </accession>
   <authors>
    Textoris J, Ivorra D, Ben Amara A, Sabatier F, Mï¿½nard JP, Heckenroth H, Bretelle F, Mege JL
   </authors>
   <title>
    Evaluation of current and new biomarkers in severe preeclampsia: a microarray approach reveals the VSIG4 gene as a potential blood biomarker.
   </title>
   <doi>
    10.1371/journal.pone.0082638
   </doi>
  </bibliography>
  <provider>
   <contact>
    Jean L Mège
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Florence Bretelle
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Julien Textoris
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Amira B Amara
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Jean P Ménard
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Delphine Ivorra
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Hélène Heckenroth
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Julien Textoris
   </contact>
   <role>
    submitter
   </role>
   <email>
    julien.textoris@gmail.com
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    Background: Preeclampsia (PE) is a placental disease characterized by hypertension and proteinuria in pregnant women, which is associated with a high maternal and infantile morbidity. However, circulating biomarkers able to predict the prognosis of PE are lacking. Methods: Thirty-eight women were included in the study. They consisted of 19 patients with PE (13 with severe PE and 6 women with non-severe PE) and 19 gestational age-matched normal pregnancy controls. We measured coagulation pathway, endothelial responses and microparticle release and circulating gene expression in PE patient groups and normotensive controls. Results: The measurement of markers associated with coagulation pathway, endothelial activation and circulating microparticles enabled to discriminate PE from normal pregnancy but were not sufficient to distinguish severe from non-severe PE. PE patients also exhibited a specific transcriptional program distinct from that of control women and subtle differences were observed between severe and non-severe PE. Functional annotation of the up-modulated signature in PE highlighted two main functions related to ribosome and complement. Importantly, we found that 8 genes were specifically up-modulated in severe preeclampsia. Among these genes, the expression of VSIG4 was significantly increased in patients with severe preeclampsia in comparison with controls and patients with non-severe preeclampsia. Conclusion: Using transcriptional signatures of blood samples, we identified the gene encoding the estrogen receptor as a potential diagnostic marker of severe preeclampsia. In addition, the determination of this gene may improve the prognostic assessment of severe preeclampsia. Thirty-eight women were included in the study: 19 patients with PE, including 6 women with non-severe PE and 13 with severe PE, and 19 women with normal pregnancy (NP) selected according to age, weight, smoking status, race, gestational age at the inclusion, and blood pH (Table 1 of manuscript). Women with NP had no history of medical illness or medication, and received routing prenatal care. The diagnostic of PE was based on a blood pressure of ≥ 140/90 mmHg taken twice, uricemia above normal laboratory range (120-420 µmol/L), and proteinuria higher than 300 mg in a 24 hour-collection, occurring after 20 gestational weeks in previously normotensive women (Table 2). The criteria used to define severe PE included one of the following conditions: a blood pressure higher than 160/110 mmHg, a proteinuria higher than 1500 mg/24h), a multisystem disorder, maternal cerebral symptoms (seizures, stroke) or intrauterine growth restriction below the 3° percentile. Women with multiple gestations, fetal congenital malformations/chromosomal abnormalities, recent infection, antiphospholipid antibodies, trauma, drug or alcohol abuse during pregnancy, preexisting hypertension, thrombophilia with PE history, or women receiving anticoagulant or antiaggregation therapy were excluded from the study. Two microarrays (one non-severe PE and one normal) were discarded from the analysis for technical reasons. Thus, only 36 microarrays are included here.
   </text>
  </description>
  <protocol>
   <id>
    1014966
   </id>
   <accession>
    P-GSE48424-1
   </accession>
  </protocol>
  <protocol>
   <id>
    1014968
   </id>
   <accession>
    P-GSE48424-4
   </accession>
  </protocol>
  <protocol>
   <id>
    1014967
   </id>
   <accession>
    P-GSE48424-5
   </accession>
  </protocol>
  <protocol>
   <id>
    1014970
   </id>
   <accession>
    P-GSE48424-2
   </accession>
  </protocol>
  <protocol>
   <id>
    1014969
   </id>
   <accession>
    P-GSE48424-3
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-GEOD-48424.raw.1.zip E-GEOD-48424.raw.2.zip">
   </raw>
   <fgem available="true" name="E-GEOD-48424.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-48424.idf.txt">
   </idf>
   <sdrf name="E-GEOD-48424.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    group
   </category>
   <value>
    normal
   </value>
   <value>
    preeclamptic
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism part
   </category>
   <value>
    villous tissue
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    GROUP
   </name>
   <value>
    normal
   </value>
   <value>
    preeclamptic
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    4
   </overallscore>
  </miamescores>
  <id>
   436278
  </id>
  <accession>
   E-GEOD-57050
  </accession>
  <secondaryaccession>
   GSE57050
  </secondaryaccession>
  <name>
   miRNA Profile in Normal and Preeclamptic Placenta
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2014-04-25
  </releasedate>
  <lastupdatedate>
   2014-06-03
  </lastupdatedate>
  <samples>
   10
  </samples>
  <assays>
   10
  </assays>
  <arraydesign>
   <id>
    18903
   </id>
   <accession>
    A-GEOD-14613
   </accession>
   <name>
    [miRNA-2_0] Affymetrix Multispecies miRNA-2_0 Array
   </name>
   <count>
    10
   </count>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    10
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    10
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    10
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    10
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    10
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    10
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Yuping Wang
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Yuping Wang
   </contact>
   <role>
    submitter
   </role>
   <email>
    ywang1@lsuhsc.edu
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    The purpose of this study was to determine the difference of the miRNA profiles between normal and preeclamptic placenta. Ten placental samples were analyzed.  Six were from preeclamptic patients and four were from normal pregnancies.
   </text>
  </description>
  <protocol>
   <id>
    1002125
   </id>
   <accession>
    P-GSE57050-7
   </accession>
  </protocol>
  <protocol>
   <id>
    1002124
   </id>
   <accession>
    P-GSE57050-1
   </accession>
  </protocol>
  <protocol>
   <id>
    1002129
   </id>
   <accession>
    P-GSE57050-2
   </accession>
  </protocol>
  <protocol>
   <id>
    1002127
   </id>
   <accession>
    P-GSE57050-5
   </accession>
  </protocol>
  <protocol>
   <id>
    1002126
   </id>
   <accession>
    P-GSE57050-6
   </accession>
  </protocol>
  <protocol>
   <id>
    1002128
   </id>
   <accession>
    P-GSE57050-3
   </accession>
  </protocol>
  <protocol>
   <id>
    1002130
   </id>
   <accession>
    P-GSE57050-4
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-GEOD-57050.raw.1.zip">
   </raw>
   <fgem available="true" name="E-GEOD-57050.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-57050.idf.txt">
   </idf>
   <sdrf name="E-GEOD-57050.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="false">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism part
   </category>
   <value>
    placenta
   </value>
  </sampleattribute>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    0
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    3
   </overallscore>
  </miamescores>
  <id>
   419265
  </id>
  <accession>
   E-GEOD-54618
  </accession>
  <secondaryaccession>
   GSE54618
  </secondaryaccession>
  <name>
   Microarray analysis of human pre-eclamptic placenta
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2014-04-01
  </releasedate>
  <lastupdatedate>
   2014-06-03
  </lastupdatedate>
  <samples>
   24
  </samples>
  <assays>
   24
  </assays>
  <arraydesign>
   <id>
    7604
   </id>
   <accession>
    A-GEOD-10558
   </accession>
   <name>
    Illumina HumanHT-12 V4.0 expression beadchip
   </name>
   <count>
    24
   </count>
   <legacy_id>
    2501282336
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    24
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    24
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    24
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    24
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    G B Afink
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    R Keijser
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    C Ris-Stalpers
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Remco Keijser
   </contact>
   <role>
    submitter
   </role>
   <email>
    r.keijser@amc.uva.nl
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    RNA was extracted from placentas selected based on normotensive pregnancy with low GBA messenger RNA expression and hypertensive pregnancy with relatively high expression of GBA messenger RNA. Total RNA was extracted from placental tissue biopsies stored in RNALater within 2 hours after delivery.
   </text>
  </description>
  <protocol>
   <id>
    985767
   </id>
   <accession>
    P-GSE54618-3
   </accession>
  </protocol>
  <protocol>
   <id>
    985768
   </id>
   <accession>
    P-GSE54618-2
   </accession>
  </protocol>
  <protocol>
   <id>
    985764
   </id>
   <accession>
    P-GSE54618-5
   </accession>
  </protocol>
  <protocol>
   <id>
    985766
   </id>
   <accession>
    P-GSE54618-4
   </accession>
  </protocol>
  <protocol>
   <id>
    985765
   </id>
   <accession>
    P-GSE54618-1
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <fgem available="true" name="E-GEOD-54618.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-54618.idf.txt">
   </idf>
   <sdrf name="E-GEOD-54618.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="false">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    genotype
   </category>
   <value>
    confined placental mosaicism
   </value>
   <value>
    control
   </value>
   <value>
    trisomy 16
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    gestational age weeks
   </category>
   <value>
    10
   </value>
   <value>
    25
   </value>
   <value>
    28
   </value>
   <value>
    32.43
   </value>
   <value>
    33
   </value>
   <value>
    33.72
   </value>
   <value>
    34
   </value>
   <value>
    36
   </value>
   <value>
    36.42
   </value>
   <value>
    36.57
   </value>
   <value>
    37
   </value>
   <value>
    37.28
   </value>
   <value>
    39
   </value>
   <value>
    5
   </value>
   <value>
    6
   </value>
   <value>
    6-10
   </value>
   <value>
    7
   </value>
   <value>
    8
   </value>
   <value>
    9
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism part
   </category>
   <value>
    placental chorionic villus
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    Sex
   </category>
   <value>
    female
   </value>
   <value>
    male
   </value>
   <value>
    N/A
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    GENOTYPE
   </name>
   <value>
    confined placental mosaicism
   </value>
   <value>
    control
   </value>
   <value>
    trisomy 16
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    GESTATIONAL AGE WEEKS
   </name>
   <value>
    10
   </value>
   <value>
    25
   </value>
   <value>
    28
   </value>
   <value>
    32.43
   </value>
   <value>
    33
   </value>
   <value>
    33.72
   </value>
   <value>
    34
   </value>
   <value>
    36
   </value>
   <value>
    36.42
   </value>
   <value>
    36.57
   </value>
   <value>
    37
   </value>
   <value>
    37.28
   </value>
   <value>
    39
   </value>
   <value>
    5
   </value>
   <value>
    6
   </value>
   <value>
    6-10
   </value>
   <value>
    7
   </value>
   <value>
    8
   </value>
   <value>
    9
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    SEX
   </name>
   <value>
    female
   </value>
   <value>
    male
   </value>
   <value>
    N/A
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    0
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    3
   </overallscore>
  </miamescores>
  <id>
   394397
  </id>
  <accession>
   E-GEOD-49343
  </accession>
  <secondaryaccession>
   GSE49343
  </secondaryaccession>
  <name>
   Overlapping DNA methylation profile between placentas with trisomy 16 and early-onset preeclampsia
  </name>
  <experimenttype>
   methylation profiling by array
  </experimenttype>
  <releasedate>
   2014-01-15
  </releasedate>
  <lastupdatedate>
   2014-01-26
  </lastupdatedate>
  <samples>
   30
  </samples>
  <assays>
   30
  </assays>
  <arraydesign>
   <id>
    19396
   </id>
   <accession>
    A-GEOD-13534
   </accession>
   <name>
    Illumina HumanMethylation450 BeadChip (HumanMethylation450_15017482_v.1.1)
   </name>
   <count>
    30
   </count>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    30
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    30
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    30
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    30
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    John D Blair
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    John Blair
   </contact>
   <role>
    submitter
   </role>
   <email>
    john.blair@mail.mcgill.ca
   </email>
  </provider>
  <provider>
   <contact>
    Sylvie Langlois
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Deborah E McFadden
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Wendy P Robinson
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    Preeclampsia is one of the leading causes of maternal death worldwide. While the root cause is still unknown, the underlying biology of the disorder is becoming more clear. We recently published a study showing large, significant differences in DNA methylation in 3rd trimester placental samples associated with early-onset preeclampsia (EOPET) compared to controls. In this study, to identify DNA methylation differences associated with preeclampsia that occur early in pregnancy and to further delineate common EOPET-associated differences, we utilized a genetic defect, trisomy 16 (T16), that is predisposing to preeclampsia. We ran T16 placental samples from the 1st trimester (n=5) and 3rd trimester (n=10) against gestational age matched controls on the Illumina Infinium HumanMethylation450 BeadChip. Third trimester samples were from pregnancies with T16 confined to the placenta (confined placental mosaicism 16;CPM16), and consisted of samples that were and were not associated with EOPET (n=5 each). We identified a large number of  DNA methylation differences in CPM16 samples compared to controls using stringent criteria (n=2254;False Discovery Rate &lt;0.01, -&gt;0.15). Several of these differences (11%) overlapped differences observed in chromosomally normal EOPET using similarly stringent criteria (FDR&lt;0.01;-&gt;0.125). Isolating EOPET-associated probes produced a similar - distribution amongst CPM16 samples, although samples associated with EOPET showed a tendency towards larger DNA methylation differences. We also identified 262 DNA methylation differences between 1st trimester T16 and 1st trimester controls. Of these, 77 overlapped differences seen in 3rd trimester CPM16. Investigating these 77 T16/CPM16 specific DNA methylation differences, we identified three probes near two genes (ARGHEF37 and JUNB) that were also present as EOPET-associated methylation differences.  In summary, we identified significant overlapping DNA methylation profiles of placentas with T16 and chromosomally normal placentas associated with EOPET. Specific DNA methylation marks within these profiles may be of future clinical utility in early identification of pregnancies susceptible to EOPET. Bisulfite converted DNA from 5 1st trimester trisomy 16 placentas, 5 chromosomally normal 1st trimester placentas, 10 third trimester placentas from confined placental mosaicism placentas and 10 chromosomally normal 3rd trimester placentas
   </text>
  </description>
  <protocol>
   <id>
    940764
   </id>
   <accession>
    P-GSE49343-29
   </accession>
  </protocol>
  <protocol>
   <id>
    940768
   </id>
   <accession>
    P-GSE49343-25
   </accession>
  </protocol>
  <protocol>
   <id>
    940767
   </id>
   <accession>
    P-GSE49343-26
   </accession>
  </protocol>
  <protocol>
   <id>
    940766
   </id>
   <accession>
    P-GSE49343-27
   </accession>
  </protocol>
  <protocol>
   <id>
    940765
   </id>
   <accession>
    P-GSE49343-28
   </accession>
  </protocol>
  <protocol>
   <id>
    940797
   </id>
   <accession>
    P-GSE49343-33
   </accession>
  </protocol>
  <protocol>
   <id>
    940795
   </id>
   <accession>
    P-GSE49343-32
   </accession>
  </protocol>
  <protocol>
   <id>
    940793
   </id>
   <accession>
    P-GSE49343-35
   </accession>
  </protocol>
  <protocol>
   <id>
    940794
   </id>
   <accession>
    P-GSE49343-34
   </accession>
  </protocol>
  <protocol>
   <id>
    940790
   </id>
   <accession>
    P-GSE49343-2
   </accession>
  </protocol>
  <protocol>
   <id>
    940796
   </id>
   <accession>
    P-GSE49343-31
   </accession>
  </protocol>
  <protocol>
   <id>
    940763
   </id>
   <accession>
    P-GSE49343-30
   </accession>
  </protocol>
  <protocol>
   <id>
    940791
   </id>
   <accession>
    P-GSE49343-1
   </accession>
  </protocol>
  <protocol>
   <id>
    940788
   </id>
   <accession>
    P-GSE49343-4
   </accession>
  </protocol>
  <protocol>
   <id>
    940789
   </id>
   <accession>
    P-GSE49343-3
   </accession>
  </protocol>
  <protocol>
   <id>
    940786
   </id>
   <accession>
    P-GSE49343-6
   </accession>
  </protocol>
  <protocol>
   <id>
    940787
   </id>
   <accession>
    P-GSE49343-5
   </accession>
  </protocol>
  <protocol>
   <id>
    940784
   </id>
   <accession>
    P-GSE49343-8
   </accession>
  </protocol>
  <protocol>
   <id>
    940782
   </id>
   <accession>
    P-GSE49343-10
   </accession>
  </protocol>
  <protocol>
   <id>
    940781
   </id>
   <accession>
    P-GSE49343-11
   </accession>
  </protocol>
  <protocol>
   <id>
    940785
   </id>
   <accession>
    P-GSE49343-7
   </accession>
  </protocol>
  <protocol>
   <id>
    940780
   </id>
   <accession>
    P-GSE49343-12
   </accession>
  </protocol>
  <protocol>
   <id>
    940792
   </id>
   <accession>
    P-GSE49343-13
   </accession>
  </protocol>
  <protocol>
   <id>
    940783
   </id>
   <accession>
    P-GSE49343-9
   </accession>
  </protocol>
  <protocol>
   <id>
    940775
   </id>
   <accession>
    P-GSE49343-18
   </accession>
  </protocol>
  <protocol>
   <id>
    940762
   </id>
   <accession>
    P-GSE49343-36
   </accession>
  </protocol>
  <protocol>
   <id>
    940774
   </id>
   <accession>
    P-GSE49343-19
   </accession>
  </protocol>
  <protocol>
   <id>
    940777
   </id>
   <accession>
    P-GSE49343-16
   </accession>
  </protocol>
  <protocol>
   <id>
    940776
   </id>
   <accession>
    P-GSE49343-17
   </accession>
  </protocol>
  <protocol>
   <id>
    940779
   </id>
   <accession>
    P-GSE49343-14
   </accession>
  </protocol>
  <protocol>
   <id>
    940778
   </id>
   <accession>
    P-GSE49343-15
   </accession>
  </protocol>
  <protocol>
   <id>
    940769
   </id>
   <accession>
    P-GSE49343-24
   </accession>
  </protocol>
  <protocol>
   <id>
    940770
   </id>
   <accession>
    P-GSE49343-23
   </accession>
  </protocol>
  <protocol>
   <id>
    940771
   </id>
   <accession>
    P-GSE49343-22
   </accession>
  </protocol>
  <protocol>
   <id>
    940772
   </id>
   <accession>
    P-GSE49343-21
   </accession>
  </protocol>
  <protocol>
   <id>
    940773
   </id>
   <accession>
    P-GSE49343-20
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <fgem available="true" name="E-GEOD-49343.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-49343.idf.txt">
   </idf>
   <sdrf name="E-GEOD-49343.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    biological replicate
   </category>
   <value>
    1
   </value>
   <value>
    2
   </value>
   <value>
    3
   </value>
   <value>
    4
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    cd14
   </category>
   <value>
    NO
   </value>
   <value>
    YES
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    cell type
   </category>
   <value>
    CD14
   </value>
   <value>
    MGC
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    source placenta
   </category>
   <value>
    1
   </value>
   <value>
    2
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    time days of culture
   </category>
   <value>
    0
   </value>
   <value>
    9
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    BIOLOGICAL REPLICATE
   </name>
   <value>
    1
   </value>
   <value>
    2
   </value>
   <value>
    3
   </value>
   <value>
    4
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    CD14
   </name>
   <value>
    NO
   </value>
   <value>
    YES
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    CELL TYPE
   </name>
   <value>
    CD14
   </value>
   <value>
    MGC
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    SOURCE PLACENTA
   </name>
   <value>
    1
   </value>
   <value>
    2
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    TIME DAYS OF CULTURE
   </name>
   <value>
    0
   </value>
   <value>
    9
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    1
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    5
   </overallscore>
  </miamescores>
  <id>
   390321
  </id>
  <accession>
   E-GEOD-38747
  </accession>
  <secondaryaccession>
   GSE38747
  </secondaryaccession>
  <name>
   Regulatory role of multinucleated giant cells derived from placental CD14+ macrophages: Pathophysiological implications
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2014-01-07
  </releasedate>
  <lastupdatedate>
   2014-06-02
  </lastupdatedate>
  <samples>
   12
  </samples>
  <assays>
   12
  </assays>
  <arraydesign>
   <id>
    11853
   </id>
   <accession>
    A-AGIL-28
   </accession>
   <name>
    Agilent Whole Human Genome Microarray 4x44K 014850 G4112F (85 cols x 532 rows)
   </name>
   <count>
    12
   </count>
   <legacy_id>
    1316855037
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    12
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    12
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    12
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    12
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    12
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    12
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bibliography>
   <accession>
    24163411
   </accession>
   <authors>
    Ben Amara A, Gorvel L, Baulan K, Derain-Court J, Buffat C, Vï¿½rollet C, Textoris J, Ghigo E, Bretelle F, Maridonneau-Parini I, Mege JL
   </authors>
   <title>
    Placental macrophages are impaired in chorioamnionitis, an infectious pathology of the placenta.
   </title>
   <doi>
    10.4049/jimmunol.1300988
   </doi>
  </bibliography>
  <provider>
   <contact>
    Jean-Louis Mège
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Abdoulaye O Barry
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Christian Capo
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Julien Textoris
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Vikram Mehaj
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Amira Ben Amara
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Eric Ghigo
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Isabelle Maridonneau-Parini
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Christel Verollet
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Justine Derain-Court
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Florence Bretelle
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Julien Textoris
   </contact>
   <role>
    submitter
   </role>
   <email>
    julien.textoris@gmail.com
   </email>
  </provider>
  <provider>
   <contact>
    Laurent Gorvel
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    The role of placental macrophages is largely ignored in the success of pregnancy. We found that CD14+ macrophages purified from at-term placentas spontaneously matured into multinucleated giant cells (MGCs). MGCs lost the expression of CD14 and co-inhibitory molecules, such as Programmed cell Death-Ligands 1 and 2. Although MGCs kept phagocytosis and property to produce ROS, their inflammatory potential measured by TNF/IL-10 imbalance and activation of p38 MAPK and NF-κB was blunted without being associated with M2 phenotype. The investigation of gene expression revealed the enrichment with categories related to inflammation, apoptosis and canonical functions of macrophages in MGCs. Whereas most of the genes associated with inflammation and immune responses were down-modulated, those such as VEGFC or associated with matrix remodeling were specifically up-regulated in MGCs. Importantly, we found that patients with preeclampsia or chorioamnionitis, two inflammatory and infectious pathologies, respectively, that affect placentas, were unable to generate MGCs. Taken together, these results suggest that MGCs represent a new way to regulate the inflammatory and cytocidal activity of placental macrophages in a context that imposes contradictory constraints, such as semi-allograft acceptance and defense against aggression. The dysregulation of MGC formation may be associated with placental inflammatory and infectious pathologies. Placental macrophages CD14+ were cultured for 9 days to form multinucleated giant cells (MGC). The transcriptome of MGCs was compared to the transcriptome of placental macrophages (CD14+)
   </text>
  </description>
  <protocol>
   <id>
    935125
   </id>
   <accession>
    P-GSE38747-1
   </accession>
  </protocol>
  <protocol>
   <id>
    935131
   </id>
   <accession>
    P-GSE38747-3
   </accession>
  </protocol>
  <protocol>
   <id>
    935129
   </id>
   <accession>
    P-GSE38747-2
   </accession>
  </protocol>
  <protocol>
   <id>
    935130
   </id>
   <accession>
    P-GSE38747-4
   </accession>
  </protocol>
  <protocol>
   <id>
    935128
   </id>
   <accession>
    P-GSE38747-5
   </accession>
  </protocol>
  <protocol>
   <id>
    935127
   </id>
   <accession>
    P-GSE38747-6
   </accession>
  </protocol>
  <protocol>
   <id>
    935126
   </id>
   <accession>
    P-GSE38747-7
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-GEOD-38747.raw.1.zip">
   </raw>
   <fgem available="true" name="E-GEOD-38747.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-38747.idf.txt">
   </idf>
   <sdrf name="E-GEOD-38747.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    condition
   </category>
   <value>
    control
   </value>
   <value>
    Pre-Eclampsia
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism part
   </category>
   <value>
    placenta
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    CONDITION
   </name>
   <value>
    control
   </value>
   <value>
    Pre-Eclampsia
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    1
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    5
   </overallscore>
  </miamescores>
  <id>
   350262
  </id>
  <accession>
   E-GEOD-47187
  </accession>
  <secondaryaccession>
   GSE47187
  </secondaryaccession>
  <name>
   Analysis of differentially expressed genes in placental tissues of Pre-eclampsia Using microarray combined with Connectivity Map database
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2013-10-01
  </releasedate>
  <lastupdatedate>
   2014-06-03
  </lastupdatedate>
  <samples>
   10
  </samples>
  <assays>
   5
  </assays>
  <arraydesign>
   <id>
    18943
   </id>
   <accession>
    A-GEOD-14550
   </accession>
   <name>
    Agilent-028004 SurePrint G3 Human GE 8x60K Microarray (Probe Name Version)
   </name>
   <count>
    5
   </count>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    5
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    5
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    5
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    5
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    5
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    5
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    wang liang
   </contact>
   <role>
    submitter
   </role>
   <email>
    llwang@biochainbj.com
   </email>
  </provider>
  <provider>
   <contact>
    Juntao Liu
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Yingna Song
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Liang Zhang
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Saiqiong Huang
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    Preeclampsia (PE), which affects 2-7% of human pregnancies, causes significant maternal and neonatal morbidity and mortality. To better understand the pathophysiology of PE, gene expression profiling of placental tissue from 5 controls and 5 PEs were assessed using microarray. A total of 224 transcripts were identified as being significantly differentially expressed (fold change &gt; 2 and q value &lt; 0.05 in the SAM software), GO enrichment analysis indicated that genes involved hypoxia, oxidative and reductive processes were significantly changed. Ten differentially expressed genes (DEGs) involved in these biological process were further verified by quantitative real-time PCR. Finally, the potential therapeutic agents for PE were explored via Connectivity Map database . In conclusion, the data obtained in this study might provide clues to better understand the pathophysiology of PE and found potential therapeutic agents for PE patients. gene expression profiling of placental tissue from 5 controls and 5 PEs were assessed using microarray.
   </text>
  </description>
  <protocol>
   <id>
    866032
   </id>
   <accession>
    P-GSE47187-7
   </accession>
  </protocol>
  <protocol>
   <id>
    866037
   </id>
   <accession>
    P-GSE47187-3
   </accession>
  </protocol>
  <protocol>
   <id>
    866036
   </id>
   <accession>
    P-GSE47187-4
   </accession>
  </protocol>
  <protocol>
   <id>
    866034
   </id>
   <accession>
    P-GSE47187-5
   </accession>
  </protocol>
  <protocol>
   <id>
    866033
   </id>
   <accession>
    P-GSE47187-6
   </accession>
  </protocol>
  <protocol>
   <id>
    866031
   </id>
   <accession>
    P-GSE47187-1
   </accession>
  </protocol>
  <protocol>
   <id>
    866035
   </id>
   <accession>
    P-GSE47187-2
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-GEOD-47187.raw.1.zip">
   </raw>
   <fgem available="true" name="E-GEOD-47187.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-47187.idf.txt">
   </idf>
   <sdrf name="E-GEOD-47187.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    disease state
   </category>
   <value>
    normal
   </value>
   <value>
    preeclampsia
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    mean arterial pressure mmhg
   </category>
   <value>
    101
   </value>
   <value>
    113
   </value>
   <value>
    120.7
   </value>
   <value>
    121.7
   </value>
   <value>
    129.7
   </value>
   <value>
    131
   </value>
   <value>
    84.3
   </value>
   <value>
    86.7
   </value>
   <value>
    89.3
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism part
   </category>
   <value>
    placenta
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    urine protein
   </category>
   <value>
    2+
   </value>
   <value>
    3+
   </value>
   <value>
    _
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    DISEASE STATE
   </name>
   <value>
    normal
   </value>
   <value>
    preeclampsia
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    MEAN ARTERIAL PRESSURE MMHG
   </name>
   <value>
    101
   </value>
   <value>
    113
   </value>
   <value>
    120.7
   </value>
   <value>
    121.7
   </value>
   <value>
    129.7
   </value>
   <value>
    131
   </value>
   <value>
    84.3
   </value>
   <value>
    86.7
   </value>
   <value>
    89.3
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    URINE PROTEIN
   </name>
   <value>
    2+
   </value>
   <value>
    3+
   </value>
   <value>
    _
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    1
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    5
   </overallscore>
  </miamescores>
  <id>
   344336
  </id>
  <accession>
   E-GEOD-50783
  </accession>
  <secondaryaccession>
   GSE50783
  </secondaryaccession>
  <name>
   LncRNAs Expression in Preeclampsia Placenta Reveals the Potential Role of LncRNAs Contributing to Preeclampsia Pathogenesis
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2013-09-12
  </releasedate>
  <lastupdatedate>
   2014-05-13
  </lastupdatedate>
  <samples>
   11
  </samples>
  <assays>
   11
  </assays>
  <arraydesign>
   <id>
    20944
   </id>
   <accession>
    A-GEOD-15314
   </accession>
   <name>
    Arraystar Human LncRNA microarray V2.0 (Agilent_033010 Probe Name version)
   </name>
   <count>
    11
   </count>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    11
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    11
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    11
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    11
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    11
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    11
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Xiaoju He
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Huiying Huang
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Jiusheng Zheng
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Yu OuYang
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Binrong Xi
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Huai Liu
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Xiaofei Zhou
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Wei Deng
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Yinyan He
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Qinhua Cai
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    xiaoju He
   </contact>
   <role>
    submitter
   </role>
   <email>
    hexiaoju21@163.com
   </email>
  </provider>
  <provider>
   <contact>
    Xiaoming Zeng
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Chen Wang
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Qixiang Huang
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Siming Xin
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    Background: Long non-coding RNAs (lncRNAs) are an important class of pervasive genes involved in a variety of biological functions. They are aberrantly expressed in many types of diseases. We want to study the lncRNAs profiles in preeclampsia. Preeclampsia has been observed in patients with molar pregnancy where a fetus is absent demonstrating that the placenta is sufficient to cause the condition. So we analyze the lncRNAs profiles in preeclampsia placentas. In this study, we described the lncRNAs profiles in 6 preeclampsia placentas (T) and 5 matched normal pregnancy placentas (N) tissues by microarray. Methodology/Principal Findings: With abundant and varied probes accounting 33,045 LncRNAs in our microarray, the number of lncRNAs that expressed at a certain level could be detected is 28,443. From the data we found there were 738 lncRNAs that differentially expressed (≥1.5 fold-change) among preeclampsia placentas compared with matched controls. Up to 18,063 coding transcripts could be detected in placenta samples through 30,215 coding transcripts probes. Coding-non-coding gene co-expression networks (CNC network) were constructed based on the correlation analysis between the differential expressed lncRNAs and mRNAs. According to the GO-Pathway analysis of differential expressed lncRNAs/mRNAs, we choose three lncRNAs to analyze the relationship between lncRNAs and preeclampsia. LOC391533, LOC284100, CEACAMP8 were evaluated by qPCR in 40 of preeclampsia placentas and 40 of controls. The results showed three lncRNAs were aberrantly expressed in preeclampsia placentas compared with controls. Conclusions/Significance: Our study is the first one to determine genome-wide lncRNAs expression patterns in preeclampsia placenta by microarray. The results displayed that clusters of lncRNAs were aberrantly expressed in preeclampsia placenta compared with controls, which revealed that lncRNAs differentially expressed in preeclampsia placenta may exert a partial or key role in preeclampsia development. Misregulation of LOC391533, LOC284100, CEACAMP8 might be associated with preeclampsia. Taken together, this study may provide potential targets for future treatment of preeclampsia and novel insights into preeclampsia biology. LncRNAs/mRNAs profiles in 6 preeclampsia placentas and 5 matched normal pregnancy placentas tissues by microarray using Arraystar v2.0.
   </text>
  </description>
  <protocol>
   <id>
    856174
   </id>
   <accession>
    P-GSE50783-3
   </accession>
  </protocol>
  <protocol>
   <id>
    856173
   </id>
   <accession>
    P-GSE50783-4
   </accession>
  </protocol>
  <protocol>
   <id>
    856171
   </id>
   <accession>
    P-GSE50783-1
   </accession>
  </protocol>
  <protocol>
   <id>
    856175
   </id>
   <accession>
    P-GSE50783-2
   </accession>
  </protocol>
  <protocol>
   <id>
    856172
   </id>
   <accession>
    P-GSE50783-5
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-GEOD-50783.raw.1.zip">
   </raw>
   <fgem available="true" name="E-GEOD-50783.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-50783.idf.txt">
   </idf>
   <sdrf name="E-GEOD-50783.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    cell type
   </category>
   <value>
    Human Umbilical Vein Endothelial Cells (HUVEC)
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    0
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    3
   </overallscore>
  </miamescores>
  <id>
   320283
  </id>
  <accession>
   E-GEOD-41681
  </accession>
  <secondaryaccession>
   GSE41681
  </secondaryaccession>
  <name>
   Influence of plasma from normal and preeclamptic women on HUVEC cells
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2013-06-30
  </releasedate>
  <lastupdatedate>
   2014-06-02
  </lastupdatedate>
  <samples>
   4
  </samples>
  <assays>
   4
  </assays>
  <arraydesign>
   <id>
    18943
   </id>
   <accession>
    A-GEOD-14550
   </accession>
   <name>
    Agilent-028004 SurePrint G3 Human GE 8x60K Microarray (Probe Name Version)
   </name>
   <count>
    4
   </count>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    4
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    4
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    4
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    4
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    4
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    4
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Daniel Vaiman
   </contact>
   <role>
    submitter
   </role>
   <email>
    vaiman@cochin.inserm.fr
   </email>
  </provider>
  <provider>
   <contact>
    Daniel Vaiman
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    Plasma from normal and preeclamptic pregnancies was collected and added in the culture medium of HUVEC cells. The aims are double: identifying putative biomarkers that could be modified recurrently in the endothelium under preeclampsia and understand at term the molecular bases of the increased risk of cardiovascular and kidney diseases in woman that have had a preeclampsia. 2 pools of 3 control plasmas and 2 pools of 4 preeclamptic plasma were organized and added at a concentration of 1/10 on HUVEC cells, during 24 hours before transcriptomic analysis
   </text>
  </description>
  <protocol>
   <id>
    797533
   </id>
   <accession>
    P-GSE41681-6
   </accession>
  </protocol>
  <protocol>
   <id>
    797532
   </id>
   <accession>
    P-GSE41681-7
   </accession>
  </protocol>
  <protocol>
   <id>
    797531
   </id>
   <accession>
    P-GSE41681-1
   </accession>
  </protocol>
  <protocol>
   <id>
    797536
   </id>
   <accession>
    P-GSE41681-3
   </accession>
  </protocol>
  <protocol>
   <id>
    797535
   </id>
   <accession>
    P-GSE41681-2
   </accession>
  </protocol>
  <protocol>
   <id>
    797534
   </id>
   <accession>
    P-GSE41681-5
   </accession>
  </protocol>
  <protocol>
   <id>
    797537
   </id>
   <accession>
    P-GSE41681-4
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-GEOD-41681.raw.1.zip">
   </raw>
   <fgem available="true" name="E-GEOD-41681.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-41681.idf.txt">
   </idf>
   <sdrf name="E-GEOD-41681.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="false">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    condition
   </category>
   <value>
    control
   </value>
   <value>
    EOPET
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    fetus gender
   </category>
   <value>
   </value>
   <value>
    female
   </value>
   <value>
    male
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    gestational age weeks
   </category>
   <value>
    24.86
   </value>
   <value>
    25
   </value>
   <value>
    25.42
   </value>
   <value>
    26
   </value>
   <value>
    26.86
   </value>
   <value>
    28
   </value>
   <value>
    28.56
   </value>
   <value>
    31.42
   </value>
   <value>
    31.7
   </value>
   <value>
    32
   </value>
   <value>
    32.28
   </value>
   <value>
    32.42
   </value>
   <value>
    32.56
   </value>
   <value>
    32.7
   </value>
   <value>
    32.86
   </value>
   <value>
    33.4
   </value>
   <value>
    33.56
   </value>
   <value>
    33.7
   </value>
   <value>
    33.86
   </value>
   <value>
    34
   </value>
   <value>
    36
   </value>
   <value>
    37.28
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism part
   </category>
   <value>
    Chorionic Villi
   </value>
   <value>
    placental chorionic villus
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    CONDITION
   </name>
   <value>
    control
   </value>
   <value>
    EOPET
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    FETUS GENDER
   </name>
   <value>
    female
   </value>
   <value>
    male
   </value>
   <value>
    not specified
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    GESTATIONAL AGE WEEKS
   </name>
   <value>
    24.86
   </value>
   <value>
    25
   </value>
   <value>
    25.42
   </value>
   <value>
    26
   </value>
   <value>
    26.86
   </value>
   <value>
    28
   </value>
   <value>
    28.56
   </value>
   <value>
    31.42
   </value>
   <value>
    31.7
   </value>
   <value>
    32
   </value>
   <value>
    32.28
   </value>
   <value>
    32.42
   </value>
   <value>
    32.56
   </value>
   <value>
    32.7
   </value>
   <value>
    32.86
   </value>
   <value>
    33.4
   </value>
   <value>
    33.56
   </value>
   <value>
    33.7
   </value>
   <value>
    33.86
   </value>
   <value>
    34
   </value>
   <value>
    36
   </value>
   <value>
    37.28
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    ORGANISM PART
   </name>
   <value>
    Chorionic Villi
   </value>
   <value>
    placental chorionic villus
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    0
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    3
   </overallscore>
  </miamescores>
  <id>
   317330
  </id>
  <accession>
   E-GEOD-44712
  </accession>
  <secondaryaccession>
   GSE44712
  </secondaryaccession>
  <name>
   Early-Onset Preeclampsia Placentas and Controls
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <experimenttype>
   methylation profiling by array
  </experimenttype>
  <releasedate>
   2013-06-21
  </releasedate>
  <lastupdatedate>
   2014-05-03
  </lastupdatedate>
  <samples>
   56
  </samples>
  <assays>
   56
  </assays>
  <arraydesign>
   <id>
    19396
   </id>
   <accession>
    A-GEOD-13534
   </accession>
   <name>
    Illumina HumanMethylation450 BeadChip (HumanMethylation450_15017482_v.1.1)
   </name>
   <count>
    40
   </count>
  </arraydesign>
  <arraydesign>
   <id>
    7604
   </id>
   <accession>
    A-GEOD-10558
   </accession>
   <name>
    Illumina HumanHT-12 V4.0 expression beadchip
   </name>
   <count>
    16
   </count>
   <legacy_id>
    2501282336
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    56
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    56
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    56
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    56
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    John Blair
   </contact>
   <role>
    submitter
   </role>
   <email>
    john.blair@mail.mcgill.ca
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
   </text>
  </description>
  <protocol>
   <id>
    791317
   </id>
   <accession>
    P-GSE44712-9
   </accession>
  </protocol>
  <protocol>
   <id>
    791306
   </id>
   <accession>
    P-GSE44712-8
   </accession>
  </protocol>
  <protocol>
   <id>
    791310
   </id>
   <accession>
    P-GSE44712-3
   </accession>
  </protocol>
  <protocol>
   <id>
    791314
   </id>
   <accession>
    P-GSE44712-2
   </accession>
  </protocol>
  <protocol>
   <id>
    235758
   </id>
   <accession>
   </accession>
  </protocol>
  <protocol>
   <id>
    791307
   </id>
   <accession>
    P-GSE44712-1
   </accession>
  </protocol>
  <protocol>
   <id>
    791308
   </id>
   <accession>
    P-GSE44712-7
   </accession>
  </protocol>
  <protocol>
   <id>
    791309
   </id>
   <accession>
    P-GSE44712-6
   </accession>
  </protocol>
  <protocol>
   <id>
    791311
   </id>
   <accession>
    P-GSE44712-5
   </accession>
  </protocol>
  <protocol>
   <id>
    791312
   </id>
   <accession>
    P-GSE44712-4
   </accession>
  </protocol>
  <protocol>
   <id>
    791313
   </id>
   <accession>
    P-GSE44712-12
   </accession>
  </protocol>
  <protocol>
   <id>
    791315
   </id>
   <accession>
    P-GSE44712-11
   </accession>
  </protocol>
  <protocol>
   <id>
    791316
   </id>
   <accession>
    P-GSE44712-10
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <fgem available="true" name="E-GEOD-44712.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-44712.idf.txt">
   </idf>
   <sdrf name="E-GEOD-44712.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="false">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    condition
   </category>
   <value>
    control
   </value>
   <value>
    EOPET
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    gestational age weeks
   </category>
   <value>
    24.86
   </value>
   <value>
    25
   </value>
   <value>
    26
   </value>
   <value>
    31.42
   </value>
   <value>
    31.7
   </value>
   <value>
    32
   </value>
   <value>
    32.42
   </value>
   <value>
    32.56
   </value>
   <value>
    32.86
   </value>
   <value>
    33.7
   </value>
   <value>
    34
   </value>
   <value>
    36
   </value>
   <value>
    37.28
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism part
   </category>
   <value>
    Chorionic Villi
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    CONDITION
   </name>
   <value>
    control
   </value>
   <value>
    EOPET
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    GESTATIONAL AGE WEEKS
   </name>
   <value>
    24.86
   </value>
   <value>
    25
   </value>
   <value>
    26
   </value>
   <value>
    31.42
   </value>
   <value>
    31.7
   </value>
   <value>
    32
   </value>
   <value>
    32.42
   </value>
   <value>
    32.56
   </value>
   <value>
    32.86
   </value>
   <value>
    33.7
   </value>
   <value>
    34
   </value>
   <value>
    36
   </value>
   <value>
    37.28
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    4
   </overallscore>
  </miamescores>
  <id>
   317327
  </id>
  <accession>
   E-GEOD-44711
  </accession>
  <secondaryaccession>
   GSE44711
  </secondaryaccession>
  <name>
   Gene expression in Early-Onset Preeclampsia Placentas and Controls
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2013-06-21
  </releasedate>
  <lastupdatedate>
   2014-06-02
  </lastupdatedate>
  <samples>
   16
  </samples>
  <assays>
   16
  </assays>
  <arraydesign>
   <id>
    7604
   </id>
   <accession>
    A-GEOD-10558
   </accession>
   <name>
    Illumina HumanHT-12 V4.0 expression beadchip
   </name>
   <count>
    16
   </count>
   <legacy_id>
    2501282336
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    16
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    16
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    16
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    16
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Wendy P Robinson
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    John Blair
   </contact>
   <role>
    submitter
   </role>
   <email>
    john.blair@mail.mcgill.ca
   </email>
  </provider>
  <provider>
   <contact>
    Peter von Dadelszen
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    John D Blair
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Ryan K Yuen
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    We investigated the DNA methylation and gene expression of 20 chorionic villi samples from early onset preeclampsia placentas to 20 gestational age matched controls. From this we were able to see a widespread disregulation in DNA methylation across a subset of genes in the genome. This may help to elucidate the underlying biological problems that lead to early onset preeclampsia. We noted that there were DNA methylation changes in many genes of importance as well as in different genomic elements such as enhancers. RNA from 8 Early Onset Preeclampsia placentas and 8 gestational age matched controls
   </text>
  </description>
  <protocol>
   <id>
    791284
   </id>
   <accession>
    P-GSE44711-5
   </accession>
  </protocol>
  <protocol>
   <id>
    791286
   </id>
   <accession>
    P-GSE44711-3
   </accession>
  </protocol>
  <protocol>
   <id>
    791285
   </id>
   <accession>
    P-GSE44711-4
   </accession>
  </protocol>
  <protocol>
   <id>
    791283
   </id>
   <accession>
    P-GSE44711-1
   </accession>
  </protocol>
  <protocol>
   <id>
    791287
   </id>
   <accession>
    P-GSE44711-2
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <fgem available="true" name="E-GEOD-44711.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-44711.idf.txt">
   </idf>
   <sdrf name="E-GEOD-44711.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="false">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    condition
   </category>
   <value>
    control
   </value>
   <value>
    EOPET
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    fetus gender
   </category>
   <value>
    female
   </value>
   <value>
    male
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    gestational age weeks
   </category>
   <value>
    24.86
   </value>
   <value>
    25
   </value>
   <value>
    25.42
   </value>
   <value>
    26
   </value>
   <value>
    26.86
   </value>
   <value>
    28
   </value>
   <value>
    28.56
   </value>
   <value>
    31.42
   </value>
   <value>
    31.7
   </value>
   <value>
    32
   </value>
   <value>
    32.28
   </value>
   <value>
    32.42
   </value>
   <value>
    32.56
   </value>
   <value>
    32.7
   </value>
   <value>
    32.86
   </value>
   <value>
    33.4
   </value>
   <value>
    33.56
   </value>
   <value>
    33.7
   </value>
   <value>
    33.86
   </value>
   <value>
    34
   </value>
   <value>
    36
   </value>
   <value>
    37.28
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism part
   </category>
   <value>
    placental chorionic villus
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    CONDITION
   </name>
   <value>
    control
   </value>
   <value>
    EOPET
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    FETUS GENDER
   </name>
   <value>
    female
   </value>
   <value>
    male
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    GESTATIONAL AGE WEEKS
   </name>
   <value>
    24.86
   </value>
   <value>
    25
   </value>
   <value>
    25.42
   </value>
   <value>
    26
   </value>
   <value>
    26.86
   </value>
   <value>
    28
   </value>
   <value>
    28.56
   </value>
   <value>
    31.42
   </value>
   <value>
    31.7
   </value>
   <value>
    32
   </value>
   <value>
    32.28
   </value>
   <value>
    32.42
   </value>
   <value>
    32.56
   </value>
   <value>
    32.7
   </value>
   <value>
    32.86
   </value>
   <value>
    33.4
   </value>
   <value>
    33.56
   </value>
   <value>
    33.7
   </value>
   <value>
    33.86
   </value>
   <value>
    34
   </value>
   <value>
    36
   </value>
   <value>
    37.28
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    0
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    3
   </overallscore>
  </miamescores>
  <id>
   317332
  </id>
  <accession>
   E-GEOD-44667
  </accession>
  <secondaryaccession>
   GSE44667
  </secondaryaccession>
  <name>
   DNA methylation in Early Onset Preeclamptic placentas
  </name>
  <experimenttype>
   methylation profiling by array
  </experimenttype>
  <releasedate>
   2013-06-21
  </releasedate>
  <lastupdatedate>
   2013-07-01
  </lastupdatedate>
  <samples>
   40
  </samples>
  <assays>
   40
  </assays>
  <arraydesign>
   <id>
    19396
   </id>
   <accession>
    A-GEOD-13534
   </accession>
   <name>
    Illumina HumanMethylation450 BeadChip (HumanMethylation450_15017482_v.1.1)
   </name>
   <count>
    40
   </count>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    40
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    40
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    40
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    40
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Wendy P Robinson
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    John D Blair
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    John Blair
   </contact>
   <role>
    submitter
   </role>
   <email>
    john.blair@mail.mcgill.ca
   </email>
  </provider>
  <provider>
   <contact>
    Ryan K Yuen
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Peter von Dadelszen
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    We investigated the DNA methylation and gene expression of 20 chorionic villi samples from early onset preeclampsia placentas to 20 gestational age matched controls. From this we were able to see a widespread disregulation in DNA methylation across a subset of genes in the genome. This may help to elucidate the underlying biological problems that lead to early onset preeclampsia. We noted that there were DNA methylation changes in many genes of importance as well as in different genomic elements such as enhancers. Bisulfite converted DNA from 20 third trimester early onset preeclampsia placentas and 20 gestational age matched controls
   </text>
  </description>
  <protocol>
   <id>
    791323
   </id>
   <accession>
    P-GSE44667-5
   </accession>
  </protocol>
  <protocol>
   <id>
    791322
   </id>
   <accession>
    P-GSE44667-6
   </accession>
  </protocol>
  <protocol>
   <id>
    791321
   </id>
   <accession>
    P-GSE44667-7
   </accession>
  </protocol>
  <protocol>
   <id>
    791320
   </id>
   <accession>
    P-GSE44667-1
   </accession>
  </protocol>
  <protocol>
   <id>
    791326
   </id>
   <accession>
    P-GSE44667-2
   </accession>
  </protocol>
  <protocol>
   <id>
    791325
   </id>
   <accession>
    P-GSE44667-3
   </accession>
  </protocol>
  <protocol>
   <id>
    791324
   </id>
   <accession>
    P-GSE44667-4
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <fgem available="true" name="E-GEOD-44667.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-44667.idf.txt">
   </idf>
   <sdrf name="E-GEOD-44667.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    phenotype
   </category>
   <value>
    normal
   </value>
   <value>
    preeclampsia
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    PHENOTYPE
   </name>
   <value>
    normal
   </value>
   <value>
    preeclampsia
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    0
   </reportersequencescore>
   <protocolscore>
    1
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    4
   </overallscore>
  </miamescores>
  <id>
   415380
  </id>
  <accession>
   E-GEOD-43942
  </accession>
  <secondaryaccession>
   GSE43942
  </secondaryaccession>
  <name>
   Gene expression profiling for placentas from pre-eclamptic and normal pregnancies
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2013-02-01
  </releasedate>
  <lastupdatedate>
   2014-04-03
  </lastupdatedate>
  <samples>
   12
  </samples>
  <assays>
   12
  </assays>
  <arraydesign>
   <id>
    7509
   </id>
   <accession>
    A-GEOD-10191
   </accession>
   <name>
    NimbleGen Homo sapiens HG18 Expression Array (12x135k)
   </name>
   <count>
    12
   </count>
   <legacy_id>
    2351978272
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    12
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    12
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    12
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    12
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    12
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    12
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Yuqian Xiang
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Xinzhi Zhao
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    qian Yu Xiang
   </contact>
   <role>
    submitter
   </role>
   <email>
    xiangqianfd@gmail.com
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    Investigation of whole genome gene expression level changes between placentas from pregnancies with PE and placentas from normal pregnancies to search for the candiadate genes for further DNA methylation analysis The differentially expressed genes LEP and SH3PXD2A were further analyzed by DNA methylation. 5 placentas from pregnancies with PE and 7 from normal subjects were included in the gene expression microarray analysis.
   </text>
  </description>
  <protocol>
   <id>
    982690
   </id>
   <accession>
    P-GSE43942-1
   </accession>
  </protocol>
  <protocol>
   <id>
    982695
   </id>
   <accession>
    P-GSE43942-2
   </accession>
  </protocol>
  <protocol>
   <id>
    982694
   </id>
   <accession>
    P-GSE43942-3
   </accession>
  </protocol>
  <protocol>
   <id>
    982693
   </id>
   <accession>
    P-GSE43942-4
   </accession>
  </protocol>
  <protocol>
   <id>
    982692
   </id>
   <accession>
    P-GSE43942-5
   </accession>
  </protocol>
  <protocol>
   <id>
    982691
   </id>
   <accession>
    P-GSE43942-6
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-GEOD-43942.raw.1.zip">
   </raw>
   <fgem available="true" name="E-GEOD-43942.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-43942.idf.txt">
   </idf>
   <sdrf name="E-GEOD-43942.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="false">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    Organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism part
   </category>
   <value>
    Fused Cytotrophoblast cells (syncitiotrophoblast)
   </value>
   <value>
    Isolated Cytotrophoblast
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    ORGANISM PART
   </name>
   <value>
    Fused Cytotrophoblast cells (syncitiotrophoblast)
   </value>
   <value>
    Isolated Cytotrophoblast
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    TREATMENT
   </name>
   <value>
    1% oxygen conditions, 0 nm vitamin D
   </value>
   <value>
    1% oxygen conditions, 10 nm vitamin D
   </value>
   <value>
    1% oxygen conditions, 100 nm vitamin D
   </value>
   <value>
    20% oxygen conditions, 0 nm vitamin D
   </value>
   <value>
    20% oxygen conditions, 10 nm vitamin D
   </value>
   <value>
    20% oxygen conditions, 100 nm vitamin D
   </value>
   <value>
    8% oxygen conditions, 0 nm vitamin D
   </value>
   <value>
    8% oxygen conditions, 10 nm vitamin D
   </value>
   <value>
    8% oxygen conditions, 100 nm vitamin D
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    0
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    3
   </overallscore>
  </miamescores>
  <id>
   270285
  </id>
  <accession>
   E-GEOD-41336
  </accession>
  <secondaryaccession>
   GSE41336
  </secondaryaccession>
  <name>
   Cultured Cyto and Syncytio-trophoblast samples exposed to varying degrees of hypoxia (methylation)
  </name>
  <experimenttype>
   methylation profiling by array
  </experimenttype>
  <releasedate>
   2013-01-18
  </releasedate>
  <lastupdatedate>
   2013-01-28
  </lastupdatedate>
  <samples>
   90
  </samples>
  <assays>
   90
  </assays>
  <arraydesign>
   <id>
    19396
   </id>
   <accession>
    A-GEOD-13534
   </accession>
   <name>
    Illumina HumanMethylation450 BeadChip (HumanMethylation450_15017482_v.1.1)
   </name>
   <count>
    90
   </count>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    90
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    90
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    90
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    90
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bibliography>
   <accession>
    23314690
   </accession>
   <authors>
    Yuen RK, Chen B, Blair JD, Robinson WP, Nelson DM
   </authors>
   <title>
    Hypoxia alters the epigenetic profile in cultured human placental trophoblasts.
   </title>
  </bibliography>
  <provider>
   <contact>
    Ryan C Yuen
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Baosheng Chen
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    John D Blair
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Wendy P Robinson
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    D M Nelson
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    John Blair
   </contact>
   <role>
    submitter
   </role>
   <email>
    john.blair@mail.mcgill.ca
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    The mechanisms by which the placenta adapts to exogenous stimuli to create a stable and healthy environment for the growing fetus are not well known. Low oxygen tension and sub-optimal vitamin D levels influence placental function and both are associated with preeclampsia, a condition associated with altered development of placental trophoblast. We hypothesized that oxygen tension, vitamin D levels, or both affect villous trophoblast by modulation of gene expression through DNA methylation. To test this we used the Illumina Infinium Human Methylation 450 BeadChip array to compare the DNA methylation profile of primary cultures of human cytotrophoblasts and syncytiotrophoblasts under three oxygen tensions and three vitamin D levels. We found no effect on global DNA methylation by either treatment, but a limited set of loci became hypermethylated in cytotrophoblasts exposed for 24 hours to 1% oxygen, as compared to the same cells exposed to 8% or 20% oxygen. Vitamin D levels had no detectable effect on methylation profiles in either trophoblast type. Hypermethylation with low oxygen tension was independently confirmed by bisulfite-pyrosequencing in a subset of functionally important genes including CP, ITGA5, SOD2, XDH and ZNF2. Intriguingly, 70 out of the 147 hypoxia-associated CpGs, overlapped with CpG sites that become hypomethylated upon differentiation of cytotrophoblasts into syncytiotrophoblasts. Furthermore, the preponderance of altered sites was located at AP-1 binding sites. We suggest that AP-1 expression is triggered by hypoxia and interacts with DNA methyltransferases (DNMTs) to target methylation at specific sites in the genome, thus causing suppression of the associated genes that are responsible for differentiation of villous cytotrophoblast to syncytiotrophoblast. DNA from 2 cell types from 5 placentas exposed to 3 different conditions of hypoxia (1%,8%,20%) and treated with 3 levels of vitamin D were bisulfite converted and run on the Illumina HumanMethylation450 BeadChip
   </text>
  </description>
  <protocol>
   <id>
    700226
   </id>
   <accession>
    P-GSE41336-80
   </accession>
  </protocol>
  <protocol>
   <id>
    700180
   </id>
   <accession>
    P-GSE41336-81
   </accession>
  </protocol>
  <protocol>
   <id>
    700179
   </id>
   <accession>
    P-GSE41336-82
   </accession>
  </protocol>
  <protocol>
   <id>
    700227
   </id>
   <accession>
    P-GSE41336-83
   </accession>
  </protocol>
  <protocol>
   <id>
    700228
   </id>
   <accession>
    P-GSE41336-84
   </accession>
  </protocol>
  <protocol>
   <id>
    700176
   </id>
   <accession>
    P-GSE41336-85
   </accession>
  </protocol>
  <protocol>
   <id>
    700178
   </id>
   <accession>
    P-GSE41336-86
   </accession>
  </protocol>
  <protocol>
   <id>
    700259
   </id>
   <accession>
    P-GSE41336-88
   </accession>
  </protocol>
  <protocol>
   <id>
    700185
   </id>
   <accession>
    P-GSE41336-87
   </accession>
  </protocol>
  <protocol>
   <id>
    700261
   </id>
   <accession>
    P-GSE41336-89
   </accession>
  </protocol>
  <protocol>
   <id>
    700222
   </id>
   <accession>
    P-GSE41336-70
   </accession>
  </protocol>
  <protocol>
   <id>
    700230
   </id>
   <accession>
    P-GSE41336-71
   </accession>
  </protocol>
  <protocol>
   <id>
    700184
   </id>
   <accession>
    P-GSE41336-74
   </accession>
  </protocol>
  <protocol>
   <id>
    700183
   </id>
   <accession>
    P-GSE41336-75
   </accession>
  </protocol>
  <protocol>
   <id>
    700223
   </id>
   <accession>
    P-GSE41336-72
   </accession>
  </protocol>
  <protocol>
   <id>
    700224
   </id>
   <accession>
    P-GSE41336-73
   </accession>
  </protocol>
  <protocol>
   <id>
    700181
   </id>
   <accession>
    P-GSE41336-79
   </accession>
  </protocol>
  <protocol>
   <id>
    700225
   </id>
   <accession>
    P-GSE41336-78
   </accession>
  </protocol>
  <protocol>
   <id>
    700182
   </id>
   <accession>
    P-GSE41336-77
   </accession>
  </protocol>
  <protocol>
   <id>
    700229
   </id>
   <accession>
    P-GSE41336-76
   </accession>
  </protocol>
  <protocol>
   <id>
    700205
   </id>
   <accession>
    P-GSE41336-61
   </accession>
  </protocol>
  <protocol>
   <id>
    700189
   </id>
   <accession>
    P-GSE41336-62
   </accession>
  </protocol>
  <protocol>
   <id>
    700188
   </id>
   <accession>
    P-GSE41336-63
   </accession>
  </protocol>
  <protocol>
   <id>
    700219
   </id>
   <accession>
    P-GSE41336-64
   </accession>
  </protocol>
  <protocol>
   <id>
    700217
   </id>
   <accession>
    P-GSE41336-60
   </accession>
  </protocol>
  <protocol>
   <id>
    700220
   </id>
   <accession>
    P-GSE41336-69
   </accession>
  </protocol>
  <protocol>
   <id>
    700231
   </id>
   <accession>
    P-GSE41336-66
   </accession>
  </protocol>
  <protocol>
   <id>
    700187
   </id>
   <accession>
    P-GSE41336-65
   </accession>
  </protocol>
  <protocol>
   <id>
    700221
   </id>
   <accession>
    P-GSE41336-68
   </accession>
  </protocol>
  <protocol>
   <id>
    700186
   </id>
   <accession>
    P-GSE41336-67
   </accession>
  </protocol>
  <protocol>
   <id>
    700248
   </id>
   <accession>
    P-GSE41336-52
   </accession>
  </protocol>
  <protocol>
   <id>
    700193
   </id>
   <accession>
    P-GSE41336-53
   </accession>
  </protocol>
  <protocol>
   <id>
    700247
   </id>
   <accession>
    P-GSE41336-50
   </accession>
  </protocol>
  <protocol>
   <id>
    700191
   </id>
   <accession>
    P-GSE41336-51
   </accession>
  </protocol>
  <protocol>
   <id>
    700218
   </id>
   <accession>
    P-GSE41336-59
   </accession>
  </protocol>
  <protocol>
   <id>
    700199
   </id>
   <accession>
    P-GSE41336-58
   </accession>
  </protocol>
  <protocol>
   <id>
    700196
   </id>
   <accession>
    P-GSE41336-57
   </accession>
  </protocol>
  <protocol>
   <id>
    700197
   </id>
   <accession>
    P-GSE41336-56
   </accession>
  </protocol>
  <protocol>
   <id>
    700244
   </id>
   <accession>
    P-GSE41336-55
   </accession>
  </protocol>
  <protocol>
   <id>
    700190
   </id>
   <accession>
    P-GSE41336-54
   </accession>
  </protocol>
  <protocol>
   <id>
    700209
   </id>
   <accession>
    P-GSE41336-8
   </accession>
  </protocol>
  <protocol>
   <id>
    700210
   </id>
   <accession>
    P-GSE41336-7
   </accession>
  </protocol>
  <protocol>
   <id>
    700208
   </id>
   <accession>
    P-GSE41336-9
   </accession>
  </protocol>
  <protocol>
   <id>
    700215
   </id>
   <accession>
    P-GSE41336-2
   </accession>
  </protocol>
  <protocol>
   <id>
    700216
   </id>
   <accession>
    P-GSE41336-1
   </accession>
  </protocol>
  <protocol>
   <id>
    700213
   </id>
   <accession>
    P-GSE41336-4
   </accession>
  </protocol>
  <protocol>
   <id>
    700195
   </id>
   <accession>
    P-GSE41336-40
   </accession>
  </protocol>
  <protocol>
   <id>
    700214
   </id>
   <accession>
    P-GSE41336-3
   </accession>
  </protocol>
  <protocol>
   <id>
    700249
   </id>
   <accession>
    P-GSE41336-42
   </accession>
  </protocol>
  <protocol>
   <id>
    700211
   </id>
   <accession>
    P-GSE41336-6
   </accession>
  </protocol>
  <protocol>
   <id>
    700212
   </id>
   <accession>
    P-GSE41336-5
   </accession>
  </protocol>
  <protocol>
   <id>
    700241
   </id>
   <accession>
    P-GSE41336-41
   </accession>
  </protocol>
  <protocol>
   <id>
    700250
   </id>
   <accession>
    P-GSE41336-43
   </accession>
  </protocol>
  <protocol>
   <id>
    700194
   </id>
   <accession>
    P-GSE41336-44
   </accession>
  </protocol>
  <protocol>
   <id>
    700243
   </id>
   <accession>
    P-GSE41336-45
   </accession>
  </protocol>
  <protocol>
   <id>
    700245
   </id>
   <accession>
    P-GSE41336-46
   </accession>
  </protocol>
  <protocol>
   <id>
    700192
   </id>
   <accession>
    P-GSE41336-47
   </accession>
  </protocol>
  <protocol>
   <id>
    700242
   </id>
   <accession>
    P-GSE41336-48
   </accession>
  </protocol>
  <protocol>
   <id>
    700246
   </id>
   <accession>
    P-GSE41336-49
   </accession>
  </protocol>
  <protocol>
   <id>
    700256
   </id>
   <accession>
    P-GSE41336-31
   </accession>
  </protocol>
  <protocol>
   <id>
    700167
   </id>
   <accession>
    P-GSE41336-30
   </accession>
  </protocol>
  <protocol>
   <id>
    700204
   </id>
   <accession>
    P-GSE41336-34
   </accession>
  </protocol>
  <protocol>
   <id>
    700198
   </id>
   <accession>
    P-GSE41336-35
   </accession>
  </protocol>
  <protocol>
   <id>
    700236
   </id>
   <accession>
    P-GSE41336-32
   </accession>
  </protocol>
  <protocol>
   <id>
    700169
   </id>
   <accession>
    P-GSE41336-33
   </accession>
  </protocol>
  <protocol>
   <id>
    700262
   </id>
   <accession>
    P-GSE41336-38
   </accession>
  </protocol>
  <protocol>
   <id>
    700251
   </id>
   <accession>
    P-GSE41336-39
   </accession>
  </protocol>
  <protocol>
   <id>
    700239
   </id>
   <accession>
    P-GSE41336-36
   </accession>
  </protocol>
  <protocol>
   <id>
    700240
   </id>
   <accession>
    P-GSE41336-37
   </accession>
  </protocol>
  <protocol>
   <id>
    700201
   </id>
   <accession>
    P-GSE41336-20
   </accession>
  </protocol>
  <protocol>
   <id>
    700252
   </id>
   <accession>
    P-GSE41336-25
   </accession>
  </protocol>
  <protocol>
   <id>
    700253
   </id>
   <accession>
    P-GSE41336-26
   </accession>
  </protocol>
  <protocol>
   <id>
    700173
   </id>
   <accession>
    P-GSE41336-27
   </accession>
  </protocol>
  <protocol>
   <id>
    700171
   </id>
   <accession>
    P-GSE41336-28
   </accession>
  </protocol>
  <protocol>
   <id>
    700238
   </id>
   <accession>
    P-GSE41336-21
   </accession>
  </protocol>
  <protocol>
   <id>
    700200
   </id>
   <accession>
    P-GSE41336-22
   </accession>
  </protocol>
  <protocol>
   <id>
    700258
   </id>
   <accession>
    P-GSE41336-23
   </accession>
  </protocol>
  <protocol>
   <id>
    700257
   </id>
   <accession>
    P-GSE41336-24
   </accession>
  </protocol>
  <protocol>
   <id>
    700237
   </id>
   <accession>
    P-GSE41336-29
   </accession>
  </protocol>
  <protocol>
   <id>
    700235
   </id>
   <accession>
    P-GSE41336-16
   </accession>
  </protocol>
  <protocol>
   <id>
    700203
   </id>
   <accession>
    P-GSE41336-17
   </accession>
  </protocol>
  <protocol>
   <id>
    700232
   </id>
   <accession>
    P-GSE41336-14
   </accession>
  </protocol>
  <protocol>
   <id>
    700234
   </id>
   <accession>
    P-GSE41336-15
   </accession>
  </protocol>
  <protocol>
   <id>
    700254
   </id>
   <accession>
    P-GSE41336-12
   </accession>
  </protocol>
  <protocol>
   <id>
    700206
   </id>
   <accession>
    P-GSE41336-13
   </accession>
  </protocol>
  <protocol>
   <id>
    700207
   </id>
   <accession>
    P-GSE41336-10
   </accession>
  </protocol>
  <protocol>
   <id>
    700233
   </id>
   <accession>
    P-GSE41336-11
   </accession>
  </protocol>
  <protocol>
   <id>
    700170
   </id>
   <accession>
    P-GSE41336-95
   </accession>
  </protocol>
  <protocol>
   <id>
    700172
   </id>
   <accession>
    P-GSE41336-94
   </accession>
  </protocol>
  <protocol>
   <id>
    700166
   </id>
   <accession>
    P-GSE41336-97
   </accession>
  </protocol>
  <protocol>
   <id>
    700168
   </id>
   <accession>
    P-GSE41336-96
   </accession>
  </protocol>
  <protocol>
   <id>
    700174
   </id>
   <accession>
    P-GSE41336-91
   </accession>
  </protocol>
  <protocol>
   <id>
    700260
   </id>
   <accession>
    P-GSE41336-90
   </accession>
  </protocol>
  <protocol>
   <id>
    700255
   </id>
   <accession>
    P-GSE41336-18
   </accession>
  </protocol>
  <protocol>
   <id>
    700177
   </id>
   <accession>
    P-GSE41336-93
   </accession>
  </protocol>
  <protocol>
   <id>
    700175
   </id>
   <accession>
    P-GSE41336-92
   </accession>
  </protocol>
  <protocol>
   <id>
    700202
   </id>
   <accession>
    P-GSE41336-19
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <fgem available="true" name="E-GEOD-41336.processed.1.zip E-GEOD-41336.processed.2.zip E-GEOD-41336.processed.3.zip">
   </fgem>
   <idf name="E-GEOD-41336.idf.txt">
   </idf>
   <sdrf name="E-GEOD-41336.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="false">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    Organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism part
   </category>
   <value>
    Isolated Cytotrophoblast
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    TREATMENT
   </name>
   <value>
    1% oxygen conditions, 0 nm vitamin D
   </value>
   <value>
    1% oxygen conditions, 10 nm vitamin D
   </value>
   <value>
    1% oxygen conditions, 100 nm vitamin D
   </value>
   <value>
    20% oxygen conditions, 0 nm vitamin D
   </value>
   <value>
    20% oxygen conditions, 10 nm vitamin D
   </value>
   <value>
    20% oxygen conditions, 100 nm vitamin D
   </value>
   <value>
    8% oxygen conditions, 0 nm vitamin D
   </value>
   <value>
    8% oxygen conditions, 10 nm vitamin D
   </value>
   <value>
    8% oxygen conditions, 100 nm vitamin D
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    4
   </overallscore>
  </miamescores>
  <id>
   270284
  </id>
  <accession>
   E-GEOD-41331
  </accession>
  <secondaryaccession>
   GSE41331
  </secondaryaccession>
  <name>
   Cultured Cyto and Syncytio-trophoblast samples exposed to varying degrees of hypoxia (expression)
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2013-01-18
  </releasedate>
  <lastupdatedate>
   2014-06-02
  </lastupdatedate>
  <samples>
   15
  </samples>
  <assays>
   15
  </assays>
  <arraydesign>
   <id>
    7604
   </id>
   <accession>
    A-GEOD-10558
   </accession>
   <name>
    Illumina HumanHT-12 V4.0 expression beadchip
   </name>
   <count>
    15
   </count>
   <legacy_id>
    2501282336
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    15
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    15
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    15
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    15
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bibliography>
   <accession>
    23314690
   </accession>
   <authors>
    Yuen RK, Chen B, Blair JD, Robinson WP, Nelson DM
   </authors>
   <title>
    Hypoxia alters the epigenetic profile in cultured human placental trophoblasts.
   </title>
  </bibliography>
  <provider>
   <contact>
    John Blair
   </contact>
   <role>
    submitter
   </role>
   <email>
    john.blair@mail.mcgill.ca
   </email>
  </provider>
  <provider>
   <contact>
    D M Nelson
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Baosheng Chen
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Ryan C Yuen
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Wendy P Robinson
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    John D Blair
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    The mechanisms by which the placenta adapts to exogenous stimuli to create a stable and healthy environment for the growing fetus are not well known. Low oxygen tension and sub-optimal vitamin D levels influence placental function and both are associated with preeclampsia, a condition associated with altered development of placental trophoblast. We hypothesized that oxygen tension, vitamin D levels, or both affect villous trophoblast by modulation of gene expression through DNA methylation. To test this we used the Illumina Infinium Human Methylation 450 BeadChip array to compare the DNA methylation profile of primary cultures of human cytotrophoblasts and syncytiotrophoblasts under three oxygen tensions and three vitamin D levels. We found no effect on global DNA methylation by either treatment, but a limited set of loci became hypermethylated in cytotrophoblasts exposed for 24 hours to 1% oxygen, as compared to the same cells exposed to 8% or 20% oxygen. Vitamin D levels had no detectable effect on methylation profiles in either trophoblast type. Hypermethylation with low oxygen tension was independently confirmed by bisulfite-pyrosequencing in a subset of functionally important genes including CP, ITGA5, SOD2, XDH and ZNF2. Intriguingly, 70 out of the 147 hypoxia-associated CpGs, overlapped with CpG sites that become hypomethylated upon differentiation of cytotrophoblasts into syncytiotrophoblasts. Furthermore, the preponderance of altered sites was located at AP-1 binding sites. We suggest that AP-1 expression is triggered by hypoxia and interacts with DNA methyltransferases (DNMTs) to target methylation at specific sites in the genome, thus causing suppression of the associated genes that are responsible for differentiation of villous cytotrophoblast to syncytiotrophoblast. RNA from cytotrophoblast from 2 placentas exposed to 3 different conditions of hypoxia (1%,8%,20%) and treated with 3 levels of vitamin D were run on the Illumina HT-12v4 Expression Array
   </text>
  </description>
  <protocol>
   <id>
    700151
   </id>
   <accession>
    P-GSE41331-16
   </accession>
  </protocol>
  <protocol>
   <id>
    700163
   </id>
   <accession>
    P-GSE41331-15
   </accession>
  </protocol>
  <protocol>
   <id>
    700146
   </id>
   <accession>
    P-GSE41331-14
   </accession>
  </protocol>
  <protocol>
   <id>
    700162
   </id>
   <accession>
    P-GSE41331-13
   </accession>
  </protocol>
  <protocol>
   <id>
    700153
   </id>
   <accession>
    P-GSE41331-19
   </accession>
  </protocol>
  <protocol>
   <id>
    700145
   </id>
   <accession>
    P-GSE41331-18
   </accession>
  </protocol>
  <protocol>
   <id>
    700148
   </id>
   <accession>
    P-GSE41331-17
   </accession>
  </protocol>
  <protocol>
   <id>
    700144
   </id>
   <accession>
    P-GSE41331-21
   </accession>
  </protocol>
  <protocol>
   <id>
    700150
   </id>
   <accession>
    P-GSE41331-20
   </accession>
  </protocol>
  <protocol>
   <id>
    700147
   </id>
   <accession>
    P-GSE41331-22
   </accession>
  </protocol>
  <protocol>
   <id>
    700149
   </id>
   <accession>
    P-GSE41331-12
   </accession>
  </protocol>
  <protocol>
   <id>
    700155
   </id>
   <accession>
    P-GSE41331-1
   </accession>
  </protocol>
  <protocol>
   <id>
    700161
   </id>
   <accession>
    P-GSE41331-11
   </accession>
  </protocol>
  <protocol>
   <id>
    700152
   </id>
   <accession>
    P-GSE41331-10
   </accession>
  </protocol>
  <protocol>
   <id>
    700159
   </id>
   <accession>
    P-GSE41331-3
   </accession>
  </protocol>
  <protocol>
   <id>
    700158
   </id>
   <accession>
    P-GSE41331-2
   </accession>
  </protocol>
  <protocol>
   <id>
    700160
   </id>
   <accession>
    P-GSE41331-9
   </accession>
  </protocol>
  <protocol>
   <id>
    700164
   </id>
   <accession>
    P-GSE41331-8
   </accession>
  </protocol>
  <protocol>
   <id>
    700165
   </id>
   <accession>
    P-GSE41331-7
   </accession>
  </protocol>
  <protocol>
   <id>
    700154
   </id>
   <accession>
    P-GSE41331-6
   </accession>
  </protocol>
  <protocol>
   <id>
    700156
   </id>
   <accession>
    P-GSE41331-5
   </accession>
  </protocol>
  <protocol>
   <id>
    700157
   </id>
   <accession>
    P-GSE41331-4
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <fgem available="true" name="E-GEOD-41331.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-41331.idf.txt">
   </idf>
   <sdrf name="E-GEOD-41331.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    culture time hrs
   </category>
   <value>
    12
   </value>
   <value>
    24
   </value>
   <value>
    48
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    Organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism part
   </category>
   <value>
    placenta
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    phenotype
   </category>
   <value>
    preeclampsia
   </value>
   <value>
    preterm labor
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    CULTURE TIME HRS
   </name>
   <value>
    12
   </value>
   <value>
    24
   </value>
   <value>
    48
   </value>
   <value>
    not specified
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    PHENOTYPE
   </name>
   <value>
    preeclampsia
   </value>
   <value>
    preterm labor
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    4
   </overallscore>
  </miamescores>
  <id>
   239614
  </id>
  <accession>
   E-GEOD-40182
  </accession>
  <secondaryaccession>
   GSE40182
  </secondaryaccession>
  <name>
   Preeclampsia: the in vivo milieu leads to cytotrophoblast dysregulation
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2012-08-17
  </releasedate>
  <lastupdatedate>
   2012-09-26
  </lastupdatedate>
  <samples>
   39
  </samples>
  <assays>
   39
  </assays>
  <arraydesign>
   <id>
    11119
   </id>
   <accession>
    A-AFFY-44
   </accession>
   <name>
    Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]
   </name>
   <count>
    39
   </count>
   <legacy_id>
    405156763
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    39
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    39
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    39
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    39
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    39
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    39
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Fei Wang
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Katherine Bianco
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Victoria Feng
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Yan Zhou
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Susan J Fisher
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Michael T McMaster
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Mirhan Kapidzic
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Matthew J Gormley
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Penelope M Drake
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Nathan M Hunkapiller
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Susan Fisher
   </contact>
   <role>
    submitter
   </role>
   <email>
    geo@ncbi.nlm.nih.gov
   </email>
  </provider>
  <provider>
   <contact>
    Masakazu Nishida
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Yana Stolyarov
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    During human pregnancy, placental cytotrophoblasts invade the uterus and its blood vessels, anchoring the progeny and rerouting maternal blood to the embryo/fetus. In preeclampsia, cytotrophoblast invasion is restricted and blood flow to the placenta is reduced. The causes of restricted cytotrophoblast invasion are unknown. Here, preeclampsia and control cytotrophoblasts were cultured for 48 h to allow differentiation/invasion. In various severe forms of preeclampsia ± intrauterine growth restriction, global transcriptional profiling revealed common aberrations in cytotrophoblast gene expression that resolved with culture. Villous cytotrophoblasts were isolated from preeclampsia placentas (PRE, n=5) and placentas of preterm labor patients without signs of infection (PTL, n=5), which served as gestation-matched controls. To better understand the CTB phenotype in the context of PE variants, we included patients with the most clinically significant forms of this condition that necessitated preterm delivery: women with severe PE ± intrauterine growth restrictions, PE with superimposed hypertension and HELLP syndrome (hemolysis, elevated liver enzymes; low platelet count). RNA was purified immediately after the cells were isolated (0 h) and after 12, 24 and 48 h in culture. The relative gene expression across the whole genome was profiled using the Affymetrix HG-U133Plus 2.0 GeneChip platform. Array quality was assesed using RMAExpress. One sample of preterm labor collected at 48h was omitted (39 arrays total). We used both LIMMA and maSigPro (R/Bioconductor) to determine differentially expressed genes.
   </text>
  </description>
  <protocol>
   <id>
    636202
   </id>
   <accession>
    P-GSE40182-6
   </accession>
  </protocol>
  <protocol>
   <id>
    636203
   </id>
   <accession>
    P-GSE40182-5
   </accession>
  </protocol>
  <protocol>
   <id>
    636200
   </id>
   <accession>
    P-GSE40182-7
   </accession>
  </protocol>
  <protocol>
   <id>
    636199
   </id>
   <accession>
    P-GSE40182-2
   </accession>
  </protocol>
  <protocol>
   <id>
    636198
   </id>
   <accession>
    P-GSE40182-1
   </accession>
  </protocol>
  <protocol>
   <id>
    636201
   </id>
   <accession>
    P-GSE40182-4
   </accession>
  </protocol>
  <protocol>
   <id>
    636204
   </id>
   <accession>
    P-GSE40182-3
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-GEOD-40182.raw.1.zip">
   </raw>
   <fgem available="true" name="E-GEOD-40182.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-40182.idf.txt">
   </idf>
   <sdrf name="E-GEOD-40182.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    gestational age
   </category>
   <value>
    17.1
   </value>
   <value>
    17.3
   </value>
   <value>
    18
   </value>
   <value>
    18.8
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    Organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism part
   </category>
   <value>
    placenta
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    GESTATIONAL AGE
   </name>
   <value>
    17.1
   </value>
   <value>
    17.3
   </value>
   <value>
    18
   </value>
   <value>
    18.8
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    4
   </overallscore>
  </miamescores>
  <id>
   206303
  </id>
  <accession>
   E-GEOD-37901
  </accession>
  <secondaryaccession>
   GSE37901
  </secondaryaccession>
  <name>
   Mid-gestational gene expression profile in placenta and link to pregnancy complications
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2012-05-10
  </releasedate>
  <lastupdatedate>
   2012-05-21
  </lastupdatedate>
  <samples>
   4
  </samples>
  <assays>
   4
  </assays>
  <arraydesign>
   <id>
    11119
   </id>
   <accession>
    A-AFFY-44
   </accession>
   <name>
    Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]
   </name>
   <count>
    4
   </count>
   <legacy_id>
    405156763
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    4
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    4
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    4
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    4
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    4
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    4
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Ave Minajeva
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Liis Uusküla
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Kristiina Rull
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Pille Teesalu
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Sulev Koks
   </contact>
   <role>
    submitter
   </role>
   <email>
    sulev.koks@ut.ee
   </email>
  </provider>
  <provider>
   <contact>
    Maris Laan
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Jaana Männik
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Sulev Kõks
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Jüri Reimand
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Pille Vaas
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    Data on the temporal dynamics of human placental gene expression is scarce. We have completed the first whole-genome profiling of human placental gene expression dynamics (GeneChips, Affymetrix®) from early to mid- gestation (10 samples; gestational weeks 5 to 18) and report 154 genes with considerable change in transcript levels (FDR P&lt;0.1). Functional enrichment analysis revealed &gt;200 GO categories that are statistically over-represented among 105 genes with dynamically increasing transcript levels. Analysis in an extended sample (n=43; gestational weeks 5 to 41) conformed a highly significant (FDR P&lt;0.05) expressional peak in mid-gestation placenta for ten genes: BMP5, CCNG2, CDH11, FST, GATM, GPR183, ITGBL1, PLAGL1, SLC16A10, STC1. A central hypothesis of our study states that the aberrant expression of genes characteristic to mid-gestation placenta may contribute to affected fetal growth, maternal preeclampsia (PE) or gestational diabetes (GD). The gene STC1 coding for Stanniocalcin 1 (STC1) was identified with a sharp placental expressional peak in mid-gestation, increased mRNA levels at term and significantly elevated STC1 protein levels in post-partum maternal plasma in all pregnancy complications. The highest STC1 levels were identified in women, who developed simultaneously PE and delivered an SGA baby (median 731 vs 418 pg/ml in controls; P=0.001). CCNG2 and LYPD6 exhibited significantly increased placental mRNA expression and enhanced intensity of immunohistochemistry staining in placental sections all studied in GD and PE cases. Aberrant expression of mid-gestation specific genes in pregnancy complications at term indicates the importance of the fine-scale tuning of the temporal dynamics of transcription regulation in placenta. Observed significantly elevated plasma STC1 in complicated pregnancies warrants further investigations of its potential as a biomarker. Interestingly, a majority of genes with high expression in mid-gestation placenta have also been implicated in adult complex disease. This observation promotes a recently opened discussion on the role of placenta in developmental programming. 4 samples; this submission is extension of our earlier study (accession GSE22490).
   </text>
  </description>
  <protocol>
   <id>
    543071
   </id>
   <accession>
    P-GSE37901-7
   </accession>
  </protocol>
  <protocol>
   <id>
    543073
   </id>
   <accession>
    P-GSE37901-6
   </accession>
  </protocol>
  <protocol>
   <id>
    543072
   </id>
   <accession>
    P-GSE37901-5
   </accession>
  </protocol>
  <protocol>
   <id>
    543074
   </id>
   <accession>
    P-GSE37901-4
   </accession>
  </protocol>
  <protocol>
   <id>
    543076
   </id>
   <accession>
    P-GSE37901-3
   </accession>
  </protocol>
  <protocol>
   <id>
    543075
   </id>
   <accession>
    P-GSE37901-2
   </accession>
  </protocol>
  <protocol>
   <id>
    543070
   </id>
   <accession>
    P-GSE37901-1
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-GEOD-37901.raw.1.zip">
   </raw>
   <fgem available="true" name="E-GEOD-37901.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-37901.idf.txt">
   </idf>
   <sdrf name="E-GEOD-37901.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    BioSourceProvider
   </category>
   <value>
    Tissue obtained with informed consent following elective termination of pregnancy.
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    gestation
   </category>
   <value>
    8 weeks
   </value>
   <value>
    8.1 weeks
   </value>
   <value>
    8.5 weeks
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    Organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    tissue
   </category>
   <value>
    placenta
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    GESTATION
   </name>
   <value>
    8 weeks
   </value>
   <value>
    8.1 weeks
   </value>
   <value>
    8.5 weeks
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    TREATMENT
   </name>
   <value>
    antiphospholipid antibody
   </value>
   <value>
    none
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    4
   </overallscore>
  </miamescores>
  <id>
   186650
  </id>
  <accession>
   E-GEOD-36083
  </accession>
  <secondaryaccession>
   GSE36083
  </secondaryaccession>
  <name>
   Transcriptomic Analysis of Placenta Affected by Antiphospholipid Antibodies: Following the TRAIL of trophoblast death
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2012-02-27
  </releasedate>
  <lastupdatedate>
   2012-03-06
  </lastupdatedate>
  <samples>
   6
  </samples>
  <assays>
   6
  </assays>
  <arraydesign>
   <id>
    11119
   </id>
   <accession>
    A-AFFY-44
   </accession>
   <name>
    Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]
   </name>
   <count>
    6
   </count>
   <legacy_id>
    405156763
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    6
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    6
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    6
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    6
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    6
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    6
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Qi Chen
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Cristin G Print
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Priyadarshini Pantham
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Roseanne Rosario
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Priyadarshini Pantham
   </contact>
   <role>
    submitter
   </role>
   <email>
    p.pantham@auckland.ac.nz
   </email>
  </provider>
  <provider>
   <contact>
    Larry W Chamley
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    Antiphospholipid antibodies, a maternal risk factor for preeclampsia, increase shedding of necrotic trophoblast debris from the placenta, leading to endothelial dysfunction. Using Affymetrix HGU133 Plus 2 microarrays, we found changes in the transcriptome of placental explants treated with antiphospholipid antibodies including seven mRNAs encoding for genes BCL2L1, MCL1, PDCD2L, FASLG, SEMA6A, PRKCE and TRAIL that are involved in the regulation of apoptosis. Quantitative real-time RT-PCR and immunohistochemistry confirmed a reduction in TRAIL expression. These results may help to understand how antiphospholipid antibodies affect trophoblast cell death and how the antibodies could contribute to the pathogenesis of preeclampsia. Three different first-trimester placentas (8-8.5 weeks gestation) were dissected into 6 explants each and cultured either with antiphospholipid antibodies (25ug/mL) or untreated media for 16h. RNA was extracted from treated placental explants and Affymetrix HGU133 Plus 2 arrays were conducted to investigate changes in mRNA expression.  Untreated: 1UNT, 2UNT, 3UNT Antiphospholipid antibody treatment: 1APL, 2APL, 3APL Biological replicates: 1, 2, 3
   </text>
  </description>
  <protocol>
   <id>
    497957
   </id>
   <accession>
    P-GSE36083-8
   </accession>
  </protocol>
  <protocol>
   <id>
    497958
   </id>
   <accession>
    P-GSE36083-3
   </accession>
  </protocol>
  <protocol>
   <id>
    497962
   </id>
   <accession>
    P-GSE36083-2
   </accession>
  </protocol>
  <protocol>
   <id>
    497955
   </id>
   <accession>
    P-GSE36083-1
   </accession>
  </protocol>
  <protocol>
   <id>
    497959
   </id>
   <accession>
    P-GSE36083-7
   </accession>
  </protocol>
  <protocol>
   <id>
    497960
   </id>
   <accession>
    P-GSE36083-6
   </accession>
  </protocol>
  <protocol>
   <id>
    497961
   </id>
   <accession>
    P-GSE36083-5
   </accession>
  </protocol>
  <protocol>
   <id>
    497956
   </id>
   <accession>
    P-GSE36083-4
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-GEOD-36083.raw.1.zip">
   </raw>
   <fgem available="true" name="E-GEOD-36083.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-36083.idf.txt">
   </idf>
   <sdrf name="E-GEOD-36083.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="false">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    batch
   </category>
   <value>
    A
   </value>
   <value>
    B
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    classification
   </category>
   <value>
    control
   </value>
   <value>
    IUGR
   </value>
   <value>
    PE
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    gender
   </category>
   <value>
    f
   </value>
   <value>
    m
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    gestational age
   </category>
   <value>
    25
   </value>
   <value>
    26
   </value>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    32
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    35
   </value>
   <value>
    36
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
   <value>
    39
   </value>
   <value>
    40
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    induction of labor
   </category>
   <value>
    induced
   </value>
   <value>
    spontaneous
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    Organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    tissue
   </category>
   <value>
    placenta
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    BATCH
   </name>
   <value>
    A
   </value>
   <value>
    B
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    CLASSIFICATION
   </name>
   <value>
    control
   </value>
   <value>
    IUGR
   </value>
   <value>
    PE
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    GENDER
   </name>
   <value>
    f
   </value>
   <value>
    m
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    GESTATIONAL AGE
   </name>
   <value>
    25
   </value>
   <value>
    26
   </value>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    32
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    35
   </value>
   <value>
    36
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
   <value>
    39
   </value>
   <value>
    40
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    INDUCTION OF LABOR
   </name>
   <value>
    induced
   </value>
   <value>
    spontaneous
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    1
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    0
   </measuredbioassaydatascore>
   <overallscore>
    4
   </overallscore>
  </miamescores>
  <id>
   180545
  </id>
  <accession>
   E-GEOD-35574
  </accession>
  <secondaryaccession>
   GSE35574
  </secondaryaccession>
  <name>
   Differentially expressed microRNAs revealed by molecular signatures of Preeclampsia and IUGR in human placenta
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2012-02-07
  </releasedate>
  <lastupdatedate>
   2012-02-15
  </lastupdatedate>
  <samples>
   94
  </samples>
  <assays>
   94
  </assays>
  <arraydesign>
   <id>
    13056
   </id>
   <accession>
    A-MEXP-930
   </accession>
   <name>
    Illumina Human-6 v2 Expression BeadChip
   </name>
   <count>
    94
   </count>
   <legacy_id>
    1549852481
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    94
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    94
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    94
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    94
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Betty H Thames
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Alison A Motsinger-Reif
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Shengdar Tsai
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Andra H James
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Jorge A Piedrahita
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Ling Guo
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Ling Guo
   </contact>
   <role>
    submitter
   </role>
   <email>
    guoling1101@gmail.com
   </email>
  </provider>
  <provider>
   <contact>
    Nicholas E Hardison
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    The placenta plays an important role as a regulator of fetal nutrition and growth throughout development and placental factors contribute to gestational abnormalities such as preeclampsia. This study describes the genome-wide gene expression profiles of a large (n=94) set of human placentas in order to uncover gene expression patterns (or molecular signatures) associated with preeclampsia and IUGR. Besides modulated modularity clustering and pathway analysis, a set of candidate miRNAs were predicted by Gene Set Enrichment Analysis (GSEA) based on differentially expressed genes. A case-control study was conducted to examine the expression patterns of these candidate miRNAs in human placentas 35 IUGR (including 8 technical repeats for batch effect), 19 preeclamptic and 40 control placentas included in this study were collected during the years of 2004-2008 and hybridized in two batches to microarrays.  Samples were randomized across arrays to control for array and batch variability.
   </text>
  </description>
  <protocol>
   <id>
    474769
   </id>
   <accession>
    P-GSE35574-2
   </accession>
  </protocol>
  <protocol>
   <id>
    474768
   </id>
   <accession>
    P-GSE35574-3
   </accession>
  </protocol>
  <protocol>
   <id>
    474764
   </id>
   <accession>
    P-GSE35574-1
   </accession>
  </protocol>
  <protocol>
   <id>
    474765
   </id>
   <accession>
    P-GSE35574-6
   </accession>
  </protocol>
  <protocol>
   <id>
    474767
   </id>
   <accession>
    P-GSE35574-4
   </accession>
  </protocol>
  <protocol>
   <id>
    474766
   </id>
   <accession>
    P-GSE35574-5
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <fgem available="true" name="E-GEOD-35574.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-35574.idf.txt">
   </idf>
   <sdrf name="E-GEOD-35574.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="false">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    cell line
   </category>
   <value>
    Swan 71
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    dose
   </category>
   <value>
    0
   </value>
   <value>
    1
   </value>
   <value>
    10
   </value>
   <value>
    100
   </value>
   <value>
    200
   </value>
   <value>
    400
   </value>
   <value>
    600
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    ligand
   </category>
   <value>
    CoCl2
   </value>
   <value>
    IL-1β
   </value>
   <value>
    PBS
   </value>
   <value>
    TNFα
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    Organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    unit
   </category>
   <value>
    ng/ml
   </value>
   <value>
    nM
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    DOSE
   </name>
   <value>
    0
   </value>
   <value>
    1
   </value>
   <value>
    10
   </value>
   <value>
    100
   </value>
   <value>
    200
   </value>
   <value>
    400
   </value>
   <value>
    600
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    LIGAND
   </name>
   <value>
    CoCl2
   </value>
   <value>
    IL-1β
   </value>
   <value>
    PBS
   </value>
   <value>
    TNFα
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    UNIT
   </name>
   <value>
    ng/ml
   </value>
   <value>
    nM
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    0
   </measuredbioassaydatascore>
   <overallscore>
    3
   </overallscore>
  </miamescores>
  <id>
   159304
  </id>
  <accession>
   E-GEOD-31679
  </accession>
  <secondaryaccession>
   GSE31679
  </secondaryaccession>
  <name>
   A Comparative Analysis of the Transcriptome of Hypoxia and Inflammation in Swan 71 Human Trophophoblast Cells: Its Implications in Preeclampsia
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2011-11-15
  </releasedate>
  <lastupdatedate>
   2011-11-21
  </lastupdatedate>
  <samples>
   39
  </samples>
  <assays>
   39
  </assays>
  <arraydesign>
   <id>
    13379
   </id>
   <accession>
    A-MEXP-1171
   </accession>
   <name>
    Illumina HumanHT-12 v3.0 Expression BeadChip
   </name>
   <count>
    39
   </count>
   <legacy_id>
    1633174974
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    39
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    39
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    39
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    39
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Joon S Hong
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Nandor G Than
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Adi L Tarca
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    John Hotra
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Chong J Kim
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Gaurav Bhatti
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Francesca Gotsch
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Yeon M Kim
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Roberto Romero
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Deug C Lee
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    gaurav bhatti
   </contact>
   <role>
    submitter
   </role>
   <email>
    gbhatti@med.wayne.edu
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    Chemical hypoxia by CoCl2 treatment and pro-inflammatory cytokines induced distinct changes in the transcriptome of Swan 71 human trophoblasts. Not Paired. Samples were treated with control treatments (PBS) as well as with CoCl2, IL-1β, and TNFα.
   </text>
  </description>
  <protocol>
   <id>
    383238
   </id>
   <accession>
    P-GSE31679-2
   </accession>
  </protocol>
  <protocol>
   <id>
    383241
   </id>
   <accession>
    P-GSE31679-3
   </accession>
  </protocol>
  <protocol>
   <id>
    383242
   </id>
   <accession>
    P-GSE31679-4
   </accession>
  </protocol>
  <protocol>
   <id>
    383240
   </id>
   <accession>
    P-GSE31679-5
   </accession>
  </protocol>
  <protocol>
   <id>
    383236
   </id>
   <accession>
    P-GSE31679-1
   </accession>
  </protocol>
  <protocol>
   <id>
    383239
   </id>
   <accession>
    P-GSE31679-6
   </accession>
  </protocol>
  <protocol>
   <id>
    383237
   </id>
   <accession>
    P-GSE31679-7
   </accession>
  </protocol>
  <protocol>
   <id>
    383235
   </id>
   <accession>
    P-GSE31679-8
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <fgem available="true" name="E-GEOD-31679.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-31679.idf.txt">
   </idf>
   <sdrf name="E-GEOD-31679.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="false">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    age
   </category>
   <value>
    20 years
   </value>
   <value>
    23 years
   </value>
   <value>
    24 years
   </value>
   <value>
    27 years
   </value>
   <value>
    28 years
   </value>
   <value>
    29 years
   </value>
   <value>
    30 years
   </value>
   <value>
    31 years
   </value>
   <value>
    32 years
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    ethnic group
   </category>
   <value>
    Chinese
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    Organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    tissue
   </category>
   <value>
    normal placentas
   </value>
   <value>
    placentas from preeclamptic pregnancies
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    AGE
   </name>
   <value>
    20 years
   </value>
   <value>
    23 years
   </value>
   <value>
    24 years
   </value>
   <value>
    27 years
   </value>
   <value>
    28 years
   </value>
   <value>
    29 years
   </value>
   <value>
    30 years
   </value>
   <value>
    31 years
   </value>
   <value>
    32 years
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    TISSUE
   </name>
   <value>
    normal placentas
   </value>
   <value>
    placentas from preeclamptic pregnancies
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    0
   </measuredbioassaydatascore>
   <overallscore>
    3
   </overallscore>
  </miamescores>
  <id>
   88752
  </id>
  <accession>
   E-GEOD-30186
  </accession>
  <secondaryaccession>
   GSE30186
  </secondaryaccession>
  <name>
   Genome-wide analysis of gene expression in placentas derived from patients with preeclampsia
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2011-06-24
  </releasedate>
  <lastupdatedate>
   2011-07-08
  </lastupdatedate>
  <samples>
   12
  </samples>
  <assays>
   12
  </assays>
  <arraydesign>
   <id>
    19392
   </id>
   <accession>
    A-GEOD-13475
   </accession>
   <name>
    Illumina HumanHT-12 V4.0 expression beadchip
   </name>
   <count>
    12
   </count>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    12
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    12
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    12
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    12
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Tao Meng
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Haiying Chen
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Tao Meng
   </contact>
   <role>
    submitter
   </role>
   <email>
    chhyrabbit@163.com
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    The purpose of this study was to perform a comprehensive analysis of gene expression profile in placentas from preeclamptic pregnancies vs normal placentas. Total RNA obtained from placental tissues of patients with normal pregnancies and patients with preeclampsia.
   </text>
  </description>
  <protocol>
   <id>
    244388
   </id>
   <accession>
    P-GSE30186-1
   </accession>
  </protocol>
  <protocol>
   <id>
    244389
   </id>
   <accession>
    P-GSE30186-4
   </accession>
  </protocol>
  <protocol>
   <id>
    244386
   </id>
   <accession>
    P-GSE30186-5
   </accession>
  </protocol>
  <protocol>
   <id>
    244385
   </id>
   <accession>
    P-GSE30186-2
   </accession>
  </protocol>
  <protocol>
   <id>
    244387
   </id>
   <accession>
    P-GSE30186-3
   </accession>
  </protocol>
  <protocol>
   <id>
    244384
   </id>
   <accession>
    P-GSE30186-6
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <fgem available="true" name="E-GEOD-30186.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-30186.idf.txt">
   </idf>
   <sdrf name="E-GEOD-30186.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    Organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    phenotype
   </category>
   <value>
    normal
   </value>
   <value>
    severe pre-eclampsia
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    tissue
   </category>
   <value>
    placentae
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    PHENOTYPE
   </name>
   <value>
    normal
   </value>
   <value>
    severe pre-eclampsia
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    4
   </overallscore>
  </miamescores>
  <id>
   68272
  </id>
  <accession>
   E-GEOD-15789
  </accession>
  <secondaryaccession>
   GSE15789
  </secondaryaccession>
  <name>
   Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2011-04-14
  </releasedate>
  <lastupdatedate>
   2014-05-03
  </lastupdatedate>
  <samples>
   16
  </samples>
  <assays>
   8
  </assays>
  <arraydesign>
   <id>
    4533
   </id>
   <accession>
    A-GEOD-8469
   </accession>
   <name>
    Capitalbio mammal microRNA V3.0
   </name>
   <count>
    8
   </count>
   <legacy_id>
    2484115140
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    8
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    8
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    8
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    8
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    8
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    8
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Yali Hu
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Jianqing Zhao
   </contact>
   <role>
    submitter
   </role>
   <email>
    jqzhao@capitalbio.com
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    To determine differential expression of microRNAs in placentae with severe pre-eclampsia and normal placenta. Differential expression of microRNAs in placentae (4 severe pre-eclampsia and 4 normal control) was screened by microarray platform, then some differential microRNAs were selected and validated with real-time quantitative reverse transcription polymerase chain reaction in placentae of severe pre-eclampsia (n=24) and normal control group (n=26). Results: We validated the expression of some microRNAs altered in the microarray, and found the following microRNAs were significantly increased in severe pre-eclampsia placentae: miR-16, miR-29b, miR-195, miR-26b, miR-181a, miR-335 and miR-222. Conclusion: These differential microRNAs may play an important role in pathogenesis of pre-eclampsia. We analyzed the microRNA expression in the placentae of Chinese patients with severe pre-eclampsia.
   </text>
  </description>
  <protocol>
   <id>
    192232
   </id>
   <accession>
    P-GSE15789-4
   </accession>
  </protocol>
  <protocol>
   <id>
    192233
   </id>
   <accession>
    P-GSE15789-5
   </accession>
  </protocol>
  <protocol>
   <id>
    192236
   </id>
   <accession>
    P-GSE15789-6
   </accession>
  </protocol>
  <protocol>
   <id>
    192234
   </id>
   <accession>
    P-GSE15789-7
   </accession>
  </protocol>
  <protocol>
   <id>
    192237
   </id>
   <accession>
    P-GSE15789-3
   </accession>
  </protocol>
  <protocol>
   <id>
    192235
   </id>
   <accession>
    P-GSE15789-2
   </accession>
  </protocol>
  <protocol>
   <id>
    192231
   </id>
   <accession>
    P-GSE15789-1
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-GEOD-15789.raw.1.zip">
   </raw>
   <fgem available="true" name="E-GEOD-15789.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-15789.idf.txt">
   </idf>
   <sdrf name="E-GEOD-15789.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    cell line
   </category>
   <value>
    Lxn (+) cell line C39-8
   </value>
   <value>
    Lxn (-) cell line MGC803
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    cell type
   </category>
   <value>
    MGC803 gastric epithelial cancer cell line, transformed with vector containing Lxn gene
   </value>
   <value>
    MGC803 gastric epithelial cancer cell line, vehicle-treated
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    Organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    phenotype
   </category>
   <value>
    normal
   </value>
   <value>
    severe pre-eclampsia
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    tissue
   </category>
   <value>
    placentae
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    CELL LINE
   </name>
   <value>
    Lxn (+) cell line C39-8
   </value>
   <value>
    Lxn (-) cell line MGC803
   </value>
   <value>
    not specified
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    CELL TYPE
   </name>
   <value>
    MGC803 gastric epithelial cancer cell line, transformed with vector containing Lxn gene
   </value>
   <value>
    MGC803 gastric epithelial cancer cell line, vehicle-treated
   </value>
   <value>
    not specified
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    PHENOTYPE
   </name>
   <value>
    normal
   </value>
   <value>
    not specified
   </value>
   <value>
    severe pre-eclampsia
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    4
   </overallscore>
  </miamescores>
  <id>
   68269
  </id>
  <accession>
   E-GEOD-15787
  </accession>
  <secondaryaccession>
   GSE15787
  </secondaryaccession>
  <name>
   Latexin is downregulated in human upper digestive track tumors and exhibits tumor suppressor potential
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2011-04-14
  </releasedate>
  <lastupdatedate>
   2014-05-03
  </lastupdatedate>
  <samples>
   18
  </samples>
  <assays>
   9
  </assays>
  <arraydesign>
   <id>
    6696
   </id>
   <accession>
    A-GEOD-8380
   </accession>
   <name>
    Capitalbio 22K Human oligo array version 1.0
   </name>
   <count>
    1
   </count>
   <legacy_id>
    2446265783
   </legacy_id>
  </arraydesign>
  <arraydesign>
   <id>
    4533
   </id>
   <accession>
    A-GEOD-8469
   </accession>
   <name>
    Capitalbio mammal microRNA V3.0
   </name>
   <count>
    8
   </count>
   <legacy_id>
    2484115140
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    9
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    9
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    9
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    9
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    9
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    9
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Yong Li
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Jianqing Zhao
   </contact>
   <role>
    submitter
   </role>
   <email>
    jqzhao@capitalbio.com
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    Latexin (Lxn) was originally isolated as a tissue specific marker of rat neuron. It is expressed in various tissues of humans and many other vertebrates. Lxn inhibits human carboxypeptidase A4 (hCPA4), whose expression is induced by histone deacetylase inhibitors in prostate cancer cells, and is associated with cancer progression. Structural analysis has shown significant similarity between Lxn protein and the tumor suppressor protein TIG1. Recent reports have demonstrated Lxn functions in the negative control of hematopoietic stem cell numbers (HSC) in mice. In the present study, an anti-Lxn monoclonal antibody 1G11 was generated and Western blot analysis showed that Lxn was expressed mainly in the cytoplasm of numerous human cell lines. Immunohistochemical analysis in gastric cancer tissues and the corresponding adjacent normal tissues showed that Lxn expression was lower in cancer tissues as compared to normal tissues. In addition, the Lxn gene was exogenously introduced into a Lxn null gastric cancer cell line, MGC803. Results of colony formation assay, soft agar assay and tumor growth in nude mice showed that over-expression of Lxn inhibits the proliferation and tumorigenicity of MGC803 cells expressing Lxn. Thirty-seven genes, whose expression were altered in response to Lxn expression were identified by microarray analysis. Methylation analysis of the central promoter region of the Lxn gene in several cell lines suggested that Lxn expression was silenced by CpG hypermethylation. Taken together, our results indicate that Lxn is a potential tumor suppressor and plays a role in negative control of tumor cell growth. We analyzed gene expression differece between Latexin (Lxn) postive cell line and negtive cells to find the active pathway and related biology function.
   </text>
  </description>
  <protocol>
   <id>
    192211
   </id>
   <accession>
    P-GSE15787-4
   </accession>
  </protocol>
  <protocol>
   <id>
    192205
   </id>
   <accession>
    P-GSE15787-5
   </accession>
  </protocol>
  <protocol>
   <id>
    192204
   </id>
   <accession>
    P-GSE15787-2
   </accession>
  </protocol>
  <protocol>
   <id>
    192212
   </id>
   <accession>
    P-GSE15787-3
   </accession>
  </protocol>
  <protocol>
   <id>
    192214
   </id>
   <accession>
    P-GSE15787-1
   </accession>
  </protocol>
  <protocol>
   <id>
    192206
   </id>
   <accession>
    P-GSE15787-11
   </accession>
  </protocol>
  <protocol>
   <id>
    192207
   </id>
   <accession>
    P-GSE15787-10
   </accession>
  </protocol>
  <protocol>
   <id>
    192213
   </id>
   <accession>
    P-GSE15787-7
   </accession>
  </protocol>
  <protocol>
   <id>
    192209
   </id>
   <accession>
    P-GSE15787-6
   </accession>
  </protocol>
  <protocol>
   <id>
    192210
   </id>
   <accession>
    P-GSE15787-9
   </accession>
  </protocol>
  <protocol>
   <id>
    192208
   </id>
   <accession>
    P-GSE15787-8
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-GEOD-15787.raw.1.zip">
   </raw>
   <fgem available="true" name="E-GEOD-15787.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-15787.idf.txt">
   </idf>
   <sdrf name="E-GEOD-15787.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    gestational age
   </category>
   <value>
    term
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    gestational age (w+d)
   </category>
   <value>
    24+4
   </value>
   <value>
    24+6
   </value>
   <value>
    26+2
   </value>
   <value>
    29+2
   </value>
   <value>
    29+6
   </value>
   <value>
    30+4
   </value>
   <value>
    37+0
   </value>
   <value>
    37+1
   </value>
   <value>
    38+0
   </value>
   <value>
    39+6
   </value>
   <value>
    40+2
   </value>
   <value>
    40+5
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    Organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    GESTATIONAL AGE (W+D)
   </name>
   <value>
    24+4
   </value>
   <value>
    24+6
   </value>
   <value>
    26+2
   </value>
   <value>
    29+2
   </value>
   <value>
    29+6
   </value>
   <value>
    30+4
   </value>
   <value>
    37+0
   </value>
   <value>
    37+1
   </value>
   <value>
    38+0
   </value>
   <value>
    39+6
   </value>
   <value>
    40+2
   </value>
   <value>
    40+5
   </value>
   <value>
    not specified
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    0
   </reportersequencescore>
   <protocolscore>
    1
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    4
   </overallscore>
  </miamescores>
  <id>
   55318
  </id>
  <accession>
   E-GEOD-22526
  </accession>
  <secondaryaccession>
   GSE22526
  </secondaryaccession>
  <name>
   Gene expression profiling of placenta from women with early- and late-onset preeclampsia reveals differences in angiogenesis
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2011-02-28
  </releasedate>
  <lastupdatedate>
   2014-05-01
  </lastupdatedate>
  <samples>
   30
  </samples>
  <assays>
   15
  </assays>
  <arraydesign>
   <id>
    19738
   </id>
   <accession>
    A-GEOD-10579
   </accession>
   <name>
    GynObsLU Human 800 PE-associated cDNA
   </name>
   <count>
    15
   </count>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    15
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    15
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    15
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    15
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    15
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    15
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Matts Olovsson
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Katja Junus
   </contact>
   <role>
    submitter
   </role>
   <email>
    geo@ncbi.nlm.nih.gov
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    Preeclampsia (PE) is a serious pregnancy associated disorder. Recently, it has been proposed that the role of the placenta differ between the two sub-groups early- and late-onset PE. To further elucidate differences between the two sub-groups, we conducted transcriptional profiling of human placenta comparing early- with late-onset PE. The analysis showed differences in angiogenesis associated genes. Two-condition experiment, early-onset PE (n=8) vs. late-onset PE (n=7).
   </text>
  </description>
  <protocol>
   <id>
    161679
   </id>
   <accession>
    P-GSE22526-1
   </accession>
  </protocol>
  <protocol>
   <id>
    161683
   </id>
   <accession>
    P-GSE22526-2
   </accession>
  </protocol>
  <protocol>
   <id>
    161684
   </id>
   <accession>
    P-GSE22526-3
   </accession>
  </protocol>
  <protocol>
   <id>
    161681
   </id>
   <accession>
    P-GSE22526-4
   </accession>
  </protocol>
  <protocol>
   <id>
    161680
   </id>
   <accession>
    P-GSE22526-5
   </accession>
  </protocol>
  <protocol>
   <id>
    161682
   </id>
   <accession>
    P-GSE22526-6
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-GEOD-22526.raw.1.zip">
   </raw>
   <fgem available="true" name="E-GEOD-22526.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-22526.idf.txt">
   </idf>
   <sdrf name="E-GEOD-22526.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="false">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    batch
   </category>
   <value>
    A
   </value>
   <value>
    B
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    classification
   </category>
   <value>
    control
   </value>
   <value>
    preeclamptic
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    gender
   </category>
   <value>
    F
   </value>
   <value>
    M
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    gestational age
   </category>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    32
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    35
   </value>
   <value>
    36
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
   <value>
    39
   </value>
   <value>
    40
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    induction of labor
   </category>
   <value>
    induced
   </value>
   <value>
    spontaneous
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    Organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    tissue
   </category>
   <value>
    placenta
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    BATCH
   </name>
   <value>
    A
   </value>
   <value>
    B
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    CLASSIFICATION
   </name>
   <value>
    control
   </value>
   <value>
    preeclamptic
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    GENDER
   </name>
   <value>
    F
   </value>
   <value>
    M
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    GESTATIONAL AGE
   </name>
   <value>
    27
   </value>
   <value>
    28
   </value>
   <value>
    29
   </value>
   <value>
    32
   </value>
   <value>
    33
   </value>
   <value>
    34
   </value>
   <value>
    35
   </value>
   <value>
    36
   </value>
   <value>
    37
   </value>
   <value>
    38
   </value>
   <value>
    39
   </value>
   <value>
    40
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    INDUCTION OF LABOR
   </name>
   <value>
    induced
   </value>
   <value>
    spontaneous
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    1
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    0
   </measuredbioassaydatascore>
   <overallscore>
    4
   </overallscore>
  </miamescores>
  <id>
   37153
  </id>
  <accession>
   E-GEOD-25906
  </accession>
  <secondaryaccession>
   GSE25906
  </secondaryaccession>
  <name>
   Transcriptional Profiling of Human Placentas from Pregnancies Complicated by Preeclampsia Reveals Disregulation of Sialic Acid Acetylesterase and Immune Signaling Pathways
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2010-12-10
  </releasedate>
  <lastupdatedate>
   2011-06-10
  </lastupdatedate>
  <samples>
   60
  </samples>
  <assays>
   60
  </assays>
  <arraydesign>
   <id>
    13056
   </id>
   <accession>
    A-MEXP-930
   </accession>
   <name>
    Illumina Human-6 v2 Expression BeadChip
   </name>
   <count>
    60
   </count>
   <legacy_id>
    1549852481
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    60
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    60
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    60
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    60
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Betty H Thames
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Steve R Bischoff
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Jorge A Piedrahita
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Nicholas E Hardison
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Andra H James
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Shengdar Tsai
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Alison A Motsinger-Reif
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Shengdar Tsai
   </contact>
   <role>
    submitter
   </role>
   <email>
    geo@ncbi.nlm.nih.gov
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    The placenta plays an important role as a regulator of fetal nutrition and growth throughout development and placental factors contribute to gestational abnormalities such as preeclampsia. This study describes the genome-wide gene expression profiles of a large (n=60) set of human placentas in order to uncover gene expression patterns associated with preeclampsia.  In addition to confirming changes in expression of soluble factors associated with preeclampsia such as sFLT1 (soluble fms-like tyrosine kinase-1), sENG (soluble endoglin), and INHA (inhibin alpha), we also find changes in immune-associated signaling pathways, offering a potential upstream explanation for the shallow trophoblast invasion and inadequate uterine remodeling typically observed in pathogenesis of preeclampsia.  Notably, we also find evidence of preeclampsia-associated placental upregulation of sialic acid acetylesterase (SIAE), a gene functionally associated with autoimmune diseases. 23 preeclamptic, and 37 control placentas included in this study were collected during the years of 2004-2008 and hybridized in two batches to microarrays.  Samples were randomized across arrays to control for array and batch variability.
   </text>
  </description>
  <protocol>
   <id>
    113244
   </id>
   <accession>
    P-GSE25906-2
   </accession>
  </protocol>
  <protocol>
   <id>
    113238
   </id>
   <accession>
    P-GSE25906-22
   </accession>
  </protocol>
  <protocol>
   <id>
    113231
   </id>
   <accession>
    P-GSE25906-3
   </accession>
  </protocol>
  <protocol>
   <id>
    113208
   </id>
   <accession>
    P-GSE25906-23
   </accession>
  </protocol>
  <protocol>
   <id>
    113207
   </id>
   <accession>
    P-GSE25906-20
   </accession>
  </protocol>
  <protocol>
   <id>
    113217
   </id>
   <accession>
    P-GSE25906-21
   </accession>
  </protocol>
  <protocol>
   <id>
    113243
   </id>
   <accession>
    P-GSE25906-1
   </accession>
  </protocol>
  <protocol>
   <id>
    113246
   </id>
   <accession>
    P-GSE25906-8
   </accession>
  </protocol>
  <protocol>
   <id>
    113251
   </id>
   <accession>
    P-GSE25906-9
   </accession>
  </protocol>
  <protocol>
   <id>
    113242
   </id>
   <accession>
    P-GSE25906-6
   </accession>
  </protocol>
  <protocol>
   <id>
    113247
   </id>
   <accession>
    P-GSE25906-7
   </accession>
  </protocol>
  <protocol>
   <id>
    113221
   </id>
   <accession>
    P-GSE25906-4
   </accession>
  </protocol>
  <protocol>
   <id>
    113236
   </id>
   <accession>
    P-GSE25906-5
   </accession>
  </protocol>
  <protocol>
   <id>
    113163
   </id>
   <accession>
    P-GSE25906-65
   </accession>
  </protocol>
  <protocol>
   <id>
    113167
   </id>
   <accession>
    P-GSE25906-64
   </accession>
  </protocol>
  <protocol>
   <id>
    113240
   </id>
   <accession>
    P-GSE25906-29
   </accession>
  </protocol>
  <protocol>
   <id>
    113215
   </id>
   <accession>
    P-GSE25906-28
   </accession>
  </protocol>
  <protocol>
   <id>
    113203
   </id>
   <accession>
    P-GSE25906-27
   </accession>
  </protocol>
  <protocol>
   <id>
    113179
   </id>
   <accession>
    P-GSE25906-61
   </accession>
  </protocol>
  <protocol>
   <id>
    113252
   </id>
   <accession>
    P-GSE25906-60
   </accession>
  </protocol>
  <protocol>
   <id>
    113202
   </id>
   <accession>
    P-GSE25906-26
   </accession>
  </protocol>
  <protocol>
   <id>
    113204
   </id>
   <accession>
    P-GSE25906-25
   </accession>
  </protocol>
  <protocol>
   <id>
    113172
   </id>
   <accession>
    P-GSE25906-63
   </accession>
  </protocol>
  <protocol>
   <id>
    113176
   </id>
   <accession>
    P-GSE25906-62
   </accession>
  </protocol>
  <protocol>
   <id>
    113229
   </id>
   <accession>
    P-GSE25906-24
   </accession>
  </protocol>
  <protocol>
   <id>
    113235
   </id>
   <accession>
    P-GSE25906-10
   </accession>
  </protocol>
  <protocol>
   <id>
    113218
   </id>
   <accession>
    P-GSE25906-11
   </accession>
  </protocol>
  <protocol>
   <id>
    113213
   </id>
   <accession>
    P-GSE25906-12
   </accession>
  </protocol>
  <protocol>
   <id>
    113250
   </id>
   <accession>
    P-GSE25906-59
   </accession>
  </protocol>
  <protocol>
   <id>
    113248
   </id>
   <accession>
    P-GSE25906-57
   </accession>
  </protocol>
  <protocol>
   <id>
    113162
   </id>
   <accession>
    P-GSE25906-58
   </accession>
  </protocol>
  <protocol>
   <id>
    113237
   </id>
   <accession>
    P-GSE25906-18
   </accession>
  </protocol>
  <protocol>
   <id>
    113212
   </id>
   <accession>
    P-GSE25906-56
   </accession>
  </protocol>
  <protocol>
   <id>
    113178
   </id>
   <accession>
    P-GSE25906-55
   </accession>
  </protocol>
  <protocol>
   <id>
    113206
   </id>
   <accession>
    P-GSE25906-17
   </accession>
  </protocol>
  <protocol>
   <id>
    113223
   </id>
   <accession>
    P-GSE25906-54
   </accession>
  </protocol>
  <protocol>
   <id>
    113224
   </id>
   <accession>
    P-GSE25906-19
   </accession>
  </protocol>
  <protocol>
   <id>
    113201
   </id>
   <accession>
    P-GSE25906-53
   </accession>
  </protocol>
  <protocol>
   <id>
    113210
   </id>
   <accession>
    P-GSE25906-14
   </accession>
  </protocol>
  <protocol>
   <id>
    113199
   </id>
   <accession>
    P-GSE25906-52
   </accession>
  </protocol>
  <protocol>
   <id>
    113171
   </id>
   <accession>
    P-GSE25906-51
   </accession>
  </protocol>
  <protocol>
   <id>
    113241
   </id>
   <accession>
    P-GSE25906-13
   </accession>
  </protocol>
  <protocol>
   <id>
    113219
   </id>
   <accession>
    P-GSE25906-16
   </accession>
  </protocol>
  <protocol>
   <id>
    113187
   </id>
   <accession>
    P-GSE25906-50
   </accession>
  </protocol>
  <protocol>
   <id>
    113211
   </id>
   <accession>
    P-GSE25906-15
   </accession>
  </protocol>
  <protocol>
   <id>
    113216
   </id>
   <accession>
    P-GSE25906-40
   </accession>
  </protocol>
  <protocol>
   <id>
    113214
   </id>
   <accession>
    P-GSE25906-41
   </accession>
  </protocol>
  <protocol>
   <id>
    113200
   </id>
   <accession>
    P-GSE25906-44
   </accession>
  </protocol>
  <protocol>
   <id>
    113190
   </id>
   <accession>
    P-GSE25906-45
   </accession>
  </protocol>
  <protocol>
   <id>
    113193
   </id>
   <accession>
    P-GSE25906-42
   </accession>
  </protocol>
  <protocol>
   <id>
    113233
   </id>
   <accession>
    P-GSE25906-43
   </accession>
  </protocol>
  <protocol>
   <id>
    113184
   </id>
   <accession>
    P-GSE25906-49
   </accession>
  </protocol>
  <protocol>
   <id>
    113182
   </id>
   <accession>
    P-GSE25906-48
   </accession>
  </protocol>
  <protocol>
   <id>
    113245
   </id>
   <accession>
    P-GSE25906-47
   </accession>
  </protocol>
  <protocol>
   <id>
    113192
   </id>
   <accession>
    P-GSE25906-46
   </accession>
  </protocol>
  <protocol>
   <id>
    113209
   </id>
   <accession>
    P-GSE25906-30
   </accession>
  </protocol>
  <protocol>
   <id>
    113249
   </id>
   <accession>
    P-GSE25906-31
   </accession>
  </protocol>
  <protocol>
   <id>
    113194
   </id>
   <accession>
    P-GSE25906-32
   </accession>
  </protocol>
  <protocol>
   <id>
    113198
   </id>
   <accession>
    P-GSE25906-33
   </accession>
  </protocol>
  <protocol>
   <id>
    113205
   </id>
   <accession>
    P-GSE25906-34
   </accession>
  </protocol>
  <protocol>
   <id>
    113239
   </id>
   <accession>
    P-GSE25906-36
   </accession>
  </protocol>
  <protocol>
   <id>
    113174
   </id>
   <accession>
    P-GSE25906-35
   </accession>
  </protocol>
  <protocol>
   <id>
    113197
   </id>
   <accession>
    P-GSE25906-38
   </accession>
  </protocol>
  <protocol>
   <id>
    113226
   </id>
   <accession>
    P-GSE25906-37
   </accession>
  </protocol>
  <protocol>
   <id>
    113228
   </id>
   <accession>
    P-GSE25906-39
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <fgem available="true" name="E-GEOD-25906.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-25906.idf.txt">
   </idf>
   <sdrf name="E-GEOD-25906.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    disease state
   </category>
   <value>
    Fetal growth restriction (FGR)
   </value>
   <value>
    Normotensive control pregnancy
   </value>
   <value>
    preeclampsia
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    Organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    tissue
   </category>
   <value>
    placenta
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    DISEASE STATE
   </name>
   <value>
    Fetal growth restriction (FGR)
   </value>
   <value>
    Normotensive control pregnancy
   </value>
   <value>
    preeclampsia
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    0
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    3
   </overallscore>
  </miamescores>
  <id>
   37611
  </id>
  <accession>
   E-GEOD-24129
  </accession>
  <secondaryaccession>
   GSE24129
  </secondaryaccession>
  <name>
   Gene expression profiling for placentas from pre-eclamptic, unexplained FGR and normal pregnancies
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2010-09-15
  </releasedate>
  <lastupdatedate>
   2011-06-10
  </lastupdatedate>
  <samples>
   24
  </samples>
  <assays>
   24
  </assays>
  <arraydesign>
   <id>
    9595
   </id>
   <accession>
    A-AFFY-141
   </accession>
   <name>
    Affymetrix GeneChip Human Gene 1.0 ST Array [HuGene-1_0-st-v1]
   </name>
   <count>
    24
   </count>
   <legacy_id>
    1759805535
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    24
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    24
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    24
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    24
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    24
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    24
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Haruki Nishizawa
   </contact>
   <role>
    submitter
   </role>
   <email>
    nharuki@fujita-hu.ac.jp
   </email>
  </provider>
  <provider>
   <contact>
    Haruki Nishizawa
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Hiroki Kurahashi
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    It has been well documented that pre-eclampsia and unexplained fetal growth restriction (FGR) has a common etiological background, but little is known about the linkage al the molecular level. we have performed global gene expression profiling by oligonucleotide microarrays for placentas from pre-eclamptic, unexplained FGR and normal pregnancies to further elucidate the mechanisms underlying the development of these two disorders. The total number of samples used was 8 from pre-eclampsia, 8 from normotensive pregnancies with FGR and 8 from those without FGR.
   </text>
  </description>
  <protocol>
   <id>
    117810
   </id>
   <accession>
    P-GSE24129-7
   </accession>
  </protocol>
  <protocol>
   <id>
    117811
   </id>
   <accession>
    P-GSE24129-6
   </accession>
  </protocol>
  <protocol>
   <id>
    117808
   </id>
   <accession>
    P-GSE24129-9
   </accession>
  </protocol>
  <protocol>
   <id>
    117803
   </id>
   <accession>
    P-GSE24129-8
   </accession>
  </protocol>
  <protocol>
   <id>
    117798
   </id>
   <accession>
    P-GSE24129-1
   </accession>
  </protocol>
  <protocol>
   <id>
    117800
   </id>
   <accession>
    P-GSE24129-3
   </accession>
  </protocol>
  <protocol>
   <id>
    117806
   </id>
   <accession>
    P-GSE24129-2
   </accession>
  </protocol>
  <protocol>
   <id>
    117804
   </id>
   <accession>
    P-GSE24129-5
   </accession>
  </protocol>
  <protocol>
   <id>
    117799
   </id>
   <accession>
    P-GSE24129-4
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-GEOD-24129.raw.1.zip">
   </raw>
   <fgem available="true" name="E-GEOD-24129.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-24129.idf.txt">
   </idf>
   <sdrf name="E-GEOD-24129.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    Organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    0
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    3
   </overallscore>
  </miamescores>
  <id>
   536
  </id>
  <accession>
   E-GEOD-10588
  </accession>
  <secondaryaccession>
   GSE10588
  </secondaryaccession>
  <name>
   Placental gene expression in severe preeclampsia
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2010-05-26
  </releasedate>
  <submissiondate>
   2008-02-20
  </submissiondate>
  <lastupdatedate>
   2014-05-02
  </lastupdatedate>
  <samples>
   43
  </samples>
  <assays>
   43
  </assays>
  <arraydesign>
   <id>
    12224
   </id>
   <accession>
    A-MEXP-503
   </accession>
   <name>
    Applied Biosystems Human Genome Survey Microarray v2.0
   </name>
   <count>
    43
   </count>
   <legacy_id>
    1198472815
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    43
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    43
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    scan
   </name>
   <bioassaydatacubes>
    43
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    scan
   </dataformat>
   <bioassays>
    43
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedDataMatrix
   </name>
   <bioassaydatacubes>
    1
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedDataMatrix
   </dataformat>
   <bioassays>
    1
   </bioassays>
   <isderived>
    1
   </isderived>
  </bioassaydatagroup>
  <bibliography>
   <accession>
    19249095
   </accession>
   <authors>
    Sitras V, Paulssen RH, Grønaas H, Leirvik J, Hanssen TA, Vårtun A, Acharya G
   </authors>
   <title>
    Differential placental gene expression in severe preeclampsia.
   </title>
  </bibliography>
  <provider>
   <contact>
    Aase Vårtun
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Halvor S Grønaas
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Ganesh Ancharya
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Ruth Hracky Paulssen
   </contact>
   <role>
    submitter
   </role>
   <email>
    ruthp@fagmed.uit.no
   </email>
  </provider>
  <provider>
   <contact>
    Ruth H Paulssen
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Vasilis Sitras
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    The series is composed of thirty hybridizations for analysis of differentially expressed genes in normal placenta tissues from patients with normal labor and placenta tissues from patients with severe preeclampsia. Patients tissues samples were obtained from (Vasilis. Total RNA extraction was performed by using the MagNa Pure Compact RNA Isolation Kit (Roche Applied Science). Keywords: Gene expression study, Disease state Twenty-six out of 50 normal placentas were randomly selected to match with 17 preeclamptic placentas, accounting for parity. Microarrays were performed applying a direct comparison design.
   </text>
  </description>
  <protocol>
   <id>
    3689
   </id>
   <accession>
    P-GSE10588-7
   </accession>
  </protocol>
  <protocol>
   <id>
    3692
   </id>
   <accession>
    P-GSE10588-6
   </accession>
  </protocol>
  <protocol>
   <id>
    3690
   </id>
   <accession>
    P-GSE10588-5
   </accession>
  </protocol>
  <protocol>
   <id>
    3694
   </id>
   <accession>
    P-GSE10588-4
   </accession>
  </protocol>
  <protocol>
   <id>
    3691
   </id>
   <accession>
    P-GSE10588-3
   </accession>
  </protocol>
  <protocol>
   <id>
    3693
   </id>
   <accession>
    P-GSE10588-2
   </accession>
  </protocol>
  <protocol>
   <id>
    3688
   </id>
   <accession>
    P-GSE10588-1
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-GEOD-10588.raw.1.zip">
   </raw>
   <fgem available="true" name="E-GEOD-10588.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-10588.idf.txt">
   </idf>
   <sdrf name="E-GEOD-10588.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <species>
   Mus musculus
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    Organism
   </category>
   <value>
    Homo sapiens
   </value>
   <value>
    Mus musculus
   </value>
  </sampleattribute>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    0
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    3
   </overallscore>
  </miamescores>
  <id>
   3759
  </id>
  <accession>
   E-GEOD-13155
  </accession>
  <secondaryaccession>
   GSE13155
  </secondaryaccession>
  <name>
   Transcription profiling of mouse placental labyrinth and human villus tree
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2009-06-22
  </releasedate>
  <submissiondate>
   2008-10-10
  </submissiondate>
  <lastupdatedate>
   2011-06-10
  </lastupdatedate>
  <samples>
   4
  </samples>
  <assays>
   4
  </assays>
  <arraydesign>
   <id>
    11001
   </id>
   <accession>
    A-AFFY-45
   </accession>
   <name>
    Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]
   </name>
   <count>
    2
   </count>
   <legacy_id>
    417942717
   </legacy_id>
  </arraydesign>
  <arraydesign>
   <id>
    11119
   </id>
   <accession>
    A-AFFY-44
   </accession>
   <name>
    Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]
   </name>
   <count>
    2
   </count>
   <legacy_id>
    405156763
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    4
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    4
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    4
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    4
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    4
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    4
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    scan
   </name>
   <bioassaydatacubes>
    4
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    scan
   </dataformat>
   <bioassays>
    4
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Brian Joseph Cox
   </contact>
   <role>
    submitter
   </role>
   <email>
    b.cox@utoronto.ca
   </email>
  </provider>
  <experimentdesign>
   unknown experiment type
  </experimentdesign>
  <description>
   <id>
   </id>
   <text>
    An important question for the use of the mouse as a model  for studying human disease is the degree of functional conservation of genetic control pathways from human to mouse. The human placenta and mouse placenta show structural similarities but there has been no systematic attempt to assess their molecular similarities or differences. We built a comprehensive database of protein and microarray data for the highly vascular exchange region micro-dissected from the human and mouse placenta near-term.  Abnormalities in this region are associated with two of the most common and serious complications of human pregnancy, maternal preeclampsia (PE) and fetal intrauterine growth restriction (IUGR), each disorder affecting ~5% of all pregnancies.  To compare the gene expression patterns in the vascular exchange regions of the human (villus tree) and mouse (labyrinth) placenta. Experiment Overall Design: Mouse labyrinth tissue was micro-dissected form naturally mated crosses of C57Bl/6J mice. Placentas were individually dissected on embryonic day 17.5. From each litter ¼ of the tissue were set aside for RNA extraction and microarray analysis and ¾ for cellular fractionation and proteomic analysis, as recently described (Kislinger et al., 2006).  Human villous trees were dissected from term normal placenta delivered by cesarean section from a term pregnancy (~ 38 weeks). Tissue was divided for organellar fractionation and RNA extraction.
   </text>
  </description>
  <protocol>
   <id>
    14929
   </id>
   <accession>
    P-G13155-4
   </accession>
  </protocol>
  <protocol>
   <id>
    14928
   </id>
   <accession>
    P-G13155-3
   </accession>
  </protocol>
  <protocol>
   <id>
    14931
   </id>
   <accession>
    P-G13155-2
   </accession>
  </protocol>
  <protocol>
   <id>
    14930
   </id>
   <accession>
    P-G13155-1
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <organism>
   Mus musculus
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-GEOD-13155.raw.1.zip">
   </raw>
   <fgem available="true" name="E-GEOD-13155.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-13155.idf.txt">
   </idf>
   <sdrf name="E-GEOD-13155.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    BioSourceProvider
   </category>
   <value>
    Bergen
   </value>
   <value>
    Trondheim
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    DiseaseState
   </category>
   <value>
    infant SGA
   </value>
   <value>
    normal
   </value>
   <value>
    preeclampsia
   </value>
   <value>
    preeclampsia+infant SGA
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    Organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    OrganismPart
   </category>
   <value>
    Decidua basalis
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    DISEASE_STATE
   </name>
   <value>
    infant SGA
   </value>
   <value>
    normal
   </value>
   <value>
    preeclampsia
   </value>
   <value>
    preeclampsia+infant SGA
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    1
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    5
   </overallscore>
  </miamescores>
  <id>
   32244
  </id>
  <accession>
   E-TABM-682
  </accession>
  <name>
   Transcription profiling of human decidua basalis to identify pre-eclampsia susceptibility genes
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2009-04-07
  </releasedate>
  <submissiondate>
   2009-01-04
  </submissiondate>
  <lastupdatedate>
   2014-05-02
  </lastupdatedate>
  <samples>
   104
  </samples>
  <assays>
   104
  </assays>
  <arraydesign>
   <id>
    13056
   </id>
   <accession>
    A-MEXP-930
   </accession>
   <name>
    Illumina Human-6 v2 Expression BeadChip
   </name>
   <count>
    104
   </count>
   <legacy_id>
    1549852481
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    1
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    1
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    1
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    1
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    scan
   </name>
   <bioassaydatacubes>
    1
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    scan
   </dataformat>
   <bioassays>
    1
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedDataMatrix
   </name>
   <bioassaydatacubes>
    1
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedDataMatrix
   </dataformat>
   <bioassays>
    1
   </bioassays>
   <isderived>
    1
   </isderived>
  </bioassaydatagroup>
  <bibliography>
   <accession>
    21343950
   </accession>
   <authors>
    Johansson A, Curran JE, Johnson MP, Freed KA, Fenstad MH, Bjørge L, Eide IP, Carless MA, Rainwater DL, Goring HH, Austgulen R, Moses EK, Blangero J.
   </authors>
   <title>
    Identification of ACOX2 as a shared genetic risk factor for preeclampsia and cardiovascular disease.
   </title>
   <doi>
    10.1038/ejhg.2011.19
   </doi>
   <issue>
    None
   </issue>
   <pages>
    796-800
   </pages>
   <year>
    2011
   </year>
  </bibliography>
  <bibliography>
   <accession>
    20931231
   </accession>
   <authors>
    Johansson A, Løset M, Mundal SB, Johnson MP, Freed KA, Fenstad MH, Moses EK, Austgulen R, Blangero J.
   </authors>
   <title>
    Partial correlation network analyses to detect altered gene interactions in human disease: using preeclampsia as a model.
   </title>
   <doi>
    10.1007/s00439-010-0893-5
   </doi>
   <issue>
    None
   </issue>
   <pages>
    25-34
   </pages>
   <year>
    2011
   </year>
  </bibliography>
  <bibliography>
   <accession>
    20643876
   </accession>
   <authors>
    Fenstad MH, Johnson MP, Løset M, Mundal SB, Roten LT, Eide IP, Bjørge L, Sande RK, Johansson AK, Dyer TD, Forsmo S, Blangero J, Moses EK, Austgulen R.
   </authors>
   <title>
    STOX2 but not STOX1 is differentially expressed in decidua from pre-eclamptic women: data from the Second Nord-Trondelag Health Study.
   </title>
   <doi>
    10.1093/molehr/gaq064
   </doi>
   <issue>
    None
   </issue>
   <pages>
    960-968
   </pages>
   <year>
    2010
   </year>
  </bibliography>
  <bibliography>
   <authors>
    Linda T. Roten; Matthew P. Johnson; Mari Løset; Siv B. Mundal; Siri Forsmo; Frank Skorpen; Mona H. Fenstad; Thomas D. Dyer; John Blangero; Eric K. Moses; Rigmor Austgulen
   </authors>
   <title>
    Evaluation of COMT as a maternal preeclampsia candidate susceptibility gene; assessed by genotyping of the Val158Met polymorphism and by transcriptinal profiling of decidual tissue
   </title>
  </bibliography>
  <bibliography>
   <accession>
    20934677
   </accession>
   <authors>
    Løset M, Mundal SB, Johnson MP, Fenstad MH, Freed KA, Lian IA, Eide IP, Bjørge L, Blangero J, Moses EK, Austgulen R.
   </authors>
   <title>
    A transcriptional profile of the decidua in preeclampsia.
   </title>
   <doi>
    10.1016/j.ajog.2010.08.043
   </doi>
   <issue>
    None
   </issue>
   <pages>
    84.e1-27
   </pages>
   <year>
    2011
   </year>
  </bibliography>
  <provider>
   <contact>
    Mona Fenstad
   </contact>
   <role>
    submitter
   </role>
   <email>
    mona.n.fenstad@ntnu.no
   </email>
  </provider>
  <experimentdesign>
   co-expression
  </experimentdesign>
  <experimentdesign>
   disease state
  </experimentdesign>
  <description>
   <id>
   </id>
   <text>
    To identify mechanisms of genetic regulation within the decidual tissue of a retrospectively ascertained cohort of preeclamptic and non-preeclamptic Norwegian women.
   </text>
  </description>
  <protocol>
   <id>
    92843
   </id>
   <accession>
    P-TABM-3659
   </accession>
  </protocol>
  <protocol>
   <id>
    92840
   </id>
   <accession>
    P-TABM-3661
   </accession>
  </protocol>
  <protocol>
   <id>
    92841
   </id>
   <accession>
    P-TABM-3660
   </accession>
  </protocol>
  <protocol>
   <id>
    92844
   </id>
   <accession>
    P-TABM-3658
   </accession>
  </protocol>
  <protocol>
   <id>
    92842
   </id>
   <accession>
    P-TABM-3657
   </accession>
  </protocol>
  <protocol>
   <id>
    92839
   </id>
   <accession>
    P-TABM-3662
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-TABM-682.raw.1.zip">
   </raw>
   <fgem available="true" name="E-TABM-682.processed.1.zip">
   </fgem>
   <idf name="E-TABM-682.idf.txt">
   </idf>
   <sdrf name="E-TABM-682.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    condition
   </category>
   <value>
    24.1wk preeclamptic
   </value>
   <value>
    24.7wk preterm
   </value>
   <value>
    25.4wk preterm
   </value>
   <value>
    25.6wk preterm
   </value>
   <value>
    27.1wk preterm
   </value>
   <value>
    29.9wk preterm
   </value>
   <value>
    30.4wk preeclamptic
   </value>
   <value>
    30.6wk preeclamptic
   </value>
   <value>
    31.1wk preeclamptic
   </value>
   <value>
    31.7wk preeclamptic
   </value>
   <value>
    31.9wk preeclamptic
   </value>
   <value>
    32.0wk preeclamptic
   </value>
   <value>
    32.9wk preeclamptic
   </value>
   <value>
    33.0wk preeclamptic
   </value>
   <value>
    33.0wk preterm
   </value>
   <value>
    33.3wk preterm
   </value>
   <value>
    33.9wk preterm
   </value>
   <value>
    34.0wk preeclamptic
   </value>
   <value>
    35.7wk preterm
   </value>
   <value>
    35.9wk preeclamptic
   </value>
   <value>
    35.9wk preterm
   </value>
   <value>
    36.6wk preterm
   </value>
   <value>
    37.6wk preeclamptic
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    Organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    CONDITION
   </name>
   <value>
    24.1wk preeclamptic
   </value>
   <value>
    24.7wk preterm
   </value>
   <value>
    25.4wk preterm
   </value>
   <value>
    25.6wk preterm
   </value>
   <value>
    27.1wk preterm
   </value>
   <value>
    29.9wk preterm
   </value>
   <value>
    30.4wk preeclamptic
   </value>
   <value>
    30.6wk preeclamptic
   </value>
   <value>
    31.1wk preeclamptic
   </value>
   <value>
    31.7wk preeclamptic
   </value>
   <value>
    31.9wk preeclamptic
   </value>
   <value>
    32.0wk preeclamptic
   </value>
   <value>
    32.9wk preeclamptic
   </value>
   <value>
    33.0wk preeclamptic
   </value>
   <value>
    33.0wk preterm
   </value>
   <value>
    33.3wk preterm
   </value>
   <value>
    33.9wk preterm
   </value>
   <value>
    34.0wk preeclamptic
   </value>
   <value>
    35.7wk preterm
   </value>
   <value>
    35.9wk preeclamptic
   </value>
   <value>
    35.9wk preterm
   </value>
   <value>
    36.6wk preterm
   </value>
   <value>
    37.6wk preeclamptic
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    4
   </overallscore>
  </miamescores>
  <id>
   60575
  </id>
  <accession>
   E-GEOD-14722
  </accession>
  <secondaryaccession>
   GSE14722
  </secondaryaccession>
  <name>
   Severe Preeclampsia-Related Changes in Gene Expression at the Maternal-Fetal Interface Include Siglec-6 and Pappalysin-2
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2009-02-06
  </releasedate>
  <lastupdatedate>
   2012-03-27
  </lastupdatedate>
  <samples>
   46
  </samples>
  <assays>
   46
  </assays>
  <arraydesign>
   <id>
    11043
   </id>
   <accession>
    A-AFFY-33
   </accession>
   <name>
    Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]
   </name>
   <count>
    23
   </count>
   <legacy_id>
    302382080
   </legacy_id>
  </arraydesign>
  <arraydesign>
   <id>
    10982
   </id>
   <accession>
    A-AFFY-34
   </accession>
   <name>
    Affymetrix GeneChip Human Genome HG-U133B [HG-U133B]
   </name>
   <count>
    23
   </count>
   <legacy_id>
    212395355
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    46
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    46
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    46
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    46
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    46
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    46
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bibliography>
   <accession>
    18818296
   </accession>
   <authors>
    Winn VD, Gormley M, Paquet AC, Kjaer-Sorensen K, Kramer A, Rumer KK, Haimov-Kochman R, Yeh RF, Overgaard MT, Varki A, Oxvig C, Fisher SJ
   </authors>
   <title>
    Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2.
   </title>
   <doi>
    10.1210/en.2008-0990
   </doi>
  </bibliography>
  <provider>
   <contact>
    Matthew Gormley
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Susan J Fisher
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Virginia D Winn
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Susan Fisher
   </contact>
   <role>
    submitter
   </role>
   <email>
    geo@ncbi.nlm.nih.gov
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    Preeclampsia (PE), which affects 4-8% of human pregnancies, causes significant maternal and neonatal morbidity and mortality. Within the basal plate, placental cytotrophoblasts (CTBs) of fetal origin invade the uterus and extensively remodel the maternal vasculature. In PE, CTB invasion is often shallow, and vascular remodeling is rudimentary. To better understand possible causes, we conducted a global analysis of gene expression at the maternal-fetal interface in placental samples from women with PE (n = 12; 24-36 wk) vs. samples from women who delivered due to preterm labor with no evidence of infection (n = 11; 24-36 wk), a condition that our previous work showed is associated with normal CTB invasion. Using the HG-U133A&amp;B Affymetrix GeneChip platform, and statistical significance set at log odds-ratio of B &gt;0, 55 genes were differentially expressed in PE. They encoded proteins previously associated with PE [e.g. Flt-1 (vascular endothelial growth factor receptor-1), leptin, CRH, and inhibin] and novel molecules [e.g. sialic acid binding Ig-like lectin 6 (Siglec-6), a potential leptin receptor, and pappalysin-2 (PAPP-A2), a protease that cleaves IGF-binding proteins]. We used quantitative PCR to validate the expression patterns of a subset of the genes. At the protein level, we confirmed PE-related changes in the expression of Siglec-6 and PAPP-A2, which localized to invasive CTBs and syncytiotrophoblasts. Notably, Siglec-6 placental expression is uniquely human, as is spontaneous PE. The functional significance of these novel observations may provide new insights into the pathogenesis of PE, and assaying the circulating levels of these proteins could have clinical utility for predicting and/or diagnosing PE.  Keywords: disease state analysis Basal plate biopsies of preterm labor (24-36 weeks; n=11) and preterm severe preeclampsia (24-36 weeeks; n=12) were isolated and the global gene expression profiles determined using Affymetrix Human GeneChips.  Comparisons between the preeclampsia samples and the preterm labor controls revealed genes differentially expressed in preeclampsia.
   </text>
  </description>
  <protocol>
   <id>
    177163
   </id>
   <accession>
    P-GSE14722-1
   </accession>
  </protocol>
  <protocol>
   <id>
    177165
   </id>
   <accession>
    P-GSE14722-5
   </accession>
  </protocol>
  <protocol>
   <id>
    177169
   </id>
   <accession>
    P-GSE14722-4
   </accession>
  </protocol>
  <protocol>
   <id>
    177166
   </id>
   <accession>
    P-GSE14722-7
   </accession>
  </protocol>
  <protocol>
   <id>
    177168
   </id>
   <accession>
    P-GSE14722-3
   </accession>
  </protocol>
  <protocol>
   <id>
    177167
   </id>
   <accession>
    P-GSE14722-2
   </accession>
  </protocol>
  <protocol>
   <id>
    177164
   </id>
   <accession>
    P-GSE14722-6
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-GEOD-14722.raw.1.zip">
   </raw>
   <fgem available="true" name="E-GEOD-14722.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-14722.idf.txt">
   </idf>
   <sdrf name="E-GEOD-14722.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    clinical information
   </category>
   <value>
    first trimester of pregnancy
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    disease
   </category>
   <value>
    normal
   </value>
   <value>
    preeclampsia
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    ethnicity
   </category>
   <value>
    Caucasian
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    karyotype
   </category>
   <value>
    wild type
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    organism part
   </category>
   <value>
    placenta
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    disease
   </name>
   <value>
    normal
   </value>
   <value>
    preeclampsia
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    4
   </overallscore>
  </miamescores>
  <id>
   330258
  </id>
  <accession>
   E-GEOD-12767
  </accession>
  <secondaryaccession>
   GSE12767
  </secondaryaccession>
  <name>
   Transcription profiling by array of human placenta from patients with preeclampsia
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2008-11-29
  </releasedate>
  <lastupdatedate>
   2013-08-15
  </lastupdatedate>
  <samples>
   12
  </samples>
  <assays>
   12
  </assays>
  <arraydesign>
   <id>
    11119
   </id>
   <accession>
    A-AFFY-44
   </accession>
   <name>
    Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]
   </name>
   <count>
    12
   </count>
   <legacy_id>
    405156763
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    12
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    12
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    scan
   </name>
   <bioassaydatacubes>
    12
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    scan
   </dataformat>
   <bioassays>
    12
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedDataMatrix
   </name>
   <bioassaydatacubes>
    1
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedDataMatrix
   </dataformat>
   <bioassays>
    1
   </bioassays>
   <isderived>
    1
   </isderived>
  </bioassaydatagroup>
  <bibliography>
   <accession>
    19027158
   </accession>
   <authors>
    Founds SA, Conley YP, Lyons-Weiler JF, Jeyabalan A, Hogge WA, Conrad KP.
   </authors>
   <title>
    Altered Global Gene Expression in First Trimester Placentas of Women Destined to Develop Preeclampsia.
   </title>
   <doi>
    10.1016/j.placenta.2008.09.015
   </doi>
   <status>
    published
   </status>
  </bibliography>
  <provider>
   <contact>
    Sandra Anne Founds
   </contact>
   <role>
    submitter
   </role>
   <email>
    foundss@pitt.edu
   </email>
  </provider>
  <experimentdesign>
   disease state design
  </experimentdesign>
  <description>
   <id>
   </id>
   <text>
    4 chorionic villus sampling specimens in pregnancies destined for preeclampsia and 8 matched controls were analyzed; 36 genes were differentially expressed using J5 score and prediction modeling in caGEDA computer program Experiment Overall Design: case-control comparisons
   </text>
  </description>
  <protocol>
   <id>
    824776
   </id>
   <accession>
    P-G12767-2
   </accession>
  </protocol>
  <protocol>
   <id>
    824775
   </id>
   <accession>
    P-G12767-1
   </accession>
  </protocol>
  <protocol>
   <id>
    51
   </id>
   <accession>
    P-AFFY-6
   </accession>
  </protocol>
  <protocol>
   <id>
    824774
   </id>
   <accession>
    P-G12767-4
   </accession>
  </protocol>
  <protocol>
   <id>
    824773
   </id>
   <accession>
    P-G12767-3
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-GEOD-12767.raw.1.zip">
   </raw>
   <fgem available="true" name="E-GEOD-12767.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-12767.idf.txt">
   </idf>
   <sdrf name="E-GEOD-12767.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    Organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    0
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    3
   </overallscore>
  </miamescores>
  <id>
   3951
  </id>
  <accession>
   E-GEOD-13475
  </accession>
  <secondaryaccession>
   GSE13475
  </secondaryaccession>
  <name>
   Transcription profiling of human choriocarcinoma cells overexpressing STOX1 mimicks transcriptional alterations observed in preeclamptic placentas
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2008-11-14
  </releasedate>
  <submissiondate>
   2008-11-05
  </submissiondate>
  <lastupdatedate>
   2011-06-10
  </lastupdatedate>
  <samples>
   2
  </samples>
  <assays>
   2
  </assays>
  <arraydesign>
   <id>
    11119
   </id>
   <accession>
    A-AFFY-44
   </accession>
   <name>
    Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]
   </name>
   <count>
    2
   </count>
   <legacy_id>
    405156763
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    2
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    2
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    2
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    2
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    2
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    2
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    scan
   </name>
   <bioassaydatacubes>
    2
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    scan
   </dataformat>
   <bioassays>
    2
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Daniel Vaiman
   </contact>
   <role>
    submitter
   </role>
   <email>
    vaiman@cochin.inserm.fr
   </email>
  </provider>
  <experimentdesign>
   unknown experiment type
  </experimentdesign>
  <description>
   <id>
   </id>
   <text>
    Background; Mutations in STOX1 were proposed as causal for predisposing to preeclampsia, a hypertensive disorder originating from placental defects, affecting up to 10% of human pregnancies. However, after the first study published in 2005 three other groups have dismissed the polymorphism described in the first paper as a causal mutation. Methodology and Principal Findings; In the present study, we have developed a choriocarcinoma cell line overexpressing STOX1. This overexpression results in the transcriptional modification of 12.5% of the genes, some of them being direct targets as shown by chromatin immunoprecipitation. STOX1 overexpression correlates strongly and specifically with transcriptomic alterations in preeclamptic placentas (r=0.30, p=9.10-7). Numerous known key modulators of preeclampsia (such as Endoglin, Syncytin, human chrionic gonadotrophin-hCG-, and Glial Cell Missing Homolog -GCM1-) were modified in these transformed choriocarcinoma cells. Conclusions; Our results contribute to reconcile contradictory data about the involvement of STOX1 in preeclampsia. In addition, they strongly suggest that anomalies in STOX1 expression are associated with the onset of preeclampsia, thus indicating that this gene should be the target of future studies. Furthermore, our cellular model could constitute an invaluable resource for studying specific aspects of this human disease. Experiment Overall Design: Microarrays expression
   </text>
  </description>
  <protocol>
   <id>
    16808
   </id>
   <accession>
    P-G13475-5
   </accession>
  </protocol>
  <protocol>
   <id>
    16806
   </id>
   <accession>
    P-G13475-4
   </accession>
  </protocol>
  <protocol>
   <id>
    16809
   </id>
   <accession>
    P-G13475-3
   </accession>
  </protocol>
  <protocol>
   <id>
    16810
   </id>
   <accession>
    P-G13475-2
   </accession>
  </protocol>
  <protocol>
   <id>
    16807
   </id>
   <accession>
    P-G13475-1
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-GEOD-13475.raw.1.zip">
   </raw>
   <fgem available="true" name="E-GEOD-13475.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-13475.idf.txt">
   </idf>
   <sdrf name="E-GEOD-13475.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    Organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    0
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    3
   </overallscore>
  </miamescores>
  <id>
   3247
  </id>
  <accession>
   E-GEOD-12216
  </accession>
  <secondaryaccession>
   GSE12216
  </secondaryaccession>
  <name>
   Gene expression profiling indicates inflammatory pathways involved in IUGR due to placental insufficiency
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2008-08-01
  </releasedate>
  <submissiondate>
   2008-07-22
  </submissiondate>
  <lastupdatedate>
   2012-03-27
  </lastupdatedate>
  <samples>
   16
  </samples>
  <assays>
   16
  </assays>
  <arraydesign>
   <id>
    12224
   </id>
   <accession>
    A-MEXP-503
   </accession>
   <name>
    Applied Biosystems Human Genome Survey Microarray v2.0
   </name>
   <count>
    16
   </count>
   <legacy_id>
    1198472815
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    16
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    16
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    normalization
   </name>
   <bioassaydatacubes>
    16
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    normalization
   </dataformat>
   <bioassays>
    16
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedData
   </name>
   <bioassaydatacubes>
    16
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedData
   </dataformat>
   <bioassays>
    16
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bibliography>
   <accession>
    19372591
   </accession>
   <authors>
    Sitras V, Paulssen R, Leirvik J, Vårtun A, Acharya G
   </authors>
   <title>
    Placental gene expression profile in intrauterine growth restriction due to placental insufficiency.
   </title>
  </bibliography>
  <provider>
   <contact>
    Ruth H Paulssen
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Jørn Leirvik
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Vasilis Sitras
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    Ruth Hracky Paulssen
   </contact>
   <role>
    submitter
   </role>
   <email>
    ruthp@fagmed.uit.no
   </email>
  </provider>
  <provider>
   <contact>
    Ganesh Acharya
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <provider>
   <contact>
    A Vårtun
   </contact>
   <role>
   </role>
   <email>
   </email>
  </provider>
  <description>
   <id>
   </id>
   <text>
    Intrauterine growth restriction (IUGR) represents a major obstetric challenge with perinatal  complications and a risk factor of developing disease in adult life. Placental insufficiency is   one of the common features accompanying IUGR. The aim of this study was to evaluate   global placental gene expression profile in IUGR compared to normal pregnancies. Placental   samples were collected by eight IUGR pregnancies with placental insufficiency ascertained   by Doppler and eight healthy controls. A 30K Human Genome Survey Microarray v.2.0   (Applied Biosystems) was used to evaluate global gene expression profile.  Principal   component analysis showed good separation in terms of gene expression patterns between the   groups. Pathway analysis with Bonferroni correction for multiple testing showed significant   (p&lt;0.05) up-regulation of inflammation mediated by chemokine and cytokine signalling   pathway in the IUGR placentas. Genes involved in metabolism of glucocorticoids (HSD11B1   and DHRS2) were found differentially expressed. We found no imprinted genes to be   differentially expressed and only one gene involved in epigenetic modifications (MBD3) to be   down-regulated in the IUGR placentas, indicating that IUGR due to placental insufficiency is   not associated to placental imprinting. Subgroup analysis between pure IUGR and IUGR with   preeclampsia placentas showed only 27 differentially expressed genes suggesting common   pathophysiology. Eight placental samples from normal human placenta compared to eight human placental samples from patients with intrauterine growth restrictions due to placental insufficiency
   </text>
  </description>
  <protocol>
   <id>
    10723
   </id>
   <accession>
    P-GSE12216-6
   </accession>
  </protocol>
  <protocol>
   <id>
    10722
   </id>
   <accession>
    P-GSE12216-7
   </accession>
  </protocol>
  <protocol>
   <id>
    10725
   </id>
   <accession>
    P-GSE12216-2
   </accession>
  </protocol>
  <protocol>
   <id>
    10724
   </id>
   <accession>
    P-GSE12216-3
   </accession>
  </protocol>
  <protocol>
   <id>
    10727
   </id>
   <accession>
    P-GSE12216-4
   </accession>
  </protocol>
  <protocol>
   <id>
    10726
   </id>
   <accession>
    P-GSE12216-5
   </accession>
  </protocol>
  <protocol>
   <id>
    10721
   </id>
   <accession>
    P-GSE12216-1
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-GEOD-12216.raw.1.zip">
   </raw>
   <fgem available="true" name="E-GEOD-12216.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-12216.idf.txt">
   </idf>
   <sdrf name="E-GEOD-12216.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    Organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    0
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    3
   </overallscore>
  </miamescores>
  <id>
   27266
  </id>
  <accession>
   E-GEOD-9984
  </accession>
  <secondaryaccession>
   GSE9984
  </secondaryaccession>
  <name>
   Transcription profiling of human placentae of different gestational ages: an opru network and uw scor study
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2008-06-17
  </releasedate>
  <submissiondate>
   2007-12-19
  </submissiondate>
  <lastupdatedate>
   2011-06-10
  </lastupdatedate>
  <samples>
   12
  </samples>
  <assays>
   12
  </assays>
  <arraydesign>
   <id>
    11119
   </id>
   <accession>
    A-AFFY-44
   </accession>
   <name>
    Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]
   </name>
   <count>
    12
   </count>
   <legacy_id>
    405156763
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    12
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    12
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    scan
   </name>
   <bioassaydatacubes>
    12
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    scan
   </dataformat>
   <bioassays>
    12
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedDataMatrix
   </name>
   <bioassaydatacubes>
    1
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedDataMatrix
   </dataformat>
   <bioassays>
    1
   </bioassays>
   <isderived>
    1
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Richard Beyer
   </contact>
   <role>
    submitter
   </role>
   <email>
    dbeyer@u.washington.edu
   </email>
  </provider>
  <experimentdesign>
   unknown experiment type
  </experimentdesign>
  <description>
   <id>
   </id>
   <text>
    We used a whole genome approach to identify major functional gene categories (including xenobiotic transporters and metabolizing enzymes) whose expression depends on gestational age. STUDY DESIGN: We compared gene expression profiles of 1st (45-59 days) and 2nd trimester (109-115 days), and C-section term placentae. RESULTS: In 1st trimester placentae, genes related to cell cycle, DNA, aminoacids and carbohydrate metabolism were significantly overrepresented, while genes related to signal transduction were downregulated. In the organism defense category, we identified genes involved in chemical response, metabolism, and transport.  Analysis of signal transduction pathways suggested, and subsequently confirmed independently, that the Wnt pathway was regulated by gestational age.  CONCLUSIONS: Our study will serve as a reference database to gain insight into the regulation of gene expression in the developing placentae and, thus, allow comparisons with placentae from complicated pregnancies such as those in women experiencing gestational diabetes, pre-eclampsia and teratogenic sequelae. Experiment Overall Design: Comparison of plaental gene expression profiles of three gestational stages (1st trimester (45-59 days), 2nd trimester (109-115 days), and C-section term placentae), with four replicates each,
   </text>
  </description>
  <protocol>
   <id>
    62
   </id>
   <accession>
    Affymetrix:Protocol:Hybridization-Unknown
   </accession>
  </protocol>
  <protocol>
   <id>
    78209
   </id>
   <accession>
    P-G9984-1
   </accession>
  </protocol>
  <protocol>
   <id>
    78208
   </id>
   <accession>
    P-G9984-2
   </accession>
  </protocol>
  <protocol>
   <id>
    51
   </id>
   <accession>
    P-AFFY-6
   </accession>
  </protocol>
  <protocol>
   <id>
    78210
   </id>
   <accession>
    P-G9984-3
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-GEOD-9984.raw.1.zip">
   </raw>
   <fgem available="true" name="E-GEOD-9984.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-9984.idf.txt">
   </idf>
   <sdrf name="E-GEOD-9984.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    Disease State
   </category>
   <value>
    normal
   </value>
   <value>
    preeclampsia
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    Organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    Organism Part
   </category>
   <value>
    abdominal fat
   </value>
   <value>
    decidua
   </value>
   <value>
    placenta
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    disease state
   </name>
   <value>
    normal
   </value>
   <value>
    preeclampsia
   </value>
  </experimentalfactor>
  <experimentalfactor>
   <name>
    organism part
   </name>
   <value>
    abdominal fat
   </value>
   <value>
    decidua
   </value>
   <value>
    placenta
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    4
   </overallscore>
  </miamescores>
  <id>
   87337
  </id>
  <accession>
   E-GEOD-6573
  </accession>
  <secondaryaccession>
   GSE6573
  </secondaryaccession>
  <name>
   Transcription profiling of human adipose tissue, decidua and placenta from patients with preeclampsia vs. unaffected indviduals reveals dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2008-06-14
  </releasedate>
  <lastupdatedate>
   2012-03-27
  </lastupdatedate>
  <samples>
   6
  </samples>
  <assays>
   6
  </assays>
  <arraydesign>
   <id>
    11119
   </id>
   <accession>
    A-AFFY-44
   </accession>
   <name>
    Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]
   </name>
   <count>
    6
   </count>
   <legacy_id>
    405156763
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    6
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    6
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    scan
   </name>
   <bioassaydatacubes>
    6
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    scan
   </dataformat>
   <bioassays>
    6
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedDataMatrix
   </name>
   <bioassaydatacubes>
    1
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedDataMatrix
   </dataformat>
   <bioassays>
    1
   </bioassays>
   <isderived>
    1
   </isderived>
  </bioassaydatagroup>
  <bibliography>
   <accession>
    17261642
   </accession>
   <authors>
    Florian Herse, Ralf Dechend, Nina K Harsem, Gerd Wallukat, Jürgen Janke, Fatimunnisa Qadri, Lydia Hering, Dominik N Muller, Friedrich C Luft, Anne C Staff
   </authors>
   <title>
    Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia.
   </title>
  </bibliography>
  <provider>
   <contact>
    Florian Herse
   </contact>
   <role>
    submitter
   </role>
   <email>
    florian.herse@charite.de
   </email>
  </provider>
  <experimentdesign>
   unknown experiment type
  </experimentdesign>
  <description>
   <id>
   </id>
   <text>
    Preeclampsia complicates more than 3% of all pregnancies in the United States and Europe. High-risk populations include women with diabetes, dyslipidemia, thrombotic disorders, hyperhomocysteinemia, hypertension, renal diseases, previous preeclampsia, twin pregnancies, and low socioeconomic status. In the latter case, the incidence may increase to 20% to 25%. Preeclampsia is a major cause of maternal and fetal morbidity and mortality. Preeclampsia is defined by systolic blood pressure of more than 140 mm Hg and diastolic blood pressure of more than 90 mm Hg after 20 weeks gestation in a previously normotensive patient, and new-onset proteinuria. Abnormal placentation associated with shallow trophoblast invasion (fetal cells from outer cell layer of the blastocyst) into endometrium (decidua) and improper spiral artery remodeling in the decidua are initial pathological steps.  In this study we analyzed the renin-angiotensin system in adipose tissue, decidua and placenta from women with uneventful pregnancy and women with preeclampsia. We also analyzed the tissue by Affymetrix chips in a comparison study (control vs. preeclampsia) Experiment Overall Design: 6 affymetrix human expression chips (GPL570) were analyzed. Experiment Overall Design: They represent 3 tissues (pooled from 10 individuals each) from patients with preeclampsia and from patients with uneventful pregnancy (collected by cesaraen section). Tissues from patients with uneventful pregnancy are the controls in comparison to tissues of patients with preeclampsia.
   </text>
  </description>
  <protocol>
   <id>
    62
   </id>
   <accession>
    Affymetrix:Protocol:Hybridization-Unknown
   </accession>
  </protocol>
  <protocol>
   <id>
    241714
   </id>
   <accession>
    P-G6573-4
   </accession>
  </protocol>
  <protocol>
   <id>
    241715
   </id>
   <accession>
    P-G6573-3
   </accession>
  </protocol>
  <protocol>
   <id>
    51
   </id>
   <accession>
    P-AFFY-6
   </accession>
  </protocol>
  <protocol>
   <id>
    241716
   </id>
   <accession>
    P-G6573-2
   </accession>
  </protocol>
  <protocol>
   <id>
    241713
   </id>
   <accession>
    P-G6573-1
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-GEOD-6573.raw.1.zip">
   </raw>
   <fgem available="true" name="E-GEOD-6573.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-6573.idf.txt">
   </idf>
   <sdrf name="E-GEOD-6573.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="false">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    Organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    0
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    0
   </measuredbioassaydatascore>
   <overallscore>
    2
   </overallscore>
  </miamescores>
  <id>
   21314
  </id>
  <accession>
   E-GEOD-4100
  </accession>
  <secondaryaccession>
   GSE4100
  </secondaryaccession>
  <name>
   Transcription profiling of human trophoblast cell cultures
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2008-06-12
  </releasedate>
  <submissiondate>
   2006-01-25
  </submissiondate>
  <lastupdatedate>
   2011-06-10
  </lastupdatedate>
  <samples>
   2
  </samples>
  <assays>
   2
  </assays>
  <arraydesign>
   <id>
    11119
   </id>
   <accession>
    A-AFFY-44
   </accession>
   <name>
    Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]
   </name>
   <count>
    2
   </count>
   <legacy_id>
    405156763
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    scan
   </name>
   <bioassaydatacubes>
    2
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    scan
   </dataformat>
   <bioassays>
    2
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedDataMatrix
   </name>
   <bioassaydatacubes>
    1
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedDataMatrix
   </dataformat>
   <bioassays>
    1
   </bioassays>
   <isderived>
    1
   </isderived>
  </bioassaydatagroup>
  <provider>
   <contact>
    Jesus Gonzalez Bosquet
   </contact>
   <role>
    submitter
   </role>
   <email>
    gonzalezbosquet.jesus@mayo.edu
   </email>
  </provider>
  <experimentdesign>
   unknown experiment type
  </experimentdesign>
  <description>
   <id>
   </id>
   <text>
    The syncytiotrophoblast develops as a result of the fusion of placental villous cytotrophoblast cells. These multinuclear cells are essential for fetal-maternal exchange and production of pregnancy-related hormones. Placental deficiency is considered a major risk factor associated with intrauterine growth restriction and preeclampsia. Better understanding of placental patho-physiology requires knowledge on gene expression regulation involved in trophoblast differentiation. Using the well-established in vitro trophoblast differentiation model, we have performed a microarray analysis on mRNA expression in trophoblast and syncytiotrophoblast cell cultures. Dramatic changes in gene expression patterns were detected during trophoblast differentiation. As many as 3524 novel and known genes are found to be up- or down regulated for more than 2-fold. Real-time PCR analysis of a group of genes confirmed the reliability of the microarray data. Overall, this study provided a global view on the molecular events underlying trophoblast differentiation. Subsequent characterization on regulation and function of the identified genes may lead to discovery of new pathways important for placental differentiation and function. Experiment Overall Design: Affymetrix GeneChipTM Human Genome U133 Plus 2.0 microarrays were used for mRNA profiling. RNA samples were subject to Agilent analysis for quality controls. cDNA was prepared from 10 µg of RNA, quantified by spectrometry, and used as a template for the synthesis of biotinylated cRNA using RNA transcript labeling reagent. The quality of the cRNA probe was verified by gel electrophoresis as well as a pilot hybridization using the Test-3 arrays. Hybridization solution containing fragmented cRNA probes and control cRNA was supplemented with herring sperm DNA and bovine serum albumin. The probe solution was heated at 99° C for 5 min followed by incubation at 45° C for 5 min before use. Hybridization was carried out at 45° C for 16 hr with constant rotation at 60 rpm. The arrays were washed and stained with streptavidin-phycoerythrin. The GeneChip 5.0 (Affymetrix) program was used to scan and quantitatively document the hybridization signals. Compilation of candidate gene and calculation of changes were performed on SpotFire and Microsoft Excel programs. To minimize the false-positive conclusion, only genes satisfying the following two criteria were considered candidate regulation targets for further analysis: 1) The gene’s hybridization signal reached an absolute level that was significantly higher than that of the background (P&lt;0.05); 2) The changes is more than 2-fold when compared to control group.
   </text>
  </description>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <fgem available="true" name="E-GEOD-4100.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-4100.idf.txt">
   </idf>
   <sdrf name="E-GEOD-4100.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="false">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    DiseaseState
   </category>
   <value>
    early onset preeclampsia
   </value>
   <value>
    late onset preeclampsia
   </value>
   <value>
    normal
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    Organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    OrganismPart
   </category>
   <value>
    placenta
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    DiseaseState
   </name>
   <value>
    early onset preeclampsia
   </value>
   <value>
    late onset preeclampsia
   </value>
   <value>
    normal
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    1
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    0
   </measuredbioassaydatascore>
   <overallscore>
    4
   </overallscore>
  </miamescores>
  <id>
   21650
  </id>
  <accession>
   E-GEOD-4707
  </accession>
  <secondaryaccession>
   GSE4707
  </secondaryaccession>
  <secondaryaccession>
   GDS2080
  </secondaryaccession>
  <name>
   Transcription profiling of placenta from women who underwent a normal pregnancy and from those suffering from early or late onset pre-eclampsia
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2008-05-07
  </releasedate>
  <submissiondate>
   2006-04-24
  </submissiondate>
  <lastupdatedate>
   2014-05-03
  </lastupdatedate>
  <samples>
   28
  </samples>
  <assays>
   14
  </assays>
  <arraydesign>
   <id>
    29705
   </id>
   <accession>
    A-AGIL-11
   </accession>
   <name>
    Agilent Whole Human Genome Oligo Microarray 012391 G4112A
   </name>
   <count>
    14
   </count>
   <legacy_id>
    376314681
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    scan
   </name>
   <bioassaydatacubes>
    14
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    scan
   </dataformat>
   <bioassays>
    14
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedDataMatrix
   </name>
   <bioassaydatacubes>
    1
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedDataMatrix
   </dataformat>
   <bioassays>
    1
   </bioassays>
   <isderived>
    1
   </isderived>
  </bioassaydatagroup>
  <bibliography>
   <accession>
    16860862
   </accession>
   <authors>
    H Nishizawa, K Pryor-Koishi, T Kato, H Kowa, H Kurahashi, Y Udagawa
   </authors>
   <title>
    Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia.
   </title>
   <issue>
    05/06/08
   </issue>
   <pages>
    487-97
   </pages>
   <publication>
    Placenta
   </publication>
   <volume>
    28
   </volume>
  </bibliography>
  <provider>
   <contact>
    Haruki Nishizawa
   </contact>
   <role>
    submitter
   </role>
   <email>
    nharuki@fujita-hu.ac.jp
   </email>
  </provider>
  <experimentdesign>
   co-expression
  </experimentdesign>
  <experimentdesign>
   disease state
  </experimentdesign>
  <description>
   <id>
   </id>
   <text>
    Pre-eclampsia is one of the most serious pregnancy-associated disorders, and is defined by hypertension (systolic blood pressure higher than 140mmHg or diastolic blood pressure higher than 90mmHg) with proteinuria (more than 0.3g/day). It is not a simple complication of pregnancy, but is rather a syndrome of multiple organ failure involving the liver, kidney, and lung, as well as coagulatory and neural systems. There is now an emerging consensus that pre-eclampsia is a complex polygenetic trait in which maternal and fetal genes, as well as environmental factors, are involved, although the precise mechanism of the disorder has remained elusive. In this study, we have performed gene expression profiling to further elucidate the mechanisms underlying the development of the pre-eclamptic condition. We thus compared the expression profiles in placentas from women who underwent a normal pregnancy and from women suffering from severe pre-eclampsia. In addition, we compared the expression data between the early and late onset forms of pre-eclampsia and obtained a number of potential new prognostic biomarkers for this disease. Experiment Overall Design: Placental biopsies were obtained during Caesarean section from both normotensive patients and from those with pre-eclampsia (n = 14) (early onset type; earlier than 31 weeks gestation, n = 6 and late onset type; 31 weeks gestation or later, n = 8). Pre-eclampsia was defined as a blood pressure of higher than 160/110 mmHg, with proteinuria of more than 2g in a 24 hour collection. The expression profiles of approximately 47,669 genes were analyzed using a Whole Human Genome Oligo Microarray Kit (Agilent Technologies). A total of 10 placentas from women with pre-eclampsia and four from normal subjects were used in the hybridizations. Reverse transcription labeling and hybridization was performed using the protocol recommended by the manufacturer. The microarray experiments were then carried out using competitive hybridization experiments with Cy3 and Cy5-labeled targets; one with test placental RNAs from patients or normal control subjects, and another using pooled normal placental RNA as a template control for normalization. The glass slides were scanned using an Agilent G2565BA microarray scanner. Scanned images were then analyzed using Feature Extraction software. The average signal intensities were corrected for median background intensity and transferred with GenBank descriptors to a Microsoft Excel data spreadsheet (Microsoft, Redmond, WA). Data analysis was performed using Genespring software version 6.1 (Silicon Genetics, Redwood City, CA). After intensity dependent normalization (Lowess), the expression levels relative to the control were calculated as a ratio, and the expression profiles were then compared between each pre-eclamptic or normal sample.
   </text>
  </description>
  <protocol>
   <id>
    59904
   </id>
   <accession>
    P-4707-1
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <fgem available="true" name="E-GEOD-4707.processed.1.zip">
   </fgem>
   <idf name="E-GEOD-4707.idf.txt">
   </idf>
   <sdrf name="E-GEOD-4707.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
 <experiment>
  <species>
   Homo sapiens
  </species>
  <rawdatafiles available="true">
  </rawdatafiles>
  <processeddatafiles available="true">
  </processeddatafiles>
  <sampleattribute>
   <category>
    BioSourceType
   </category>
   <value>
    frozen_sample
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    DevelopmentalStage
   </category>
   <value>
    adult
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    DiseaseState
   </category>
   <value>
    fetal growth restriction
   </value>
   <value>
    normal
   </value>
   <value>
    preeclampsia
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    Organism
   </category>
   <value>
    Homo sapiens
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    OrganismPart
   </category>
   <value>
    decidua
   </value>
  </sampleattribute>
  <sampleattribute>
   <category>
    Sex
   </category>
   <value>
    female
   </value>
  </sampleattribute>
  <experimentalfactor>
   <name>
    disease state
   </name>
   <value>
    fetal growth restriction
   </value>
   <value>
    normal
   </value>
   <value>
    preeclampsia
   </value>
   <value>
    preeclampsia;fetal growth restriction
   </value>
  </experimentalfactor>
  <miamescores>
   <reportersequencescore>
    1
   </reportersequencescore>
   <protocolscore>
    0
   </protocolscore>
   <factorvaluescore>
    1
   </factorvaluescore>
   <derivedbioassaydatascore>
    1
   </derivedbioassaydatascore>
   <measuredbioassaydatascore>
    1
   </measuredbioassaydatascore>
   <overallscore>
    4
   </overallscore>
  </miamescores>
  <id>
   27481
  </id>
  <accession>
   E-MEXP-1050
  </accession>
  <name>
   Transcription profiling of decidua basalis from women with normal pregnancies or preeclampsia and/or fetal growth restriction
  </name>
  <experimenttype>
   transcription profiling by array
  </experimenttype>
  <releasedate>
   2007-08-31
  </releasedate>
  <submissiondate>
   2007-04-11
  </submissiondate>
  <lastupdatedate>
   2014-05-02
  </lastupdatedate>
  <samples>
   35
  </samples>
  <assays>
   35
  </assays>
  <arraydesign>
   <id>
    10917
   </id>
   <accession>
    A-AFFY-41
   </accession>
   <name>
    Affymetrix GeneChip Human Genome Focus Array [HG-Focus]
   </name>
   <count>
    35
   </count>
   <legacy_id>
    327974795
   </legacy_id>
  </arraydesign>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    rawData
   </name>
   <bioassaydatacubes>
    35
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    rawData
   </dataformat>
   <bioassays>
    35
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    scan
   </name>
   <bioassaydatacubes>
    35
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    scan
   </dataformat>
   <bioassays>
    35
   </bioassays>
   <isderived>
    0
   </isderived>
  </bioassaydatagroup>
  <bioassaydatagroup>
   <id>
   </id>
   <name>
    processedDataMatrix
   </name>
   <bioassaydatacubes>
    1
   </bioassaydatacubes>
   <arraydesignprovider>
   </arraydesignprovider>
   <dataformat>
    processedDataMatrix
   </dataformat>
   <bioassays>
    1
   </bioassays>
   <isderived>
    1
   </isderived>
  </bioassaydatagroup>
  <bibliography>
   <accession>
    18307065
   </accession>
   <authors>
    Eide IP, Isaksen CV, Salvesen KA, Langaas M, Schønberg SA, Austgulen R
   </authors>
   <title>
    Decidual expression and maternal serum levels of heme oxygenase 1 are increased in pre-eclampsia
   </title>
   <issue>
    3
   </issue>
   <pages>
    272-9
   </pages>
   <publication>
    Acta Obstet Gynecol Scand
   </publication>
   <volume>
    87
   </volume>
   <year>
    2008
   </year>
  </bibliography>
  <provider>
   <contact>
    Irina P Eide
   </contact>
   <role>
    submitter
   </role>
   <email>
    irina.p.eide@ntnu.no
   </email>
  </provider>
  <experimentdesign>
   co-expression
  </experimentdesign>
  <experimentdesign>
   disease state
  </experimentdesign>
  <description>
   <id>
   </id>
   <text>
    The aim of the study was to compare gene expression profiles in decidua basalis from cases with complicated pregnancies to those from healthy pregnant controls. Cases included pregnant women with preeclampsia (PE) and/or fetal growth restriction (FGR). Decidual tissue was obtained by vacuum suction of the placental bed after the placenta was delivered. Women with PE and/or FGR were included as cases. PE was defined as persistent hypertension (blood pressure (BP) ¡Ý 140/90 mm Hg), plus proteinuria (¡Ý0.3g/24 h or ¡Ý2+ according to a dipstick test), developing after 20 weeks of pregnancy. FGR implied birth weight under 2 standard deviations (SD) below the expected birth weight, as related to gestational age (GA) and sex. Due to tissue sampling procedures, only cases delivered by cesarean section (CS) were included. Healthy women with normal pregnancies, undergoing CS for various reasons considered irrelevant to the aim of this study (e. g. breech presentation and previous CS), served as controls. Tissue was immediately submerged in a RNA stabilisation solution (RNAlater, Ambion, Huntingdon, U.K.), incubated at 4¡ãC overnight and stored at -80¡ãC
   </text>
  </description>
  <protocol>
   <id>
    62
   </id>
   <accession>
    Affymetrix:Protocol:Hybridization-Unknown
   </accession>
  </protocol>
  <protocol>
   <id>
    79461
   </id>
   <accession>
    P-MEXP-49839
   </accession>
  </protocol>
  <protocol>
   <id>
    79257
   </id>
   <accession>
    Affymetrix:Protocol:Hybridization-Midi_Euk2v3[]
   </accession>
  </protocol>
  <protocol>
   <id>
    79460
   </id>
   <accession>
    Affymetrix:Protocol:Hybridization-Mini_Euk2v3[]
   </accession>
  </protocol>
  <protocol>
   <id>
    79462
   </id>
   <accession>
    P-MEXP-49844
   </accession>
  </protocol>
  <protocol>
   <id>
    77
   </id>
   <accession>
    P-AFFY-2
   </accession>
  </protocol>
  <protocol>
   <id>
    79459
   </id>
   <accession>
    P-MEXP-49840
   </accession>
  </protocol>
  <protocol>
   <id>
    51
   </id>
   <accession>
    P-AFFY-6
   </accession>
  </protocol>
  <protocol>
   <id>
    79458
   </id>
   <accession>
    P-MEXP-51541
   </accession>
  </protocol>
  <organism>
   Homo sapiens
  </organism>
  <files>
   <!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                -->
   <raw celcount="0" count="true" name="E-MEXP-1050.raw.1.zip">
   </raw>
   <fgem available="true" name="E-MEXP-1050.processed.1.zip">
   </fgem>
   <idf name="E-MEXP-1050.idf.txt">
   </idf>
   <sdrf name="E-MEXP-1050.sdrf.txt">
   </sdrf>
  </files>
 </experiment>
</experiments>
